data_2k5c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k5c _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.661 ' H ' ' HZ2' ' A' ' 73' ' ' LYS . 41.4 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.342 0.127 . . . . 1.0 111.342 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -107.72 142.5 37.62 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.215 1.572 . . . . 1.0 110.855 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -123.26 138.34 54.65 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.785 1.303 . . . . 1.0 111.259 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.447 ' SG ' HD12 ' A' ' 13' ' ' ILE . 14.3 t -72.71 122.85 88.64 Favored Pre-proline 0 CA--C 1.582 2.173 0 C-N-CA 124.731 1.212 . . . . 1.0 112.675 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.54 -1.68 11.39 Favored 'Trans proline' 1 C--N 1.435 5.085 0 C-N-CA 122.106 1.871 . . . . 1.0 115.085 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.447 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -100.0 -55.97 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 124.614 1.165 . . . . 1.0 109.406 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -103.8 -41.93 5.76 Favored 'General case' 0 C--N 1.373 1.589 0 O-C-N 124.544 1.152 . . . . 1.0 112.985 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.82 35.73 7.1 Favored Glycine 0 C--N 1.369 2.371 0 O-C-N 124.751 1.282 . . . . 1.0 114.253 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -95.51 148.72 35.07 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 116.871 -1.538 . . . . 1.0 111.807 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -69.22 140.78 45.61 Favored 'Trans proline' 1 C--N 1.448 5.775 0 C-N-CA 122.844 2.363 . . . . 1.0 114.955 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.37 145.43 51.08 Favored 'General case' 0 C--O 1.249 1.052 0 O-C-N 125.524 1.765 . . . . 1.0 110.324 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -99.39 135.26 41.06 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.716 1.26 . . . . 1.0 110.888 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' O ' HG12 ' A' ' 24' ' ' ILE . 59.5 m95 -69.19 -24.87 64.1 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.049 1.339 . . . . 1.0 113.326 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -70.39 -30.42 67.31 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.022 1.729 . . . . 1.0 113.03 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.42 -35.07 63.4 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 125.16 1.384 . . . . 1.0 113.127 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -40.25 85.18 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.866 1.667 . . . . 1.0 113.602 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.8 mm -74.64 -41.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 C-N-CA 125.581 1.552 . . . . 1.0 110.531 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -67.29 -35.92 80.47 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.338 1.455 . . . . 1.0 113.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.4 -22.93 40.76 Favored 'General case' 0 C--N 1.375 1.685 0 C-N-CA 125.409 1.483 . . . . 1.0 113.452 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.457 ' SD ' ' HE1' ' A' ' 52' ' ' PHE . 55.2 mtp -102.65 1.61 34.85 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 124.563 1.164 . . . . 1.0 113.0 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.45 12.96 3.26 Favored 'General case' 0 CA--C 1.582 2.177 0 C-N-CA 124.805 1.242 . . . . 1.0 113.765 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -8.12 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 125.344 1.457 . . . . 1.0 113.283 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.453 HD12 ' O ' ' A' ' 27' ' ' MET . 1.1 mt -98.98 137.53 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 125.109 1.364 . . . . 1.0 108.553 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -74.6 -27.36 60.44 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 124.831 1.332 . . . . 1.0 113.879 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.79 -22.86 62.32 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 125.243 1.417 . . . . 1.0 112.926 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -34.1 65.73 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.527 1.931 . . . . 1.0 114.384 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.48 -28.33 69.89 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 125.268 1.427 . . . . 1.0 112.303 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.22 -34.62 20.41 Favored 'General case' 0 C--N 1.376 1.758 0 C-N-CA 125.421 1.488 . . . . 1.0 112.481 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.76 -39.63 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 C-N-CA 125.679 1.592 . . . . 1.0 110.423 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.44 ' O ' HD22 ' A' ' 78' ' ' LEU . 10.0 m -61.14 -20.07 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 125.188 1.395 . . . . 1.0 114.716 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -85.57 -19.95 30.31 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.091 1.356 . . . . 1.0 113.571 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.6 110.93 12.69 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 124.21 1.004 . . . . 1.0 111.666 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -60.35 -32.26 71.1 Favored 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 126.221 1.808 . . . . 1.0 115.451 177.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.43 -31.83 71.43 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.311 1.444 . . . . 1.0 113.337 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 72.3 mtp180 -82.42 -34.75 28.12 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.05 1.34 . . . . 1.0 112.869 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' O ' HG22 ' A' ' 47' ' ' VAL . 3.4 t80 -70.51 -44.32 67.84 Favored 'General case' 0 C--N 1.389 2.287 0 C-N-CA 125.08 1.352 . . . . 1.0 112.605 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.437 HD22 ' O ' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -70.21 -35.96 74.25 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.987 1.315 . . . . 1.0 113.144 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.15 -29.63 63.0 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.385 1.474 . . . . 1.0 113.204 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.1 tt0 -78.95 -34.4 44.41 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.368 1.467 . . . . 1.0 113.016 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 43' ' ' PHE . 89.7 t -69.89 -40.22 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.552 1.541 . . . . 1.0 109.762 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.12 -34.26 70.9 Favored 'General case' 0 N--CA 1.511 2.609 0 C-N-CA 125.575 1.55 . . . . 1.0 113.167 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.63 -27.36 29.19 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.318 1.447 . . . . 1.0 113.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -98.97 151.91 20.38 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.636 1.174 . . . . 1.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.05 148.0 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 O-C-N 124.664 1.227 . . . . 1.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.457 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 88.4 m-85 -121.71 152.04 39.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.671 1.232 . . . . 1.0 110.699 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -101.85 141.76 34.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.202 0.939 . . . . 1.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 24.1 t -96.05 119.39 64.69 Favored Pre-proline 0 CA--C 1.572 1.802 0 O-C-N 124.848 1.343 . . . . 1.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.07 -7.74 19.37 Favored 'Trans proline' 1 C--N 1.437 5.2 0 C-N-CA 122.25 1.967 . . . . 1.0 115.233 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 t -88.32 -51.94 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 C-N-CA 124.694 1.198 . . . . 1.0 110.299 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.38 -50.56 3.89 Favored 'General case' 0 C--N 1.367 1.343 0 O-C-N 124.691 1.245 . . . . 1.0 112.084 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 -14.57 12.1 Favored Glycine 0 C--N 1.371 2.523 0 O-C-N 124.473 1.108 . . . . 1.0 115.18 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -82.17 153.52 25.95 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 124.859 1.264 . . . . 1.0 112.565 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.45 138.41 31.5 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.163 1.385 . . . . 1.0 112.006 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -129.17 141.27 51.22 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 125.185 1.553 . . . . 1.0 109.814 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.3 151.53 19.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.318 1.011 . . . . 1.0 112.381 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.79 -8.02 86.33 Favored Glycine 0 C--N 1.378 2.884 0 O-C-N 124.437 1.085 . . . . 1.0 114.639 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -86.32 -19.6 29.57 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.466 1.506 . . . . 1.0 111.659 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.4 p -97.53 6.82 47.55 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.966 1.306 . . . . 1.0 112.055 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.76 159.07 55.75 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-O 117.344 -1.312 . . . . 1.0 111.393 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -69.68 154.51 67.98 Favored 'Trans proline' 1 C--N 1.441 5.432 0 C-N-CA 123.197 2.598 . . . . 1.0 114.227 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -68.26 -17.97 64.43 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 115.173 1.545 . . . . 1.0 115.173 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -83.67 -33.68 25.15 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.496 1.118 . . . . 1.0 112.221 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.5 mt-10 -69.86 -28.68 65.86 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.585 1.554 . . . . 1.0 113.49 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' O ' HD22 ' A' ' 44' ' ' LEU . . . -64.27 -31.91 73.3 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.727 1.611 . . . . 1.0 112.852 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.19 -27.88 62.84 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 125.693 1.597 . . . . 1.0 111.987 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HZ2' ' H ' ' A' ' 8' ' ' MET . 94.9 mttt -68.26 -28.77 67.5 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 125.962 1.705 . . . . 1.0 112.65 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.97 -40.06 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 C-N-CA 126.026 1.73 . . . . 1.0 109.331 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -28.0 65.57 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 125.772 1.629 . . . . 1.0 113.401 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -71.58 -42.63 67.54 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.188 1.795 . . . . 1.0 113.019 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.4 pp -67.28 -37.25 83.14 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.353 1.061 . . . . 1.0 112.513 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.441 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -71.2 -37.46 72.11 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.881 1.673 . . . . 1.0 113.079 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.68 -31.96 36.14 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.359 1.463 . . . . 1.0 114.129 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -98.64 57.81 1.18 Allowed 'General case' 0 C--O 1.26 1.646 0 CA-C-O 123.093 1.425 . . . . 1.0 110.712 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.45 145.61 24.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.005 -1.907 . . . . 1.0 111.48 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttm 77.46 112.02 0.07 Allowed 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 127.46 2.304 . . . . 1.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.22 -74.49 0.22 Allowed Glycine 0 C--N 1.36 1.874 0 O-C-N 125.037 1.46 . . . . 1.0 112.953 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.59 31.02 5.36 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 125.314 1.243 . . . . 1.0 115.348 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.39 120.12 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.05 130.17 51.75 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 125.177 1.548 . . . . 1.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.39 -32.59 32.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.887 1.275 . . . . 1.0 114.029 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.32 -35.73 40.68 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 124.964 1.305 . . . . 1.0 113.3 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -94.73 -15.34 23.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.652 1.22 . . . . 1.0 113.336 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 60.12 51.31 5.78 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 127.193 2.197 . . . . 1.0 113.903 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -113.34 128.83 56.59 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.899 -1.501 . . . . 1.0 110.435 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.46 130.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 124.99 1.431 . . . . 1.0 108.147 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -121.71 137.04 54.92 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 125.048 1.467 . . . . 1.0 111.364 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.83 130.93 53.48 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.126 1.517 . . . . 1.0 109.727 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 mttp . . . . . 0 C--O 1.253 1.238 0 O-C-N 125.213 1.57 . . . . 1.0 111.287 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 36.4 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.85 138.67 41.65 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 125.272 1.608 . . . . 1.0 110.884 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -106.81 138.64 42.61 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 124.901 1.375 . . . . 1.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.8 t -73.76 130.3 83.69 Favored Pre-proline 0 CA--C 1.582 2.207 0 CA-C-O 116.907 -1.52 . . . . 1.0 112.151 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.12 -11.75 27.37 Favored 'Trans proline' 1 C--N 1.441 5.404 0 C-N-CA 122.573 2.182 . . . . 1.0 114.406 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 57' ' ' CYS . 1.5 mp -93.73 -55.12 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.221 1.408 . . . . 1.0 110.482 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 29.1 p -103.35 -41.16 6.11 Favored 'General case' 0 C--N 1.372 1.569 0 O-C-N 124.302 1.001 . . . . 1.0 113.424 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.13 34.6 8.67 Favored Glycine 0 C--N 1.371 2.525 0 O-C-N 124.818 1.324 . . . . 1.0 113.324 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.527 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -92.74 144.63 28.91 Favored Pre-proline 0 C--N 1.369 1.447 0 CA-C-O 117.016 -1.468 . . . . 1.0 112.808 -178.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.59 135.36 38.66 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 122.46 2.107 . . . . 1.0 114.839 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mt -120.16 144.92 47.41 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 125.333 1.646 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.09 129.01 38.14 Favored 'General case' 0 C--N 1.362 1.111 0 O-C-N 124.876 1.36 . . . . 1.0 111.072 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.489 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.0 m95 -68.66 -25.58 64.89 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 125.136 1.374 . . . . 1.0 113.115 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 mt-10 -70.16 -32.27 70.15 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.936 1.695 . . . . 1.0 112.59 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -76.55 -34.1 58.51 Favored 'General case' 0 C--N 1.385 2.136 0 C-N-CA 125.225 1.41 . . . . 1.0 112.712 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -41.32 91.8 Favored 'General case' 0 C--N 1.383 2.051 0 C-N-CA 126.495 1.918 . . . . 1.0 112.764 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 20' ' ' TRP . 5.9 mm -78.97 -38.59 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 125.607 1.563 . . . . 1.0 110.445 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -65.49 -35.38 80.73 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 125.475 1.51 . . . . 1.0 113.491 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.46 -24.04 39.81 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.876 1.671 . . . . 1.0 112.451 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.487 ' O ' HD12 ' A' ' 30' ' ' ILE . 24.0 mtp -101.56 9.06 41.6 Favored 'General case' 0 CA--C 1.575 1.908 0 O-C-N 124.805 1.316 . . . . 1.0 112.943 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 13.4 13.77 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 124.163 0.985 . . . . 1.0 112.978 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.92 -6.36 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 125.606 1.562 . . . . 1.0 113.317 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -97.96 140.84 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 125.285 1.434 . . . . 1.0 109.048 -178.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.71 -19.1 42.22 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.852 1.345 . . . . 1.0 113.306 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.8 -19.94 50.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.183 1.393 . . . . 1.0 112.584 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.51 -35.77 70.69 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 126.327 1.851 . . . . 1.0 113.374 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.02 -28.0 69.28 Favored 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 125.337 1.455 . . . . 1.0 112.182 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -87.63 -33.88 18.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.843 1.657 . . . . 1.0 112.149 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -71.26 -40.25 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.991 0 C-N-CA 125.739 1.616 . . . . 1.0 110.634 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.504 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.1 m -58.75 -24.47 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 C-N-CA 125.687 1.595 . . . . 1.0 114.741 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -87.73 -15.24 37.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 1.0 113.022 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -125.36 106.34 9.76 Favored 'General case' 0 C--N 1.375 1.684 0 C-N-CA 124.473 1.109 . . . . 1.0 111.767 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' O ' HD11 ' A' ' 44' ' ' LEU . 11.6 mtm180 -59.11 -33.12 70.48 Favored 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 125.956 1.702 . . . . 1.0 113.863 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.14 -31.21 68.63 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.943 1.697 . . . . 1.0 112.839 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -82.0 -33.58 30.05 Favored 'General case' 0 C--N 1.38 1.917 0 C-N-CA 125.196 1.398 . . . . 1.0 112.552 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.19 -43.95 63.74 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 124.938 1.295 . . . . 1.0 112.815 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.494 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -70.33 -31.27 68.49 Favored 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 125.359 1.463 . . . . 1.0 113.049 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -26.68 33.58 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 125.305 1.442 . . . . 1.0 112.932 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.8 mm100 -79.25 -38.18 36.18 Favored 'General case' 0 C--N 1.384 2.093 0 C-N-CA 124.798 1.239 . . . . 1.0 112.615 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 68.3 t -68.16 -40.04 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 125.472 1.509 . . . . 1.0 109.68 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.48 -24.83 62.07 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 125.522 1.529 . . . . 1.0 113.142 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.29 -15.85 19.62 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.111 1.364 . . . . 1.0 113.153 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -93.19 151.29 19.92 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 124.62 1.168 . . . . 1.0 112.315 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.9 t -97.94 140.64 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 125.092 1.495 . . . . 1.0 107.791 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -128.44 146.31 50.84 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.602 1.814 . . . . 1.0 109.571 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -105.1 142.25 35.22 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 124.779 1.299 . . . . 1.0 111.259 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.69 131.38 37.95 Favored Pre-proline 0 CA--C 1.574 1.875 0 O-C-N 124.982 1.427 . . . . 1.0 111.352 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.68 -9.62 22.77 Favored 'Trans proline' 1 C--N 1.437 5.221 0 C-N-CA 122.439 2.092 . . . . 1.0 114.268 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.06 -53.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 125.274 1.43 . . . . 1.0 109.709 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 25.0 m -88.73 -53.98 4.37 Favored 'General case' 0 C--N 1.379 1.874 0 O-C-N 124.253 0.971 . . . . 1.0 112.1 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.32 6.63 61.23 Favored Glycine 0 C--N 1.37 2.45 0 O-C-N 124.885 1.366 . . . . 1.0 113.378 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.26 165.83 16.16 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 126.126 1.77 . . . . 1.0 112.332 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.2 134.28 35.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.06 1.344 . . . . 1.0 110.733 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.08 153.41 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.393 1.477 . . . . 1.0 109.983 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.49 154.04 21.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.577 1.173 . . . . 1.0 112.398 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.0 -1.19 72.39 Favored Glycine 0 C--N 1.378 2.881 0 O-C-N 124.446 1.091 . . . . 1.0 114.424 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -85.65 -17.41 36.19 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.169 1.387 . . . . 1.0 111.596 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.5 p -95.55 3.31 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.993 1.317 . . . . 1.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.44 152.71 73.35 Favored Pre-proline 0 CA--C 1.58 2.108 0 CA-C-O 116.86 -1.543 . . . . 1.0 111.703 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -64.1 149.87 89.51 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 123.252 2.634 . . . . 1.0 114.931 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -65.05 -17.83 64.79 Favored 'General case' 0 N--CA 1.51 2.533 0 C-N-CA 125.517 1.527 . . . . 1.0 114.835 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -82.53 -33.13 28.32 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.03 1.332 . . . . 1.0 111.533 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.18 -30.16 66.08 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.787 1.635 . . . . 1.0 113.042 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.494 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -66.87 -36.3 82.0 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 125.58 1.552 . . . . 1.0 112.388 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -71.8 -24.22 61.7 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 125.41 1.484 . . . . 1.0 112.356 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -74.76 -27.94 60.55 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 126.181 1.792 . . . . 1.0 112.439 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 t -67.11 -39.73 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 C-N-CA 126.195 1.798 . . . . 1.0 110.305 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -60.56 -29.46 69.18 Favored 'General case' 0 N--CA 1.511 2.605 0 C-N-CA 125.608 1.563 . . . . 1.0 113.651 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.18 -40.81 71.01 Favored 'General case' 0 C--N 1.384 2.087 0 C-N-CA 125.731 1.613 . . . . 1.0 113.212 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.7 pp -70.15 -34.96 73.68 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 124.903 1.281 . . . . 1.0 113.554 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -79.32 -24.18 42.98 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.105 1.362 . . . . 1.0 112.453 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -85.36 -14.61 45.87 Favored 'General case' 0 C--N 1.382 2.002 0 C-N-CA 124.862 1.265 . . . . 1.0 113.357 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.12 -36.96 84.53 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 125.667 1.587 . . . . 1.0 113.819 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 61.57 -58.72 0.11 Allowed 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 128.112 2.565 . . . . 1.0 114.174 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -128.59 136.46 50.74 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 125.115 1.366 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -174.07 -102.02 0.15 Allowed Glycine 0 C--N 1.356 1.679 0 O-C-N 125.151 1.532 . . . . 1.0 111.807 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.76 44.66 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 O-C-N 125.504 1.355 . . . . 1.0 113.395 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.3 123.6 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.812 -1.551 . . . . 1.0 106.812 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.75 128.74 45.88 Favored 'General case' 0 C--O 1.248 1.015 0 O-C-N 125.324 1.64 . . . . 1.0 110.252 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -80.81 -26.38 37.14 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.807 1.243 . . . . 1.0 114.071 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -80.94 -38.4 27.88 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 125.14 1.376 . . . . 1.0 113.178 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -97.32 -14.4 21.32 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 124.555 1.159 . . . . 1.0 113.678 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttm 60.35 55.81 3.41 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 127.342 2.257 . . . . 1.0 113.319 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 86.5 mtt180 -115.93 130.2 56.72 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.16 127.38 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 125.126 1.516 . . . . 1.0 107.996 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -119.66 136.81 54.24 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 125.374 1.671 . . . . 1.0 110.537 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.29 129.14 56.61 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 124.973 1.42 . . . . 1.0 111.583 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt . . . . . 0 N--CA 1.48 1.03 0 O-C-N 125.777 1.923 . . . . 1.0 111.06 179.562 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.4 mmt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 111.238 0.088 . . . . 1.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.5 139.91 41.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 125.268 1.605 . . . . 1.0 110.488 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -128.42 138.9 52.54 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.774 1.296 . . . . 1.0 111.114 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 27.1 t -73.14 121.27 84.68 Favored Pre-proline 0 CA--C 1.582 2.21 0 CA-C-O 117.58 -1.2 . . . . 1.0 111.784 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 -6.37 18.97 Favored 'Trans proline' 1 C--N 1.433 4.974 0 C-N-CA 121.965 1.777 . . . . 1.0 114.834 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -95.72 -55.41 6.13 Favored 'Isoleucine or valine' 0 C--N 1.372 1.575 0 C-N-CA 125.069 1.348 . . . . 1.0 110.05 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.2 p -103.79 -41.75 5.82 Favored 'General case' 0 C--N 1.374 1.634 0 O-C-N 124.245 0.965 . . . . 1.0 112.795 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.99 36.3 6.06 Favored Glycine 0 C--N 1.367 2.288 0 O-C-N 124.711 1.257 . . . . 1.0 114.151 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.42 ' OG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -97.89 147.52 33.17 Favored Pre-proline 0 CA--C 1.565 1.552 0 CA-C-O 116.848 -1.548 . . . . 1.0 111.83 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.71 139.13 39.64 Favored 'Trans proline' 1 C--N 1.446 5.708 0 C-N-CA 122.733 2.288 . . . . 1.0 114.33 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 mt -124.37 146.17 49.01 Favored 'General case' 0 C--O 1.25 1.131 0 O-C-N 125.436 1.71 . . . . 1.0 110.302 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.32 124.91 38.64 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 124.682 1.239 . . . . 1.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.471 ' O ' HG12 ' A' ' 24' ' ' ILE . 44.8 m95 -69.25 -24.83 64.04 Favored 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 125.091 1.356 . . . . 1.0 112.594 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 35.9 mt-10 -69.94 -31.59 69.42 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.72 1.608 . . . . 1.0 112.094 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -76.37 -34.0 58.92 Favored 'General case' 0 C--N 1.39 2.344 0 C-N-CA 124.923 1.289 . . . . 1.0 112.455 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -41.04 93.95 Favored 'General case' 0 C--N 1.381 1.967 0 C-N-CA 126.199 1.8 . . . . 1.0 112.711 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.2 mm -79.79 -39.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 C-N-CA 125.419 1.488 . . . . 1.0 110.641 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.63 -35.36 79.99 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 125.297 1.439 . . . . 1.0 113.678 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.68 -22.97 42.78 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 125.541 1.536 . . . . 1.0 112.586 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.492 ' O ' HD12 ' A' ' 30' ' ' ILE . 30.7 mtt -105.21 10.29 33.78 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 124.991 1.432 . . . . 1.0 112.128 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.39 23.26 4.62 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.007 0.923 . . . . 1.0 112.935 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.85 6.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 125.096 1.358 . . . . 1.0 112.79 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 27' ' ' MET . 1.1 mt -109.27 139.69 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.037 1.335 . . . . 1.0 109.138 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.0 -20.47 28.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.142 1.526 . . . . 1.0 112.235 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' HD12 ' A' ' 36' ' ' ILE . 10.4 m120 -91.6 19.54 6.21 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.179 1.391 . . . . 1.0 112.055 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.84 -36.3 56.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.313 1.445 . . . . 1.0 111.778 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -55.67 -23.88 30.84 Favored 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 126.068 1.747 . . . . 1.0 114.684 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.79 -43.83 15.02 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 125.074 1.35 . . . . 1.0 111.495 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 32' ' ' ASN . 3.2 mt -72.8 -43.05 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 125.297 1.439 . . . . 1.0 110.934 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -68.26 -19.26 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.757 0 C-N-CA 125.124 1.37 . . . . 1.0 114.132 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -91.96 -17.77 24.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.621 1.2 . . . . 1.0 112.698 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.0 105.47 9.61 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 124.351 1.06 . . . . 1.0 111.412 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -57.19 -31.63 65.65 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 125.386 1.475 . . . . 1.0 114.104 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.3 -33.49 74.42 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.778 1.631 . . . . 1.0 112.652 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -82.16 -35.84 28.01 Favored 'General case' 0 C--N 1.377 1.792 0 C-N-CA 125.339 1.456 . . . . 1.0 112.429 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.5 t80 -73.69 -45.27 53.45 Favored 'General case' 0 C--N 1.39 2.357 0 C-N-CA 125.089 1.356 . . . . 1.0 112.523 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.58 -28.18 66.72 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 124.597 1.159 . . . . 1.0 113.048 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.77 -28.61 36.36 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.154 1.382 . . . . 1.0 112.619 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 2.2 tt0 -79.6 -38.25 34.37 Favored 'General case' 0 C--N 1.381 1.968 0 C-N-CA 125.094 1.358 . . . . 1.0 112.337 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 43' ' ' PHE . 49.1 t -68.99 -42.07 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.215 0 C-N-CA 125.341 1.456 . . . . 1.0 109.635 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.89 -28.28 67.37 Favored 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.455 1.502 . . . . 1.0 113.544 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -91.92 -26.75 18.29 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.863 1.265 . . . . 1.0 113.488 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -97.6 147.42 24.32 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 124.566 1.146 . . . . 1.0 111.254 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.0 151.89 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 O-C-N 124.835 1.335 . . . . 1.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -122.56 144.57 49.01 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.949 1.406 . . . . 1.0 110.434 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -96.77 138.77 33.83 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 124.787 1.305 . . . . 1.0 111.268 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.6 t -96.5 111.76 57.99 Favored Pre-proline 0 CA--C 1.576 1.961 0 O-C-N 125.026 1.454 . . . . 1.0 110.654 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -70.57 -8.07 22.76 Favored 'Trans proline' 1 C--N 1.439 5.299 0 C-N-CA 122.984 2.456 . . . . 1.0 114.348 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.42 HG11 ' OG ' ' A' ' 16' ' ' SER . 1.8 t -85.31 -51.97 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 125.577 1.551 . . . . 1.0 110.597 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.1 p -103.76 -48.14 4.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.722 1.264 . . . . 1.0 112.504 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.1 -10.94 14.93 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 124.442 1.089 . . . . 1.0 114.348 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.4 147.82 25.27 Favored 'General case' 0 C--N 1.376 1.738 0 C-N-CA 124.963 1.305 . . . . 1.0 111.476 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.74 138.54 31.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.783 1.233 . . . . 1.0 112.36 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -122.35 143.11 49.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.214 1.571 . . . . 1.0 109.833 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -95.31 151.67 19.06 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 124.318 1.012 . . . . 1.0 112.659 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.21 -9.07 80.48 Favored Glycine 0 C--N 1.379 2.932 0 O-C-N 124.661 1.226 . . . . 1.0 115.125 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -87.55 -18.25 30.18 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.256 1.422 . . . . 1.0 112.047 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 p -99.63 2.68 44.73 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.841 1.256 . . . . 1.0 112.018 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 152.89 81.22 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 116.982 -1.485 . . . . 1.0 111.969 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.49 152.2 82.59 Favored 'Trans proline' 1 C--N 1.444 5.553 0 C-N-CA 123.289 2.659 . . . . 1.0 114.67 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -66.98 -19.58 65.74 Favored 'General case' 0 N--CA 1.507 2.405 0 C-N-CA 125.19 1.396 . . . . 1.0 114.566 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -79.6 -34.17 40.93 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 125.002 1.321 . . . . 1.0 112.073 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -70.12 -29.46 66.42 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.743 1.617 . . . . 1.0 113.239 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.18 71.93 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.845 1.658 . . . . 1.0 112.863 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.01 -26.2 63.02 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 1.0 112.933 176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -68.7 -28.03 66.48 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.968 1.707 . . . . 1.0 112.785 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t -65.92 -33.91 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.09 0 C-N-CA 126.519 1.928 . . . . 1.0 110.281 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.27 -29.16 69.9 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 125.784 1.634 . . . . 1.0 113.828 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -68.27 -38.5 81.81 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 125.67 1.588 . . . . 1.0 113.068 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.2 pp -72.84 -29.29 63.1 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.599 1.16 . . . . 1.0 112.825 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -26.93 43.5 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 125.405 1.482 . . . . 1.0 113.055 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -98.16 -20.18 17.45 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.423 1.089 . . . . 1.0 113.57 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.06 62.24 0.64 Allowed 'General case' 0 C--O 1.259 1.562 0 CA-C-O 123.127 1.442 . . . . 1.0 110.919 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -69.38 -34.98 75.34 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 113.349 -1.75 . . . . 1.0 113.106 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -106.36 120.3 41.52 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 124.973 1.42 . . . . 1.0 108.709 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.44 84.63 1.68 Allowed Glycine 0 C--N 1.363 2.071 0 O-C-N 124.661 1.226 . . . . 1.0 112.934 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 136.36 -57.99 0.67 Allowed Glycine 0 C--N 1.359 1.827 0 O-C-N 125.307 1.24 . . . . 1.0 113.468 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.4 mp -109.05 124.6 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 125.104 1.12 . . . . 1.0 108.126 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.06 133.11 56.01 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.495 1.747 . . . . 1.0 110.19 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -80.53 -29.35 37.19 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.588 1.18 . . . . 1.0 113.911 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.18 -35.42 28.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 124.877 1.271 . . . . 1.0 112.935 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -92.76 -17.88 23.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.613 1.196 . . . . 1.0 113.495 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 59.2 45.59 14.13 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 127.157 2.183 . . . . 1.0 113.516 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 9.1 mmm180 -115.27 138.19 51.22 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.284 -1.326 . . . . 1.0 111.435 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.84 126.92 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 125.174 1.546 . . . . 1.0 108.235 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 12.1 tttt -127.11 129.35 47.77 Favored 'General case' 0 C--O 1.251 1.143 0 O-C-N 125.28 1.612 . . . . 1.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 132.97 52.74 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.762 1.289 . . . . 1.0 110.716 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.7 mttm . . . . . 0 C--O 1.252 1.221 0 O-C-N 125.289 1.618 . . . . 1.0 111.357 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 110.851 -0.055 . . . . 1.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.73 138.61 44.78 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 125.179 1.549 . . . . 1.0 110.829 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -110.94 139.06 46.6 Favored 'General case' 0 C--O 1.248 1.013 0 O-C-N 124.9 1.375 . . . . 1.0 110.906 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.499 ' SG ' HD12 ' A' ' 13' ' ' ILE . 47.3 t -71.8 132.34 85.14 Favored Pre-proline 0 CA--C 1.578 2.038 0 CA-C-O 117.262 -1.351 . . . . 1.0 112.44 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.71 -8.45 20.39 Favored 'Trans proline' 1 C--N 1.43 4.854 0 C-N-CA 122.178 1.919 . . . . 1.0 114.761 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.499 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.2 -55.9 5.66 Favored 'Isoleucine or valine' 0 C--N 1.372 1.569 0 C-N-CA 124.975 1.31 . . . . 1.0 109.955 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 27.2 p -101.23 -41.15 6.82 Favored 'General case' 0 C--N 1.371 1.536 0 O-C-N 124.079 0.862 . . . . 1.0 113.003 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.73 34.14 9.4 Favored Glycine 0 C--N 1.37 2.464 0 O-C-N 124.691 1.244 . . . . 1.0 113.112 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.451 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -93.16 145.91 30.94 Favored Pre-proline 0 C--N 1.368 1.411 0 CA-C-O 117.177 -1.392 . . . . 1.0 112.586 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.71 134.28 34.59 Favored 'Trans proline' 1 C--N 1.445 5.624 0 C-N-CA 122.422 2.081 . . . . 1.0 114.475 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt -118.63 143.16 47.0 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 125.277 1.611 . . . . 1.0 110.202 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.28 130.85 37.1 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.789 1.306 . . . . 1.0 111.212 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.499 ' O ' HG12 ' A' ' 24' ' ' ILE . 45.8 m95 -68.78 -24.8 64.46 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 125.078 1.351 . . . . 1.0 113.046 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.1 mt-10 -70.01 -33.77 72.45 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 125.623 1.569 . . . . 1.0 112.178 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.98 -34.69 57.53 Favored 'General case' 0 C--N 1.386 2.193 0 C-N-CA 125.268 1.427 . . . . 1.0 112.776 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.13 -41.3 94.93 Favored 'General case' 0 C--N 1.382 1.994 0 C-N-CA 126.036 1.734 . . . . 1.0 112.839 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -79.94 -37.99 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 C-N-CA 125.271 1.428 . . . . 1.0 110.48 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.57 -35.25 79.75 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.093 1.357 . . . . 1.0 113.472 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.24 -23.83 40.58 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.653 1.581 . . . . 1.0 112.55 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.493 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -103.65 13.77 32.52 Favored 'General case' 0 CA--C 1.576 1.979 0 O-C-N 124.768 1.293 . . . . 1.0 112.48 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.11 16.79 12.11 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 123.937 0.895 . . . . 1.0 112.882 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.88 -4.05 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 C-N-CA 125.457 1.503 . . . . 1.0 113.427 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -99.71 140.92 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 125.251 1.421 . . . . 1.0 109.125 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.78 -18.06 41.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.888 1.367 . . . . 1.0 113.033 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.66 -16.3 54.35 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 124.975 1.31 . . . . 1.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.87 -34.74 65.75 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 126.252 1.821 . . . . 1.0 113.006 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.06 -30.34 71.52 Favored 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 125.317 1.447 . . . . 1.0 112.281 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.71 -35.73 20.65 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 125.461 1.504 . . . . 1.0 112.251 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -72.2 -39.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.905 0 C-N-CA 126.011 1.724 . . . . 1.0 110.549 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.518 ' O ' HD22 ' A' ' 78' ' ' LEU . 2.5 p -63.17 -18.85 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 C-N-CA 125.561 1.544 . . . . 1.0 114.237 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.98 -19.41 25.75 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.75 1.22 . . . . 1.0 113.311 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -125.3 111.11 14.82 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.364 1.066 . . . . 1.0 111.688 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.44 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.0 mpt_? -60.05 -33.45 72.06 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 125.603 1.561 . . . . 1.0 113.57 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.19 -31.06 69.41 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 125.636 1.575 . . . . 1.0 112.632 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -82.16 -33.42 29.53 Favored 'General case' 0 C--N 1.379 1.85 0 C-N-CA 125.119 1.368 . . . . 1.0 112.154 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' O ' HG21 ' A' ' 47' ' ' VAL . 3.0 t80 -71.65 -43.98 65.12 Favored 'General case' 0 C--N 1.394 2.508 0 C-N-CA 125.137 1.375 . . . . 1.0 112.41 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.83 -28.8 65.99 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.925 1.29 . . . . 1.0 112.41 177.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 -27.07 29.64 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 125.455 1.502 . . . . 1.0 112.787 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.0 mm-40 -78.11 -39.12 42.34 Favored 'General case' 0 C--N 1.383 2.024 0 C-N-CA 124.775 1.23 . . . . 1.0 112.84 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' HA3' ' A' ' 63' ' ' GLY . 46.0 t -68.8 -40.77 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.03 0 C-N-CA 125.234 1.414 . . . . 1.0 109.621 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.29 -26.69 63.92 Favored 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.491 1.516 . . . . 1.0 113.024 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.36 -26.0 19.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.076 1.351 . . . . 1.0 112.851 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -96.18 144.64 26.22 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 124.64 1.176 . . . . 1.0 110.943 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.9 150.85 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 O-C-N 124.948 1.405 . . . . 1.0 110.732 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.03 145.5 50.97 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.856 1.348 . . . . 1.0 110.523 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -101.4 142.69 32.43 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.663 1.227 . . . . 1.0 111.3 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -89.04 123.38 67.5 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 117.385 -1.293 . . . . 1.0 110.943 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.26 -9.93 26.27 Favored 'Trans proline' 1 C--N 1.439 5.301 0 C-N-CA 122.81 2.34 . . . . 1.0 113.548 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.15 -52.78 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 125.638 1.575 . . . . 1.0 110.177 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.498 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 46.0 m -90.13 -52.74 4.79 Favored 'General case' 0 C--N 1.38 1.893 0 O-C-N 124.22 0.95 . . . . 1.0 112.383 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.67 42.14 Favored Glycine 0 C--N 1.368 2.316 0 O-C-N 124.796 1.31 . . . . 1.0 112.899 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -86.57 152.58 22.5 Favored 'General case' 0 C--N 1.379 1.888 0 C-N-CA 125.759 1.624 . . . . 1.0 111.272 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.28 136.66 32.9 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.436 1.095 . . . . 1.0 111.577 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -130.14 144.15 51.19 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 125.475 1.734 . . . . 1.0 109.159 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -92.2 153.85 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.186 0.929 . . . . 1.0 113.047 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -77.27 -4.43 83.93 Favored Glycine 0 C--N 1.377 2.826 0 O-C-N 124.404 1.065 . . . . 1.0 114.793 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -85.81 -15.16 42.85 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.355 1.462 . . . . 1.0 112.054 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 p -95.59 5.64 50.97 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 124.524 1.13 . . . . 1.0 111.562 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 63' ' ' GLY . 5.8 mt -74.53 150.51 86.9 Favored Pre-proline 0 C--N 1.387 2.23 0 CA-C-O 116.811 -1.566 . . . . 1.0 112.48 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.98 151.69 83.31 Favored 'Trans proline' 1 C--N 1.441 5.434 0 C-N-CA 123.139 2.559 . . . . 1.0 113.739 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -65.71 -18.34 65.26 Favored 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 114.715 1.376 . . . . 1.0 114.715 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -83.45 -34.43 25.44 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.974 1.309 . . . . 1.0 111.68 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -70.36 -29.15 65.75 Favored 'General case' 0 C--N 1.387 2.198 0 C-N-CA 125.741 1.616 . . . . 1.0 113.513 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.18 75.29 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.497 1.519 . . . . 1.0 112.809 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -73.85 -28.21 61.47 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.729 1.612 . . . . 1.0 112.358 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -71.33 -26.94 63.05 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 126.054 1.742 . . . . 1.0 112.746 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.587 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.7 -38.31 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 C-N-CA 126.49 1.916 . . . . 1.0 110.366 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -60.06 -28.18 67.57 Favored 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.277 1.431 . . . . 1.0 113.864 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -40.79 79.94 Favored 'General case' 0 C--N 1.383 2.064 0 C-N-CA 125.616 1.567 . . . . 1.0 113.496 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.1 pp -71.04 -34.52 71.33 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.911 1.284 . . . . 1.0 113.013 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.518 HD22 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.08 -22.65 44.96 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.479 1.512 . . . . 1.0 112.531 177.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -86.37 -9.66 55.92 Favored 'General case' 0 C--N 1.383 2.038 0 C-N-CA 124.586 1.154 . . . . 1.0 113.061 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.55 -35.59 75.55 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.59 1.556 . . . . 1.0 113.75 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.67 -72.01 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 127.621 2.368 . . . . 1.0 113.816 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -128.48 135.31 49.27 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 125.201 1.401 . . . . 1.0 109.393 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.45 114.6 3.97 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 125.018 1.449 . . . . 1.0 111.445 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 109.3 -43.24 1.75 Allowed Glycine 0 C--N 1.356 1.648 0 O-C-N 125.404 1.296 . . . . 1.0 113.846 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -107.47 124.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.32 127.99 54.61 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 125.443 1.714 . . . . 1.0 110.002 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.55 -32.85 36.56 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.683 1.239 . . . . 1.0 113.778 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.23 -36.16 30.35 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.004 1.322 . . . . 1.0 112.901 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.34 -16.14 24.98 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.695 1.198 . . . . 1.0 113.525 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.17 44.26 16.05 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 127.112 2.165 . . . . 1.0 113.479 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 99.4 mtt180 -114.0 135.89 53.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.318 -1.31 . . . . 1.0 111.175 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.76 127.0 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 125.471 1.732 . . . . 1.0 107.727 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 2.8 tttp -122.66 133.11 54.52 Favored 'General case' 0 C--O 1.25 1.123 0 O-C-N 125.309 1.631 . . . . 1.0 110.464 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.48 129.85 53.2 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.04 1.462 . . . . 1.0 110.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 mttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.373 1.671 . . . . 1.0 111.287 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 39.6 mtt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.466 0.172 . . . . 1.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.49 139.42 40.13 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 125.253 1.596 . . . . 1.0 110.732 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.38 139.2 45.81 Favored 'General case' 0 C--O 1.249 1.027 0 O-C-N 124.79 1.307 . . . . 1.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.51 129.11 91.81 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 116.905 -1.521 . . . . 1.0 111.687 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.35 -13.03 30.43 Favored 'Trans proline' 1 C--N 1.438 5.238 0 C-N-CA 122.373 2.048 . . . . 1.0 114.598 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.33 -54.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 125.395 1.478 . . . . 1.0 110.7 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' HB3' ' SG ' ' A' ' 57' ' ' CYS . 29.6 p -105.29 -40.4 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.261 0.976 . . . . 1.0 113.433 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.91 38.43 5.77 Favored Glycine 0 C--N 1.371 2.499 0 O-C-N 124.71 1.256 . . . . 1.0 113.05 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -92.13 142.97 26.85 Favored Pre-proline 0 CA--C 1.567 1.625 0 CA-C-O 116.609 -1.662 . . . . 1.0 113.042 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.68 137.28 38.34 Favored 'Trans proline' 1 C--N 1.451 5.94 0 C-N-CA 122.557 2.171 . . . . 1.0 113.08 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -118.76 143.45 46.89 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 125.143 1.527 . . . . 1.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.64 131.61 41.7 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.979 1.424 . . . . 1.0 110.956 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.507 ' O ' HG12 ' A' ' 24' ' ' ILE . 55.0 m95 -68.51 -26.43 65.44 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.025 1.33 . . . . 1.0 112.968 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.0 mt-10 -70.0 -33.1 71.6 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 125.692 1.597 . . . . 1.0 112.094 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.69 -33.46 58.23 Favored 'General case' 0 C--N 1.387 2.202 0 C-N-CA 125.077 1.351 . . . . 1.0 112.509 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.4 OUTLIER -65.87 -41.42 91.63 Favored 'General case' 0 C--N 1.389 2.285 0 C-N-CA 125.824 1.65 . . . . 1.0 112.743 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.8 mm -76.97 -39.46 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 C-N-CA 125.411 1.484 . . . . 1.0 110.461 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -67.61 -36.6 81.14 Favored 'General case' 0 C--N 1.385 2.151 0 C-N-CA 125.281 1.432 . . . . 1.0 113.57 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.96 -22.5 39.52 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.645 1.578 . . . . 1.0 112.842 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -104.54 12.75 32.78 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.537 1.148 . . . . 1.0 111.856 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 12.23 26.81 Favored 'General case' 0 CA--C 1.575 1.91 0 C-N-CA 123.733 0.813 . . . . 1.0 113.014 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.68 1.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 C-N-CA 125.903 1.681 . . . . 1.0 113.074 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.441 HD11 ' O ' ' A' ' 27' ' ' MET . 0.8 OUTLIER -108.84 140.15 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 125.187 1.395 . . . . 1.0 109.109 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -80.87 -19.67 43.95 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 124.808 1.243 . . . . 1.0 113.748 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -79.09 -21.3 46.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.979 1.312 . . . . 1.0 112.554 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.59 -34.97 69.79 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.279 1.832 . . . . 1.0 113.153 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.1 -30.7 69.43 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 125.584 1.554 . . . . 1.0 111.975 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.16 -33.95 19.22 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 125.652 1.581 . . . . 1.0 112.485 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.436 HG12 HE22 ' A' ' 46' ' ' GLN . 7.0 mt -71.5 -37.18 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.841 1.656 . . . . 1.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 m -61.98 -18.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 125.06 1.344 . . . . 1.0 114.394 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -93.11 -18.88 22.08 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.341 1.456 . . . . 1.0 112.595 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -121.61 104.84 9.92 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 124.104 0.962 . . . . 1.0 111.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 44' ' ' LEU . 11.4 ptp180 -58.24 -36.85 73.81 Favored 'General case' 0 N--CA 1.517 2.904 0 C-N-CA 126.071 1.748 . . . . 1.0 113.973 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.26 -32.75 74.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.042 1.737 . . . . 1.0 112.776 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -83.74 -31.67 25.88 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.417 1.487 . . . . 1.0 112.256 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 47' ' ' VAL . 3.2 t80 -74.56 -46.92 35.8 Favored 'General case' 0 C--N 1.392 2.441 0 C-N-CA 124.739 1.216 . . . . 1.0 113.14 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -71.4 -33.59 69.61 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 124.928 1.291 . . . . 1.0 113.152 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.37 -28.44 61.11 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.336 1.454 . . . . 1.0 113.161 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 mt-30 -80.05 -35.82 36.56 Favored 'General case' 0 C--N 1.381 1.97 0 C-N-CA 124.985 1.314 . . . . 1.0 112.945 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 43' ' ' PHE . 58.5 t -67.98 -40.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.36 0 C-N-CA 125.267 1.427 . . . . 1.0 109.547 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.02 -22.59 61.39 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.546 1.539 . . . . 1.0 113.459 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.8 -26.39 14.72 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.943 1.297 . . . . 1.0 112.603 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -99.05 144.06 28.62 Favored 'General case' 0 C--N 1.374 1.661 0 O-C-N 124.358 1.036 . . . . 1.0 111.28 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 151.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 O-C-N 125.451 1.719 . . . . 1.0 111.564 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.88 148.04 45.88 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 125.003 1.44 . . . . 1.0 109.795 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -98.64 140.97 32.06 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.666 1.229 . . . . 1.0 111.458 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.08 132.93 34.64 Favored Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 124.956 1.41 . . . . 1.0 111.635 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.15 -9.16 21.77 Favored 'Trans proline' 1 C--N 1.43 4.841 0 C-N-CA 122.535 2.156 . . . . 1.0 114.238 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.64 -51.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 125.336 1.454 . . . . 1.0 110.019 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 21.6 m -90.4 -52.84 4.71 Favored 'General case' 0 C--N 1.378 1.808 0 O-C-N 124.23 0.956 . . . . 1.0 112.45 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.27 Favored Glycine 0 C--N 1.37 2.417 0 O-C-N 124.67 1.231 . . . . 1.0 113.655 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.06 154.43 17.34 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 125.445 1.498 . . . . 1.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -88.07 133.86 33.88 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 124.326 1.05 . . . . 1.0 111.715 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -131.2 148.17 52.68 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 125.408 1.693 . . . . 1.0 109.382 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -91.18 149.33 21.83 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.19 -0.19 81.99 Favored Glycine 0 C--N 1.374 2.673 0 O-C-N 124.648 1.217 . . . . 1.0 114.573 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -85.22 -15.4 43.72 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.407 1.483 . . . . 1.0 111.872 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.4 p -91.07 2.28 56.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.688 1.195 . . . . 1.0 111.484 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.67 144.61 45.86 Favored Pre-proline 0 C--N 1.386 2.178 0 CA-C-O 117.242 -1.361 . . . . 1.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.1 157.06 61.57 Favored 'Trans proline' 1 C--N 1.437 5.211 0 C-N-CA 122.897 2.398 . . . . 1.0 114.066 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.48 -30.71 71.46 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 124.606 1.163 . . . . 1.0 113.502 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.22 -38.71 84.2 Favored 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.764 1.626 . . . . 1.0 113.309 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.6 -28.7 62.94 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 124.874 1.27 . . . . 1.0 112.836 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.24 72.22 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.957 1.703 . . . . 1.0 112.691 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.96 -25.07 60.89 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.713 1.605 . . . . 1.0 112.573 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -73.64 -28.51 61.83 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.743 1.617 . . . . 1.0 112.387 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.95 -36.22 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 C-N-CA 126.333 1.853 . . . . 1.0 110.17 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.17 -29.43 70.55 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.326 1.45 . . . . 1.0 113.475 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.07 -39.06 89.76 Favored 'General case' 0 C--N 1.389 2.303 0 C-N-CA 125.733 1.613 . . . . 1.0 113.09 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -74.0 -32.2 63.3 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 124.779 1.232 . . . . 1.0 112.495 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -82.86 -22.39 34.06 Favored 'General case' 0 C--N 1.371 1.54 0 C-N-CA 125.502 1.521 . . . . 1.0 112.901 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -87.01 -21.64 26.0 Favored 'General case' 0 C--N 1.381 1.941 0 C-N-CA 124.715 1.206 . . . . 1.0 112.587 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.32 -34.57 28.52 Favored 'General case' 0 C--N 1.379 1.859 0 C-N-CA 125.003 1.321 . . . . 1.0 113.023 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.95 -59.08 0.15 Allowed 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 127.931 2.493 . . . . 1.0 114.026 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -124.72 134.83 52.7 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 126.147 1.779 . . . . 1.0 109.444 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.42 -111.7 0.27 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 125.062 1.476 . . . . 1.0 111.686 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -113.73 49.09 0.87 Allowed Glycine 0 C--N 1.351 1.416 0 O-C-N 125.768 1.511 . . . . 1.0 112.238 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.19 123.2 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -118.17 128.17 54.46 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 125.417 1.698 . . . . 1.0 109.874 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -80.71 -27.37 36.99 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 124.707 1.203 . . . . 1.0 113.212 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.2 -36.15 27.57 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.434 1.494 . . . . 1.0 112.856 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -94.41 -17.48 22.47 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 124.594 1.184 . . . . 1.0 112.992 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 56.88 58.23 4.18 Favored 'General case' 0 N--CA 1.525 3.298 0 C-N-CA 126.896 2.078 . . . . 1.0 112.015 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -125.23 129.11 49.4 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.508 -1.678 . . . . 1.0 110.307 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.43 128.06 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 125.535 1.772 . . . . 1.0 107.9 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.23 131.4 53.91 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 125.486 1.741 . . . . 1.0 109.977 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.08 131.56 54.04 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 125.13 1.519 . . . . 1.0 110.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 C--O 1.252 1.212 0 O-C-N 125.212 1.57 . . . . 1.0 111.315 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.366 0.136 . . . . 1.0 111.366 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 140.45 41.55 Favored 'General case' 0 C--O 1.244 0.805 0 O-C-N 125.418 1.699 . . . . 1.0 110.478 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -120.87 138.27 54.16 Favored 'General case' 0 C--O 1.248 0.999 0 O-C-N 124.889 1.368 . . . . 1.0 110.825 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 13' ' ' ILE . 48.5 t -73.25 131.23 83.38 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 117.28 -1.343 . . . . 1.0 111.8 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.91 -10.13 22.82 Favored 'Trans proline' 1 C--N 1.432 4.97 0 C-N-CA 121.954 1.769 . . . . 1.0 114.77 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.584 HD13 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mt -95.1 -55.62 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 125.164 1.386 . . . . 1.0 110.179 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 28.2 p -102.83 -41.72 6.08 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 124.165 0.915 . . . . 1.0 113.171 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.38 38.0 7.36 Favored Glycine 0 C--N 1.372 2.543 0 O-C-N 124.687 1.242 . . . . 1.0 112.572 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.559 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -88.38 143.81 33.0 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 116.962 -1.494 . . . . 1.0 113.039 -178.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.65 126.98 16.3 Favored 'Trans proline' 1 C--N 1.449 5.861 0 C-N-CA 122.79 2.327 . . . . 1.0 114.642 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mt -122.9 145.01 48.84 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 125.208 1.567 . . . . 1.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' HD11 ' A' ' 23' ' ' LEU . 84.3 mttt -93.62 130.33 39.57 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 124.858 1.349 . . . . 1.0 110.563 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.472 ' O ' HG12 ' A' ' 24' ' ' ILE . 31.1 m95 -68.05 -27.35 66.45 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 124.736 1.215 . . . . 1.0 112.822 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 8.8 pt-20 -72.63 -33.44 66.63 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.639 1.976 . . . . 1.0 113.152 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.79 -32.6 63.85 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 125.212 1.405 . . . . 1.0 113.418 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -68.24 -37.71 81.07 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.103 1.761 . . . . 1.0 113.282 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.7 mm -77.04 -28.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 C-N-CA 125.665 1.586 . . . . 1.0 110.835 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.75 -34.3 71.71 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 125.261 1.424 . . . . 1.0 113.209 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.0 -22.79 39.17 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.346 1.458 . . . . 1.0 112.851 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.442 ' O ' HD12 ' A' ' 30' ' ' ILE . 38.7 mtp -104.62 14.7 29.39 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 124.701 1.25 . . . . 1.0 112.757 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 24.96 5.01 Favored 'General case' 0 CA--C 1.578 2.053 0 C-N-CA 123.665 0.786 . . . . 1.0 112.867 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.51 0.28 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 C-N-CA 125.092 1.357 . . . . 1.0 111.98 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.93 140.68 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 125.155 1.382 . . . . 1.0 109.205 -178.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.39 -18.43 48.96 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 124.75 1.281 . . . . 1.0 113.778 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -81.09 -18.6 46.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.902 1.281 . . . . 1.0 112.356 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.48 -35.64 74.49 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.196 1.798 . . . . 1.0 113.15 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.33 -29.87 69.15 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 125.47 1.508 . . . . 1.0 112.161 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.72 -33.36 20.04 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.596 1.559 . . . . 1.0 112.458 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.8 mt -71.63 -39.65 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.982 0 C-N-CA 125.696 1.598 . . . . 1.0 110.632 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.495 ' O ' HD23 ' A' ' 78' ' ' LEU . 9.2 m -60.17 -20.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 125.355 1.462 . . . . 1.0 114.66 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.89 -18.85 25.37 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.128 1.371 . . . . 1.0 113.352 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -125.55 109.31 12.51 Favored 'General case' 0 C--N 1.373 1.588 0 C-N-CA 124.195 0.998 . . . . 1.0 111.709 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.1 mpp_? -59.42 -34.1 72.06 Favored 'General case' 0 N--CA 1.517 2.918 0 C-N-CA 125.348 1.459 . . . . 1.0 113.605 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.93 -30.53 70.69 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.724 1.609 . . . . 1.0 112.742 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -82.17 -33.56 29.44 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 125.354 1.462 . . . . 1.0 112.211 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -73.06 -43.78 61.48 Favored 'General case' 0 C--N 1.392 2.455 0 C-N-CA 125.144 1.378 . . . . 1.0 112.698 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -68.64 -30.93 69.74 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 124.864 1.266 . . . . 1.0 112.45 177.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.53 40.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.899 1.374 . . . . 1.0 112.831 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 2.7 mm100 -79.37 -38.83 34.06 Favored 'General case' 0 C--N 1.385 2.121 0 C-N-CA 125.133 1.373 . . . . 1.0 112.524 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 43' ' ' PHE . 28.5 t -71.46 -40.04 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 125.238 1.415 . . . . 1.0 109.896 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.511 2.596 0 C-N-CA 125.268 1.427 . . . . 1.0 113.558 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.73 -26.61 16.21 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.853 1.261 . . . . 1.0 113.042 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 6.1 m-85 -95.01 143.87 26.14 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 124.851 1.261 . . . . 1.0 111.521 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.4 153.09 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.677 0 O-C-N 125.062 1.476 . . . . 1.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.15 145.61 51.73 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 124.969 1.418 . . . . 1.0 111.072 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.43 141.65 35.6 Favored 'General case' 0 C--O 1.25 1.119 0 O-C-N 124.905 1.378 . . . . 1.0 111.161 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.68 128.91 48.75 Favored Pre-proline 0 CA--C 1.57 1.713 0 O-C-N 124.769 1.293 . . . . 1.0 111.231 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.19 -9.5 21.95 Favored 'Trans proline' 1 C--N 1.43 4.856 0 C-N-CA 122.418 2.079 . . . . 1.0 114.156 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.86 -51.22 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.463 1.505 . . . . 1.0 110.312 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.477 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.6 m -89.32 -52.81 4.85 Favored 'General case' 0 C--N 1.378 1.816 0 O-C-N 124.301 1.001 . . . . 1.0 112.635 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.16 -10.36 47.29 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 124.708 1.255 . . . . 1.0 113.108 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -85.69 152.48 23.05 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 125.726 1.61 . . . . 1.0 111.306 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.72 136.93 32.75 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.377 1.048 . . . . 1.0 112.056 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.97 143.75 51.2 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 125.425 1.703 . . . . 1.0 109.175 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.38 151.86 19.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.253 0.971 . . . . 1.0 112.547 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.35 -8.82 80.69 Favored Glycine 0 C--N 1.378 2.886 0 O-C-N 124.362 1.039 . . . . 1.0 114.659 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -86.77 -20.98 26.83 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.498 1.519 . . . . 1.0 111.945 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -95.34 5.49 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.959 1.303 . . . . 1.0 111.784 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.69 70.22 Favored Pre-proline 0 C--N 1.386 2.174 0 CA-C-O 116.981 -1.485 . . . . 1.0 112.034 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -62.23 147.71 94.51 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 123.102 2.535 . . . . 1.0 114.693 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -64.05 -18.41 64.32 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 125.44 1.496 . . . . 1.0 114.649 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -82.74 -30.05 29.32 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 124.98 1.312 . . . . 1.0 111.843 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -73.91 -28.41 61.52 Favored 'General case' 0 C--N 1.384 2.105 0 C-N-CA 125.659 1.584 . . . . 1.0 113.059 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.44 -32.2 73.7 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 125.819 1.648 . . . . 1.0 112.615 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -74.49 -26.34 59.95 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.606 1.563 . . . . 1.0 112.148 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -73.09 -26.94 61.44 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.931 1.692 . . . . 1.0 112.604 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.3 t -64.37 -37.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 C-N-CA 126.125 1.77 . . . . 1.0 110.048 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -60.79 -29.72 69.62 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 125.012 1.325 . . . . 1.0 114.038 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.12 -41.13 82.2 Favored 'General case' 0 C--N 1.383 2.05 0 C-N-CA 125.609 1.564 . . . . 1.0 113.175 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.63 -34.7 70.04 Favored 'General case' 0 C--N 1.379 1.881 0 C-N-CA 124.857 1.263 . . . . 1.0 112.979 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -81.21 -22.14 39.06 Favored 'General case' 0 C--N 1.373 1.614 0 O-C-N 124.915 1.384 . . . . 1.0 112.652 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -85.62 -15.3 42.96 Favored 'General case' 0 C--N 1.386 2.177 0 C-N-CA 124.275 1.03 . . . . 1.0 112.815 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.65 -35.91 82.15 Favored 'General case' 0 C--N 1.388 2.256 0 C-N-CA 125.356 1.462 . . . . 1.0 113.469 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.97 -66.44 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 127.864 2.466 . . . . 1.0 114.147 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -130.38 137.37 49.85 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 125.684 1.594 . . . . 1.0 109.249 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.5 -106.94 0.21 Allowed Glycine 0 C--N 1.351 1.379 0 O-C-N 125.017 1.448 . . . . 1.0 111.656 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.97 46.35 1.19 Allowed Glycine 0 C--N 1.354 1.564 0 O-C-N 125.662 1.448 . . . . 1.0 113.051 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.45 122.31 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -122.05 129.95 52.86 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.443 1.714 . . . . 1.0 110.166 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.77 -28.88 36.25 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.728 1.267 . . . . 1.0 113.326 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.36 -37.0 26.28 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.119 1.368 . . . . 1.0 112.973 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.73 -17.98 23.53 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.567 1.147 . . . . 1.0 113.091 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.4 mttt 57.4 61.85 2.36 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 127.171 2.188 . . . . 1.0 112.125 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 98.3 mtt180 -125.5 128.99 48.88 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 113.381 -1.736 . . . . 1.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 2.0 t -123.46 129.06 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 125.504 1.752 . . . . 1.0 107.424 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.22 135.31 53.34 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 125.156 1.535 . . . . 1.0 110.213 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.54 128.55 56.06 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.056 1.472 . . . . 1.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--O 1.249 1.057 0 O-C-N 125.466 1.729 . . . . 1.0 111.325 -179.912 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 35.7 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 111.221 0.082 . . . . 1.0 111.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -112.16 140.0 47.22 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.264 1.602 . . . . 1.0 110.611 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -124.28 139.17 54.17 Favored 'General case' 0 C--O 1.247 0.961 0 O-C-N 124.947 1.405 . . . . 1.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' SG ' HD11 ' A' ' 13' ' ' ILE . 22.9 t -76.52 121.53 85.03 Favored Pre-proline 0 CA--C 1.576 1.98 0 O-C-N 124.531 1.144 . . . . 1.0 111.214 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.89 -6.07 18.01 Favored 'Trans proline' 1 C--N 1.428 4.74 0 C-N-CA 122.083 1.855 . . . . 1.0 114.512 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.402 HD11 ' SG ' ' A' ' 11' ' ' CYS . 1.2 mt -97.03 -55.59 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 124.993 1.317 . . . . 1.0 110.103 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -101.68 -39.09 7.61 Favored 'General case' 0 C--N 1.37 1.467 0 O-C-N 124.543 1.152 . . . . 1.0 112.979 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.54 30.07 12.68 Favored Glycine 0 C--N 1.368 2.325 0 O-C-N 124.901 1.376 . . . . 1.0 113.456 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -93.76 146.79 32.39 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 117.001 -1.476 . . . . 1.0 112.536 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.08 136.02 39.47 Favored 'Trans proline' 1 C--N 1.451 5.965 0 C-N-CA 122.706 2.271 . . . . 1.0 113.971 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.57 145.97 47.44 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 125.445 1.716 . . . . 1.0 110.778 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -95.14 125.73 39.99 Favored 'General case' 0 C--N 1.361 1.099 0 O-C-N 124.971 1.419 . . . . 1.0 110.96 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.501 ' O ' HG12 ' A' ' 24' ' ' ILE . 38.5 m95 -68.6 -25.0 64.65 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 124.897 1.279 . . . . 1.0 112.798 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 34.5 mt-10 -69.69 -32.8 71.62 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.64 1.576 . . . . 1.0 112.009 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.07 -34.4 57.06 Favored 'General case' 0 C--N 1.382 2.012 0 C-N-CA 124.869 1.268 . . . . 1.0 112.331 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.15 -40.67 94.7 Favored 'General case' 0 C--N 1.385 2.126 0 C-N-CA 125.934 1.694 . . . . 1.0 112.774 178.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 20' ' ' TRP . 11.0 mm -78.68 -38.68 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 C-N-CA 125.506 1.522 . . . . 1.0 110.077 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -68.54 -34.11 75.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 124.881 1.272 . . . . 1.0 113.249 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.27 -23.38 37.99 Favored 'General case' 0 C--N 1.375 1.704 0 C-N-CA 125.427 1.491 . . . . 1.0 112.53 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -103.32 15.55 28.85 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 124.652 1.22 . . . . 1.0 112.045 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 14.75 27.57 Favored 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 124.061 0.944 . . . . 1.0 112.654 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.48 4.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 C-N-CA 125.76 1.624 . . . . 1.0 112.779 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 27' ' ' MET . 0.7 OUTLIER -105.12 141.36 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.654 1.182 . . . . 1.0 109.011 -178.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -81.3 -17.6 48.73 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.783 1.302 . . . . 1.0 113.372 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -86.6 -11.19 52.16 Favored 'General case' 0 C--N 1.371 1.532 0 C-N-CA 124.899 1.28 . . . . 1.0 112.152 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -56.41 -36.86 69.42 Favored 'General case' 0 N--CA 1.511 2.616 0 C-N-CA 125.514 1.526 . . . . 1.0 112.419 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.37 -29.57 69.99 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 124.771 1.228 . . . . 1.0 112.13 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.94 -38.8 17.6 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.11 1.364 . . . . 1.0 112.006 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.407 HG12 ' OE1' ' A' ' 46' ' ' GLN . 5.2 mt -72.17 -40.78 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 C-N-CA 125.329 1.451 . . . . 1.0 110.805 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.534 ' O ' HD22 ' A' ' 78' ' ' LEU . 2.7 p -65.85 -18.26 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.599 2.864 0 C-N-CA 125.574 1.55 . . . . 1.0 113.884 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.79 -18.64 28.92 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.716 1.207 . . . . 1.0 113.259 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.04 111.97 15.33 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 124.537 1.135 . . . . 1.0 111.17 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.5 mtm180 -59.29 -35.48 73.85 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 125.54 1.536 . . . . 1.0 113.125 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.51 -30.28 69.06 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 1.0 113.351 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 80.9 mtt180 -81.64 -34.24 30.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.055 1.342 . . . . 1.0 112.396 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.48 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.8 t80 -74.66 -41.99 59.3 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 124.829 1.252 . . . . 1.0 112.664 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.4 mt -66.21 -32.48 73.93 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.626 1.17 . . . . 1.0 112.654 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.45 -24.65 34.18 Favored 'General case' 0 C--N 1.371 1.525 0 O-C-N 124.994 1.434 . . . . 1.0 112.356 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -79.23 -36.2 40.38 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.041 1.336 . . . . 1.0 112.72 178.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 43' ' ' PHE . 32.8 t -72.13 -41.18 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 125.369 1.467 . . . . 1.0 109.463 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 125.592 1.557 . . . . 1.0 113.412 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -95.47 -25.34 16.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.605 1.19 . . . . 1.0 112.986 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -101.18 144.66 29.8 Favored 'General case' 0 C--N 1.368 1.399 0 C-N-CA 124.496 1.118 . . . . 1.0 111.126 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.24 155.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 O-C-N 125.073 1.483 . . . . 1.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.38 144.08 51.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 125.194 1.559 . . . . 1.0 110.108 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -95.2 138.59 32.7 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.823 -1.535 . . . . 1.0 111.463 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.5 t -96.54 115.11 65.49 Favored Pre-proline 0 CA--C 1.568 1.673 0 O-C-N 125.044 1.465 . . . . 1.0 110.306 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.08 -5.77 17.17 Favored 'Trans proline' 1 C--N 1.432 4.93 0 C-N-CA 122.333 2.022 . . . . 1.0 114.415 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.2 t -89.99 -51.11 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 126.12 1.768 . . . . 1.0 110.557 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.8 p -103.03 -48.68 3.98 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.625 1.203 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.53 -2.56 21.86 Favored Glycine 0 C--N 1.368 2.321 0 O-C-N 124.466 1.104 . . . . 1.0 114.123 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -94.95 146.4 24.27 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 124.961 1.304 . . . . 1.0 111.197 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.61 139.37 30.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.696 1.248 . . . . 1.0 112.23 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -123.19 145.12 48.9 Favored 'General case' 0 C--O 1.247 0.96 0 O-C-N 125.46 1.725 . . . . 1.0 109.547 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.72 151.04 20.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.348 1.03 . . . . 1.0 112.267 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.5 -9.19 81.76 Favored Glycine 0 C--N 1.377 2.861 0 O-C-N 124.293 0.996 . . . . 1.0 114.479 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -86.61 -19.59 29.13 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.186 1.394 . . . . 1.0 112.072 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -94.7 3.6 54.85 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.848 1.259 . . . . 1.0 111.752 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.22 146.44 38.13 Favored Pre-proline 0 C--N 1.382 1.996 0 CA-C-O 117.491 -1.242 . . . . 1.0 111.763 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.08 154.99 70.76 Favored 'Trans proline' 1 C--N 1.436 5.166 0 C-N-CA 122.972 2.448 . . . . 1.0 114.706 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.89 -31.62 72.86 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.437 1.095 . . . . 1.0 113.384 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.02 -37.81 75.03 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 125.333 1.453 . . . . 1.0 113.541 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.8 mt-10 -77.02 -28.32 54.91 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 124.851 1.26 . . . . 1.0 112.452 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.19 73.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.954 1.702 . . . . 1.0 112.628 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.51 -25.28 61.34 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.501 1.52 . . . . 1.0 112.398 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.45 -26.39 60.91 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 125.908 1.683 . . . . 1.0 112.5 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.39 -36.98 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 C-N-CA 126.37 1.868 . . . . 1.0 110.206 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' A' ' 44' ' ' LEU . 46.8 m-85 -60.26 -29.82 69.04 Favored 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 125.398 1.479 . . . . 1.0 113.59 176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -43.19 84.21 Favored 'General case' 0 C--N 1.382 1.987 0 C-N-CA 125.331 1.452 . . . . 1.0 113.196 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -69.98 -32.99 71.48 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.015 1.326 . . . . 1.0 112.849 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -81.3 -18.42 45.89 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.208 1.403 . . . . 1.0 112.835 178.071 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -102.1 -13.92 17.3 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 124.53 1.132 . . . . 1.0 111.935 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.81 69.42 0.7 Allowed 'General case' 0 C--N 1.372 1.548 0 CA-C-O 122.893 1.33 . . . . 1.0 109.339 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -75.18 -24.16 57.81 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 113.443 -1.708 . . . . 1.0 112.949 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -106.66 134.61 49.54 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 124.837 1.335 . . . . 1.0 109.342 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.63 -96.64 0.16 Allowed Glycine 0 C--N 1.356 1.657 0 O-C-N 124.981 1.426 . . . . 1.0 112.148 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.26 50.99 0.79 Allowed Glycine 0 C--N 1.362 1.993 0 O-C-N 125.439 1.317 . . . . 1.0 113.623 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -119.97 121.58 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.11 133.67 51.57 Favored 'General case' 0 C--O 1.249 1.026 0 O-C-N 125.487 1.742 . . . . 1.0 110.61 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -80.37 -32.12 37.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.71 1.256 . . . . 1.0 113.252 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.94 -36.39 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.086 1.355 . . . . 1.0 112.997 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.17 -20.09 20.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.475 1.11 . . . . 1.0 113.173 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.7 mttm 58.28 56.35 4.52 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 127.07 2.148 . . . . 1.0 113.11 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 93.3 mtt180 -115.41 128.68 56.22 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.44 -1.709 . . . . 1.0 110.431 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.48 125.26 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 125.466 1.729 . . . . 1.0 108.457 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -121.18 131.9 54.51 Favored 'General case' 0 C--O 1.251 1.174 0 O-C-N 125.519 1.762 . . . . 1.0 109.988 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.6 133.32 55.39 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 125.202 1.563 . . . . 1.0 110.576 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.1 mttt . . . . . 0 C--O 1.252 1.236 0 O-C-N 125.338 1.649 . . . . 1.0 111.244 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.865 -0.05 . . . . 1.0 110.865 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.81 138.95 43.14 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 125.315 1.635 . . . . 1.0 110.627 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.37 138.94 49.91 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 124.93 1.394 . . . . 1.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.4 t -70.19 123.15 88.3 Favored Pre-proline 0 CA--C 1.577 1.992 0 O-C-N 124.477 1.11 . . . . 1.0 112.199 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.64 -11.5 26.16 Favored 'Trans proline' 1 C--N 1.43 4.826 0 C-N-CA 121.932 1.755 . . . . 1.0 114.922 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.81 -53.8 8.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 C-N-CA 125.299 1.44 . . . . 1.0 111.018 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.6 -41.15 6.05 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 124.218 0.949 . . . . 1.0 112.434 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 29.51 8.63 Favored Glycine 0 C--N 1.366 2.239 0 O-C-N 124.678 1.236 . . . . 1.0 113.748 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.22 144.68 29.39 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 116.796 -1.573 . . . . 1.0 113.096 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.88 139.29 39.45 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 122.71 2.273 . . . . 1.0 113.661 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 144.36 48.22 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.32 1.638 . . . . 1.0 110.432 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -95.76 133.17 40.19 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.928 1.392 . . . . 1.0 111.052 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.484 ' O ' HG12 ' A' ' 24' ' ' ILE . 60.8 m95 -68.69 -26.45 65.3 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 124.798 1.239 . . . . 1.0 113.248 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -72.09 -31.24 65.89 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.645 1.578 . . . . 1.0 112.623 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.92 -34.5 62.14 Favored 'General case' 0 C--N 1.385 2.123 0 C-N-CA 125.168 1.387 . . . . 1.0 112.603 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -39.89 87.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 125.758 1.623 . . . . 1.0 113.882 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.6 mm -78.58 -41.03 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 125.156 1.382 . . . . 1.0 110.676 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.3 -36.71 82.07 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 124.84 1.256 . . . . 1.0 113.311 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.72 -21.11 48.56 Favored 'General case' 0 C--N 1.375 1.714 0 C-N-CA 125.308 1.443 . . . . 1.0 112.967 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.505 ' SD ' ' HE1' ' A' ' 52' ' ' PHE . 35.0 mtp -105.56 16.78 24.9 Favored 'General case' 0 CA--C 1.575 1.923 0 O-C-N 124.67 1.231 . . . . 1.0 112.367 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.8 18.43 14.49 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.48 13.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 124.765 1.226 . . . . 1.0 111.918 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -114.81 140.5 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 124.736 1.215 . . . . 1.0 108.723 -178.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.04 -16.28 44.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 125.028 1.455 . . . . 1.0 113.411 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -83.55 -15.66 48.38 Favored 'General case' 0 C--N 1.376 1.725 0 C-N-CA 125.065 1.346 . . . . 1.0 112.556 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.06 -35.48 69.39 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 126.354 1.862 . . . . 1.0 113.315 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.33 -29.18 69.73 Favored 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 125.384 1.474 . . . . 1.0 112.411 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.85 -33.87 19.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.43 1.492 . . . . 1.0 112.662 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 mt -71.46 -39.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.909 0 C-N-CA 125.837 1.655 . . . . 1.0 110.457 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.505 ' O ' HD22 ' A' ' 78' ' ' LEU . 10.3 m -61.57 -18.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 125.669 1.588 . . . . 1.0 114.692 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -88.38 -19.05 27.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.823 1.327 . . . . 1.0 113.256 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.48 110.67 12.99 Favored 'General case' 0 C--N 1.373 1.599 0 C-N-CA 124.473 1.109 . . . . 1.0 111.973 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.452 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -61.54 -32.38 72.44 Favored 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 125.331 1.452 . . . . 1.0 113.015 176.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.95 -31.88 71.07 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 125.475 1.51 . . . . 1.0 113.207 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -82.26 -32.65 29.54 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 125.212 1.405 . . . . 1.0 112.594 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 47' ' ' VAL . 3.4 t80 -73.08 -46.01 53.93 Favored 'General case' 0 C--N 1.386 2.186 0 C-N-CA 124.976 1.31 . . . . 1.0 113.098 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -71.59 -33.16 68.8 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.033 1.333 . . . . 1.0 112.777 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.04 72.8 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.835 1.654 . . . . 1.0 112.742 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 8.9 mt-30 -78.75 -35.29 44.82 Favored 'General case' 0 C--N 1.382 1.986 0 C-N-CA 124.821 1.248 . . . . 1.0 112.908 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 43' ' ' PHE . 59.1 t -69.05 -40.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.117 1.367 . . . . 1.0 109.173 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.63 -25.46 59.24 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 125.676 1.59 . . . . 1.0 113.477 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -94.32 -25.31 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.803 1.315 . . . . 1.0 113.522 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 34.1 m-85 -105.33 143.3 33.68 Favored 'General case' 0 C--N 1.366 1.307 0 O-C-N 124.454 1.096 . . . . 1.0 111.466 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.75 153.83 3.2 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 O-C-N 125.094 1.496 . . . . 1.0 111.599 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.505 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 99.1 m-85 -125.14 144.26 50.52 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 125.093 1.496 . . . . 1.0 110.332 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -95.17 139.89 30.86 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.208 1.567 . . . . 1.0 111.072 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -92.35 130.23 38.28 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 125.057 1.473 . . . . 1.0 111.807 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.68 -8.06 20.99 Favored 'Trans proline' 1 C--N 1.437 5.205 0 C-N-CA 122.698 2.265 . . . . 1.0 114.292 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.22 -55.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 124.843 1.257 . . . . 1.0 110.43 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.2 p -98.14 -52.5 3.67 Favored 'General case' 0 C--N 1.372 1.547 0 O-C-N 124.302 1.001 . . . . 1.0 111.682 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.31 25.12 7.98 Favored Glycine 0 C--N 1.367 2.267 0 O-C-N 124.722 1.264 . . . . 1.0 114.747 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -105.64 147.97 27.88 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 124.591 1.156 . . . . 1.0 111.076 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -83.65 134.38 34.78 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 124.563 1.165 . . . . 1.0 112.393 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -132.8 148.33 52.31 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 125.444 1.715 . . . . 1.0 109.826 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -94.05 149.82 20.89 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.339 1.024 . . . . 1.0 112.627 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 -9.27 86.95 Favored Glycine 0 C--N 1.375 2.714 0 O-C-N 124.727 1.267 . . . . 1.0 114.111 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -82.34 -17.29 46.22 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 125.31 1.444 . . . . 1.0 112.671 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -91.24 -5.41 54.85 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 124.363 1.065 . . . . 1.0 112.194 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 145.48 44.83 Favored Pre-proline 0 C--N 1.385 2.114 0 CA-C-O 117.232 -1.366 . . . . 1.0 111.887 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.4 160.1 44.31 Favored 'Trans proline' 1 C--N 1.437 5.234 0 C-N-CA 123.024 2.483 . . . . 1.0 114.679 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -62.44 -30.13 71.01 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.501 1.12 . . . . 1.0 113.735 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.1 -37.76 77.94 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 125.561 1.545 . . . . 1.0 112.999 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.74 -29.34 40.52 Favored 'General case' 0 C--N 1.381 1.962 0 C-N-CA 124.985 1.314 . . . . 1.0 111.746 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.06 73.48 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 125.834 1.654 . . . . 1.0 112.312 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.41 -28.12 63.79 Favored 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 125.791 1.637 . . . . 1.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -68.58 -27.87 66.44 Favored 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 125.978 1.711 . . . . 1.0 112.547 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.9 t -65.6 -37.37 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.019 0 C-N-CA 126.322 1.849 . . . . 1.0 109.97 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -28.37 69.9 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 125.182 1.393 . . . . 1.0 113.349 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.29 -41.21 77.09 Favored 'General case' 0 C--N 1.383 2.046 0 C-N-CA 125.473 1.509 . . . . 1.0 112.913 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -70.72 -32.1 69.19 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.763 1.225 . . . . 1.0 113.243 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -81.25 -20.31 41.25 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.237 1.415 . . . . 1.0 112.868 177.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -99.88 -16.0 18.17 Favored 'General case' 0 C--N 1.371 1.519 0 C-N-CA 124.76 1.224 . . . . 1.0 112.189 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -108.82 69.01 0.7 Allowed 'General case' 0 C--N 1.37 1.495 0 CA-C-O 122.898 1.332 . . . . 1.0 109.46 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -71.75 -28.44 63.66 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.308 -1.769 . . . . 1.0 113.083 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -103.53 134.89 46.13 Favored 'General case' 0 C--N 1.366 1.303 0 O-C-N 124.989 1.431 . . . . 1.0 109.718 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.98 -95.29 0.14 Allowed Glycine 0 C--N 1.355 1.588 0 O-C-N 125.165 1.541 . . . . 1.0 112.18 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.01 46.9 0.96 Allowed Glycine 0 C--N 1.361 1.922 0 O-C-N 125.34 1.259 . . . . 1.0 113.824 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -120.3 122.58 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -124.77 131.56 53.44 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 125.574 1.796 . . . . 1.0 110.468 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -80.85 -27.51 36.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.85 1.344 . . . . 1.0 113.51 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.44 -35.65 27.36 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.207 1.403 . . . . 1.0 112.581 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -94.88 -17.37 22.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 124.692 1.245 . . . . 1.0 113.436 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mttm 58.98 50.76 7.92 Favored 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 127.166 2.186 . . . . 1.0 113.99 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 71.7 mtm180 -115.58 130.83 57.01 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.796 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.6 123.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 125.462 1.727 . . . . 1.0 107.793 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -124.7 132.38 53.39 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 125.716 1.885 . . . . 1.0 110.387 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 132.26 56.36 Favored 'General case' 0 C--O 1.246 0.898 0 O-C-N 125.332 1.645 . . . . 1.0 108.929 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.523 3.179 0 C-N-CA 127.386 2.274 . . . . 1.0 113.465 179.887 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.7 tpp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.873 -0.047 . . . . 1.0 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.02 139.8 47.23 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 125.286 1.616 . . . . 1.0 110.521 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -115.12 138.78 50.51 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.896 1.372 . . . . 1.0 110.724 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.0 t -74.67 119.65 77.73 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 117.29 -1.338 . . . . 1.0 111.819 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.17 -25.16 50.73 Favored 'Trans proline' 1 C--N 1.439 5.302 0 C-N-CA 122.3 2.0 . . . . 1.0 113.789 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.26 -54.14 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 C-N-CA 126.35 1.86 . . . . 1.0 112.826 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -108.64 -44.39 4.06 Favored 'General case' 0 C--N 1.37 1.457 0 O-C-N 124.175 0.922 . . . . 1.0 112.339 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.72 6.16 Favored Glycine 0 C--N 1.367 2.28 0 O-C-N 124.717 1.261 . . . . 1.0 113.725 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.81 146.48 31.39 Favored Pre-proline 0 C--N 1.369 1.44 0 CA-C-O 117.115 -1.421 . . . . 1.0 112.467 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.18 139.35 42.01 Favored 'Trans proline' 1 C--N 1.449 5.859 0 C-N-CA 122.728 2.286 . . . . 1.0 113.854 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.59 143.52 49.26 Favored 'General case' 0 C--O 1.25 1.124 0 O-C-N 125.341 1.651 . . . . 1.0 110.177 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.78 134.7 39.73 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 124.874 1.359 . . . . 1.0 111.005 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.3 m95 -68.49 -27.01 65.75 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.955 1.302 . . . . 1.0 112.872 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 7.3 pt-20 -71.76 -32.28 67.52 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.355 1.862 . . . . 1.0 112.661 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.1 -34.29 66.1 Favored 'General case' 0 C--N 1.385 2.152 0 C-N-CA 125.443 1.497 . . . . 1.0 112.963 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.8 OUTLIER -67.74 -39.91 84.2 Favored 'General case' 0 C--N 1.382 2.02 0 C-N-CA 125.665 1.586 . . . . 1.0 113.372 177.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -78.91 -40.96 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 125.524 1.529 . . . . 1.0 110.568 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.73 -38.16 86.12 Favored 'General case' 0 C--N 1.386 2.183 0 C-N-CA 125.144 1.377 . . . . 1.0 113.369 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.39 -20.91 50.18 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 125.466 1.506 . . . . 1.0 112.929 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.5 ' O ' HD13 ' A' ' 30' ' ' ILE . 3.0 mmt -106.01 12.25 30.67 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.813 1.321 . . . . 1.0 112.09 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.72 17.95 11.02 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.587 0.755 . . . . 1.0 113.02 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.8 11.02 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 C-N-CA 125.638 1.575 . . . . 1.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 27' ' ' MET . 1.2 mt -115.21 138.3 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.827 1.251 . . . . 1.0 108.935 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.54 -17.85 35.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.132 1.52 . . . . 1.0 112.439 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.419 ' O ' HD13 ' A' ' 36' ' ' ILE . 47.9 m-80 -91.93 14.4 15.8 Favored 'General case' 0 CA--C 1.574 1.87 0 C-N-CA 125.289 1.436 . . . . 1.0 111.786 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -76.15 -36.21 58.85 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.387 1.475 . . . . 1.0 111.799 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -57.78 -23.8 54.13 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 126.026 1.73 . . . . 1.0 114.339 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.15 -43.64 14.79 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 125.352 1.461 . . . . 1.0 111.539 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 32' ' ' ASN . 3.5 mt -72.41 -42.4 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 125.589 1.555 . . . . 1.0 110.824 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.75 -14.06 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.013 0 C-N-CA 125.318 1.447 . . . . 1.0 114.243 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -92.06 -22.29 20.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.839 1.256 . . . . 1.0 112.447 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.13 106.41 10.75 Favored 'General case' 0 C--N 1.371 1.51 0 O-C-N 124.569 1.168 . . . . 1.0 111.293 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -58.1 -33.89 69.6 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 125.829 1.651 . . . . 1.0 113.908 176.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.23 -33.08 74.59 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 125.813 1.645 . . . . 1.0 112.35 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.58 -34.36 27.74 Favored 'General case' 0 C--N 1.381 1.942 0 C-N-CA 125.619 1.568 . . . . 1.0 112.502 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.0 t80 -72.7 -45.95 56.18 Favored 'General case' 0 C--N 1.394 2.519 0 C-N-CA 125.207 1.403 . . . . 1.0 112.524 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.14 -33.11 72.92 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 124.932 1.293 . . . . 1.0 112.366 178.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.58 -31.63 65.37 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.82 1.648 . . . . 1.0 112.919 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.5 tt0 -79.24 -37.09 38.86 Favored 'General case' 0 C--N 1.384 2.084 0 C-N-CA 124.96 1.304 . . . . 1.0 112.482 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.7 t -69.29 -41.56 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 C-N-CA 125.455 1.502 . . . . 1.0 109.539 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 42.3 mt-10 -70.28 -25.56 63.4 Favored 'General case' 0 N--CA 1.516 2.832 0 C-N-CA 125.658 1.583 . . . . 1.0 113.545 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.53 -25.62 16.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.097 1.359 . . . . 1.0 113.171 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.11 141.7 35.39 Favored 'General case' 0 C--N 1.369 1.454 0 O-C-N 124.384 1.053 . . . . 1.0 111.658 -179.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.401 HG21 ' OE1' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -90.96 152.23 3.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 125.255 1.597 . . . . 1.0 111.634 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.18 144.16 50.08 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.062 1.476 . . . . 1.0 110.391 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -96.35 140.54 30.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.144 1.527 . . . . 1.0 111.07 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.9 t -94.69 130.75 32.35 Favored Pre-proline 0 CA--C 1.565 1.539 0 O-C-N 125.295 1.622 . . . . 1.0 112.044 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.02 -4.24 14.88 Favored 'Trans proline' 1 C--N 1.435 5.117 0 C-N-CA 122.353 2.035 . . . . 1.0 114.504 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.95 -54.83 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 125.389 1.475 . . . . 1.0 110.133 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 p -101.89 -52.6 3.14 Favored 'General case' 0 C--N 1.371 1.537 0 O-C-N 124.434 1.084 . . . . 1.0 111.566 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 22.07 9.56 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 124.547 1.154 . . . . 1.0 114.479 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -99.95 145.55 27.71 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 124.754 1.221 . . . . 1.0 111.215 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' OE1' HG21 ' A' ' 51' ' ' VAL . 14.2 mt-10 -84.39 133.75 34.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.856 1.348 . . . . 1.0 111.858 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -132.69 147.4 52.33 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 125.601 1.813 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.04 151.11 19.76 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.745 1.278 . . . . 1.0 112.729 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 48' ' ' GLU . . . -80.83 1.28 84.44 Favored Glycine 0 C--N 1.372 2.564 0 O-C-N 124.912 1.382 . . . . 1.0 114.508 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -88.85 -16.42 32.03 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.911 1.285 . . . . 1.0 112.015 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 p -89.78 -12.84 38.09 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 124.883 1.273 . . . . 1.0 113.312 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -75.29 146.88 82.14 Favored Pre-proline 0 CA--C 1.584 2.25 0 CA-C-O 116.747 -1.597 . . . . 1.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.51 156.28 66.78 Favored 'Trans proline' 1 C--N 1.445 5.643 0 C-N-CA 122.999 2.466 . . . . 1.0 113.4 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -58.98 -30.75 68.19 Favored 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.982 1.313 . . . . 1.0 114.146 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -61.03 -36.26 79.06 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.622 1.569 . . . . 1.0 113.111 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -76.55 -28.97 56.48 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 125.017 1.327 . . . . 1.0 111.905 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.43 -32.41 72.43 Favored 'General case' 0 C--N 1.388 2.281 0 C-N-CA 126.002 1.721 . . . . 1.0 112.449 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.79 -26.6 62.48 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 125.943 1.697 . . . . 1.0 112.662 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.99 -28.66 66.81 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 126.099 1.759 . . . . 1.0 112.565 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -66.53 -35.23 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 C-N-CA 126.481 1.912 . . . . 1.0 109.975 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.62 -29.43 70.68 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 125.539 1.535 . . . . 1.0 113.014 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -67.24 -38.87 85.91 Favored 'General case' 0 C--N 1.386 2.172 0 C-N-CA 125.845 1.658 . . . . 1.0 113.05 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.9 pp -75.01 -30.89 61.25 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 124.685 1.194 . . . . 1.0 112.46 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.1 -22.35 39.21 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 125.817 1.647 . . . . 1.0 113.25 177.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -99.86 -9.84 22.42 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 124.752 1.221 . . . . 1.0 112.869 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 1.1 m-20 -107.01 58.78 0.63 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-O 123.106 1.432 . . . . 1.0 111.016 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.53 -30.52 70.2 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.39 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -115.11 113.57 24.18 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 124.96 1.412 . . . . 1.0 109.168 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.79 106.14 1.34 Allowed Glycine 0 C--N 1.366 2.227 0 CA-C-N 114.552 -1.204 . . . . 1.0 113.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.31 -59.2 0.69 Allowed Glycine 0 C--N 1.36 1.867 0 O-C-N 125.453 1.325 . . . . 1.0 113.625 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.39 126.08 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 125.103 1.12 . . . . 1.0 108.314 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -119.4 134.16 55.35 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 125.57 1.794 . . . . 1.0 110.084 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -80.0 -31.46 39.72 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.875 1.27 . . . . 1.0 113.743 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.6 -35.61 29.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.275 1.43 . . . . 1.0 113.111 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -92.09 -15.92 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.733 1.213 . . . . 1.0 113.432 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 58.55 32.89 22.64 Favored 'General case' 0 N--CA 1.533 3.71 0 C-N-CA 127.158 2.183 . . . . 1.0 113.925 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -106.24 136.42 45.98 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 114.28 -1.327 . . . . 1.0 111.355 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.28 126.72 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.405 1.691 . . . . 1.0 107.838 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -122.51 128.4 50.76 Favored 'General case' 0 C--O 1.25 1.127 0 O-C-N 125.429 1.706 . . . . 1.0 109.89 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.18 132.29 47.27 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 124.978 1.424 . . . . 1.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 C--O 1.249 1.031 0 O-C-N 125.33 1.644 . . . . 1.0 111.208 179.805 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.5 ptm . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 111.282 0.105 . . . . 1.0 111.282 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -111.02 139.71 46.15 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 125.316 1.635 . . . . 1.0 110.601 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -118.52 139.04 52.07 Favored 'General case' 0 C--O 1.25 1.082 0 O-C-N 124.655 1.222 . . . . 1.0 110.981 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.0 t -70.81 121.02 82.65 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 117.777 -1.106 . . . . 1.0 111.761 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.01 -4.35 15.27 Favored 'Trans proline' 1 C--N 1.434 5.044 0 C-N-CA 122.19 1.927 . . . . 1.0 114.843 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.02 -56.05 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 125.253 1.421 . . . . 1.0 109.766 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.64 -41.04 6.07 Favored 'General case' 0 C--N 1.37 1.488 0 O-C-N 124.338 1.024 . . . . 1.0 113.195 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.9 34.57 6.46 Favored Glycine 0 C--N 1.368 2.327 0 O-C-N 124.81 1.319 . . . . 1.0 114.02 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -91.39 142.59 27.16 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 116.928 -1.51 . . . . 1.0 112.796 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 131.62 24.45 Favored 'Trans proline' 1 C--N 1.449 5.819 0 C-N-CA 122.602 2.201 . . . . 1.0 114.376 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mt -122.96 144.55 49.16 Favored 'General case' 0 C--O 1.25 1.118 0 O-C-N 125.125 1.516 . . . . 1.0 110.762 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.07 133.95 41.06 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 124.802 1.313 . . . . 1.0 110.681 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.505 ' O ' HG12 ' A' ' 24' ' ' ILE . 52.9 m95 -68.53 -26.65 65.54 Favored 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 124.899 1.28 . . . . 1.0 113.426 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.27 -31.75 66.03 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.59 1.556 . . . . 1.0 113.097 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.15 -33.48 65.52 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 125.277 1.431 . . . . 1.0 112.915 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.03 -39.92 82.99 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.884 1.674 . . . . 1.0 112.858 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 20' ' ' TRP . 6.1 mm -74.43 -41.03 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 125.806 1.643 . . . . 1.0 110.604 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.86 -36.86 83.29 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.389 1.476 . . . . 1.0 113.24 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.29 -22.63 41.39 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 125.355 1.462 . . . . 1.0 112.841 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.477 ' O ' HD11 ' A' ' 30' ' ' ILE . 48.6 mtp -104.61 12.1 33.42 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 124.681 1.238 . . . . 1.0 112.41 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.3 16.63 8.33 Favored 'General case' 0 CA--C 1.58 2.098 0 C-N-CA 123.826 0.85 . . . . 1.0 112.914 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -3.74 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 C-N-CA 125.747 1.619 . . . . 1.0 112.965 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.477 HD11 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.5 137.48 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.982 1.313 . . . . 1.0 109.255 -177.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.36 -27.07 61.29 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 125.752 1.621 . . . . 1.0 114.374 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -77.65 -17.98 57.17 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.117 1.367 . . . . 1.0 113.209 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.92 -36.46 72.5 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 126.077 1.751 . . . . 1.0 113.188 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -60.58 -29.34 69.13 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.468 1.507 . . . . 1.0 112.463 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.41 -34.52 20.14 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.48 1.512 . . . . 1.0 112.409 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.8 mt -71.04 -41.06 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 C-N-CA 125.759 1.624 . . . . 1.0 110.664 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' O ' HD22 ' A' ' 78' ' ' LEU . 8.9 m -59.39 -21.82 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 125.545 1.538 . . . . 1.0 114.84 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -87.94 -21.11 25.09 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 125.052 1.341 . . . . 1.0 112.796 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -121.66 106.66 11.54 Favored 'General case' 0 C--N 1.371 1.541 0 O-C-N 124.323 1.015 . . . . 1.0 112.124 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.425 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.35 -34.82 72.84 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 126.106 1.762 . . . . 1.0 113.853 176.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.0 -32.24 72.5 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 125.941 1.696 . . . . 1.0 112.727 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -82.69 -32.54 28.01 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.329 1.451 . . . . 1.0 112.228 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.531 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -75.41 -46.51 32.37 Favored 'General case' 0 C--N 1.387 2.215 0 C-N-CA 125.013 1.325 . . . . 1.0 112.946 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -69.66 -33.37 72.5 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 124.789 1.236 . . . . 1.0 112.958 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.513 1.525 . . . . 1.0 113.206 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 5.4 mt-30 -79.29 -35.21 41.61 Favored 'General case' 0 C--N 1.379 1.86 0 C-N-CA 125.077 1.351 . . . . 1.0 112.833 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.0 t -67.84 -41.22 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 125.241 1.416 . . . . 1.0 109.354 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.63 -24.3 60.0 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 125.316 1.447 . . . . 1.0 113.507 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -94.42 -25.52 16.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.859 1.264 . . . . 1.0 113.327 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.08 148.46 25.71 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 124.343 1.057 . . . . 1.0 111.049 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -97.51 155.82 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 O-C-N 124.758 1.286 . . . . 1.0 110.439 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 95.8 m-85 -126.41 143.76 51.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.086 1.491 . . . . 1.0 110.311 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -97.11 137.39 36.23 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.861 1.351 . . . . 1.0 111.423 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.08 106.52 19.81 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 124.972 1.42 . . . . 1.0 110.025 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -69.39 -7.94 22.27 Favored 'Trans proline' 1 C--N 1.44 5.355 0 C-N-CA 123.132 2.555 . . . . 1.0 114.193 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.76 -50.94 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.944 1.698 . . . . 1.0 110.403 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.7 p -104.47 -50.15 3.39 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 124.596 1.185 . . . . 1.0 112.186 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.31 -0.42 14.35 Favored Glycine 0 C--N 1.37 2.434 0 O-C-N 124.534 1.146 . . . . 1.0 114.209 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -93.74 150.85 20.05 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 125.162 1.385 . . . . 1.0 111.521 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.18 138.16 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.607 1.163 . . . . 1.0 111.141 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.13 143.17 51.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.165 1.54 . . . . 1.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.69 150.45 21.78 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.431 1.082 . . . . 1.0 112.24 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.22 -8.34 83.3 Favored Glycine 0 C--N 1.377 2.83 0 O-C-N 124.485 1.116 . . . . 1.0 114.867 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -86.39 -20.89 27.56 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.386 1.474 . . . . 1.0 111.87 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.9 p -94.09 1.67 56.12 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.903 1.281 . . . . 1.0 112.61 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 144.77 30.43 Favored Pre-proline 0 C--N 1.379 1.856 0 CA-C-O 117.146 -1.407 . . . . 1.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.21 158.32 55.37 Favored 'Trans proline' 1 C--N 1.445 5.641 0 C-N-CA 123.032 2.488 . . . . 1.0 114.705 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -61.96 -33.07 73.61 Favored 'General case' 0 N--CA 1.515 2.776 0 C-N-CA 124.85 1.26 . . . . 1.0 113.074 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.31 -40.4 77.81 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 125.468 1.507 . . . . 1.0 112.505 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 29.1 mt-10 -76.73 -28.84 55.94 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.044 1.338 . . . . 1.0 112.102 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.402 ' O ' HD22 ' A' ' 44' ' ' LEU . . . -68.44 -32.99 73.41 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 125.814 1.646 . . . . 1.0 112.391 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.7 -24.99 61.91 Favored 'General case' 0 C--N 1.382 2.018 0 C-N-CA 125.637 1.575 . . . . 1.0 112.697 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.62 -28.18 66.68 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 125.902 1.681 . . . . 1.0 112.217 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.97 -38.5 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 C-N-CA 126.385 1.874 . . . . 1.0 109.738 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -27.16 69.08 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 125.355 1.462 . . . . 1.0 113.352 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -68.49 -41.05 80.65 Favored 'General case' 0 C--N 1.388 2.245 0 C-N-CA 125.789 1.636 . . . . 1.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.44 -30.52 66.13 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.83 1.252 . . . . 1.0 112.739 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.6 -24.93 49.54 Favored 'General case' 0 C--N 1.378 1.806 0 C-N-CA 125.597 1.559 . . . . 1.0 112.726 177.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.3 -16.69 21.2 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 124.802 1.241 . . . . 1.0 112.231 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.77 62.51 0.6 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 123.057 1.408 . . . . 1.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.57 -25.09 62.05 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 113.48 -1.691 . . . . 1.0 113.313 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -106.72 134.25 50.15 Favored 'General case' 0 C--O 1.254 1.302 0 O-C-N 125.069 1.481 . . . . 1.0 109.254 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.58 -102.54 0.22 Allowed Glycine 0 C--N 1.356 1.652 0 O-C-N 124.949 1.405 . . . . 1.0 112.095 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.9 55.52 0.73 Allowed Glycine 0 C--N 1.359 1.825 0 O-C-N 125.441 1.318 . . . . 1.0 113.272 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -118.71 120.95 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 129.92 50.6 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 125.26 1.6 . . . . 1.0 110.599 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -80.86 -33.74 34.23 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.731 1.269 . . . . 1.0 113.445 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -82.28 -35.88 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.081 1.352 . . . . 1.0 112.95 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -88.7 -16.88 31.17 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.767 1.227 . . . . 1.0 113.139 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.0 mttt 59.11 52.41 6.24 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 127.337 2.255 . . . . 1.0 112.406 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 68.3 mtp180 -122.39 124.34 43.44 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 113.934 -1.484 . . . . 1.0 110.144 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.27 124.0 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 125.347 1.654 . . . . 1.0 107.391 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -124.86 134.71 52.61 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 125.401 1.688 . . . . 1.0 110.347 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.81 127.63 55.21 Favored 'General case' 0 C--O 1.252 1.207 0 O-C-N 125.205 1.565 . . . . 1.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.283 1.615 . . . . 1.0 111.247 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.661 ' H ' ' HZ2' ' A' ' 73' ' ' LYS . 41.4 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.342 0.127 . . . . 1.0 111.342 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -107.72 142.5 37.62 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.215 1.572 . . . . 1.0 110.855 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -123.26 138.34 54.65 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.785 1.303 . . . . 1.0 111.259 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.447 ' SG ' HD12 ' A' ' 13' ' ' ILE . 14.3 t -72.71 122.85 88.64 Favored Pre-proline 0 CA--C 1.582 2.173 0 C-N-CA 124.731 1.212 . . . . 1.0 112.675 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.54 -1.68 11.39 Favored 'Trans proline' 1 C--N 1.435 5.085 0 C-N-CA 122.106 1.871 . . . . 1.0 115.085 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.447 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -100.0 -55.97 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 124.614 1.165 . . . . 1.0 109.406 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -103.8 -41.93 5.76 Favored 'General case' 0 C--N 1.373 1.589 0 O-C-N 124.544 1.152 . . . . 1.0 112.985 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.82 35.73 7.1 Favored Glycine 0 C--N 1.369 2.371 0 O-C-N 124.751 1.282 . . . . 1.0 114.253 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -95.51 148.72 35.07 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 116.871 -1.538 . . . . 1.0 111.807 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -69.22 140.78 45.61 Favored 'Trans proline' 1 C--N 1.448 5.775 0 C-N-CA 122.844 2.363 . . . . 1.0 114.955 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.37 145.43 51.08 Favored 'General case' 0 C--O 1.249 1.052 0 O-C-N 125.524 1.765 . . . . 1.0 110.324 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -99.39 135.26 41.06 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.716 1.26 . . . . 1.0 110.888 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' O ' HG12 ' A' ' 24' ' ' ILE . 59.5 m95 -69.19 -24.87 64.1 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.049 1.339 . . . . 1.0 113.326 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -70.39 -30.42 67.31 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.022 1.729 . . . . 1.0 113.03 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.42 -35.07 63.4 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 125.16 1.384 . . . . 1.0 113.127 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -40.25 85.18 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.866 1.667 . . . . 1.0 113.602 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.8 mm -74.64 -41.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 C-N-CA 125.581 1.552 . . . . 1.0 110.531 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -67.29 -35.92 80.47 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.338 1.455 . . . . 1.0 113.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.4 -22.93 40.76 Favored 'General case' 0 C--N 1.375 1.685 0 C-N-CA 125.409 1.483 . . . . 1.0 113.452 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.457 ' SD ' ' HE1' ' A' ' 52' ' ' PHE . 55.2 mtp -102.65 1.61 34.85 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 124.563 1.164 . . . . 1.0 113.0 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.45 12.96 3.26 Favored 'General case' 0 CA--C 1.582 2.177 0 C-N-CA 124.805 1.242 . . . . 1.0 113.765 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -8.12 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 125.344 1.457 . . . . 1.0 113.283 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.453 HD12 ' O ' ' A' ' 27' ' ' MET . 1.1 mt -98.98 137.53 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 125.109 1.364 . . . . 1.0 108.553 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -74.6 -27.36 60.44 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 124.831 1.332 . . . . 1.0 113.879 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.79 -22.86 62.32 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 125.243 1.417 . . . . 1.0 112.926 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -34.1 65.73 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.527 1.931 . . . . 1.0 114.384 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.48 -28.33 69.89 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 125.268 1.427 . . . . 1.0 112.303 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.22 -34.62 20.41 Favored 'General case' 0 C--N 1.376 1.758 0 C-N-CA 125.421 1.488 . . . . 1.0 112.481 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.76 -39.63 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 C-N-CA 125.679 1.592 . . . . 1.0 110.423 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.44 ' O ' HD22 ' A' ' 78' ' ' LEU . 10.0 m -61.14 -20.07 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 125.188 1.395 . . . . 1.0 114.716 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -85.57 -19.95 30.31 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.091 1.356 . . . . 1.0 113.571 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.6 110.93 12.69 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 124.21 1.004 . . . . 1.0 111.666 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -60.35 -32.26 71.1 Favored 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 126.221 1.808 . . . . 1.0 115.451 177.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.43 -31.83 71.43 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.311 1.444 . . . . 1.0 113.337 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 72.3 mtp180 -82.42 -34.75 28.12 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.05 1.34 . . . . 1.0 112.869 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' O ' HG22 ' A' ' 47' ' ' VAL . 3.4 t80 -70.51 -44.32 67.84 Favored 'General case' 0 C--N 1.389 2.287 0 C-N-CA 125.08 1.352 . . . . 1.0 112.605 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.437 HD22 ' O ' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -70.21 -35.96 74.25 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.987 1.315 . . . . 1.0 113.144 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.15 -29.63 63.0 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.385 1.474 . . . . 1.0 113.204 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.1 tt0 -78.95 -34.4 44.41 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.368 1.467 . . . . 1.0 113.016 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 43' ' ' PHE . 89.7 t -69.89 -40.22 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.552 1.541 . . . . 1.0 109.762 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.12 -34.26 70.9 Favored 'General case' 0 N--CA 1.511 2.609 0 C-N-CA 125.575 1.55 . . . . 1.0 113.167 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.63 -27.36 29.19 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.318 1.447 . . . . 1.0 113.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -98.97 151.91 20.38 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.636 1.174 . . . . 1.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.05 148.0 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 O-C-N 124.664 1.227 . . . . 1.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.457 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 88.4 m-85 -121.71 152.04 39.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.671 1.232 . . . . 1.0 110.699 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -101.85 141.76 34.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.202 0.939 . . . . 1.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 24.1 t -96.05 119.39 64.69 Favored Pre-proline 0 CA--C 1.572 1.802 0 O-C-N 124.848 1.343 . . . . 1.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.07 -7.74 19.37 Favored 'Trans proline' 1 C--N 1.437 5.2 0 C-N-CA 122.25 1.967 . . . . 1.0 115.233 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 t -88.32 -51.94 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 C-N-CA 124.694 1.198 . . . . 1.0 110.299 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.38 -50.56 3.89 Favored 'General case' 0 C--N 1.367 1.343 0 O-C-N 124.691 1.245 . . . . 1.0 112.084 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 -14.57 12.1 Favored Glycine 0 C--N 1.371 2.523 0 O-C-N 124.473 1.108 . . . . 1.0 115.18 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -82.17 153.52 25.95 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 124.859 1.264 . . . . 1.0 112.565 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.45 138.41 31.5 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.163 1.385 . . . . 1.0 112.006 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -129.17 141.27 51.22 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 125.185 1.553 . . . . 1.0 109.814 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.3 151.53 19.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.318 1.011 . . . . 1.0 112.381 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.79 -8.02 86.33 Favored Glycine 0 C--N 1.378 2.884 0 O-C-N 124.437 1.085 . . . . 1.0 114.639 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -86.32 -19.6 29.57 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.466 1.506 . . . . 1.0 111.659 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.4 p -97.53 6.82 47.55 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.966 1.306 . . . . 1.0 112.055 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.76 159.07 55.75 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-O 117.344 -1.312 . . . . 1.0 111.393 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -69.68 154.51 67.98 Favored 'Trans proline' 1 C--N 1.441 5.432 0 C-N-CA 123.197 2.598 . . . . 1.0 114.227 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -68.26 -17.97 64.43 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 115.173 1.545 . . . . 1.0 115.173 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -83.67 -33.68 25.15 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.496 1.118 . . . . 1.0 112.221 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.5 mt-10 -69.86 -28.68 65.86 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.585 1.554 . . . . 1.0 113.49 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' O ' HD22 ' A' ' 44' ' ' LEU . . . -64.27 -31.91 73.3 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.727 1.611 . . . . 1.0 112.852 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.19 -27.88 62.84 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 125.693 1.597 . . . . 1.0 111.987 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HZ2' ' H ' ' A' ' 8' ' ' MET . 94.9 mttt -68.26 -28.77 67.5 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 125.962 1.705 . . . . 1.0 112.65 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.97 -40.06 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 C-N-CA 126.026 1.73 . . . . 1.0 109.331 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -28.0 65.57 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 125.772 1.629 . . . . 1.0 113.401 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -71.58 -42.63 67.54 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.188 1.795 . . . . 1.0 113.019 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.4 pp -67.28 -37.25 83.14 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.353 1.061 . . . . 1.0 112.513 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.441 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -71.2 -37.46 72.11 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.881 1.673 . . . . 1.0 113.079 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.68 -31.96 36.14 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.359 1.463 . . . . 1.0 114.129 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -98.64 57.81 1.18 Allowed 'General case' 0 C--O 1.26 1.646 0 CA-C-O 123.093 1.425 . . . . 1.0 110.712 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.45 145.61 24.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.005 -1.907 . . . . 1.0 111.48 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttm 77.46 112.02 0.07 Allowed 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 127.46 2.304 . . . . 1.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.22 -74.49 0.22 Allowed Glycine 0 C--N 1.36 1.874 0 O-C-N 125.037 1.46 . . . . 1.0 112.953 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.59 31.02 5.36 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 125.314 1.243 . . . . 1.0 115.348 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.39 120.12 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.05 130.17 51.75 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 125.177 1.548 . . . . 1.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.39 -32.59 32.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.887 1.275 . . . . 1.0 114.029 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.32 -35.73 40.68 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 124.964 1.305 . . . . 1.0 113.3 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -94.73 -15.34 23.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.652 1.22 . . . . 1.0 113.336 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 60.12 51.31 5.78 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 127.193 2.197 . . . . 1.0 113.903 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -113.34 128.83 56.59 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.899 -1.501 . . . . 1.0 110.435 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.46 130.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 124.99 1.431 . . . . 1.0 108.147 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -121.71 137.04 54.92 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 125.048 1.467 . . . . 1.0 111.364 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.83 130.93 53.48 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.126 1.517 . . . . 1.0 109.727 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 mttp . . . . . 0 C--O 1.253 1.238 0 O-C-N 125.213 1.57 . . . . 1.0 111.287 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 36.4 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.85 138.67 41.65 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 125.272 1.608 . . . . 1.0 110.884 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -106.81 138.64 42.61 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 124.901 1.375 . . . . 1.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.8 t -73.76 130.3 83.69 Favored Pre-proline 0 CA--C 1.582 2.207 0 CA-C-O 116.907 -1.52 . . . . 1.0 112.151 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.12 -11.75 27.37 Favored 'Trans proline' 1 C--N 1.441 5.404 0 C-N-CA 122.573 2.182 . . . . 1.0 114.406 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 57' ' ' CYS . 1.5 mp -93.73 -55.12 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.221 1.408 . . . . 1.0 110.482 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 29.1 p -103.35 -41.16 6.11 Favored 'General case' 0 C--N 1.372 1.569 0 O-C-N 124.302 1.001 . . . . 1.0 113.424 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.13 34.6 8.67 Favored Glycine 0 C--N 1.371 2.525 0 O-C-N 124.818 1.324 . . . . 1.0 113.324 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.527 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -92.74 144.63 28.91 Favored Pre-proline 0 C--N 1.369 1.447 0 CA-C-O 117.016 -1.468 . . . . 1.0 112.808 -178.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.59 135.36 38.66 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 122.46 2.107 . . . . 1.0 114.839 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mt -120.16 144.92 47.41 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 125.333 1.646 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.09 129.01 38.14 Favored 'General case' 0 C--N 1.362 1.111 0 O-C-N 124.876 1.36 . . . . 1.0 111.072 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.489 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.0 m95 -68.66 -25.58 64.89 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 125.136 1.374 . . . . 1.0 113.115 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 mt-10 -70.16 -32.27 70.15 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.936 1.695 . . . . 1.0 112.59 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -76.55 -34.1 58.51 Favored 'General case' 0 C--N 1.385 2.136 0 C-N-CA 125.225 1.41 . . . . 1.0 112.712 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -41.32 91.8 Favored 'General case' 0 C--N 1.383 2.051 0 C-N-CA 126.495 1.918 . . . . 1.0 112.764 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 20' ' ' TRP . 5.9 mm -78.97 -38.59 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 125.607 1.563 . . . . 1.0 110.445 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -65.49 -35.38 80.73 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 125.475 1.51 . . . . 1.0 113.491 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.46 -24.04 39.81 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.876 1.671 . . . . 1.0 112.451 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.487 ' O ' HD12 ' A' ' 30' ' ' ILE . 24.0 mtp -101.56 9.06 41.6 Favored 'General case' 0 CA--C 1.575 1.908 0 O-C-N 124.805 1.316 . . . . 1.0 112.943 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 13.4 13.77 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 124.163 0.985 . . . . 1.0 112.978 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.92 -6.36 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 125.606 1.562 . . . . 1.0 113.317 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -97.96 140.84 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 125.285 1.434 . . . . 1.0 109.048 -178.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.71 -19.1 42.22 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.852 1.345 . . . . 1.0 113.306 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.8 -19.94 50.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.183 1.393 . . . . 1.0 112.584 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.51 -35.77 70.69 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 126.327 1.851 . . . . 1.0 113.374 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.02 -28.0 69.28 Favored 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 125.337 1.455 . . . . 1.0 112.182 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -87.63 -33.88 18.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.843 1.657 . . . . 1.0 112.149 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -71.26 -40.25 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.991 0 C-N-CA 125.739 1.616 . . . . 1.0 110.634 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.504 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.1 m -58.75 -24.47 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 C-N-CA 125.687 1.595 . . . . 1.0 114.741 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -87.73 -15.24 37.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 1.0 113.022 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -125.36 106.34 9.76 Favored 'General case' 0 C--N 1.375 1.684 0 C-N-CA 124.473 1.109 . . . . 1.0 111.767 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' O ' HD11 ' A' ' 44' ' ' LEU . 11.6 mtm180 -59.11 -33.12 70.48 Favored 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 125.956 1.702 . . . . 1.0 113.863 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.14 -31.21 68.63 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.943 1.697 . . . . 1.0 112.839 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -82.0 -33.58 30.05 Favored 'General case' 0 C--N 1.38 1.917 0 C-N-CA 125.196 1.398 . . . . 1.0 112.552 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.19 -43.95 63.74 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 124.938 1.295 . . . . 1.0 112.815 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.494 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -70.33 -31.27 68.49 Favored 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 125.359 1.463 . . . . 1.0 113.049 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -26.68 33.58 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 125.305 1.442 . . . . 1.0 112.932 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.8 mm100 -79.25 -38.18 36.18 Favored 'General case' 0 C--N 1.384 2.093 0 C-N-CA 124.798 1.239 . . . . 1.0 112.615 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 68.3 t -68.16 -40.04 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 125.472 1.509 . . . . 1.0 109.68 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.48 -24.83 62.07 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 125.522 1.529 . . . . 1.0 113.142 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.29 -15.85 19.62 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.111 1.364 . . . . 1.0 113.153 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -93.19 151.29 19.92 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 124.62 1.168 . . . . 1.0 112.315 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.9 t -97.94 140.64 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 125.092 1.495 . . . . 1.0 107.791 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -128.44 146.31 50.84 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.602 1.814 . . . . 1.0 109.571 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -105.1 142.25 35.22 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 124.779 1.299 . . . . 1.0 111.259 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.69 131.38 37.95 Favored Pre-proline 0 CA--C 1.574 1.875 0 O-C-N 124.982 1.427 . . . . 1.0 111.352 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.68 -9.62 22.77 Favored 'Trans proline' 1 C--N 1.437 5.221 0 C-N-CA 122.439 2.092 . . . . 1.0 114.268 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.06 -53.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 125.274 1.43 . . . . 1.0 109.709 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 25.0 m -88.73 -53.98 4.37 Favored 'General case' 0 C--N 1.379 1.874 0 O-C-N 124.253 0.971 . . . . 1.0 112.1 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.32 6.63 61.23 Favored Glycine 0 C--N 1.37 2.45 0 O-C-N 124.885 1.366 . . . . 1.0 113.378 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.26 165.83 16.16 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 126.126 1.77 . . . . 1.0 112.332 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.2 134.28 35.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.06 1.344 . . . . 1.0 110.733 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.08 153.41 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.393 1.477 . . . . 1.0 109.983 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.49 154.04 21.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.577 1.173 . . . . 1.0 112.398 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.0 -1.19 72.39 Favored Glycine 0 C--N 1.378 2.881 0 O-C-N 124.446 1.091 . . . . 1.0 114.424 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -85.65 -17.41 36.19 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.169 1.387 . . . . 1.0 111.596 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.5 p -95.55 3.31 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.993 1.317 . . . . 1.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.44 152.71 73.35 Favored Pre-proline 0 CA--C 1.58 2.108 0 CA-C-O 116.86 -1.543 . . . . 1.0 111.703 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -64.1 149.87 89.51 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 123.252 2.634 . . . . 1.0 114.931 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -65.05 -17.83 64.79 Favored 'General case' 0 N--CA 1.51 2.533 0 C-N-CA 125.517 1.527 . . . . 1.0 114.835 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -82.53 -33.13 28.32 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.03 1.332 . . . . 1.0 111.533 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.18 -30.16 66.08 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.787 1.635 . . . . 1.0 113.042 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.494 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -66.87 -36.3 82.0 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 125.58 1.552 . . . . 1.0 112.388 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -71.8 -24.22 61.7 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 125.41 1.484 . . . . 1.0 112.356 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -74.76 -27.94 60.55 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 126.181 1.792 . . . . 1.0 112.439 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 t -67.11 -39.73 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 C-N-CA 126.195 1.798 . . . . 1.0 110.305 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -60.56 -29.46 69.18 Favored 'General case' 0 N--CA 1.511 2.605 0 C-N-CA 125.608 1.563 . . . . 1.0 113.651 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.18 -40.81 71.01 Favored 'General case' 0 C--N 1.384 2.087 0 C-N-CA 125.731 1.613 . . . . 1.0 113.212 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.7 pp -70.15 -34.96 73.68 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 124.903 1.281 . . . . 1.0 113.554 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -79.32 -24.18 42.98 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.105 1.362 . . . . 1.0 112.453 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -85.36 -14.61 45.87 Favored 'General case' 0 C--N 1.382 2.002 0 C-N-CA 124.862 1.265 . . . . 1.0 113.357 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.12 -36.96 84.53 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 125.667 1.587 . . . . 1.0 113.819 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 61.57 -58.72 0.11 Allowed 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 128.112 2.565 . . . . 1.0 114.174 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -128.59 136.46 50.74 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 125.115 1.366 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -174.07 -102.02 0.15 Allowed Glycine 0 C--N 1.356 1.679 0 O-C-N 125.151 1.532 . . . . 1.0 111.807 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.76 44.66 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 O-C-N 125.504 1.355 . . . . 1.0 113.395 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.3 123.6 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.812 -1.551 . . . . 1.0 106.812 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.75 128.74 45.88 Favored 'General case' 0 C--O 1.248 1.015 0 O-C-N 125.324 1.64 . . . . 1.0 110.252 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -80.81 -26.38 37.14 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.807 1.243 . . . . 1.0 114.071 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -80.94 -38.4 27.88 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 125.14 1.376 . . . . 1.0 113.178 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -97.32 -14.4 21.32 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 124.555 1.159 . . . . 1.0 113.678 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttm 60.35 55.81 3.41 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 127.342 2.257 . . . . 1.0 113.319 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 86.5 mtt180 -115.93 130.2 56.72 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.16 127.38 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 125.126 1.516 . . . . 1.0 107.996 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -119.66 136.81 54.24 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 125.374 1.671 . . . . 1.0 110.537 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.29 129.14 56.61 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 124.973 1.42 . . . . 1.0 111.583 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt . . . . . 0 N--CA 1.48 1.03 0 O-C-N 125.777 1.923 . . . . 1.0 111.06 179.562 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.4 mmt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 111.238 0.088 . . . . 1.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.5 139.91 41.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 125.268 1.605 . . . . 1.0 110.488 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -128.42 138.9 52.54 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.774 1.296 . . . . 1.0 111.114 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 27.1 t -73.14 121.27 84.68 Favored Pre-proline 0 CA--C 1.582 2.21 0 CA-C-O 117.58 -1.2 . . . . 1.0 111.784 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 -6.37 18.97 Favored 'Trans proline' 1 C--N 1.433 4.974 0 C-N-CA 121.965 1.777 . . . . 1.0 114.834 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -95.72 -55.41 6.13 Favored 'Isoleucine or valine' 0 C--N 1.372 1.575 0 C-N-CA 125.069 1.348 . . . . 1.0 110.05 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.2 p -103.79 -41.75 5.82 Favored 'General case' 0 C--N 1.374 1.634 0 O-C-N 124.245 0.965 . . . . 1.0 112.795 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.99 36.3 6.06 Favored Glycine 0 C--N 1.367 2.288 0 O-C-N 124.711 1.257 . . . . 1.0 114.151 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.42 ' OG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -97.89 147.52 33.17 Favored Pre-proline 0 CA--C 1.565 1.552 0 CA-C-O 116.848 -1.548 . . . . 1.0 111.83 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.71 139.13 39.64 Favored 'Trans proline' 1 C--N 1.446 5.708 0 C-N-CA 122.733 2.288 . . . . 1.0 114.33 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 mt -124.37 146.17 49.01 Favored 'General case' 0 C--O 1.25 1.131 0 O-C-N 125.436 1.71 . . . . 1.0 110.302 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.32 124.91 38.64 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 124.682 1.239 . . . . 1.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.471 ' O ' HG12 ' A' ' 24' ' ' ILE . 44.8 m95 -69.25 -24.83 64.04 Favored 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 125.091 1.356 . . . . 1.0 112.594 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 35.9 mt-10 -69.94 -31.59 69.42 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.72 1.608 . . . . 1.0 112.094 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -76.37 -34.0 58.92 Favored 'General case' 0 C--N 1.39 2.344 0 C-N-CA 124.923 1.289 . . . . 1.0 112.455 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -41.04 93.95 Favored 'General case' 0 C--N 1.381 1.967 0 C-N-CA 126.199 1.8 . . . . 1.0 112.711 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.2 mm -79.79 -39.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 C-N-CA 125.419 1.488 . . . . 1.0 110.641 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.63 -35.36 79.99 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 125.297 1.439 . . . . 1.0 113.678 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.68 -22.97 42.78 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 125.541 1.536 . . . . 1.0 112.586 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.492 ' O ' HD12 ' A' ' 30' ' ' ILE . 30.7 mtt -105.21 10.29 33.78 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 124.991 1.432 . . . . 1.0 112.128 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.39 23.26 4.62 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.007 0.923 . . . . 1.0 112.935 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.85 6.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 125.096 1.358 . . . . 1.0 112.79 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 27' ' ' MET . 1.1 mt -109.27 139.69 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.037 1.335 . . . . 1.0 109.138 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.0 -20.47 28.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.142 1.526 . . . . 1.0 112.235 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' HD12 ' A' ' 36' ' ' ILE . 10.4 m120 -91.6 19.54 6.21 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.179 1.391 . . . . 1.0 112.055 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.84 -36.3 56.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.313 1.445 . . . . 1.0 111.778 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -55.67 -23.88 30.84 Favored 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 126.068 1.747 . . . . 1.0 114.684 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.79 -43.83 15.02 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 125.074 1.35 . . . . 1.0 111.495 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 32' ' ' ASN . 3.2 mt -72.8 -43.05 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 125.297 1.439 . . . . 1.0 110.934 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -68.26 -19.26 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.757 0 C-N-CA 125.124 1.37 . . . . 1.0 114.132 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -91.96 -17.77 24.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.621 1.2 . . . . 1.0 112.698 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.0 105.47 9.61 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 124.351 1.06 . . . . 1.0 111.412 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -57.19 -31.63 65.65 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 125.386 1.475 . . . . 1.0 114.104 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.3 -33.49 74.42 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.778 1.631 . . . . 1.0 112.652 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -82.16 -35.84 28.01 Favored 'General case' 0 C--N 1.377 1.792 0 C-N-CA 125.339 1.456 . . . . 1.0 112.429 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.5 t80 -73.69 -45.27 53.45 Favored 'General case' 0 C--N 1.39 2.357 0 C-N-CA 125.089 1.356 . . . . 1.0 112.523 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.58 -28.18 66.72 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 124.597 1.159 . . . . 1.0 113.048 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.77 -28.61 36.36 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.154 1.382 . . . . 1.0 112.619 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 2.2 tt0 -79.6 -38.25 34.37 Favored 'General case' 0 C--N 1.381 1.968 0 C-N-CA 125.094 1.358 . . . . 1.0 112.337 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 43' ' ' PHE . 49.1 t -68.99 -42.07 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.215 0 C-N-CA 125.341 1.456 . . . . 1.0 109.635 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.89 -28.28 67.37 Favored 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.455 1.502 . . . . 1.0 113.544 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -91.92 -26.75 18.29 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.863 1.265 . . . . 1.0 113.488 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -97.6 147.42 24.32 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 124.566 1.146 . . . . 1.0 111.254 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.0 151.89 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 O-C-N 124.835 1.335 . . . . 1.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -122.56 144.57 49.01 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.949 1.406 . . . . 1.0 110.434 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -96.77 138.77 33.83 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 124.787 1.305 . . . . 1.0 111.268 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.6 t -96.5 111.76 57.99 Favored Pre-proline 0 CA--C 1.576 1.961 0 O-C-N 125.026 1.454 . . . . 1.0 110.654 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -70.57 -8.07 22.76 Favored 'Trans proline' 1 C--N 1.439 5.299 0 C-N-CA 122.984 2.456 . . . . 1.0 114.348 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.42 HG11 ' OG ' ' A' ' 16' ' ' SER . 1.8 t -85.31 -51.97 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 125.577 1.551 . . . . 1.0 110.597 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.1 p -103.76 -48.14 4.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.722 1.264 . . . . 1.0 112.504 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.1 -10.94 14.93 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 124.442 1.089 . . . . 1.0 114.348 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.4 147.82 25.27 Favored 'General case' 0 C--N 1.376 1.738 0 C-N-CA 124.963 1.305 . . . . 1.0 111.476 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.74 138.54 31.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.783 1.233 . . . . 1.0 112.36 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -122.35 143.11 49.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.214 1.571 . . . . 1.0 109.833 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -95.31 151.67 19.06 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 124.318 1.012 . . . . 1.0 112.659 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.21 -9.07 80.48 Favored Glycine 0 C--N 1.379 2.932 0 O-C-N 124.661 1.226 . . . . 1.0 115.125 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -87.55 -18.25 30.18 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.256 1.422 . . . . 1.0 112.047 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 p -99.63 2.68 44.73 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.841 1.256 . . . . 1.0 112.018 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 152.89 81.22 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 116.982 -1.485 . . . . 1.0 111.969 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.49 152.2 82.59 Favored 'Trans proline' 1 C--N 1.444 5.553 0 C-N-CA 123.289 2.659 . . . . 1.0 114.67 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -66.98 -19.58 65.74 Favored 'General case' 0 N--CA 1.507 2.405 0 C-N-CA 125.19 1.396 . . . . 1.0 114.566 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -79.6 -34.17 40.93 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 125.002 1.321 . . . . 1.0 112.073 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -70.12 -29.46 66.42 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.743 1.617 . . . . 1.0 113.239 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.18 71.93 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.845 1.658 . . . . 1.0 112.863 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.01 -26.2 63.02 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 1.0 112.933 176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -68.7 -28.03 66.48 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.968 1.707 . . . . 1.0 112.785 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t -65.92 -33.91 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.09 0 C-N-CA 126.519 1.928 . . . . 1.0 110.281 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.27 -29.16 69.9 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 125.784 1.634 . . . . 1.0 113.828 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -68.27 -38.5 81.81 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 125.67 1.588 . . . . 1.0 113.068 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.2 pp -72.84 -29.29 63.1 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.599 1.16 . . . . 1.0 112.825 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -26.93 43.5 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 125.405 1.482 . . . . 1.0 113.055 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -98.16 -20.18 17.45 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.423 1.089 . . . . 1.0 113.57 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.06 62.24 0.64 Allowed 'General case' 0 C--O 1.259 1.562 0 CA-C-O 123.127 1.442 . . . . 1.0 110.919 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -69.38 -34.98 75.34 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 113.349 -1.75 . . . . 1.0 113.106 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -106.36 120.3 41.52 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 124.973 1.42 . . . . 1.0 108.709 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.44 84.63 1.68 Allowed Glycine 0 C--N 1.363 2.071 0 O-C-N 124.661 1.226 . . . . 1.0 112.934 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 136.36 -57.99 0.67 Allowed Glycine 0 C--N 1.359 1.827 0 O-C-N 125.307 1.24 . . . . 1.0 113.468 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.4 mp -109.05 124.6 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 125.104 1.12 . . . . 1.0 108.126 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.06 133.11 56.01 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.495 1.747 . . . . 1.0 110.19 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -80.53 -29.35 37.19 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.588 1.18 . . . . 1.0 113.911 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.18 -35.42 28.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 124.877 1.271 . . . . 1.0 112.935 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -92.76 -17.88 23.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.613 1.196 . . . . 1.0 113.495 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 59.2 45.59 14.13 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 127.157 2.183 . . . . 1.0 113.516 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 9.1 mmm180 -115.27 138.19 51.22 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.284 -1.326 . . . . 1.0 111.435 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.84 126.92 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 125.174 1.546 . . . . 1.0 108.235 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 12.1 tttt -127.11 129.35 47.77 Favored 'General case' 0 C--O 1.251 1.143 0 O-C-N 125.28 1.612 . . . . 1.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 132.97 52.74 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.762 1.289 . . . . 1.0 110.716 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.7 mttm . . . . . 0 C--O 1.252 1.221 0 O-C-N 125.289 1.618 . . . . 1.0 111.357 179.799 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 110.851 -0.055 . . . . 1.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.73 138.61 44.78 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 125.179 1.549 . . . . 1.0 110.829 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -110.94 139.06 46.6 Favored 'General case' 0 C--O 1.248 1.013 0 O-C-N 124.9 1.375 . . . . 1.0 110.906 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.499 ' SG ' HD12 ' A' ' 13' ' ' ILE . 47.3 t -71.8 132.34 85.14 Favored Pre-proline 0 CA--C 1.578 2.038 0 CA-C-O 117.262 -1.351 . . . . 1.0 112.44 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.71 -8.45 20.39 Favored 'Trans proline' 1 C--N 1.43 4.854 0 C-N-CA 122.178 1.919 . . . . 1.0 114.761 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.499 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.2 -55.9 5.66 Favored 'Isoleucine or valine' 0 C--N 1.372 1.569 0 C-N-CA 124.975 1.31 . . . . 1.0 109.955 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 27.2 p -101.23 -41.15 6.82 Favored 'General case' 0 C--N 1.371 1.536 0 O-C-N 124.079 0.862 . . . . 1.0 113.003 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.73 34.14 9.4 Favored Glycine 0 C--N 1.37 2.464 0 O-C-N 124.691 1.244 . . . . 1.0 113.112 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.451 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -93.16 145.91 30.94 Favored Pre-proline 0 C--N 1.368 1.411 0 CA-C-O 117.177 -1.392 . . . . 1.0 112.586 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.71 134.28 34.59 Favored 'Trans proline' 1 C--N 1.445 5.624 0 C-N-CA 122.422 2.081 . . . . 1.0 114.475 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt -118.63 143.16 47.0 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 125.277 1.611 . . . . 1.0 110.202 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.28 130.85 37.1 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.789 1.306 . . . . 1.0 111.212 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.499 ' O ' HG12 ' A' ' 24' ' ' ILE . 45.8 m95 -68.78 -24.8 64.46 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 125.078 1.351 . . . . 1.0 113.046 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.1 mt-10 -70.01 -33.77 72.45 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 125.623 1.569 . . . . 1.0 112.178 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.98 -34.69 57.53 Favored 'General case' 0 C--N 1.386 2.193 0 C-N-CA 125.268 1.427 . . . . 1.0 112.776 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.13 -41.3 94.93 Favored 'General case' 0 C--N 1.382 1.994 0 C-N-CA 126.036 1.734 . . . . 1.0 112.839 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -79.94 -37.99 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 C-N-CA 125.271 1.428 . . . . 1.0 110.48 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.57 -35.25 79.75 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.093 1.357 . . . . 1.0 113.472 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.24 -23.83 40.58 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.653 1.581 . . . . 1.0 112.55 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.493 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -103.65 13.77 32.52 Favored 'General case' 0 CA--C 1.576 1.979 0 O-C-N 124.768 1.293 . . . . 1.0 112.48 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.11 16.79 12.11 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 123.937 0.895 . . . . 1.0 112.882 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.88 -4.05 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 C-N-CA 125.457 1.503 . . . . 1.0 113.427 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -99.71 140.92 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 125.251 1.421 . . . . 1.0 109.125 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.78 -18.06 41.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.888 1.367 . . . . 1.0 113.033 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.66 -16.3 54.35 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 124.975 1.31 . . . . 1.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.87 -34.74 65.75 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 126.252 1.821 . . . . 1.0 113.006 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.06 -30.34 71.52 Favored 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 125.317 1.447 . . . . 1.0 112.281 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.71 -35.73 20.65 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 125.461 1.504 . . . . 1.0 112.251 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -72.2 -39.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.905 0 C-N-CA 126.011 1.724 . . . . 1.0 110.549 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.518 ' O ' HD22 ' A' ' 78' ' ' LEU . 2.5 p -63.17 -18.85 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 C-N-CA 125.561 1.544 . . . . 1.0 114.237 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.98 -19.41 25.75 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.75 1.22 . . . . 1.0 113.311 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -125.3 111.11 14.82 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.364 1.066 . . . . 1.0 111.688 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.44 ' O ' HD13 ' A' ' 44' ' ' LEU . 2.0 mpt_? -60.05 -33.45 72.06 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 125.603 1.561 . . . . 1.0 113.57 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.19 -31.06 69.41 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 125.636 1.575 . . . . 1.0 112.632 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -82.16 -33.42 29.53 Favored 'General case' 0 C--N 1.379 1.85 0 C-N-CA 125.119 1.368 . . . . 1.0 112.154 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' O ' HG21 ' A' ' 47' ' ' VAL . 3.0 t80 -71.65 -43.98 65.12 Favored 'General case' 0 C--N 1.394 2.508 0 C-N-CA 125.137 1.375 . . . . 1.0 112.41 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.83 -28.8 65.99 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.925 1.29 . . . . 1.0 112.41 177.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 -27.07 29.64 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 125.455 1.502 . . . . 1.0 112.787 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.0 mm-40 -78.11 -39.12 42.34 Favored 'General case' 0 C--N 1.383 2.024 0 C-N-CA 124.775 1.23 . . . . 1.0 112.84 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' HA3' ' A' ' 63' ' ' GLY . 46.0 t -68.8 -40.77 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.03 0 C-N-CA 125.234 1.414 . . . . 1.0 109.621 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.29 -26.69 63.92 Favored 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.491 1.516 . . . . 1.0 113.024 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.36 -26.0 19.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.076 1.351 . . . . 1.0 112.851 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -96.18 144.64 26.22 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 124.64 1.176 . . . . 1.0 110.943 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.9 150.85 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 O-C-N 124.948 1.405 . . . . 1.0 110.732 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.03 145.5 50.97 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.856 1.348 . . . . 1.0 110.523 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -101.4 142.69 32.43 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.663 1.227 . . . . 1.0 111.3 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -89.04 123.38 67.5 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 117.385 -1.293 . . . . 1.0 110.943 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.26 -9.93 26.27 Favored 'Trans proline' 1 C--N 1.439 5.301 0 C-N-CA 122.81 2.34 . . . . 1.0 113.548 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.15 -52.78 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 125.638 1.575 . . . . 1.0 110.177 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.498 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 46.0 m -90.13 -52.74 4.79 Favored 'General case' 0 C--N 1.38 1.893 0 O-C-N 124.22 0.95 . . . . 1.0 112.383 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.67 42.14 Favored Glycine 0 C--N 1.368 2.316 0 O-C-N 124.796 1.31 . . . . 1.0 112.899 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -86.57 152.58 22.5 Favored 'General case' 0 C--N 1.379 1.888 0 C-N-CA 125.759 1.624 . . . . 1.0 111.272 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.28 136.66 32.9 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.436 1.095 . . . . 1.0 111.577 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -130.14 144.15 51.19 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 125.475 1.734 . . . . 1.0 109.159 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -92.2 153.85 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.186 0.929 . . . . 1.0 113.047 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -77.27 -4.43 83.93 Favored Glycine 0 C--N 1.377 2.826 0 O-C-N 124.404 1.065 . . . . 1.0 114.793 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -85.81 -15.16 42.85 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.355 1.462 . . . . 1.0 112.054 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 p -95.59 5.64 50.97 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 124.524 1.13 . . . . 1.0 111.562 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 63' ' ' GLY . 5.8 mt -74.53 150.51 86.9 Favored Pre-proline 0 C--N 1.387 2.23 0 CA-C-O 116.811 -1.566 . . . . 1.0 112.48 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.98 151.69 83.31 Favored 'Trans proline' 1 C--N 1.441 5.434 0 C-N-CA 123.139 2.559 . . . . 1.0 113.739 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -65.71 -18.34 65.26 Favored 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 114.715 1.376 . . . . 1.0 114.715 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -83.45 -34.43 25.44 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.974 1.309 . . . . 1.0 111.68 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -70.36 -29.15 65.75 Favored 'General case' 0 C--N 1.387 2.198 0 C-N-CA 125.741 1.616 . . . . 1.0 113.513 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.18 75.29 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.497 1.519 . . . . 1.0 112.809 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -73.85 -28.21 61.47 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.729 1.612 . . . . 1.0 112.358 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -71.33 -26.94 63.05 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 126.054 1.742 . . . . 1.0 112.746 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.587 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.7 -38.31 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 C-N-CA 126.49 1.916 . . . . 1.0 110.366 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -60.06 -28.18 67.57 Favored 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.277 1.431 . . . . 1.0 113.864 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -40.79 79.94 Favored 'General case' 0 C--N 1.383 2.064 0 C-N-CA 125.616 1.567 . . . . 1.0 113.496 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.1 pp -71.04 -34.52 71.33 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.911 1.284 . . . . 1.0 113.013 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD22 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.08 -22.65 44.96 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.479 1.512 . . . . 1.0 112.531 177.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -86.37 -9.66 55.92 Favored 'General case' 0 C--N 1.383 2.038 0 C-N-CA 124.586 1.154 . . . . 1.0 113.061 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.55 -35.59 75.55 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.59 1.556 . . . . 1.0 113.75 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.67 -72.01 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 127.621 2.368 . . . . 1.0 113.816 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -128.48 135.31 49.27 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 125.201 1.401 . . . . 1.0 109.393 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.45 114.6 3.97 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 125.018 1.449 . . . . 1.0 111.445 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 109.3 -43.24 1.75 Allowed Glycine 0 C--N 1.356 1.648 0 O-C-N 125.404 1.296 . . . . 1.0 113.846 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -107.47 124.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.32 127.99 54.61 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 125.443 1.714 . . . . 1.0 110.002 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.55 -32.85 36.56 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.683 1.239 . . . . 1.0 113.778 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.23 -36.16 30.35 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.004 1.322 . . . . 1.0 112.901 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.34 -16.14 24.98 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.695 1.198 . . . . 1.0 113.525 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.17 44.26 16.05 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 127.112 2.165 . . . . 1.0 113.479 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 99.4 mtt180 -114.0 135.89 53.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.318 -1.31 . . . . 1.0 111.175 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.76 127.0 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 125.471 1.732 . . . . 1.0 107.727 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 2.8 tttp -122.66 133.11 54.52 Favored 'General case' 0 C--O 1.25 1.123 0 O-C-N 125.309 1.631 . . . . 1.0 110.464 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.48 129.85 53.2 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.04 1.462 . . . . 1.0 110.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 mttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.373 1.671 . . . . 1.0 111.287 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 39.6 mtt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.466 0.172 . . . . 1.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.49 139.42 40.13 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 125.253 1.596 . . . . 1.0 110.732 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.38 139.2 45.81 Favored 'General case' 0 C--O 1.249 1.027 0 O-C-N 124.79 1.307 . . . . 1.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.51 129.11 91.81 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 116.905 -1.521 . . . . 1.0 111.687 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.35 -13.03 30.43 Favored 'Trans proline' 1 C--N 1.438 5.238 0 C-N-CA 122.373 2.048 . . . . 1.0 114.598 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.33 -54.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 125.395 1.478 . . . . 1.0 110.7 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' HB3' ' SG ' ' A' ' 57' ' ' CYS . 29.6 p -105.29 -40.4 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.261 0.976 . . . . 1.0 113.433 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.91 38.43 5.77 Favored Glycine 0 C--N 1.371 2.499 0 O-C-N 124.71 1.256 . . . . 1.0 113.05 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -92.13 142.97 26.85 Favored Pre-proline 0 CA--C 1.567 1.625 0 CA-C-O 116.609 -1.662 . . . . 1.0 113.042 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.68 137.28 38.34 Favored 'Trans proline' 1 C--N 1.451 5.94 0 C-N-CA 122.557 2.171 . . . . 1.0 113.08 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -118.76 143.45 46.89 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 125.143 1.527 . . . . 1.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.64 131.61 41.7 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.979 1.424 . . . . 1.0 110.956 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.507 ' O ' HG12 ' A' ' 24' ' ' ILE . 55.0 m95 -68.51 -26.43 65.44 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.025 1.33 . . . . 1.0 112.968 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.0 mt-10 -70.0 -33.1 71.6 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 125.692 1.597 . . . . 1.0 112.094 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.69 -33.46 58.23 Favored 'General case' 0 C--N 1.387 2.202 0 C-N-CA 125.077 1.351 . . . . 1.0 112.509 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.4 OUTLIER -65.87 -41.42 91.63 Favored 'General case' 0 C--N 1.389 2.285 0 C-N-CA 125.824 1.65 . . . . 1.0 112.743 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.8 mm -76.97 -39.46 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 C-N-CA 125.411 1.484 . . . . 1.0 110.461 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -67.61 -36.6 81.14 Favored 'General case' 0 C--N 1.385 2.151 0 C-N-CA 125.281 1.432 . . . . 1.0 113.57 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.96 -22.5 39.52 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.645 1.578 . . . . 1.0 112.842 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -104.54 12.75 32.78 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.537 1.148 . . . . 1.0 111.856 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 12.23 26.81 Favored 'General case' 0 CA--C 1.575 1.91 0 C-N-CA 123.733 0.813 . . . . 1.0 113.014 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.68 1.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 C-N-CA 125.903 1.681 . . . . 1.0 113.074 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.441 HD11 ' O ' ' A' ' 27' ' ' MET . 0.8 OUTLIER -108.84 140.15 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 125.187 1.395 . . . . 1.0 109.109 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -80.87 -19.67 43.95 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 124.808 1.243 . . . . 1.0 113.748 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -79.09 -21.3 46.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.979 1.312 . . . . 1.0 112.554 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.59 -34.97 69.79 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.279 1.832 . . . . 1.0 113.153 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.1 -30.7 69.43 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 125.584 1.554 . . . . 1.0 111.975 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.16 -33.95 19.22 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 125.652 1.581 . . . . 1.0 112.485 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.436 HG12 HE22 ' A' ' 46' ' ' GLN . 7.0 mt -71.5 -37.18 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.841 1.656 . . . . 1.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 m -61.98 -18.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 125.06 1.344 . . . . 1.0 114.394 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -93.11 -18.88 22.08 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.341 1.456 . . . . 1.0 112.595 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -121.61 104.84 9.92 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 124.104 0.962 . . . . 1.0 111.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 44' ' ' LEU . 11.4 ptp180 -58.24 -36.85 73.81 Favored 'General case' 0 N--CA 1.517 2.904 0 C-N-CA 126.071 1.748 . . . . 1.0 113.973 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.26 -32.75 74.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.042 1.737 . . . . 1.0 112.776 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -83.74 -31.67 25.88 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.417 1.487 . . . . 1.0 112.256 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 47' ' ' VAL . 3.2 t80 -74.56 -46.92 35.8 Favored 'General case' 0 C--N 1.392 2.441 0 C-N-CA 124.739 1.216 . . . . 1.0 113.14 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -71.4 -33.59 69.61 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 124.928 1.291 . . . . 1.0 113.152 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.37 -28.44 61.11 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.336 1.454 . . . . 1.0 113.161 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 mt-30 -80.05 -35.82 36.56 Favored 'General case' 0 C--N 1.381 1.97 0 C-N-CA 124.985 1.314 . . . . 1.0 112.945 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 43' ' ' PHE . 58.5 t -67.98 -40.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.36 0 C-N-CA 125.267 1.427 . . . . 1.0 109.547 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.02 -22.59 61.39 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.546 1.539 . . . . 1.0 113.459 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.8 -26.39 14.72 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.943 1.297 . . . . 1.0 112.603 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.499 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -99.05 144.06 28.62 Favored 'General case' 0 C--N 1.374 1.661 0 O-C-N 124.358 1.036 . . . . 1.0 111.28 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 151.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 O-C-N 125.451 1.719 . . . . 1.0 111.564 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.88 148.04 45.88 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 125.003 1.44 . . . . 1.0 109.795 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -98.64 140.97 32.06 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.666 1.229 . . . . 1.0 111.458 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.08 132.93 34.64 Favored Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 124.956 1.41 . . . . 1.0 111.635 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.15 -9.16 21.77 Favored 'Trans proline' 1 C--N 1.43 4.841 0 C-N-CA 122.535 2.156 . . . . 1.0 114.238 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.64 -51.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 125.336 1.454 . . . . 1.0 110.019 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 21.6 m -90.4 -52.84 4.71 Favored 'General case' 0 C--N 1.378 1.808 0 O-C-N 124.23 0.956 . . . . 1.0 112.45 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.27 Favored Glycine 0 C--N 1.37 2.417 0 O-C-N 124.67 1.231 . . . . 1.0 113.655 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.06 154.43 17.34 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 125.445 1.498 . . . . 1.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -88.07 133.86 33.88 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 124.326 1.05 . . . . 1.0 111.715 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -131.2 148.17 52.68 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 125.408 1.693 . . . . 1.0 109.382 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -91.18 149.33 21.83 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.19 -0.19 81.99 Favored Glycine 0 C--N 1.374 2.673 0 O-C-N 124.648 1.217 . . . . 1.0 114.573 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -85.22 -15.4 43.72 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.407 1.483 . . . . 1.0 111.872 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.4 p -91.07 2.28 56.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.688 1.195 . . . . 1.0 111.484 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.67 144.61 45.86 Favored Pre-proline 0 C--N 1.386 2.178 0 CA-C-O 117.242 -1.361 . . . . 1.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.1 157.06 61.57 Favored 'Trans proline' 1 C--N 1.437 5.211 0 C-N-CA 122.897 2.398 . . . . 1.0 114.066 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.48 -30.71 71.46 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 124.606 1.163 . . . . 1.0 113.502 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.22 -38.71 84.2 Favored 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.764 1.626 . . . . 1.0 113.309 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.6 -28.7 62.94 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 124.874 1.27 . . . . 1.0 112.836 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.24 72.22 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.957 1.703 . . . . 1.0 112.691 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.96 -25.07 60.89 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.713 1.605 . . . . 1.0 112.573 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -73.64 -28.51 61.83 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.743 1.617 . . . . 1.0 112.387 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.95 -36.22 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 C-N-CA 126.333 1.853 . . . . 1.0 110.17 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.17 -29.43 70.55 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.326 1.45 . . . . 1.0 113.475 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.07 -39.06 89.76 Favored 'General case' 0 C--N 1.389 2.303 0 C-N-CA 125.733 1.613 . . . . 1.0 113.09 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -74.0 -32.2 63.3 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 124.779 1.232 . . . . 1.0 112.495 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -82.86 -22.39 34.06 Favored 'General case' 0 C--N 1.371 1.54 0 C-N-CA 125.502 1.521 . . . . 1.0 112.901 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -87.01 -21.64 26.0 Favored 'General case' 0 C--N 1.381 1.941 0 C-N-CA 124.715 1.206 . . . . 1.0 112.587 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.32 -34.57 28.52 Favored 'General case' 0 C--N 1.379 1.859 0 C-N-CA 125.003 1.321 . . . . 1.0 113.023 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.95 -59.08 0.15 Allowed 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 127.931 2.493 . . . . 1.0 114.026 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -124.72 134.83 52.7 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 126.147 1.779 . . . . 1.0 109.444 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.42 -111.7 0.27 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 125.062 1.476 . . . . 1.0 111.686 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -113.73 49.09 0.87 Allowed Glycine 0 C--N 1.351 1.416 0 O-C-N 125.768 1.511 . . . . 1.0 112.238 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.19 123.2 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -118.17 128.17 54.46 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 125.417 1.698 . . . . 1.0 109.874 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -80.71 -27.37 36.99 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 124.707 1.203 . . . . 1.0 113.212 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.2 -36.15 27.57 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.434 1.494 . . . . 1.0 112.856 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -94.41 -17.48 22.47 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 124.594 1.184 . . . . 1.0 112.992 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 56.88 58.23 4.18 Favored 'General case' 0 N--CA 1.525 3.298 0 C-N-CA 126.896 2.078 . . . . 1.0 112.015 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -125.23 129.11 49.4 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.508 -1.678 . . . . 1.0 110.307 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.43 128.06 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 125.535 1.772 . . . . 1.0 107.9 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.23 131.4 53.91 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 125.486 1.741 . . . . 1.0 109.977 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.08 131.56 54.04 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 125.13 1.519 . . . . 1.0 110.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 C--O 1.252 1.212 0 O-C-N 125.212 1.57 . . . . 1.0 111.315 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.366 0.136 . . . . 1.0 111.366 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 140.45 41.55 Favored 'General case' 0 C--O 1.244 0.805 0 O-C-N 125.418 1.699 . . . . 1.0 110.478 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -120.87 138.27 54.16 Favored 'General case' 0 C--O 1.248 0.999 0 O-C-N 124.889 1.368 . . . . 1.0 110.825 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 13' ' ' ILE . 48.5 t -73.25 131.23 83.38 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 117.28 -1.343 . . . . 1.0 111.8 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.91 -10.13 22.82 Favored 'Trans proline' 1 C--N 1.432 4.97 0 C-N-CA 121.954 1.769 . . . . 1.0 114.77 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.584 HD13 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mt -95.1 -55.62 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 125.164 1.386 . . . . 1.0 110.179 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 28.2 p -102.83 -41.72 6.08 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 124.165 0.915 . . . . 1.0 113.171 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.38 38.0 7.36 Favored Glycine 0 C--N 1.372 2.543 0 O-C-N 124.687 1.242 . . . . 1.0 112.572 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.559 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -88.38 143.81 33.0 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 116.962 -1.494 . . . . 1.0 113.039 -178.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.65 126.98 16.3 Favored 'Trans proline' 1 C--N 1.449 5.861 0 C-N-CA 122.79 2.327 . . . . 1.0 114.642 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mt -122.9 145.01 48.84 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 125.208 1.567 . . . . 1.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' HD11 ' A' ' 23' ' ' LEU . 84.3 mttt -93.62 130.33 39.57 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 124.858 1.349 . . . . 1.0 110.563 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.472 ' O ' HG12 ' A' ' 24' ' ' ILE . 31.1 m95 -68.05 -27.35 66.45 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 124.736 1.215 . . . . 1.0 112.822 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 8.8 pt-20 -72.63 -33.44 66.63 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.639 1.976 . . . . 1.0 113.152 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.79 -32.6 63.85 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 125.212 1.405 . . . . 1.0 113.418 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -68.24 -37.71 81.07 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.103 1.761 . . . . 1.0 113.282 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.7 mm -77.04 -28.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 C-N-CA 125.665 1.586 . . . . 1.0 110.835 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.75 -34.3 71.71 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 125.261 1.424 . . . . 1.0 113.209 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.0 -22.79 39.17 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.346 1.458 . . . . 1.0 112.851 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.442 ' O ' HD12 ' A' ' 30' ' ' ILE . 38.7 mtp -104.62 14.7 29.39 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 124.701 1.25 . . . . 1.0 112.757 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 24.96 5.01 Favored 'General case' 0 CA--C 1.578 2.053 0 C-N-CA 123.665 0.786 . . . . 1.0 112.867 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.51 0.28 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 C-N-CA 125.092 1.357 . . . . 1.0 111.98 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.93 140.68 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 125.155 1.382 . . . . 1.0 109.205 -178.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.39 -18.43 48.96 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 124.75 1.281 . . . . 1.0 113.778 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -81.09 -18.6 46.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.902 1.281 . . . . 1.0 112.356 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.48 -35.64 74.49 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.196 1.798 . . . . 1.0 113.15 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.33 -29.87 69.15 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 125.47 1.508 . . . . 1.0 112.161 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.72 -33.36 20.04 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.596 1.559 . . . . 1.0 112.458 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.8 mt -71.63 -39.65 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.982 0 C-N-CA 125.696 1.598 . . . . 1.0 110.632 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.495 ' O ' HD23 ' A' ' 78' ' ' LEU . 9.2 m -60.17 -20.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 125.355 1.462 . . . . 1.0 114.66 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.89 -18.85 25.37 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.128 1.371 . . . . 1.0 113.352 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -125.55 109.31 12.51 Favored 'General case' 0 C--N 1.373 1.588 0 C-N-CA 124.195 0.998 . . . . 1.0 111.709 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.1 mpp_? -59.42 -34.1 72.06 Favored 'General case' 0 N--CA 1.517 2.918 0 C-N-CA 125.348 1.459 . . . . 1.0 113.605 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.93 -30.53 70.69 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.724 1.609 . . . . 1.0 112.742 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -82.17 -33.56 29.44 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 125.354 1.462 . . . . 1.0 112.211 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -73.06 -43.78 61.48 Favored 'General case' 0 C--N 1.392 2.455 0 C-N-CA 125.144 1.378 . . . . 1.0 112.698 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -68.64 -30.93 69.74 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 124.864 1.266 . . . . 1.0 112.45 177.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.53 40.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.899 1.374 . . . . 1.0 112.831 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 2.7 mm100 -79.37 -38.83 34.06 Favored 'General case' 0 C--N 1.385 2.121 0 C-N-CA 125.133 1.373 . . . . 1.0 112.524 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 43' ' ' PHE . 28.5 t -71.46 -40.04 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 125.238 1.415 . . . . 1.0 109.896 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.511 2.596 0 C-N-CA 125.268 1.427 . . . . 1.0 113.558 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.73 -26.61 16.21 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.853 1.261 . . . . 1.0 113.042 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 6.1 m-85 -95.01 143.87 26.14 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 124.851 1.261 . . . . 1.0 111.521 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.4 153.09 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.677 0 O-C-N 125.062 1.476 . . . . 1.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.15 145.61 51.73 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 124.969 1.418 . . . . 1.0 111.072 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.43 141.65 35.6 Favored 'General case' 0 C--O 1.25 1.119 0 O-C-N 124.905 1.378 . . . . 1.0 111.161 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.68 128.91 48.75 Favored Pre-proline 0 CA--C 1.57 1.713 0 O-C-N 124.769 1.293 . . . . 1.0 111.231 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.19 -9.5 21.95 Favored 'Trans proline' 1 C--N 1.43 4.856 0 C-N-CA 122.418 2.079 . . . . 1.0 114.156 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.86 -51.22 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.463 1.505 . . . . 1.0 110.312 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.477 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.6 m -89.32 -52.81 4.85 Favored 'General case' 0 C--N 1.378 1.816 0 O-C-N 124.301 1.001 . . . . 1.0 112.635 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.16 -10.36 47.29 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 124.708 1.255 . . . . 1.0 113.108 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -85.69 152.48 23.05 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 125.726 1.61 . . . . 1.0 111.306 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.72 136.93 32.75 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.377 1.048 . . . . 1.0 112.056 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.97 143.75 51.2 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 125.425 1.703 . . . . 1.0 109.175 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.38 151.86 19.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.253 0.971 . . . . 1.0 112.547 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.35 -8.82 80.69 Favored Glycine 0 C--N 1.378 2.886 0 O-C-N 124.362 1.039 . . . . 1.0 114.659 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -86.77 -20.98 26.83 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.498 1.519 . . . . 1.0 111.945 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -95.34 5.49 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.959 1.303 . . . . 1.0 111.784 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.69 70.22 Favored Pre-proline 0 C--N 1.386 2.174 0 CA-C-O 116.981 -1.485 . . . . 1.0 112.034 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -62.23 147.71 94.51 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 123.102 2.535 . . . . 1.0 114.693 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -64.05 -18.41 64.32 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 125.44 1.496 . . . . 1.0 114.649 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -82.74 -30.05 29.32 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 124.98 1.312 . . . . 1.0 111.843 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -73.91 -28.41 61.52 Favored 'General case' 0 C--N 1.384 2.105 0 C-N-CA 125.659 1.584 . . . . 1.0 113.059 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.44 -32.2 73.7 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 125.819 1.648 . . . . 1.0 112.615 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -74.49 -26.34 59.95 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.606 1.563 . . . . 1.0 112.148 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -73.09 -26.94 61.44 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.931 1.692 . . . . 1.0 112.604 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.3 t -64.37 -37.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 C-N-CA 126.125 1.77 . . . . 1.0 110.048 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -60.79 -29.72 69.62 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 125.012 1.325 . . . . 1.0 114.038 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.12 -41.13 82.2 Favored 'General case' 0 C--N 1.383 2.05 0 C-N-CA 125.609 1.564 . . . . 1.0 113.175 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.63 -34.7 70.04 Favored 'General case' 0 C--N 1.379 1.881 0 C-N-CA 124.857 1.263 . . . . 1.0 112.979 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -81.21 -22.14 39.06 Favored 'General case' 0 C--N 1.373 1.614 0 O-C-N 124.915 1.384 . . . . 1.0 112.652 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -85.62 -15.3 42.96 Favored 'General case' 0 C--N 1.386 2.177 0 C-N-CA 124.275 1.03 . . . . 1.0 112.815 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.65 -35.91 82.15 Favored 'General case' 0 C--N 1.388 2.256 0 C-N-CA 125.356 1.462 . . . . 1.0 113.469 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.97 -66.44 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 127.864 2.466 . . . . 1.0 114.147 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -130.38 137.37 49.85 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 125.684 1.594 . . . . 1.0 109.249 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.5 -106.94 0.21 Allowed Glycine 0 C--N 1.351 1.379 0 O-C-N 125.017 1.448 . . . . 1.0 111.656 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.97 46.35 1.19 Allowed Glycine 0 C--N 1.354 1.564 0 O-C-N 125.662 1.448 . . . . 1.0 113.051 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.45 122.31 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -122.05 129.95 52.86 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.443 1.714 . . . . 1.0 110.166 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.77 -28.88 36.25 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.728 1.267 . . . . 1.0 113.326 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.36 -37.0 26.28 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.119 1.368 . . . . 1.0 112.973 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.73 -17.98 23.53 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.567 1.147 . . . . 1.0 113.091 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.4 mttt 57.4 61.85 2.36 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 127.171 2.188 . . . . 1.0 112.125 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 98.3 mtt180 -125.5 128.99 48.88 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 113.381 -1.736 . . . . 1.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 2.0 t -123.46 129.06 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 125.504 1.752 . . . . 1.0 107.424 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.22 135.31 53.34 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 125.156 1.535 . . . . 1.0 110.213 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.54 128.55 56.06 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.056 1.472 . . . . 1.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--O 1.249 1.057 0 O-C-N 125.466 1.729 . . . . 1.0 111.325 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 35.7 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 111.221 0.082 . . . . 1.0 111.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -112.16 140.0 47.22 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.264 1.602 . . . . 1.0 110.611 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -124.28 139.17 54.17 Favored 'General case' 0 C--O 1.247 0.961 0 O-C-N 124.947 1.405 . . . . 1.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' SG ' HD11 ' A' ' 13' ' ' ILE . 22.9 t -76.52 121.53 85.03 Favored Pre-proline 0 CA--C 1.576 1.98 0 O-C-N 124.531 1.144 . . . . 1.0 111.214 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.89 -6.07 18.01 Favored 'Trans proline' 1 C--N 1.428 4.74 0 C-N-CA 122.083 1.855 . . . . 1.0 114.512 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.402 HD11 ' SG ' ' A' ' 11' ' ' CYS . 1.2 mt -97.03 -55.59 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 124.993 1.317 . . . . 1.0 110.103 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -101.68 -39.09 7.61 Favored 'General case' 0 C--N 1.37 1.467 0 O-C-N 124.543 1.152 . . . . 1.0 112.979 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.54 30.07 12.68 Favored Glycine 0 C--N 1.368 2.325 0 O-C-N 124.901 1.376 . . . . 1.0 113.456 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -93.76 146.79 32.39 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 117.001 -1.476 . . . . 1.0 112.536 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.08 136.02 39.47 Favored 'Trans proline' 1 C--N 1.451 5.965 0 C-N-CA 122.706 2.271 . . . . 1.0 113.971 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.57 145.97 47.44 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 125.445 1.716 . . . . 1.0 110.778 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -95.14 125.73 39.99 Favored 'General case' 0 C--N 1.361 1.099 0 O-C-N 124.971 1.419 . . . . 1.0 110.96 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.501 ' O ' HG12 ' A' ' 24' ' ' ILE . 38.5 m95 -68.6 -25.0 64.65 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 124.897 1.279 . . . . 1.0 112.798 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 34.5 mt-10 -69.69 -32.8 71.62 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.64 1.576 . . . . 1.0 112.009 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.07 -34.4 57.06 Favored 'General case' 0 C--N 1.382 2.012 0 C-N-CA 124.869 1.268 . . . . 1.0 112.331 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.15 -40.67 94.7 Favored 'General case' 0 C--N 1.385 2.126 0 C-N-CA 125.934 1.694 . . . . 1.0 112.774 178.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 20' ' ' TRP . 11.0 mm -78.68 -38.68 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 C-N-CA 125.506 1.522 . . . . 1.0 110.077 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -68.54 -34.11 75.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 124.881 1.272 . . . . 1.0 113.249 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.27 -23.38 37.99 Favored 'General case' 0 C--N 1.375 1.704 0 C-N-CA 125.427 1.491 . . . . 1.0 112.53 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -103.32 15.55 28.85 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 124.652 1.22 . . . . 1.0 112.045 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 14.75 27.57 Favored 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 124.061 0.944 . . . . 1.0 112.654 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.48 4.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 C-N-CA 125.76 1.624 . . . . 1.0 112.779 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 27' ' ' MET . 0.7 OUTLIER -105.12 141.36 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.654 1.182 . . . . 1.0 109.011 -178.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -81.3 -17.6 48.73 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.783 1.302 . . . . 1.0 113.372 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -86.6 -11.19 52.16 Favored 'General case' 0 C--N 1.371 1.532 0 C-N-CA 124.899 1.28 . . . . 1.0 112.152 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -56.41 -36.86 69.42 Favored 'General case' 0 N--CA 1.511 2.616 0 C-N-CA 125.514 1.526 . . . . 1.0 112.419 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.37 -29.57 69.99 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 124.771 1.228 . . . . 1.0 112.13 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.94 -38.8 17.6 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.11 1.364 . . . . 1.0 112.006 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.407 HG12 ' OE1' ' A' ' 46' ' ' GLN . 5.2 mt -72.17 -40.78 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 C-N-CA 125.329 1.451 . . . . 1.0 110.805 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.534 ' O ' HD22 ' A' ' 78' ' ' LEU . 2.7 p -65.85 -18.26 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.599 2.864 0 C-N-CA 125.574 1.55 . . . . 1.0 113.884 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.79 -18.64 28.92 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.716 1.207 . . . . 1.0 113.259 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.04 111.97 15.33 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 124.537 1.135 . . . . 1.0 111.17 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.5 mtm180 -59.29 -35.48 73.85 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 125.54 1.536 . . . . 1.0 113.125 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.51 -30.28 69.06 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 1.0 113.351 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 80.9 mtt180 -81.64 -34.24 30.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.055 1.342 . . . . 1.0 112.396 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.48 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.8 t80 -74.66 -41.99 59.3 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 124.829 1.252 . . . . 1.0 112.664 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.4 mt -66.21 -32.48 73.93 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.626 1.17 . . . . 1.0 112.654 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.45 -24.65 34.18 Favored 'General case' 0 C--N 1.371 1.525 0 O-C-N 124.994 1.434 . . . . 1.0 112.356 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -79.23 -36.2 40.38 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.041 1.336 . . . . 1.0 112.72 178.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 43' ' ' PHE . 32.8 t -72.13 -41.18 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 125.369 1.467 . . . . 1.0 109.463 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 125.592 1.557 . . . . 1.0 113.412 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -95.47 -25.34 16.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.605 1.19 . . . . 1.0 112.986 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -101.18 144.66 29.8 Favored 'General case' 0 C--N 1.368 1.399 0 C-N-CA 124.496 1.118 . . . . 1.0 111.126 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.24 155.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 O-C-N 125.073 1.483 . . . . 1.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.38 144.08 51.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 125.194 1.559 . . . . 1.0 110.108 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -95.2 138.59 32.7 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.823 -1.535 . . . . 1.0 111.463 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.5 t -96.54 115.11 65.49 Favored Pre-proline 0 CA--C 1.568 1.673 0 O-C-N 125.044 1.465 . . . . 1.0 110.306 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.08 -5.77 17.17 Favored 'Trans proline' 1 C--N 1.432 4.93 0 C-N-CA 122.333 2.022 . . . . 1.0 114.415 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.2 t -89.99 -51.11 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 126.12 1.768 . . . . 1.0 110.557 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.8 p -103.03 -48.68 3.98 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.625 1.203 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.53 -2.56 21.86 Favored Glycine 0 C--N 1.368 2.321 0 O-C-N 124.466 1.104 . . . . 1.0 114.123 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -94.95 146.4 24.27 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 124.961 1.304 . . . . 1.0 111.197 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.61 139.37 30.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.696 1.248 . . . . 1.0 112.23 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -123.19 145.12 48.9 Favored 'General case' 0 C--O 1.247 0.96 0 O-C-N 125.46 1.725 . . . . 1.0 109.547 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.72 151.04 20.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.348 1.03 . . . . 1.0 112.267 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.5 -9.19 81.76 Favored Glycine 0 C--N 1.377 2.861 0 O-C-N 124.293 0.996 . . . . 1.0 114.479 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -86.61 -19.59 29.13 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.186 1.394 . . . . 1.0 112.072 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -94.7 3.6 54.85 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.848 1.259 . . . . 1.0 111.752 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.22 146.44 38.13 Favored Pre-proline 0 C--N 1.382 1.996 0 CA-C-O 117.491 -1.242 . . . . 1.0 111.763 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.08 154.99 70.76 Favored 'Trans proline' 1 C--N 1.436 5.166 0 C-N-CA 122.972 2.448 . . . . 1.0 114.706 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.89 -31.62 72.86 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.437 1.095 . . . . 1.0 113.384 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.02 -37.81 75.03 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 125.333 1.453 . . . . 1.0 113.541 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.8 mt-10 -77.02 -28.32 54.91 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 124.851 1.26 . . . . 1.0 112.452 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.19 73.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.954 1.702 . . . . 1.0 112.628 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.51 -25.28 61.34 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.501 1.52 . . . . 1.0 112.398 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.45 -26.39 60.91 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 125.908 1.683 . . . . 1.0 112.5 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.39 -36.98 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 C-N-CA 126.37 1.868 . . . . 1.0 110.206 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' A' ' 44' ' ' LEU . 46.8 m-85 -60.26 -29.82 69.04 Favored 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 125.398 1.479 . . . . 1.0 113.59 176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -43.19 84.21 Favored 'General case' 0 C--N 1.382 1.987 0 C-N-CA 125.331 1.452 . . . . 1.0 113.196 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -69.98 -32.99 71.48 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.015 1.326 . . . . 1.0 112.849 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -81.3 -18.42 45.89 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.208 1.403 . . . . 1.0 112.835 178.071 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -102.1 -13.92 17.3 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 124.53 1.132 . . . . 1.0 111.935 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.81 69.42 0.7 Allowed 'General case' 0 C--N 1.372 1.548 0 CA-C-O 122.893 1.33 . . . . 1.0 109.339 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -75.18 -24.16 57.81 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 113.443 -1.708 . . . . 1.0 112.949 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -106.66 134.61 49.54 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 124.837 1.335 . . . . 1.0 109.342 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.63 -96.64 0.16 Allowed Glycine 0 C--N 1.356 1.657 0 O-C-N 124.981 1.426 . . . . 1.0 112.148 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.26 50.99 0.79 Allowed Glycine 0 C--N 1.362 1.993 0 O-C-N 125.439 1.317 . . . . 1.0 113.623 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -119.97 121.58 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.11 133.67 51.57 Favored 'General case' 0 C--O 1.249 1.026 0 O-C-N 125.487 1.742 . . . . 1.0 110.61 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -80.37 -32.12 37.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.71 1.256 . . . . 1.0 113.252 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.94 -36.39 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.086 1.355 . . . . 1.0 112.997 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.17 -20.09 20.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.475 1.11 . . . . 1.0 113.173 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.7 mttm 58.28 56.35 4.52 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 127.07 2.148 . . . . 1.0 113.11 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 93.3 mtt180 -115.41 128.68 56.22 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.44 -1.709 . . . . 1.0 110.431 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.48 125.26 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 125.466 1.729 . . . . 1.0 108.457 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -121.18 131.9 54.51 Favored 'General case' 0 C--O 1.251 1.174 0 O-C-N 125.519 1.762 . . . . 1.0 109.988 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.6 133.32 55.39 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 125.202 1.563 . . . . 1.0 110.576 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.1 mttt . . . . . 0 C--O 1.252 1.236 0 O-C-N 125.338 1.649 . . . . 1.0 111.244 179.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.865 -0.05 . . . . 1.0 110.865 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.81 138.95 43.14 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 125.315 1.635 . . . . 1.0 110.627 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.37 138.94 49.91 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 124.93 1.394 . . . . 1.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.4 t -70.19 123.15 88.3 Favored Pre-proline 0 CA--C 1.577 1.992 0 O-C-N 124.477 1.11 . . . . 1.0 112.199 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.64 -11.5 26.16 Favored 'Trans proline' 1 C--N 1.43 4.826 0 C-N-CA 121.932 1.755 . . . . 1.0 114.922 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.81 -53.8 8.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 C-N-CA 125.299 1.44 . . . . 1.0 111.018 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.6 -41.15 6.05 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 124.218 0.949 . . . . 1.0 112.434 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 29.51 8.63 Favored Glycine 0 C--N 1.366 2.239 0 O-C-N 124.678 1.236 . . . . 1.0 113.748 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.22 144.68 29.39 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 116.796 -1.573 . . . . 1.0 113.096 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.88 139.29 39.45 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 122.71 2.273 . . . . 1.0 113.661 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 144.36 48.22 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.32 1.638 . . . . 1.0 110.432 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -95.76 133.17 40.19 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.928 1.392 . . . . 1.0 111.052 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.484 ' O ' HG12 ' A' ' 24' ' ' ILE . 60.8 m95 -68.69 -26.45 65.3 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 124.798 1.239 . . . . 1.0 113.248 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -72.09 -31.24 65.89 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.645 1.578 . . . . 1.0 112.623 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.92 -34.5 62.14 Favored 'General case' 0 C--N 1.385 2.123 0 C-N-CA 125.168 1.387 . . . . 1.0 112.603 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -39.89 87.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 125.758 1.623 . . . . 1.0 113.882 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.6 mm -78.58 -41.03 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 125.156 1.382 . . . . 1.0 110.676 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.3 -36.71 82.07 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 124.84 1.256 . . . . 1.0 113.311 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.72 -21.11 48.56 Favored 'General case' 0 C--N 1.375 1.714 0 C-N-CA 125.308 1.443 . . . . 1.0 112.967 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.505 ' SD ' ' HE1' ' A' ' 52' ' ' PHE . 35.0 mtp -105.56 16.78 24.9 Favored 'General case' 0 CA--C 1.575 1.923 0 O-C-N 124.67 1.231 . . . . 1.0 112.367 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.8 18.43 14.49 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.48 13.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 124.765 1.226 . . . . 1.0 111.918 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -114.81 140.5 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 124.736 1.215 . . . . 1.0 108.723 -178.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.04 -16.28 44.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 125.028 1.455 . . . . 1.0 113.411 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -83.55 -15.66 48.38 Favored 'General case' 0 C--N 1.376 1.725 0 C-N-CA 125.065 1.346 . . . . 1.0 112.556 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -57.06 -35.48 69.39 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 126.354 1.862 . . . . 1.0 113.315 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.33 -29.18 69.73 Favored 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 125.384 1.474 . . . . 1.0 112.411 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.85 -33.87 19.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.43 1.492 . . . . 1.0 112.662 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 mt -71.46 -39.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.909 0 C-N-CA 125.837 1.655 . . . . 1.0 110.457 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.505 ' O ' HD22 ' A' ' 78' ' ' LEU . 10.3 m -61.57 -18.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 125.669 1.588 . . . . 1.0 114.692 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -88.38 -19.05 27.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.823 1.327 . . . . 1.0 113.256 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.48 110.67 12.99 Favored 'General case' 0 C--N 1.373 1.599 0 C-N-CA 124.473 1.109 . . . . 1.0 111.973 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.452 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -61.54 -32.38 72.44 Favored 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 125.331 1.452 . . . . 1.0 113.015 176.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.95 -31.88 71.07 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 125.475 1.51 . . . . 1.0 113.207 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -82.26 -32.65 29.54 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 125.212 1.405 . . . . 1.0 112.594 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 47' ' ' VAL . 3.4 t80 -73.08 -46.01 53.93 Favored 'General case' 0 C--N 1.386 2.186 0 C-N-CA 124.976 1.31 . . . . 1.0 113.098 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -71.59 -33.16 68.8 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.033 1.333 . . . . 1.0 112.777 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.04 72.8 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.835 1.654 . . . . 1.0 112.742 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 8.9 mt-30 -78.75 -35.29 44.82 Favored 'General case' 0 C--N 1.382 1.986 0 C-N-CA 124.821 1.248 . . . . 1.0 112.908 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 43' ' ' PHE . 59.1 t -69.05 -40.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.117 1.367 . . . . 1.0 109.173 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.63 -25.46 59.24 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 125.676 1.59 . . . . 1.0 113.477 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -94.32 -25.31 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.803 1.315 . . . . 1.0 113.522 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 34.1 m-85 -105.33 143.3 33.68 Favored 'General case' 0 C--N 1.366 1.307 0 O-C-N 124.454 1.096 . . . . 1.0 111.466 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.75 153.83 3.2 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 O-C-N 125.094 1.496 . . . . 1.0 111.599 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.505 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 99.1 m-85 -125.14 144.26 50.52 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 125.093 1.496 . . . . 1.0 110.332 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -95.17 139.89 30.86 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.208 1.567 . . . . 1.0 111.072 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -92.35 130.23 38.28 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 125.057 1.473 . . . . 1.0 111.807 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.68 -8.06 20.99 Favored 'Trans proline' 1 C--N 1.437 5.205 0 C-N-CA 122.698 2.265 . . . . 1.0 114.292 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.22 -55.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 124.843 1.257 . . . . 1.0 110.43 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.2 p -98.14 -52.5 3.67 Favored 'General case' 0 C--N 1.372 1.547 0 O-C-N 124.302 1.001 . . . . 1.0 111.682 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.31 25.12 7.98 Favored Glycine 0 C--N 1.367 2.267 0 O-C-N 124.722 1.264 . . . . 1.0 114.747 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -105.64 147.97 27.88 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 124.591 1.156 . . . . 1.0 111.076 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -83.65 134.38 34.78 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 124.563 1.165 . . . . 1.0 112.393 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -132.8 148.33 52.31 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 125.444 1.715 . . . . 1.0 109.826 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -94.05 149.82 20.89 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.339 1.024 . . . . 1.0 112.627 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 -9.27 86.95 Favored Glycine 0 C--N 1.375 2.714 0 O-C-N 124.727 1.267 . . . . 1.0 114.111 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -82.34 -17.29 46.22 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 125.31 1.444 . . . . 1.0 112.671 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -91.24 -5.41 54.85 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 124.363 1.065 . . . . 1.0 112.194 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 145.48 44.83 Favored Pre-proline 0 C--N 1.385 2.114 0 CA-C-O 117.232 -1.366 . . . . 1.0 111.887 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.4 160.1 44.31 Favored 'Trans proline' 1 C--N 1.437 5.234 0 C-N-CA 123.024 2.483 . . . . 1.0 114.679 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -62.44 -30.13 71.01 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.501 1.12 . . . . 1.0 113.735 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.1 -37.76 77.94 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 125.561 1.545 . . . . 1.0 112.999 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.74 -29.34 40.52 Favored 'General case' 0 C--N 1.381 1.962 0 C-N-CA 124.985 1.314 . . . . 1.0 111.746 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.06 73.48 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 125.834 1.654 . . . . 1.0 112.312 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.41 -28.12 63.79 Favored 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 125.791 1.637 . . . . 1.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -68.58 -27.87 66.44 Favored 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 125.978 1.711 . . . . 1.0 112.547 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.9 t -65.6 -37.37 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.019 0 C-N-CA 126.322 1.849 . . . . 1.0 109.97 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -28.37 69.9 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 125.182 1.393 . . . . 1.0 113.349 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.29 -41.21 77.09 Favored 'General case' 0 C--N 1.383 2.046 0 C-N-CA 125.473 1.509 . . . . 1.0 112.913 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -70.72 -32.1 69.19 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.763 1.225 . . . . 1.0 113.243 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -81.25 -20.31 41.25 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.237 1.415 . . . . 1.0 112.868 177.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -99.88 -16.0 18.17 Favored 'General case' 0 C--N 1.371 1.519 0 C-N-CA 124.76 1.224 . . . . 1.0 112.189 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -108.82 69.01 0.7 Allowed 'General case' 0 C--N 1.37 1.495 0 CA-C-O 122.898 1.332 . . . . 1.0 109.46 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -71.75 -28.44 63.66 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.308 -1.769 . . . . 1.0 113.083 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -103.53 134.89 46.13 Favored 'General case' 0 C--N 1.366 1.303 0 O-C-N 124.989 1.431 . . . . 1.0 109.718 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.98 -95.29 0.14 Allowed Glycine 0 C--N 1.355 1.588 0 O-C-N 125.165 1.541 . . . . 1.0 112.18 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.01 46.9 0.96 Allowed Glycine 0 C--N 1.361 1.922 0 O-C-N 125.34 1.259 . . . . 1.0 113.824 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -120.3 122.58 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -124.77 131.56 53.44 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 125.574 1.796 . . . . 1.0 110.468 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -80.85 -27.51 36.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.85 1.344 . . . . 1.0 113.51 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.44 -35.65 27.36 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.207 1.403 . . . . 1.0 112.581 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -94.88 -17.37 22.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 124.692 1.245 . . . . 1.0 113.436 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mttm 58.98 50.76 7.92 Favored 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 127.166 2.186 . . . . 1.0 113.99 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 71.7 mtm180 -115.58 130.83 57.01 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.796 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.6 123.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 125.462 1.727 . . . . 1.0 107.793 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -124.7 132.38 53.39 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 125.716 1.885 . . . . 1.0 110.387 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 132.26 56.36 Favored 'General case' 0 C--O 1.246 0.898 0 O-C-N 125.332 1.645 . . . . 1.0 108.929 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.523 3.179 0 C-N-CA 127.386 2.274 . . . . 1.0 113.465 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.7 tpp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.873 -0.047 . . . . 1.0 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.02 139.8 47.23 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 125.286 1.616 . . . . 1.0 110.521 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -115.12 138.78 50.51 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.896 1.372 . . . . 1.0 110.724 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.0 t -74.67 119.65 77.73 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 117.29 -1.338 . . . . 1.0 111.819 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.17 -25.16 50.73 Favored 'Trans proline' 1 C--N 1.439 5.302 0 C-N-CA 122.3 2.0 . . . . 1.0 113.789 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.26 -54.14 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 C-N-CA 126.35 1.86 . . . . 1.0 112.826 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -108.64 -44.39 4.06 Favored 'General case' 0 C--N 1.37 1.457 0 O-C-N 124.175 0.922 . . . . 1.0 112.339 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.72 6.16 Favored Glycine 0 C--N 1.367 2.28 0 O-C-N 124.717 1.261 . . . . 1.0 113.725 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.81 146.48 31.39 Favored Pre-proline 0 C--N 1.369 1.44 0 CA-C-O 117.115 -1.421 . . . . 1.0 112.467 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.18 139.35 42.01 Favored 'Trans proline' 1 C--N 1.449 5.859 0 C-N-CA 122.728 2.286 . . . . 1.0 113.854 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.59 143.52 49.26 Favored 'General case' 0 C--O 1.25 1.124 0 O-C-N 125.341 1.651 . . . . 1.0 110.177 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.78 134.7 39.73 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 124.874 1.359 . . . . 1.0 111.005 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.3 m95 -68.49 -27.01 65.75 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.955 1.302 . . . . 1.0 112.872 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 7.3 pt-20 -71.76 -32.28 67.52 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.355 1.862 . . . . 1.0 112.661 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.1 -34.29 66.1 Favored 'General case' 0 C--N 1.385 2.152 0 C-N-CA 125.443 1.497 . . . . 1.0 112.963 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.8 OUTLIER -67.74 -39.91 84.2 Favored 'General case' 0 C--N 1.382 2.02 0 C-N-CA 125.665 1.586 . . . . 1.0 113.372 177.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -78.91 -40.96 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 125.524 1.529 . . . . 1.0 110.568 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.73 -38.16 86.12 Favored 'General case' 0 C--N 1.386 2.183 0 C-N-CA 125.144 1.377 . . . . 1.0 113.369 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.39 -20.91 50.18 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 125.466 1.506 . . . . 1.0 112.929 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.5 ' O ' HD13 ' A' ' 30' ' ' ILE . 3.0 mmt -106.01 12.25 30.67 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.813 1.321 . . . . 1.0 112.09 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.72 17.95 11.02 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.587 0.755 . . . . 1.0 113.02 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.8 11.02 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 C-N-CA 125.638 1.575 . . . . 1.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 27' ' ' MET . 1.2 mt -115.21 138.3 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.827 1.251 . . . . 1.0 108.935 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.54 -17.85 35.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.132 1.52 . . . . 1.0 112.439 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.419 ' O ' HD13 ' A' ' 36' ' ' ILE . 47.9 m-80 -91.93 14.4 15.8 Favored 'General case' 0 CA--C 1.574 1.87 0 C-N-CA 125.289 1.436 . . . . 1.0 111.786 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -76.15 -36.21 58.85 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.387 1.475 . . . . 1.0 111.799 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -57.78 -23.8 54.13 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 126.026 1.73 . . . . 1.0 114.339 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.15 -43.64 14.79 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 125.352 1.461 . . . . 1.0 111.539 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 32' ' ' ASN . 3.5 mt -72.41 -42.4 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 125.589 1.555 . . . . 1.0 110.824 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.75 -14.06 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.013 0 C-N-CA 125.318 1.447 . . . . 1.0 114.243 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -92.06 -22.29 20.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.839 1.256 . . . . 1.0 112.447 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.13 106.41 10.75 Favored 'General case' 0 C--N 1.371 1.51 0 O-C-N 124.569 1.168 . . . . 1.0 111.293 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -58.1 -33.89 69.6 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 125.829 1.651 . . . . 1.0 113.908 176.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.23 -33.08 74.59 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 125.813 1.645 . . . . 1.0 112.35 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.58 -34.36 27.74 Favored 'General case' 0 C--N 1.381 1.942 0 C-N-CA 125.619 1.568 . . . . 1.0 112.502 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.0 t80 -72.7 -45.95 56.18 Favored 'General case' 0 C--N 1.394 2.519 0 C-N-CA 125.207 1.403 . . . . 1.0 112.524 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.14 -33.11 72.92 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 124.932 1.293 . . . . 1.0 112.366 178.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.58 -31.63 65.37 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.82 1.648 . . . . 1.0 112.919 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.5 tt0 -79.24 -37.09 38.86 Favored 'General case' 0 C--N 1.384 2.084 0 C-N-CA 124.96 1.304 . . . . 1.0 112.482 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.7 t -69.29 -41.56 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 C-N-CA 125.455 1.502 . . . . 1.0 109.539 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 42.3 mt-10 -70.28 -25.56 63.4 Favored 'General case' 0 N--CA 1.516 2.832 0 C-N-CA 125.658 1.583 . . . . 1.0 113.545 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.53 -25.62 16.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.097 1.359 . . . . 1.0 113.171 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.11 141.7 35.39 Favored 'General case' 0 C--N 1.369 1.454 0 O-C-N 124.384 1.053 . . . . 1.0 111.658 -179.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.401 HG21 ' OE1' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -90.96 152.23 3.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 125.255 1.597 . . . . 1.0 111.634 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.18 144.16 50.08 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.062 1.476 . . . . 1.0 110.391 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -96.35 140.54 30.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.144 1.527 . . . . 1.0 111.07 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.9 t -94.69 130.75 32.35 Favored Pre-proline 0 CA--C 1.565 1.539 0 O-C-N 125.295 1.622 . . . . 1.0 112.044 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.02 -4.24 14.88 Favored 'Trans proline' 1 C--N 1.435 5.117 0 C-N-CA 122.353 2.035 . . . . 1.0 114.504 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.95 -54.83 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 125.389 1.475 . . . . 1.0 110.133 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 p -101.89 -52.6 3.14 Favored 'General case' 0 C--N 1.371 1.537 0 O-C-N 124.434 1.084 . . . . 1.0 111.566 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 22.07 9.56 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 124.547 1.154 . . . . 1.0 114.479 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -99.95 145.55 27.71 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 124.754 1.221 . . . . 1.0 111.215 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' OE1' HG21 ' A' ' 51' ' ' VAL . 14.2 mt-10 -84.39 133.75 34.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.856 1.348 . . . . 1.0 111.858 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -132.69 147.4 52.33 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 125.601 1.813 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.04 151.11 19.76 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.745 1.278 . . . . 1.0 112.729 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 48' ' ' GLU . . . -80.83 1.28 84.44 Favored Glycine 0 C--N 1.372 2.564 0 O-C-N 124.912 1.382 . . . . 1.0 114.508 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -88.85 -16.42 32.03 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.911 1.285 . . . . 1.0 112.015 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 p -89.78 -12.84 38.09 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 124.883 1.273 . . . . 1.0 113.312 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -75.29 146.88 82.14 Favored Pre-proline 0 CA--C 1.584 2.25 0 CA-C-O 116.747 -1.597 . . . . 1.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.51 156.28 66.78 Favored 'Trans proline' 1 C--N 1.445 5.643 0 C-N-CA 122.999 2.466 . . . . 1.0 113.4 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -58.98 -30.75 68.19 Favored 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.982 1.313 . . . . 1.0 114.146 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -61.03 -36.26 79.06 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.622 1.569 . . . . 1.0 113.111 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -76.55 -28.97 56.48 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 125.017 1.327 . . . . 1.0 111.905 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.43 -32.41 72.43 Favored 'General case' 0 C--N 1.388 2.281 0 C-N-CA 126.002 1.721 . . . . 1.0 112.449 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.79 -26.6 62.48 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 125.943 1.697 . . . . 1.0 112.662 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.99 -28.66 66.81 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 126.099 1.759 . . . . 1.0 112.565 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -66.53 -35.23 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 C-N-CA 126.481 1.912 . . . . 1.0 109.975 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.62 -29.43 70.68 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 125.539 1.535 . . . . 1.0 113.014 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -67.24 -38.87 85.91 Favored 'General case' 0 C--N 1.386 2.172 0 C-N-CA 125.845 1.658 . . . . 1.0 113.05 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.9 pp -75.01 -30.89 61.25 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 124.685 1.194 . . . . 1.0 112.46 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.1 -22.35 39.21 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 125.817 1.647 . . . . 1.0 113.25 177.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -99.86 -9.84 22.42 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 124.752 1.221 . . . . 1.0 112.869 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 1.1 m-20 -107.01 58.78 0.63 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-O 123.106 1.432 . . . . 1.0 111.016 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.53 -30.52 70.2 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.39 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -115.11 113.57 24.18 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 124.96 1.412 . . . . 1.0 109.168 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.79 106.14 1.34 Allowed Glycine 0 C--N 1.366 2.227 0 CA-C-N 114.552 -1.204 . . . . 1.0 113.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.31 -59.2 0.69 Allowed Glycine 0 C--N 1.36 1.867 0 O-C-N 125.453 1.325 . . . . 1.0 113.625 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.39 126.08 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 125.103 1.12 . . . . 1.0 108.314 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -119.4 134.16 55.35 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 125.57 1.794 . . . . 1.0 110.084 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -80.0 -31.46 39.72 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.875 1.27 . . . . 1.0 113.743 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.6 -35.61 29.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.275 1.43 . . . . 1.0 113.111 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -92.09 -15.92 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.733 1.213 . . . . 1.0 113.432 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 58.55 32.89 22.64 Favored 'General case' 0 N--CA 1.533 3.71 0 C-N-CA 127.158 2.183 . . . . 1.0 113.925 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -106.24 136.42 45.98 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 114.28 -1.327 . . . . 1.0 111.355 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.28 126.72 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.405 1.691 . . . . 1.0 107.838 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -122.51 128.4 50.76 Favored 'General case' 0 C--O 1.25 1.127 0 O-C-N 125.429 1.706 . . . . 1.0 109.89 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.18 132.29 47.27 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 124.978 1.424 . . . . 1.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 C--O 1.249 1.031 0 O-C-N 125.33 1.644 . . . . 1.0 111.208 179.805 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 5.5 ptm . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 111.282 0.105 . . . . 1.0 111.282 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -111.02 139.71 46.15 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 125.316 1.635 . . . . 1.0 110.601 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -118.52 139.04 52.07 Favored 'General case' 0 C--O 1.25 1.082 0 O-C-N 124.655 1.222 . . . . 1.0 110.981 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.0 t -70.81 121.02 82.65 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 117.777 -1.106 . . . . 1.0 111.761 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.01 -4.35 15.27 Favored 'Trans proline' 1 C--N 1.434 5.044 0 C-N-CA 122.19 1.927 . . . . 1.0 114.843 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.02 -56.05 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 125.253 1.421 . . . . 1.0 109.766 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.64 -41.04 6.07 Favored 'General case' 0 C--N 1.37 1.488 0 O-C-N 124.338 1.024 . . . . 1.0 113.195 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.9 34.57 6.46 Favored Glycine 0 C--N 1.368 2.327 0 O-C-N 124.81 1.319 . . . . 1.0 114.02 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -91.39 142.59 27.16 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 116.928 -1.51 . . . . 1.0 112.796 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 131.62 24.45 Favored 'Trans proline' 1 C--N 1.449 5.819 0 C-N-CA 122.602 2.201 . . . . 1.0 114.376 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mt -122.96 144.55 49.16 Favored 'General case' 0 C--O 1.25 1.118 0 O-C-N 125.125 1.516 . . . . 1.0 110.762 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.07 133.95 41.06 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 124.802 1.313 . . . . 1.0 110.681 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.505 ' O ' HG12 ' A' ' 24' ' ' ILE . 52.9 m95 -68.53 -26.65 65.54 Favored 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 124.899 1.28 . . . . 1.0 113.426 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.27 -31.75 66.03 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.59 1.556 . . . . 1.0 113.097 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.15 -33.48 65.52 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 125.277 1.431 . . . . 1.0 112.915 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.03 -39.92 82.99 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.884 1.674 . . . . 1.0 112.858 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 20' ' ' TRP . 6.1 mm -74.43 -41.03 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 125.806 1.643 . . . . 1.0 110.604 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.86 -36.86 83.29 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.389 1.476 . . . . 1.0 113.24 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.29 -22.63 41.39 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 125.355 1.462 . . . . 1.0 112.841 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.477 ' O ' HD11 ' A' ' 30' ' ' ILE . 48.6 mtp -104.61 12.1 33.42 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 124.681 1.238 . . . . 1.0 112.41 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.3 16.63 8.33 Favored 'General case' 0 CA--C 1.58 2.098 0 C-N-CA 123.826 0.85 . . . . 1.0 112.914 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -3.74 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 C-N-CA 125.747 1.619 . . . . 1.0 112.965 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.477 HD11 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.5 137.48 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.982 1.313 . . . . 1.0 109.255 -177.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.36 -27.07 61.29 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 125.752 1.621 . . . . 1.0 114.374 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -77.65 -17.98 57.17 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.117 1.367 . . . . 1.0 113.209 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.92 -36.46 72.5 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 126.077 1.751 . . . . 1.0 113.188 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -60.58 -29.34 69.13 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.468 1.507 . . . . 1.0 112.463 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.41 -34.52 20.14 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.48 1.512 . . . . 1.0 112.409 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.8 mt -71.04 -41.06 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 C-N-CA 125.759 1.624 . . . . 1.0 110.664 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' O ' HD22 ' A' ' 78' ' ' LEU . 8.9 m -59.39 -21.82 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 125.545 1.538 . . . . 1.0 114.84 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -87.94 -21.11 25.09 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 125.052 1.341 . . . . 1.0 112.796 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -121.66 106.66 11.54 Favored 'General case' 0 C--N 1.371 1.541 0 O-C-N 124.323 1.015 . . . . 1.0 112.124 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.425 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.35 -34.82 72.84 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 126.106 1.762 . . . . 1.0 113.853 176.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.0 -32.24 72.5 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 125.941 1.696 . . . . 1.0 112.727 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -82.69 -32.54 28.01 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.329 1.451 . . . . 1.0 112.228 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.531 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -75.41 -46.51 32.37 Favored 'General case' 0 C--N 1.387 2.215 0 C-N-CA 125.013 1.325 . . . . 1.0 112.946 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -69.66 -33.37 72.5 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 124.789 1.236 . . . . 1.0 112.958 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.513 1.525 . . . . 1.0 113.206 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 5.4 mt-30 -79.29 -35.21 41.61 Favored 'General case' 0 C--N 1.379 1.86 0 C-N-CA 125.077 1.351 . . . . 1.0 112.833 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.0 t -67.84 -41.22 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 125.241 1.416 . . . . 1.0 109.354 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.63 -24.3 60.0 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 125.316 1.447 . . . . 1.0 113.507 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -94.42 -25.52 16.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.859 1.264 . . . . 1.0 113.327 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.08 148.46 25.71 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 124.343 1.057 . . . . 1.0 111.049 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -97.51 155.82 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 O-C-N 124.758 1.286 . . . . 1.0 110.439 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.475 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 95.8 m-85 -126.41 143.76 51.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.086 1.491 . . . . 1.0 110.311 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -97.11 137.39 36.23 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.861 1.351 . . . . 1.0 111.423 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.08 106.52 19.81 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 124.972 1.42 . . . . 1.0 110.025 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -69.39 -7.94 22.27 Favored 'Trans proline' 1 C--N 1.44 5.355 0 C-N-CA 123.132 2.555 . . . . 1.0 114.193 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.76 -50.94 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.944 1.698 . . . . 1.0 110.403 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.7 p -104.47 -50.15 3.39 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 124.596 1.185 . . . . 1.0 112.186 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.31 -0.42 14.35 Favored Glycine 0 C--N 1.37 2.434 0 O-C-N 124.534 1.146 . . . . 1.0 114.209 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -93.74 150.85 20.05 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 125.162 1.385 . . . . 1.0 111.521 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.18 138.16 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.607 1.163 . . . . 1.0 111.141 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.13 143.17 51.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.165 1.54 . . . . 1.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.69 150.45 21.78 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.431 1.082 . . . . 1.0 112.24 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.22 -8.34 83.3 Favored Glycine 0 C--N 1.377 2.83 0 O-C-N 124.485 1.116 . . . . 1.0 114.867 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -86.39 -20.89 27.56 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.386 1.474 . . . . 1.0 111.87 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.9 p -94.09 1.67 56.12 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.903 1.281 . . . . 1.0 112.61 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 144.77 30.43 Favored Pre-proline 0 C--N 1.379 1.856 0 CA-C-O 117.146 -1.407 . . . . 1.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.21 158.32 55.37 Favored 'Trans proline' 1 C--N 1.445 5.641 0 C-N-CA 123.032 2.488 . . . . 1.0 114.705 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -61.96 -33.07 73.61 Favored 'General case' 0 N--CA 1.515 2.776 0 C-N-CA 124.85 1.26 . . . . 1.0 113.074 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.31 -40.4 77.81 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 125.468 1.507 . . . . 1.0 112.505 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 29.1 mt-10 -76.73 -28.84 55.94 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.044 1.338 . . . . 1.0 112.102 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.402 ' O ' HD22 ' A' ' 44' ' ' LEU . . . -68.44 -32.99 73.41 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 125.814 1.646 . . . . 1.0 112.391 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.7 -24.99 61.91 Favored 'General case' 0 C--N 1.382 2.018 0 C-N-CA 125.637 1.575 . . . . 1.0 112.697 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.62 -28.18 66.68 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 125.902 1.681 . . . . 1.0 112.217 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.525 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.97 -38.5 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 C-N-CA 126.385 1.874 . . . . 1.0 109.738 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -27.16 69.08 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 125.355 1.462 . . . . 1.0 113.352 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -68.49 -41.05 80.65 Favored 'General case' 0 C--N 1.388 2.245 0 C-N-CA 125.789 1.636 . . . . 1.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.44 -30.52 66.13 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.83 1.252 . . . . 1.0 112.739 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.6 -24.93 49.54 Favored 'General case' 0 C--N 1.378 1.806 0 C-N-CA 125.597 1.559 . . . . 1.0 112.726 177.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.3 -16.69 21.2 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 124.802 1.241 . . . . 1.0 112.231 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.77 62.51 0.6 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 123.057 1.408 . . . . 1.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.57 -25.09 62.05 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 113.48 -1.691 . . . . 1.0 113.313 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -106.72 134.25 50.15 Favored 'General case' 0 C--O 1.254 1.302 0 O-C-N 125.069 1.481 . . . . 1.0 109.254 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.58 -102.54 0.22 Allowed Glycine 0 C--N 1.356 1.652 0 O-C-N 124.949 1.405 . . . . 1.0 112.095 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.9 55.52 0.73 Allowed Glycine 0 C--N 1.359 1.825 0 O-C-N 125.441 1.318 . . . . 1.0 113.272 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -118.71 120.95 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 129.92 50.6 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 125.26 1.6 . . . . 1.0 110.599 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -80.86 -33.74 34.23 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.731 1.269 . . . . 1.0 113.445 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -82.28 -35.88 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.081 1.352 . . . . 1.0 112.95 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -88.7 -16.88 31.17 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.767 1.227 . . . . 1.0 113.139 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.0 mttt 59.11 52.41 6.24 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 127.337 2.255 . . . . 1.0 112.406 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 68.3 mtp180 -122.39 124.34 43.44 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 113.934 -1.484 . . . . 1.0 110.144 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.27 124.0 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 125.347 1.654 . . . . 1.0 107.391 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -124.86 134.71 52.61 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 125.401 1.688 . . . . 1.0 110.347 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.81 127.63 55.21 Favored 'General case' 0 C--O 1.252 1.207 0 O-C-N 125.205 1.565 . . . . 1.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.283 1.615 . . . . 1.0 111.247 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.342 0.127 . . . . 1.0 111.342 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -107.72 142.5 37.62 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.215 1.572 . . . . 1.0 110.855 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -123.26 138.34 54.65 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.785 1.303 . . . . 1.0 111.259 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.535 ' SG ' HD12 ' A' ' 13' ' ' ILE . 14.3 t -72.71 122.85 88.64 Favored Pre-proline 0 CA--C 1.582 2.173 0 C-N-CA 124.731 1.212 . . . . 1.0 112.675 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.54 -1.68 11.39 Favored 'Trans proline' 1 C--N 1.435 5.085 0 C-N-CA 122.106 1.871 . . . . 1.0 115.085 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.535 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -100.0 -55.97 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 124.614 1.165 . . . . 1.0 109.406 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -103.8 -41.93 5.76 Favored 'General case' 0 C--N 1.373 1.589 0 O-C-N 124.544 1.152 . . . . 1.0 112.985 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 90.82 35.73 7.1 Favored Glycine 0 C--N 1.369 2.371 0 O-C-N 124.751 1.282 . . . . 1.0 114.253 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -95.51 148.72 35.07 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 116.871 -1.538 . . . . 1.0 111.807 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -69.22 140.78 45.61 Favored 'Trans proline' 1 C--N 1.448 5.775 0 C-N-CA 122.844 2.363 . . . . 1.0 114.955 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.37 145.43 51.08 Favored 'General case' 0 C--O 1.249 1.052 0 O-C-N 125.524 1.765 . . . . 1.0 110.324 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -99.39 135.26 41.06 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.716 1.26 . . . . 1.0 110.888 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.438 ' O ' HG12 ' A' ' 24' ' ' ILE . 59.5 m95 -69.19 -24.87 64.1 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.049 1.339 . . . . 1.0 113.326 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -70.39 -30.42 67.31 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.022 1.729 . . . . 1.0 113.03 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.42 -35.07 63.4 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 125.16 1.384 . . . . 1.0 113.127 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -40.25 85.18 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.866 1.667 . . . . 1.0 113.602 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.8 mm -74.64 -41.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 C-N-CA 125.581 1.552 . . . . 1.0 110.531 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -67.29 -35.92 80.47 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.338 1.455 . . . . 1.0 113.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.4 -22.93 40.76 Favored 'General case' 0 C--N 1.375 1.685 0 C-N-CA 125.409 1.483 . . . . 1.0 113.452 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.493 ' O ' HD12 ' A' ' 30' ' ' ILE . 55.2 mtp -102.65 1.61 34.85 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 124.563 1.164 . . . . 1.0 113.0 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.45 12.96 3.26 Favored 'General case' 0 CA--C 1.582 2.177 0 C-N-CA 124.805 1.242 . . . . 1.0 113.765 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -8.12 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 125.344 1.457 . . . . 1.0 113.283 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 27' ' ' MET . 1.1 mt -98.98 137.53 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 125.109 1.364 . . . . 1.0 108.553 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -74.6 -27.36 60.44 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 124.831 1.332 . . . . 1.0 113.879 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.79 -22.86 62.32 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 125.243 1.417 . . . . 1.0 112.926 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -56.11 -34.1 65.73 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.527 1.931 . . . . 1.0 114.384 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.48 -28.33 69.89 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 125.268 1.427 . . . . 1.0 112.303 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.22 -34.62 20.41 Favored 'General case' 0 C--N 1.376 1.758 0 C-N-CA 125.421 1.488 . . . . 1.0 112.481 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 33' ' ' PHE . 4.5 mt -71.76 -39.63 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 C-N-CA 125.679 1.592 . . . . 1.0 110.423 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.0 m -61.14 -20.07 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 125.188 1.395 . . . . 1.0 114.716 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -85.57 -19.95 30.31 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.091 1.356 . . . . 1.0 113.571 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.6 110.93 12.69 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 124.21 1.004 . . . . 1.0 111.666 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.447 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -60.35 -32.26 71.1 Favored 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 126.221 1.808 . . . . 1.0 115.451 177.296 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.43 -31.83 71.43 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.311 1.444 . . . . 1.0 113.337 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 72.3 mtp180 -82.42 -34.75 28.12 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.05 1.34 . . . . 1.0 112.869 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 t80 -70.51 -44.32 67.84 Favored 'General case' 0 C--N 1.389 2.287 0 C-N-CA 125.08 1.352 . . . . 1.0 112.605 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -70.21 -35.96 74.25 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.987 1.315 . . . . 1.0 113.144 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.15 -29.63 63.0 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.385 1.474 . . . . 1.0 113.204 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.1 tt0 -78.95 -34.4 44.41 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.368 1.467 . . . . 1.0 113.016 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 43' ' ' PHE . 89.7 t -69.89 -40.22 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.552 1.541 . . . . 1.0 109.762 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.12 -34.26 70.9 Favored 'General case' 0 N--CA 1.511 2.609 0 C-N-CA 125.575 1.55 . . . . 1.0 113.167 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.63 -27.36 29.19 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.318 1.447 . . . . 1.0 113.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -98.97 151.91 20.38 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.636 1.174 . . . . 1.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.05 148.0 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 O-C-N 124.664 1.227 . . . . 1.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.456 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 88.4 m-85 -121.71 152.04 39.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.671 1.232 . . . . 1.0 110.699 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -101.85 141.76 34.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.202 0.939 . . . . 1.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 24.1 t -96.05 119.39 64.69 Favored Pre-proline 0 CA--C 1.572 1.802 0 O-C-N 124.848 1.343 . . . . 1.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.07 -7.74 19.37 Favored 'Trans proline' 1 C--N 1.437 5.2 0 C-N-CA 122.25 1.967 . . . . 1.0 115.233 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 t -88.32 -51.94 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 C-N-CA 124.694 1.198 . . . . 1.0 110.299 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.38 -50.56 3.89 Favored 'General case' 0 C--N 1.367 1.343 0 O-C-N 124.691 1.245 . . . . 1.0 112.084 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 -14.57 12.1 Favored Glycine 0 C--N 1.371 2.523 0 O-C-N 124.473 1.108 . . . . 1.0 115.18 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -82.17 153.52 25.95 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 124.859 1.264 . . . . 1.0 112.565 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.45 138.41 31.5 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.163 1.385 . . . . 1.0 112.006 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -129.17 141.27 51.22 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 125.185 1.553 . . . . 1.0 109.814 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.3 151.53 19.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.318 1.011 . . . . 1.0 112.381 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.79 -8.02 86.33 Favored Glycine 0 C--N 1.378 2.884 0 O-C-N 124.437 1.085 . . . . 1.0 114.639 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -86.32 -19.6 29.57 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.466 1.506 . . . . 1.0 111.659 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.4 p -97.53 6.82 47.55 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.966 1.306 . . . . 1.0 112.055 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.76 159.07 55.75 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-O 117.344 -1.312 . . . . 1.0 111.393 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -69.68 154.51 67.98 Favored 'Trans proline' 1 C--N 1.441 5.432 0 C-N-CA 123.197 2.598 . . . . 1.0 114.227 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -68.26 -17.97 64.43 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 115.173 1.545 . . . . 1.0 115.173 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -83.67 -33.68 25.15 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.496 1.118 . . . . 1.0 112.221 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.5 mt-10 -69.86 -28.68 65.86 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.585 1.554 . . . . 1.0 113.49 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -64.27 -31.91 73.3 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.727 1.611 . . . . 1.0 112.852 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.19 -27.88 62.84 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 125.693 1.597 . . . . 1.0 111.987 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -68.26 -28.77 67.5 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 125.962 1.705 . . . . 1.0 112.65 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.472 ' O ' HD12 ' A' ' 78' ' ' LEU . 2.8 t -66.97 -40.06 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 C-N-CA 126.026 1.73 . . . . 1.0 109.331 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -28.0 65.57 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 125.772 1.629 . . . . 1.0 113.401 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -71.58 -42.63 67.54 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.188 1.795 . . . . 1.0 113.019 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.4 pp -67.28 -37.25 83.14 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.353 1.061 . . . . 1.0 112.513 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -71.2 -37.46 72.11 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.881 1.673 . . . . 1.0 113.079 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.68 -31.96 36.14 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.359 1.463 . . . . 1.0 114.129 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -98.64 57.81 1.18 Allowed 'General case' 0 C--O 1.26 1.646 0 CA-C-O 123.093 1.425 . . . . 1.0 110.712 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.45 145.61 24.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.005 -1.907 . . . . 1.0 111.48 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttm 77.46 112.02 0.07 Allowed 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 127.46 2.304 . . . . 1.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.22 -74.49 0.22 Allowed Glycine 0 C--N 1.36 1.874 0 O-C-N 125.037 1.46 . . . . 1.0 112.953 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.59 31.02 5.36 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 125.314 1.243 . . . . 1.0 115.348 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.39 120.12 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.05 130.17 51.75 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 125.177 1.548 . . . . 1.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.39 -32.59 32.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.887 1.275 . . . . 1.0 114.029 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.32 -35.73 40.68 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 124.964 1.305 . . . . 1.0 113.3 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -94.73 -15.34 23.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.652 1.22 . . . . 1.0 113.336 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 60.12 51.31 5.78 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 127.193 2.197 . . . . 1.0 113.903 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -113.34 128.83 56.59 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.899 -1.501 . . . . 1.0 110.435 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.46 130.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 124.99 1.431 . . . . 1.0 108.147 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -121.71 137.04 54.92 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 125.048 1.467 . . . . 1.0 111.364 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.83 130.93 53.48 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.126 1.517 . . . . 1.0 109.727 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 mttp . . . . . 0 C--O 1.253 1.238 0 O-C-N 125.213 1.57 . . . . 1.0 111.287 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 36.4 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.85 138.67 41.65 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 125.272 1.608 . . . . 1.0 110.884 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -106.81 138.64 42.61 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 124.901 1.375 . . . . 1.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.8 t -73.76 130.3 83.69 Favored Pre-proline 0 CA--C 1.582 2.207 0 CA-C-O 116.907 -1.52 . . . . 1.0 112.151 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.12 -11.75 27.37 Favored 'Trans proline' 1 C--N 1.441 5.404 0 C-N-CA 122.573 2.182 . . . . 1.0 114.406 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.507 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -93.73 -55.12 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.221 1.408 . . . . 1.0 110.482 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 29.1 p -103.35 -41.16 6.11 Favored 'General case' 0 C--N 1.372 1.569 0 O-C-N 124.302 1.001 . . . . 1.0 113.424 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 89.13 34.6 8.67 Favored Glycine 0 C--N 1.371 2.525 0 O-C-N 124.818 1.324 . . . . 1.0 113.324 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.532 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -92.74 144.63 28.91 Favored Pre-proline 0 C--N 1.369 1.447 0 CA-C-O 117.016 -1.468 . . . . 1.0 112.808 -178.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.59 135.36 38.66 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 122.46 2.107 . . . . 1.0 114.839 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mt -120.16 144.92 47.41 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 125.333 1.646 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.09 129.01 38.14 Favored 'General case' 0 C--N 1.362 1.111 0 O-C-N 124.876 1.36 . . . . 1.0 111.072 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.0 m95 -68.66 -25.58 64.89 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 125.136 1.374 . . . . 1.0 113.115 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 mt-10 -70.16 -32.27 70.15 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.936 1.695 . . . . 1.0 112.59 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -76.55 -34.1 58.51 Favored 'General case' 0 C--N 1.385 2.136 0 C-N-CA 125.225 1.41 . . . . 1.0 112.712 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -41.32 91.8 Favored 'General case' 0 C--N 1.383 2.051 0 C-N-CA 126.495 1.918 . . . . 1.0 112.764 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' TRP . 5.9 mm -78.97 -38.59 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 125.607 1.563 . . . . 1.0 110.445 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -65.49 -35.38 80.73 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 125.475 1.51 . . . . 1.0 113.491 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.46 -24.04 39.81 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.876 1.671 . . . . 1.0 112.451 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.475 ' O ' HD12 ' A' ' 30' ' ' ILE . 24.0 mtp -101.56 9.06 41.6 Favored 'General case' 0 CA--C 1.575 1.908 0 O-C-N 124.805 1.316 . . . . 1.0 112.943 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 13.4 13.77 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 124.163 0.985 . . . . 1.0 112.978 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.92 -6.36 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 125.606 1.562 . . . . 1.0 113.317 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -97.96 140.84 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 125.285 1.434 . . . . 1.0 109.048 -178.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.71 -19.1 42.22 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.852 1.345 . . . . 1.0 113.306 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.8 -19.94 50.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.183 1.393 . . . . 1.0 112.584 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.565 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.5 t80 -57.51 -35.77 70.69 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 126.327 1.851 . . . . 1.0 113.374 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.02 -28.0 69.28 Favored 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 125.337 1.455 . . . . 1.0 112.182 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -87.63 -33.88 18.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.843 1.657 . . . . 1.0 112.149 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.3 mt -71.26 -40.25 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.991 0 C-N-CA 125.739 1.616 . . . . 1.0 110.634 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.514 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.1 m -58.75 -24.47 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 C-N-CA 125.687 1.595 . . . . 1.0 114.741 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -87.73 -15.24 37.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 1.0 113.022 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -125.36 106.34 9.76 Favored 'General case' 0 C--N 1.375 1.684 0 C-N-CA 124.473 1.109 . . . . 1.0 111.767 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.457 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.6 mtm180 -59.11 -33.12 70.48 Favored 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 125.956 1.702 . . . . 1.0 113.863 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.14 -31.21 68.63 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.943 1.697 . . . . 1.0 112.839 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -82.0 -33.58 30.05 Favored 'General case' 0 C--N 1.38 1.917 0 C-N-CA 125.196 1.398 . . . . 1.0 112.552 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.4 t80 -72.19 -43.95 63.74 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 124.938 1.295 . . . . 1.0 112.815 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -70.33 -31.27 68.49 Favored 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 125.359 1.463 . . . . 1.0 113.049 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -26.68 33.58 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 125.305 1.442 . . . . 1.0 112.932 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 3.3 mm-40 -79.25 -38.18 36.18 Favored 'General case' 0 C--N 1.384 2.093 0 C-N-CA 124.798 1.239 . . . . 1.0 112.615 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 43' ' ' PHE . 68.3 t -68.16 -40.04 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 125.472 1.509 . . . . 1.0 109.68 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.48 -24.83 62.07 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 125.522 1.529 . . . . 1.0 113.142 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.29 -15.85 19.62 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.111 1.364 . . . . 1.0 113.153 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -93.19 151.29 19.92 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 124.62 1.168 . . . . 1.0 112.315 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG11 ' OE1' ' A' ' 60' ' ' GLU . 82.9 t -97.94 140.64 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 125.092 1.495 . . . . 1.0 107.791 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -128.44 146.31 50.84 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.602 1.814 . . . . 1.0 109.571 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -105.1 142.25 35.22 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 124.779 1.299 . . . . 1.0 111.259 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.69 131.38 37.95 Favored Pre-proline 0 CA--C 1.574 1.875 0 O-C-N 124.982 1.427 . . . . 1.0 111.352 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.68 -9.62 22.77 Favored 'Trans proline' 1 C--N 1.437 5.221 0 C-N-CA 122.439 2.092 . . . . 1.0 114.268 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.06 -53.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 125.274 1.43 . . . . 1.0 109.709 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 25.0 m -88.73 -53.98 4.37 Favored 'General case' 0 C--N 1.379 1.874 0 O-C-N 124.253 0.971 . . . . 1.0 112.1 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.32 6.63 61.23 Favored Glycine 0 C--N 1.37 2.45 0 O-C-N 124.885 1.366 . . . . 1.0 113.378 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.26 165.83 16.16 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 126.126 1.77 . . . . 1.0 112.332 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE1' HG11 ' A' ' 51' ' ' VAL . 43.9 mt-10 -92.2 134.28 35.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.06 1.344 . . . . 1.0 110.733 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.08 153.41 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.393 1.477 . . . . 1.0 109.983 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.49 154.04 21.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.577 1.173 . . . . 1.0 112.398 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.0 -1.19 72.39 Favored Glycine 0 C--N 1.378 2.881 0 O-C-N 124.446 1.091 . . . . 1.0 114.424 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -85.65 -17.41 36.19 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.169 1.387 . . . . 1.0 111.596 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.5 p -95.55 3.31 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.993 1.317 . . . . 1.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.44 152.71 73.35 Favored Pre-proline 0 CA--C 1.58 2.108 0 CA-C-O 116.86 -1.543 . . . . 1.0 111.703 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -64.1 149.87 89.51 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 123.252 2.634 . . . . 1.0 114.931 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -65.05 -17.83 64.79 Favored 'General case' 0 N--CA 1.51 2.533 0 C-N-CA 125.517 1.527 . . . . 1.0 114.835 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -82.53 -33.13 28.32 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.03 1.332 . . . . 1.0 111.533 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.18 -30.16 66.08 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.787 1.635 . . . . 1.0 113.042 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -66.87 -36.3 82.0 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 125.58 1.552 . . . . 1.0 112.388 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -71.8 -24.22 61.7 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 125.41 1.484 . . . . 1.0 112.356 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -74.76 -27.94 60.55 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 126.181 1.792 . . . . 1.0 112.439 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 t -67.11 -39.73 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 C-N-CA 126.195 1.798 . . . . 1.0 110.305 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 40' ' ' ARG . 1.4 t80 -60.56 -29.46 69.18 Favored 'General case' 0 N--CA 1.511 2.605 0 C-N-CA 125.608 1.563 . . . . 1.0 113.651 177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.18 -40.81 71.01 Favored 'General case' 0 C--N 1.384 2.087 0 C-N-CA 125.731 1.613 . . . . 1.0 113.212 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.7 pp -70.15 -34.96 73.68 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 124.903 1.281 . . . . 1.0 113.554 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.514 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.32 -24.18 42.98 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.105 1.362 . . . . 1.0 112.453 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.406 ' OD1' ' HD3' ' A' ' 40' ' ' ARG . 2.6 m120 -85.36 -14.61 45.87 Favored 'General case' 0 C--N 1.382 2.002 0 C-N-CA 124.862 1.265 . . . . 1.0 113.357 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.12 -36.96 84.53 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 125.667 1.587 . . . . 1.0 113.819 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 61.57 -58.72 0.11 Allowed 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 128.112 2.565 . . . . 1.0 114.174 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -128.59 136.46 50.74 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 125.115 1.366 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -174.07 -102.02 0.15 Allowed Glycine 0 C--N 1.356 1.679 0 O-C-N 125.151 1.532 . . . . 1.0 111.807 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.76 44.66 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 O-C-N 125.504 1.355 . . . . 1.0 113.395 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.3 123.6 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.812 -1.551 . . . . 1.0 106.812 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.75 128.74 45.88 Favored 'General case' 0 C--O 1.248 1.015 0 O-C-N 125.324 1.64 . . . . 1.0 110.252 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -80.81 -26.38 37.14 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.807 1.243 . . . . 1.0 114.071 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -80.94 -38.4 27.88 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 125.14 1.376 . . . . 1.0 113.178 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -97.32 -14.4 21.32 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 124.555 1.159 . . . . 1.0 113.678 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttm 60.35 55.81 3.41 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 127.342 2.257 . . . . 1.0 113.319 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 86.5 mtt180 -115.93 130.2 56.72 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.16 127.38 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 125.126 1.516 . . . . 1.0 107.996 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -119.66 136.81 54.24 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 125.374 1.671 . . . . 1.0 110.537 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.29 129.14 56.61 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 124.973 1.42 . . . . 1.0 111.583 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt . . . . . 0 N--CA 1.48 1.03 0 O-C-N 125.777 1.923 . . . . 1.0 111.06 179.562 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.4 mmt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 111.238 0.088 . . . . 1.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' HB2' ' NE1' ' A' ' 20' ' ' TRP . . . -107.5 139.91 41.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 125.268 1.605 . . . . 1.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -128.42 138.9 52.54 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.774 1.296 . . . . 1.0 111.114 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 13' ' ' ILE . 27.1 t -73.14 121.27 84.68 Favored Pre-proline 0 CA--C 1.582 2.21 0 CA-C-O 117.58 -1.2 . . . . 1.0 111.784 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 -6.37 18.97 Favored 'Trans proline' 1 C--N 1.433 4.974 0 C-N-CA 121.965 1.777 . . . . 1.0 114.834 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.536 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.3 mt -95.72 -55.41 6.13 Favored 'Isoleucine or valine' 0 C--N 1.372 1.575 0 C-N-CA 125.069 1.348 . . . . 1.0 110.05 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.2 p -103.79 -41.75 5.82 Favored 'General case' 0 C--N 1.374 1.634 0 O-C-N 124.245 0.965 . . . . 1.0 112.795 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.99 36.3 6.06 Favored Glycine 0 C--N 1.367 2.288 0 O-C-N 124.711 1.257 . . . . 1.0 114.151 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.439 ' OG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -97.89 147.52 33.17 Favored Pre-proline 0 CA--C 1.565 1.552 0 CA-C-O 116.848 -1.548 . . . . 1.0 111.83 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.71 139.13 39.64 Favored 'Trans proline' 1 C--N 1.446 5.708 0 C-N-CA 122.733 2.288 . . . . 1.0 114.33 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 mt -124.37 146.17 49.01 Favored 'General case' 0 C--O 1.25 1.131 0 O-C-N 125.436 1.71 . . . . 1.0 110.302 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.32 124.91 38.64 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 124.682 1.239 . . . . 1.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.481 ' O ' HG12 ' A' ' 24' ' ' ILE . 44.8 m95 -69.25 -24.83 64.04 Favored 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 125.091 1.356 . . . . 1.0 112.594 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 35.9 mt-10 -69.94 -31.59 69.42 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.72 1.608 . . . . 1.0 112.094 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -76.37 -34.0 58.92 Favored 'General case' 0 C--N 1.39 2.344 0 C-N-CA 124.923 1.289 . . . . 1.0 112.455 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -41.04 93.95 Favored 'General case' 0 C--N 1.381 1.967 0 C-N-CA 126.199 1.8 . . . . 1.0 112.711 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.2 mm -79.79 -39.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 C-N-CA 125.419 1.488 . . . . 1.0 110.641 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.63 -35.36 79.99 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 125.297 1.439 . . . . 1.0 113.678 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.68 -22.97 42.78 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 125.541 1.536 . . . . 1.0 112.586 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.468 ' O ' HD12 ' A' ' 30' ' ' ILE . 30.7 mtt -105.21 10.29 33.78 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 124.991 1.432 . . . . 1.0 112.128 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.39 23.26 4.62 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.007 0.923 . . . . 1.0 112.935 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.85 6.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 125.096 1.358 . . . . 1.0 112.79 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 32' ' ' ASN . 1.1 mt -109.27 139.69 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.037 1.335 . . . . 1.0 109.138 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.0 -20.47 28.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.142 1.526 . . . . 1.0 112.235 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.51 ' H ' HG22 ' A' ' 30' ' ' ILE . 10.4 m120 -91.6 19.54 6.21 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.179 1.391 . . . . 1.0 112.055 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.84 -36.3 56.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.313 1.445 . . . . 1.0 111.778 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 37' ' ' VAL . 29.1 mt-10 -55.67 -23.88 30.84 Favored 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 126.068 1.747 . . . . 1.0 114.684 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.79 -43.83 15.02 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 125.074 1.35 . . . . 1.0 111.495 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 43' ' ' PHE . 3.2 mt -72.8 -43.05 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 125.297 1.439 . . . . 1.0 110.934 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 34' ' ' GLU . 1.9 p -68.26 -19.26 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.757 0 C-N-CA 125.124 1.37 . . . . 1.0 114.132 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -91.96 -17.77 24.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.621 1.2 . . . . 1.0 112.698 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.0 105.47 9.61 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 124.351 1.06 . . . . 1.0 111.412 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -57.19 -31.63 65.65 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 125.386 1.475 . . . . 1.0 114.104 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.3 -33.49 74.42 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.778 1.631 . . . . 1.0 112.652 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -82.16 -35.84 28.01 Favored 'General case' 0 C--N 1.377 1.792 0 C-N-CA 125.339 1.456 . . . . 1.0 112.429 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.5 t80 -73.69 -45.27 53.45 Favored 'General case' 0 C--N 1.39 2.357 0 C-N-CA 125.089 1.356 . . . . 1.0 112.523 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.58 -28.18 66.72 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 124.597 1.159 . . . . 1.0 113.048 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.77 -28.61 36.36 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.154 1.382 . . . . 1.0 112.619 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.9 tt0 -79.6 -38.25 34.37 Favored 'General case' 0 C--N 1.381 1.968 0 C-N-CA 125.094 1.358 . . . . 1.0 112.337 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 43' ' ' PHE . 49.1 t -68.99 -42.07 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.215 0 C-N-CA 125.341 1.456 . . . . 1.0 109.635 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.89 -28.28 67.37 Favored 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.455 1.502 . . . . 1.0 113.544 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -91.92 -26.75 18.29 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.863 1.265 . . . . 1.0 113.488 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -97.6 147.42 24.32 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 124.566 1.146 . . . . 1.0 111.254 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.0 151.89 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 O-C-N 124.835 1.335 . . . . 1.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -122.56 144.57 49.01 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.949 1.406 . . . . 1.0 110.434 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -96.77 138.77 33.83 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 124.787 1.305 . . . . 1.0 111.268 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.6 t -96.5 111.76 57.99 Favored Pre-proline 0 CA--C 1.576 1.961 0 O-C-N 125.026 1.454 . . . . 1.0 110.654 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -70.57 -8.07 22.76 Favored 'Trans proline' 1 C--N 1.439 5.299 0 C-N-CA 122.984 2.456 . . . . 1.0 114.348 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG11 ' OG ' ' A' ' 16' ' ' SER . 1.8 t -85.31 -51.97 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 125.577 1.551 . . . . 1.0 110.597 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.1 p -103.76 -48.14 4.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.722 1.264 . . . . 1.0 112.504 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.1 -10.94 14.93 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 124.442 1.089 . . . . 1.0 114.348 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.4 147.82 25.27 Favored 'General case' 0 C--N 1.376 1.738 0 C-N-CA 124.963 1.305 . . . . 1.0 111.476 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.74 138.54 31.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.783 1.233 . . . . 1.0 112.36 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -122.35 143.11 49.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.214 1.571 . . . . 1.0 109.833 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -95.31 151.67 19.06 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 124.318 1.012 . . . . 1.0 112.659 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.21 -9.07 80.48 Favored Glycine 0 C--N 1.379 2.932 0 O-C-N 124.661 1.226 . . . . 1.0 115.125 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -87.55 -18.25 30.18 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.256 1.422 . . . . 1.0 112.047 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 p -99.63 2.68 44.73 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.841 1.256 . . . . 1.0 112.018 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 152.89 81.22 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 116.982 -1.485 . . . . 1.0 111.969 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.49 152.2 82.59 Favored 'Trans proline' 1 C--N 1.444 5.553 0 C-N-CA 123.289 2.659 . . . . 1.0 114.67 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -66.98 -19.58 65.74 Favored 'General case' 0 N--CA 1.507 2.405 0 C-N-CA 125.19 1.396 . . . . 1.0 114.566 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -79.6 -34.17 40.93 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 125.002 1.321 . . . . 1.0 112.073 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -70.12 -29.46 66.42 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.743 1.617 . . . . 1.0 113.239 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.18 71.93 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.845 1.658 . . . . 1.0 112.863 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.01 -26.2 63.02 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 1.0 112.933 176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -68.7 -28.03 66.48 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.968 1.707 . . . . 1.0 112.785 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t -65.92 -33.91 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.09 0 C-N-CA 126.519 1.928 . . . . 1.0 110.281 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.27 -29.16 69.9 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 125.784 1.634 . . . . 1.0 113.828 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -68.27 -38.5 81.81 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 125.67 1.588 . . . . 1.0 113.068 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.2 pp -72.84 -29.29 63.1 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.599 1.16 . . . . 1.0 112.825 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -26.93 43.5 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 125.405 1.482 . . . . 1.0 113.055 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -98.16 -20.18 17.45 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.423 1.089 . . . . 1.0 113.57 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.06 62.24 0.64 Allowed 'General case' 0 C--O 1.259 1.562 0 CA-C-O 123.127 1.442 . . . . 1.0 110.919 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -69.38 -34.98 75.34 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 113.349 -1.75 . . . . 1.0 113.106 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -106.36 120.3 41.52 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 124.973 1.42 . . . . 1.0 108.709 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.44 84.63 1.68 Allowed Glycine 0 C--N 1.363 2.071 0 O-C-N 124.661 1.226 . . . . 1.0 112.934 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 136.36 -57.99 0.67 Allowed Glycine 0 C--N 1.359 1.827 0 O-C-N 125.307 1.24 . . . . 1.0 113.468 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.4 mp -109.05 124.6 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 125.104 1.12 . . . . 1.0 108.126 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.06 133.11 56.01 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.495 1.747 . . . . 1.0 110.19 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -80.53 -29.35 37.19 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.588 1.18 . . . . 1.0 113.911 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.18 -35.42 28.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 124.877 1.271 . . . . 1.0 112.935 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -92.76 -17.88 23.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.613 1.196 . . . . 1.0 113.495 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 59.2 45.59 14.13 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 127.157 2.183 . . . . 1.0 113.516 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 9.1 mmm180 -115.27 138.19 51.22 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.284 -1.326 . . . . 1.0 111.435 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.84 126.92 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 125.174 1.546 . . . . 1.0 108.235 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 12.1 tttt -127.11 129.35 47.77 Favored 'General case' 0 C--O 1.251 1.143 0 O-C-N 125.28 1.612 . . . . 1.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 132.97 52.74 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.762 1.289 . . . . 1.0 110.716 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.7 mttm . . . . . 0 C--O 1.252 1.221 0 O-C-N 125.289 1.618 . . . . 1.0 111.357 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 110.851 -0.055 . . . . 1.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.73 138.61 44.78 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 125.179 1.549 . . . . 1.0 110.829 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -110.94 139.06 46.6 Favored 'General case' 0 C--O 1.248 1.013 0 O-C-N 124.9 1.375 . . . . 1.0 110.906 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 13' ' ' ILE . 47.3 t -71.8 132.34 85.14 Favored Pre-proline 0 CA--C 1.578 2.038 0 CA-C-O 117.262 -1.351 . . . . 1.0 112.44 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.71 -8.45 20.39 Favored 'Trans proline' 1 C--N 1.43 4.854 0 C-N-CA 122.178 1.919 . . . . 1.0 114.761 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.541 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.2 -55.9 5.66 Favored 'Isoleucine or valine' 0 C--N 1.372 1.569 0 C-N-CA 124.975 1.31 . . . . 1.0 109.955 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 27.2 p -101.23 -41.15 6.82 Favored 'General case' 0 C--N 1.371 1.536 0 O-C-N 124.079 0.862 . . . . 1.0 113.003 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 88.73 34.14 9.4 Favored Glycine 0 C--N 1.37 2.464 0 O-C-N 124.691 1.244 . . . . 1.0 113.112 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.461 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -93.16 145.91 30.94 Favored Pre-proline 0 C--N 1.368 1.411 0 CA-C-O 117.177 -1.392 . . . . 1.0 112.586 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.71 134.28 34.59 Favored 'Trans proline' 1 C--N 1.445 5.624 0 C-N-CA 122.422 2.081 . . . . 1.0 114.475 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt -118.63 143.16 47.0 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 125.277 1.611 . . . . 1.0 110.202 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.28 130.85 37.1 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.789 1.306 . . . . 1.0 111.212 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 24' ' ' ILE . 45.8 m95 -68.78 -24.8 64.46 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 125.078 1.351 . . . . 1.0 113.046 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.1 mt-10 -70.01 -33.77 72.45 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 125.623 1.569 . . . . 1.0 112.178 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.98 -34.69 57.53 Favored 'General case' 0 C--N 1.386 2.193 0 C-N-CA 125.268 1.427 . . . . 1.0 112.776 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.13 -41.3 94.93 Favored 'General case' 0 C--N 1.382 1.994 0 C-N-CA 126.036 1.734 . . . . 1.0 112.839 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -79.94 -37.99 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 C-N-CA 125.271 1.428 . . . . 1.0 110.48 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.57 -35.25 79.75 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.093 1.357 . . . . 1.0 113.472 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.24 -23.83 40.58 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.653 1.581 . . . . 1.0 112.55 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -103.65 13.77 32.52 Favored 'General case' 0 CA--C 1.576 1.979 0 O-C-N 124.768 1.293 . . . . 1.0 112.48 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.11 16.79 12.11 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 123.937 0.895 . . . . 1.0 112.882 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.88 -4.05 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 C-N-CA 125.457 1.503 . . . . 1.0 113.427 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -99.71 140.92 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 125.251 1.421 . . . . 1.0 109.125 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.78 -18.06 41.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.888 1.367 . . . . 1.0 113.033 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.66 -16.3 54.35 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 124.975 1.31 . . . . 1.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.87 -34.74 65.75 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 126.252 1.821 . . . . 1.0 113.006 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.06 -30.34 71.52 Favored 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 125.317 1.447 . . . . 1.0 112.281 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.71 -35.73 20.65 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 125.461 1.504 . . . . 1.0 112.251 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -72.2 -39.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.905 0 C-N-CA 126.011 1.724 . . . . 1.0 110.549 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.531 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.5 p -63.17 -18.85 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 C-N-CA 125.561 1.544 . . . . 1.0 114.237 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.98 -19.41 25.75 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.75 1.22 . . . . 1.0 113.311 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -125.3 111.11 14.82 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.364 1.066 . . . . 1.0 111.688 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.0 mpt_? -60.05 -33.45 72.06 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 125.603 1.561 . . . . 1.0 113.57 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.19 -31.06 69.41 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 125.636 1.575 . . . . 1.0 112.632 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -82.16 -33.42 29.53 Favored 'General case' 0 C--N 1.379 1.85 0 C-N-CA 125.119 1.368 . . . . 1.0 112.154 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.473 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.0 t80 -71.65 -43.98 65.12 Favored 'General case' 0 C--N 1.394 2.508 0 C-N-CA 125.137 1.375 . . . . 1.0 112.41 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.83 -28.8 65.99 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.925 1.29 . . . . 1.0 112.41 177.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 -27.07 29.64 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 125.455 1.502 . . . . 1.0 112.787 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.0 mm-40 -78.11 -39.12 42.34 Favored 'General case' 0 C--N 1.383 2.024 0 C-N-CA 124.775 1.23 . . . . 1.0 112.84 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 43' ' ' PHE . 46.0 t -68.8 -40.77 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.03 0 C-N-CA 125.234 1.414 . . . . 1.0 109.621 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.29 -26.69 63.92 Favored 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.491 1.516 . . . . 1.0 113.024 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.36 -26.0 19.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.076 1.351 . . . . 1.0 112.851 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -96.18 144.64 26.22 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 124.64 1.176 . . . . 1.0 110.943 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.9 150.85 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 O-C-N 124.948 1.405 . . . . 1.0 110.732 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.03 145.5 50.97 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.856 1.348 . . . . 1.0 110.523 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -101.4 142.69 32.43 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.663 1.227 . . . . 1.0 111.3 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -89.04 123.38 67.5 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 117.385 -1.293 . . . . 1.0 110.943 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.26 -9.93 26.27 Favored 'Trans proline' 1 C--N 1.439 5.301 0 C-N-CA 122.81 2.34 . . . . 1.0 113.548 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.15 -52.78 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 125.638 1.575 . . . . 1.0 110.177 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 46.0 m -90.13 -52.74 4.79 Favored 'General case' 0 C--N 1.38 1.893 0 O-C-N 124.22 0.95 . . . . 1.0 112.383 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.67 42.14 Favored Glycine 0 C--N 1.368 2.316 0 O-C-N 124.796 1.31 . . . . 1.0 112.899 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -86.57 152.58 22.5 Favored 'General case' 0 C--N 1.379 1.888 0 C-N-CA 125.759 1.624 . . . . 1.0 111.272 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.28 136.66 32.9 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.436 1.095 . . . . 1.0 111.577 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -130.14 144.15 51.19 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 125.475 1.734 . . . . 1.0 109.159 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -92.2 153.85 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.186 0.929 . . . . 1.0 113.047 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -77.27 -4.43 83.93 Favored Glycine 0 C--N 1.377 2.826 0 O-C-N 124.404 1.065 . . . . 1.0 114.793 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -85.81 -15.16 42.85 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.355 1.462 . . . . 1.0 112.054 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 p -95.59 5.64 50.97 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 124.524 1.13 . . . . 1.0 111.562 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 63' ' ' GLY . 5.8 mt -74.53 150.51 86.9 Favored Pre-proline 0 C--N 1.387 2.23 0 CA-C-O 116.811 -1.566 . . . . 1.0 112.48 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.98 151.69 83.31 Favored 'Trans proline' 1 C--N 1.441 5.434 0 C-N-CA 123.139 2.559 . . . . 1.0 113.739 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -65.71 -18.34 65.26 Favored 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 114.715 1.376 . . . . 1.0 114.715 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -83.45 -34.43 25.44 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.974 1.309 . . . . 1.0 111.68 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -70.36 -29.15 65.75 Favored 'General case' 0 C--N 1.387 2.198 0 C-N-CA 125.741 1.616 . . . . 1.0 113.513 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.18 75.29 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.497 1.519 . . . . 1.0 112.809 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -73.85 -28.21 61.47 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.729 1.612 . . . . 1.0 112.358 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -71.33 -26.94 63.05 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 126.054 1.742 . . . . 1.0 112.746 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.7 -38.31 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 C-N-CA 126.49 1.916 . . . . 1.0 110.366 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -60.06 -28.18 67.57 Favored 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.277 1.431 . . . . 1.0 113.864 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -40.79 79.94 Favored 'General case' 0 C--N 1.383 2.064 0 C-N-CA 125.616 1.567 . . . . 1.0 113.496 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.1 pp -71.04 -34.52 71.33 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.911 1.284 . . . . 1.0 113.013 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.08 -22.65 44.96 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.479 1.512 . . . . 1.0 112.531 177.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -86.37 -9.66 55.92 Favored 'General case' 0 C--N 1.383 2.038 0 C-N-CA 124.586 1.154 . . . . 1.0 113.061 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.55 -35.59 75.55 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.59 1.556 . . . . 1.0 113.75 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.67 -72.01 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 127.621 2.368 . . . . 1.0 113.816 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -128.48 135.31 49.27 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 125.201 1.401 . . . . 1.0 109.393 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.45 114.6 3.97 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 125.018 1.449 . . . . 1.0 111.445 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 109.3 -43.24 1.75 Allowed Glycine 0 C--N 1.356 1.648 0 O-C-N 125.404 1.296 . . . . 1.0 113.846 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -107.47 124.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.32 127.99 54.61 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 125.443 1.714 . . . . 1.0 110.002 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.55 -32.85 36.56 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.683 1.239 . . . . 1.0 113.778 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.23 -36.16 30.35 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.004 1.322 . . . . 1.0 112.901 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.34 -16.14 24.98 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.695 1.198 . . . . 1.0 113.525 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.17 44.26 16.05 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 127.112 2.165 . . . . 1.0 113.479 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 99.4 mtt180 -114.0 135.89 53.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.318 -1.31 . . . . 1.0 111.175 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.76 127.0 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 125.471 1.732 . . . . 1.0 107.727 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 2.8 tttp -122.66 133.11 54.52 Favored 'General case' 0 C--O 1.25 1.123 0 O-C-N 125.309 1.631 . . . . 1.0 110.464 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.48 129.85 53.2 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.04 1.462 . . . . 1.0 110.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 mttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.373 1.671 . . . . 1.0 111.287 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 39.6 mtt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.466 0.172 . . . . 1.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.49 139.42 40.13 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 125.253 1.596 . . . . 1.0 110.732 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.38 139.2 45.81 Favored 'General case' 0 C--O 1.249 1.027 0 O-C-N 124.79 1.307 . . . . 1.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.522 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.4 t -69.51 129.11 91.81 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 116.905 -1.521 . . . . 1.0 111.687 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.35 -13.03 30.43 Favored 'Trans proline' 1 C--N 1.438 5.238 0 C-N-CA 122.373 2.048 . . . . 1.0 114.598 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.522 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.6 mp -91.33 -54.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 125.395 1.478 . . . . 1.0 110.7 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.29 -40.4 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.261 0.976 . . . . 1.0 113.433 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.91 38.43 5.77 Favored Glycine 0 C--N 1.371 2.499 0 O-C-N 124.71 1.256 . . . . 1.0 113.05 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -92.13 142.97 26.85 Favored Pre-proline 0 CA--C 1.567 1.625 0 CA-C-O 116.609 -1.662 . . . . 1.0 113.042 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.68 137.28 38.34 Favored 'Trans proline' 1 C--N 1.451 5.94 0 C-N-CA 122.557 2.171 . . . . 1.0 113.08 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -118.76 143.45 46.89 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 125.143 1.527 . . . . 1.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.64 131.61 41.7 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.979 1.424 . . . . 1.0 110.956 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.513 ' O ' HG12 ' A' ' 24' ' ' ILE . 55.0 m95 -68.51 -26.43 65.44 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.025 1.33 . . . . 1.0 112.968 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.0 mt-10 -70.0 -33.1 71.6 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 125.692 1.597 . . . . 1.0 112.094 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.69 -33.46 58.23 Favored 'General case' 0 C--N 1.387 2.202 0 C-N-CA 125.077 1.351 . . . . 1.0 112.509 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.4 OUTLIER -65.87 -41.42 91.63 Favored 'General case' 0 C--N 1.389 2.285 0 C-N-CA 125.824 1.65 . . . . 1.0 112.743 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.8 mm -76.97 -39.46 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 C-N-CA 125.411 1.484 . . . . 1.0 110.461 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -67.61 -36.6 81.14 Favored 'General case' 0 C--N 1.385 2.151 0 C-N-CA 125.281 1.432 . . . . 1.0 113.57 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.96 -22.5 39.52 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.645 1.578 . . . . 1.0 112.842 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -104.54 12.75 32.78 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.537 1.148 . . . . 1.0 111.856 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 12.23 26.81 Favored 'General case' 0 CA--C 1.575 1.91 0 C-N-CA 123.733 0.813 . . . . 1.0 113.014 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.68 1.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 C-N-CA 125.903 1.681 . . . . 1.0 113.074 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 27' ' ' MET . 0.8 OUTLIER -108.84 140.15 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 125.187 1.395 . . . . 1.0 109.109 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -80.87 -19.67 43.95 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 124.808 1.243 . . . . 1.0 113.748 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -79.09 -21.3 46.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.979 1.312 . . . . 1.0 112.554 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.4 t80 -57.59 -34.97 69.79 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.279 1.832 . . . . 1.0 113.153 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.1 -30.7 69.43 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 125.584 1.554 . . . . 1.0 111.975 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.16 -33.95 19.22 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 125.652 1.581 . . . . 1.0 112.485 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 33' ' ' PHE . 7.0 mt -71.5 -37.18 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.841 1.656 . . . . 1.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 m -61.98 -18.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 125.06 1.344 . . . . 1.0 114.394 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -93.11 -18.88 22.08 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.341 1.456 . . . . 1.0 112.595 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -121.61 104.84 9.92 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 124.104 0.962 . . . . 1.0 111.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.4 ptp180 -58.24 -36.85 73.81 Favored 'General case' 0 N--CA 1.517 2.904 0 C-N-CA 126.071 1.748 . . . . 1.0 113.973 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.26 -32.75 74.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.042 1.737 . . . . 1.0 112.776 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -83.74 -31.67 25.88 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.417 1.487 . . . . 1.0 112.256 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.2 t80 -74.56 -46.92 35.8 Favored 'General case' 0 C--N 1.392 2.441 0 C-N-CA 124.739 1.216 . . . . 1.0 113.14 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -71.4 -33.59 69.61 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 124.928 1.291 . . . . 1.0 113.152 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.37 -28.44 61.11 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.336 1.454 . . . . 1.0 113.161 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 mt-30 -80.05 -35.82 36.56 Favored 'General case' 0 C--N 1.381 1.97 0 C-N-CA 124.985 1.314 . . . . 1.0 112.945 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.5 t -67.98 -40.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.36 0 C-N-CA 125.267 1.427 . . . . 1.0 109.547 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.02 -22.59 61.39 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.546 1.539 . . . . 1.0 113.459 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.8 -26.39 14.72 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.943 1.297 . . . . 1.0 112.603 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -99.05 144.06 28.62 Favored 'General case' 0 C--N 1.374 1.661 0 O-C-N 124.358 1.036 . . . . 1.0 111.28 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 151.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 O-C-N 125.451 1.719 . . . . 1.0 111.564 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.88 148.04 45.88 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 125.003 1.44 . . . . 1.0 109.795 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -98.64 140.97 32.06 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.666 1.229 . . . . 1.0 111.458 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.08 132.93 34.64 Favored Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 124.956 1.41 . . . . 1.0 111.635 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.15 -9.16 21.77 Favored 'Trans proline' 1 C--N 1.43 4.841 0 C-N-CA 122.535 2.156 . . . . 1.0 114.238 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.64 -51.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 125.336 1.454 . . . . 1.0 110.019 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.6 m -90.4 -52.84 4.71 Favored 'General case' 0 C--N 1.378 1.808 0 O-C-N 124.23 0.956 . . . . 1.0 112.45 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.27 Favored Glycine 0 C--N 1.37 2.417 0 O-C-N 124.67 1.231 . . . . 1.0 113.655 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.06 154.43 17.34 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 125.445 1.498 . . . . 1.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -88.07 133.86 33.88 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 124.326 1.05 . . . . 1.0 111.715 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -131.2 148.17 52.68 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 125.408 1.693 . . . . 1.0 109.382 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -91.18 149.33 21.83 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.19 -0.19 81.99 Favored Glycine 0 C--N 1.374 2.673 0 O-C-N 124.648 1.217 . . . . 1.0 114.573 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -85.22 -15.4 43.72 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.407 1.483 . . . . 1.0 111.872 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.4 p -91.07 2.28 56.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.688 1.195 . . . . 1.0 111.484 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.67 144.61 45.86 Favored Pre-proline 0 C--N 1.386 2.178 0 CA-C-O 117.242 -1.361 . . . . 1.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.1 157.06 61.57 Favored 'Trans proline' 1 C--N 1.437 5.211 0 C-N-CA 122.897 2.398 . . . . 1.0 114.066 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.48 -30.71 71.46 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 124.606 1.163 . . . . 1.0 113.502 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.22 -38.71 84.2 Favored 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.764 1.626 . . . . 1.0 113.309 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.6 -28.7 62.94 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 124.874 1.27 . . . . 1.0 112.836 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.24 72.22 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.957 1.703 . . . . 1.0 112.691 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.96 -25.07 60.89 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.713 1.605 . . . . 1.0 112.573 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -73.64 -28.51 61.83 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.743 1.617 . . . . 1.0 112.387 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.527 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.95 -36.22 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 C-N-CA 126.333 1.853 . . . . 1.0 110.17 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.17 -29.43 70.55 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.326 1.45 . . . . 1.0 113.475 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.07 -39.06 89.76 Favored 'General case' 0 C--N 1.389 2.303 0 C-N-CA 125.733 1.613 . . . . 1.0 113.09 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -74.0 -32.2 63.3 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 124.779 1.232 . . . . 1.0 112.495 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -82.86 -22.39 34.06 Favored 'General case' 0 C--N 1.371 1.54 0 C-N-CA 125.502 1.521 . . . . 1.0 112.901 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -87.01 -21.64 26.0 Favored 'General case' 0 C--N 1.381 1.941 0 C-N-CA 124.715 1.206 . . . . 1.0 112.587 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.32 -34.57 28.52 Favored 'General case' 0 C--N 1.379 1.859 0 C-N-CA 125.003 1.321 . . . . 1.0 113.023 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.95 -59.08 0.15 Allowed 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 127.931 2.493 . . . . 1.0 114.026 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -124.72 134.83 52.7 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 126.147 1.779 . . . . 1.0 109.444 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.42 -111.7 0.27 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 125.062 1.476 . . . . 1.0 111.686 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -113.73 49.09 0.87 Allowed Glycine 0 C--N 1.351 1.416 0 O-C-N 125.768 1.511 . . . . 1.0 112.238 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.19 123.2 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -118.17 128.17 54.46 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 125.417 1.698 . . . . 1.0 109.874 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -80.71 -27.37 36.99 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 124.707 1.203 . . . . 1.0 113.212 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.2 -36.15 27.57 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.434 1.494 . . . . 1.0 112.856 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -94.41 -17.48 22.47 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 124.594 1.184 . . . . 1.0 112.992 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 56.88 58.23 4.18 Favored 'General case' 0 N--CA 1.525 3.298 0 C-N-CA 126.896 2.078 . . . . 1.0 112.015 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -125.23 129.11 49.4 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.508 -1.678 . . . . 1.0 110.307 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.479 HG21 ' HB ' ' A' ' 24' ' ' ILE . 1.8 t -120.43 128.06 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 125.535 1.772 . . . . 1.0 107.9 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.23 131.4 53.91 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 125.486 1.741 . . . . 1.0 109.977 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.08 131.56 54.04 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 125.13 1.519 . . . . 1.0 110.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 C--O 1.252 1.212 0 O-C-N 125.212 1.57 . . . . 1.0 111.315 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.366 0.136 . . . . 1.0 111.366 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 140.45 41.55 Favored 'General case' 0 C--O 1.244 0.805 0 O-C-N 125.418 1.699 . . . . 1.0 110.478 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -120.87 138.27 54.16 Favored 'General case' 0 C--O 1.248 0.999 0 O-C-N 124.889 1.368 . . . . 1.0 110.825 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.5 t -73.25 131.23 83.38 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 117.28 -1.343 . . . . 1.0 111.8 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.91 -10.13 22.82 Favored 'Trans proline' 1 C--N 1.432 4.97 0 C-N-CA 121.954 1.769 . . . . 1.0 114.77 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.555 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mt -95.1 -55.62 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 125.164 1.386 . . . . 1.0 110.179 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 28.2 p -102.83 -41.72 6.08 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 124.165 0.915 . . . . 1.0 113.171 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 88.38 38.0 7.36 Favored Glycine 0 C--N 1.372 2.543 0 O-C-N 124.687 1.242 . . . . 1.0 112.572 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.564 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -88.38 143.81 33.0 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 116.962 -1.494 . . . . 1.0 113.039 -178.06 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.65 126.98 16.3 Favored 'Trans proline' 1 C--N 1.449 5.861 0 C-N-CA 122.79 2.327 . . . . 1.0 114.642 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mt -122.9 145.01 48.84 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 125.208 1.567 . . . . 1.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' O ' HD12 ' A' ' 23' ' ' LEU . 84.3 mttt -93.62 130.33 39.57 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 124.858 1.349 . . . . 1.0 110.563 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.479 ' O ' HG12 ' A' ' 24' ' ' ILE . 31.1 m95 -68.05 -27.35 66.45 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 124.736 1.215 . . . . 1.0 112.822 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 8.8 pt-20 -72.63 -33.44 66.63 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.639 1.976 . . . . 1.0 113.152 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.79 -32.6 63.85 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 125.212 1.405 . . . . 1.0 113.418 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -68.24 -37.71 81.07 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.103 1.761 . . . . 1.0 113.282 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.7 mm -77.04 -28.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 C-N-CA 125.665 1.586 . . . . 1.0 110.835 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.75 -34.3 71.71 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 125.261 1.424 . . . . 1.0 113.209 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.0 -22.79 39.17 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.346 1.458 . . . . 1.0 112.851 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.446 ' O ' HD12 ' A' ' 30' ' ' ILE . 38.7 mtp -104.62 14.7 29.39 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 124.701 1.25 . . . . 1.0 112.757 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 24.96 5.01 Favored 'General case' 0 CA--C 1.578 2.053 0 C-N-CA 123.665 0.786 . . . . 1.0 112.867 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.51 0.28 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 C-N-CA 125.092 1.357 . . . . 1.0 111.98 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.93 140.68 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 125.155 1.382 . . . . 1.0 109.205 -178.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.39 -18.43 48.96 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 124.75 1.281 . . . . 1.0 113.778 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -81.09 -18.6 46.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.902 1.281 . . . . 1.0 112.356 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.576 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.7 t80 -59.48 -35.64 74.49 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.196 1.798 . . . . 1.0 113.15 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.33 -29.87 69.15 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 125.47 1.508 . . . . 1.0 112.161 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.72 -33.36 20.04 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.596 1.559 . . . . 1.0 112.458 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.8 mt -71.63 -39.65 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.982 0 C-N-CA 125.696 1.598 . . . . 1.0 110.632 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 78' ' ' LEU . 9.2 m -60.17 -20.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 125.355 1.462 . . . . 1.0 114.66 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.89 -18.85 25.37 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.128 1.371 . . . . 1.0 113.352 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -125.55 109.31 12.51 Favored 'General case' 0 C--N 1.373 1.588 0 C-N-CA 124.195 0.998 . . . . 1.0 111.709 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.488 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.1 mpp_? -59.42 -34.1 72.06 Favored 'General case' 0 N--CA 1.517 2.918 0 C-N-CA 125.348 1.459 . . . . 1.0 113.605 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.93 -30.53 70.69 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.724 1.609 . . . . 1.0 112.742 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -82.17 -33.56 29.44 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 125.354 1.462 . . . . 1.0 112.211 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -73.06 -43.78 61.48 Favored 'General case' 0 C--N 1.392 2.455 0 C-N-CA 125.144 1.378 . . . . 1.0 112.698 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -68.64 -30.93 69.74 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 124.864 1.266 . . . . 1.0 112.45 177.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.53 40.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.899 1.374 . . . . 1.0 112.831 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.431 HE21 HD13 ' A' ' 36' ' ' ILE . 2.7 mm100 -79.37 -38.83 34.06 Favored 'General case' 0 C--N 1.385 2.121 0 C-N-CA 125.133 1.373 . . . . 1.0 112.524 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 43' ' ' PHE . 28.5 t -71.46 -40.04 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 125.238 1.415 . . . . 1.0 109.896 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.511 2.596 0 C-N-CA 125.268 1.427 . . . . 1.0 113.558 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.73 -26.61 16.21 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.853 1.261 . . . . 1.0 113.042 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.01 143.87 26.14 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 124.851 1.261 . . . . 1.0 111.521 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.4 153.09 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.677 0 O-C-N 125.062 1.476 . . . . 1.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.15 145.61 51.73 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 124.969 1.418 . . . . 1.0 111.072 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.43 141.65 35.6 Favored 'General case' 0 C--O 1.25 1.119 0 O-C-N 124.905 1.378 . . . . 1.0 111.161 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.68 128.91 48.75 Favored Pre-proline 0 CA--C 1.57 1.713 0 O-C-N 124.769 1.293 . . . . 1.0 111.231 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.19 -9.5 21.95 Favored 'Trans proline' 1 C--N 1.43 4.856 0 C-N-CA 122.418 2.079 . . . . 1.0 114.156 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.86 -51.22 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.463 1.505 . . . . 1.0 110.312 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.6 m -89.32 -52.81 4.85 Favored 'General case' 0 C--N 1.378 1.816 0 O-C-N 124.301 1.001 . . . . 1.0 112.635 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.16 -10.36 47.29 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 124.708 1.255 . . . . 1.0 113.108 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -85.69 152.48 23.05 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 125.726 1.61 . . . . 1.0 111.306 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.72 136.93 32.75 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.377 1.048 . . . . 1.0 112.056 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.97 143.75 51.2 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 125.425 1.703 . . . . 1.0 109.175 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.38 151.86 19.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.253 0.971 . . . . 1.0 112.547 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.35 -8.82 80.69 Favored Glycine 0 C--N 1.378 2.886 0 O-C-N 124.362 1.039 . . . . 1.0 114.659 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -86.77 -20.98 26.83 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.498 1.519 . . . . 1.0 111.945 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -95.34 5.49 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.959 1.303 . . . . 1.0 111.784 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.69 70.22 Favored Pre-proline 0 C--N 1.386 2.174 0 CA-C-O 116.981 -1.485 . . . . 1.0 112.034 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -62.23 147.71 94.51 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 123.102 2.535 . . . . 1.0 114.693 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -64.05 -18.41 64.32 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 125.44 1.496 . . . . 1.0 114.649 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -82.74 -30.05 29.32 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 124.98 1.312 . . . . 1.0 111.843 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -73.91 -28.41 61.52 Favored 'General case' 0 C--N 1.384 2.105 0 C-N-CA 125.659 1.584 . . . . 1.0 113.059 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.44 -32.2 73.7 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 125.819 1.648 . . . . 1.0 112.615 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -74.49 -26.34 59.95 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.606 1.563 . . . . 1.0 112.148 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -73.09 -26.94 61.44 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.931 1.692 . . . . 1.0 112.604 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.3 t -64.37 -37.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 C-N-CA 126.125 1.77 . . . . 1.0 110.048 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -60.79 -29.72 69.62 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 125.012 1.325 . . . . 1.0 114.038 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.12 -41.13 82.2 Favored 'General case' 0 C--N 1.383 2.05 0 C-N-CA 125.609 1.564 . . . . 1.0 113.175 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.63 -34.7 70.04 Favored 'General case' 0 C--N 1.379 1.881 0 C-N-CA 124.857 1.263 . . . . 1.0 112.979 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -81.21 -22.14 39.06 Favored 'General case' 0 C--N 1.373 1.614 0 O-C-N 124.915 1.384 . . . . 1.0 112.652 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.62 -15.3 42.96 Favored 'General case' 0 C--N 1.386 2.177 0 C-N-CA 124.275 1.03 . . . . 1.0 112.815 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.65 -35.91 82.15 Favored 'General case' 0 C--N 1.388 2.256 0 C-N-CA 125.356 1.462 . . . . 1.0 113.469 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.97 -66.44 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 127.864 2.466 . . . . 1.0 114.147 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -130.38 137.37 49.85 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 125.684 1.594 . . . . 1.0 109.249 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.5 -106.94 0.21 Allowed Glycine 0 C--N 1.351 1.379 0 O-C-N 125.017 1.448 . . . . 1.0 111.656 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.97 46.35 1.19 Allowed Glycine 0 C--N 1.354 1.564 0 O-C-N 125.662 1.448 . . . . 1.0 113.051 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.45 122.31 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -122.05 129.95 52.86 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.443 1.714 . . . . 1.0 110.166 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.77 -28.88 36.25 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.728 1.267 . . . . 1.0 113.326 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.36 -37.0 26.28 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.119 1.368 . . . . 1.0 112.973 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.73 -17.98 23.53 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.567 1.147 . . . . 1.0 113.091 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.4 mttt 57.4 61.85 2.36 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 127.171 2.188 . . . . 1.0 112.125 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 98.3 mtt180 -125.5 128.99 48.88 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 113.381 -1.736 . . . . 1.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 2.0 t -123.46 129.06 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 125.504 1.752 . . . . 1.0 107.424 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.22 135.31 53.34 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 125.156 1.535 . . . . 1.0 110.213 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.54 128.55 56.06 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.056 1.472 . . . . 1.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--O 1.249 1.057 0 O-C-N 125.466 1.729 . . . . 1.0 111.325 -179.912 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.438 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 35.7 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 111.221 0.082 . . . . 1.0 111.221 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -112.16 140.0 47.22 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.264 1.602 . . . . 1.0 110.611 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -124.28 139.17 54.17 Favored 'General case' 0 C--O 1.247 0.961 0 O-C-N 124.947 1.405 . . . . 1.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.576 ' SG ' HD12 ' A' ' 13' ' ' ILE . 22.9 t -76.52 121.53 85.03 Favored Pre-proline 0 CA--C 1.576 1.98 0 O-C-N 124.531 1.144 . . . . 1.0 111.214 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.89 -6.07 18.01 Favored 'Trans proline' 1 C--N 1.428 4.74 0 C-N-CA 122.083 1.855 . . . . 1.0 114.512 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.576 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.2 mt -97.03 -55.59 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 124.993 1.317 . . . . 1.0 110.103 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -101.68 -39.09 7.61 Favored 'General case' 0 C--N 1.37 1.467 0 O-C-N 124.543 1.152 . . . . 1.0 112.979 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.54 30.07 12.68 Favored Glycine 0 C--N 1.368 2.325 0 O-C-N 124.901 1.376 . . . . 1.0 113.456 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -93.76 146.79 32.39 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 117.001 -1.476 . . . . 1.0 112.536 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.08 136.02 39.47 Favored 'Trans proline' 1 C--N 1.451 5.965 0 C-N-CA 122.706 2.271 . . . . 1.0 113.971 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.57 145.97 47.44 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 125.445 1.716 . . . . 1.0 110.778 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -95.14 125.73 39.99 Favored 'General case' 0 C--N 1.361 1.099 0 O-C-N 124.971 1.419 . . . . 1.0 110.96 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.51 ' O ' HG12 ' A' ' 24' ' ' ILE . 38.5 m95 -68.6 -25.0 64.65 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 124.897 1.279 . . . . 1.0 112.798 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 34.5 mt-10 -69.69 -32.8 71.62 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.64 1.576 . . . . 1.0 112.009 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.07 -34.4 57.06 Favored 'General case' 0 C--N 1.382 2.012 0 C-N-CA 124.869 1.268 . . . . 1.0 112.331 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.15 -40.67 94.7 Favored 'General case' 0 C--N 1.385 2.126 0 C-N-CA 125.934 1.694 . . . . 1.0 112.774 178.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 20' ' ' TRP . 11.0 mm -78.68 -38.68 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 C-N-CA 125.506 1.522 . . . . 1.0 110.077 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -68.54 -34.11 75.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 124.881 1.272 . . . . 1.0 113.249 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.27 -23.38 37.99 Favored 'General case' 0 C--N 1.375 1.704 0 C-N-CA 125.427 1.491 . . . . 1.0 112.53 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -103.32 15.55 28.85 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 124.652 1.22 . . . . 1.0 112.045 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 14.75 27.57 Favored 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 124.061 0.944 . . . . 1.0 112.654 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.48 4.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 C-N-CA 125.76 1.624 . . . . 1.0 112.779 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -105.12 141.36 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.654 1.182 . . . . 1.0 109.011 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -81.3 -17.6 48.73 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.783 1.302 . . . . 1.0 113.372 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -86.6 -11.19 52.16 Favored 'General case' 0 C--N 1.371 1.532 0 C-N-CA 124.899 1.28 . . . . 1.0 112.152 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -56.41 -36.86 69.42 Favored 'General case' 0 N--CA 1.511 2.616 0 C-N-CA 125.514 1.526 . . . . 1.0 112.419 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.37 -29.57 69.99 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 124.771 1.228 . . . . 1.0 112.13 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.94 -38.8 17.6 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.11 1.364 . . . . 1.0 112.006 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.411 HG12 ' OE1' ' A' ' 46' ' ' GLN . 5.2 mt -72.17 -40.78 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 C-N-CA 125.329 1.451 . . . . 1.0 110.805 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.7 p -65.85 -18.26 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.599 2.864 0 C-N-CA 125.574 1.55 . . . . 1.0 113.884 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.79 -18.64 28.92 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.716 1.207 . . . . 1.0 113.259 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.04 111.97 15.33 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 124.537 1.135 . . . . 1.0 111.17 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.494 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.5 mtm180 -59.29 -35.48 73.85 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 125.54 1.536 . . . . 1.0 113.125 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.51 -30.28 69.06 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 1.0 113.351 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 80.9 mtt180 -81.64 -34.24 30.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.055 1.342 . . . . 1.0 112.396 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.8 t80 -74.66 -41.99 59.3 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 124.829 1.252 . . . . 1.0 112.664 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.4 mt -66.21 -32.48 73.93 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.626 1.17 . . . . 1.0 112.654 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.45 -24.65 34.18 Favored 'General case' 0 C--N 1.371 1.525 0 O-C-N 124.994 1.434 . . . . 1.0 112.356 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -79.23 -36.2 40.38 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.041 1.336 . . . . 1.0 112.72 178.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 43' ' ' PHE . 32.8 t -72.13 -41.18 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 125.369 1.467 . . . . 1.0 109.463 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 125.592 1.557 . . . . 1.0 113.412 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -95.47 -25.34 16.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.605 1.19 . . . . 1.0 112.986 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -101.18 144.66 29.8 Favored 'General case' 0 C--N 1.368 1.399 0 C-N-CA 124.496 1.118 . . . . 1.0 111.126 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.24 155.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 O-C-N 125.073 1.483 . . . . 1.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.38 144.08 51.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 125.194 1.559 . . . . 1.0 110.108 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -95.2 138.59 32.7 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.823 -1.535 . . . . 1.0 111.463 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.5 t -96.54 115.11 65.49 Favored Pre-proline 0 CA--C 1.568 1.673 0 O-C-N 125.044 1.465 . . . . 1.0 110.306 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.08 -5.77 17.17 Favored 'Trans proline' 1 C--N 1.432 4.93 0 C-N-CA 122.333 2.022 . . . . 1.0 114.415 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.2 t -89.99 -51.11 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 126.12 1.768 . . . . 1.0 110.557 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.8 p -103.03 -48.68 3.98 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.625 1.203 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.53 -2.56 21.86 Favored Glycine 0 C--N 1.368 2.321 0 O-C-N 124.466 1.104 . . . . 1.0 114.123 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -94.95 146.4 24.27 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 124.961 1.304 . . . . 1.0 111.197 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.61 139.37 30.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.696 1.248 . . . . 1.0 112.23 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -123.19 145.12 48.9 Favored 'General case' 0 C--O 1.247 0.96 0 O-C-N 125.46 1.725 . . . . 1.0 109.547 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.72 151.04 20.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.348 1.03 . . . . 1.0 112.267 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.5 -9.19 81.76 Favored Glycine 0 C--N 1.377 2.861 0 O-C-N 124.293 0.996 . . . . 1.0 114.479 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -86.61 -19.59 29.13 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.186 1.394 . . . . 1.0 112.072 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -94.7 3.6 54.85 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.848 1.259 . . . . 1.0 111.752 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.22 146.44 38.13 Favored Pre-proline 0 C--N 1.382 1.996 0 CA-C-O 117.491 -1.242 . . . . 1.0 111.763 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.08 154.99 70.76 Favored 'Trans proline' 1 C--N 1.436 5.166 0 C-N-CA 122.972 2.448 . . . . 1.0 114.706 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.89 -31.62 72.86 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.437 1.095 . . . . 1.0 113.384 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.02 -37.81 75.03 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 125.333 1.453 . . . . 1.0 113.541 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.8 mt-10 -77.02 -28.32 54.91 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 124.851 1.26 . . . . 1.0 112.452 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.19 73.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.954 1.702 . . . . 1.0 112.628 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.51 -25.28 61.34 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.501 1.52 . . . . 1.0 112.398 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 91.7 mttt -73.45 -26.39 60.91 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 125.908 1.683 . . . . 1.0 112.5 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.39 -36.98 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 C-N-CA 126.37 1.868 . . . . 1.0 110.206 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.26 -29.82 69.04 Favored 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 125.398 1.479 . . . . 1.0 113.59 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -43.19 84.21 Favored 'General case' 0 C--N 1.382 1.987 0 C-N-CA 125.331 1.452 . . . . 1.0 113.196 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -69.98 -32.99 71.48 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.015 1.326 . . . . 1.0 112.849 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -81.3 -18.42 45.89 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.208 1.403 . . . . 1.0 112.835 178.071 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -102.1 -13.92 17.3 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 124.53 1.132 . . . . 1.0 111.935 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.81 69.42 0.7 Allowed 'General case' 0 C--N 1.372 1.548 0 CA-C-O 122.893 1.33 . . . . 1.0 109.339 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -75.18 -24.16 57.81 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 113.443 -1.708 . . . . 1.0 112.949 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -106.66 134.61 49.54 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 124.837 1.335 . . . . 1.0 109.342 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.63 -96.64 0.16 Allowed Glycine 0 C--N 1.356 1.657 0 O-C-N 124.981 1.426 . . . . 1.0 112.148 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.26 50.99 0.79 Allowed Glycine 0 C--N 1.362 1.993 0 O-C-N 125.439 1.317 . . . . 1.0 113.623 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -119.97 121.58 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.11 133.67 51.57 Favored 'General case' 0 C--O 1.249 1.026 0 O-C-N 125.487 1.742 . . . . 1.0 110.61 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -80.37 -32.12 37.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.71 1.256 . . . . 1.0 113.252 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.94 -36.39 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.086 1.355 . . . . 1.0 112.997 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.17 -20.09 20.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.475 1.11 . . . . 1.0 113.173 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.7 mttm 58.28 56.35 4.52 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 127.07 2.148 . . . . 1.0 113.11 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 93.3 mtt180 -115.41 128.68 56.22 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.44 -1.709 . . . . 1.0 110.431 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.48 125.26 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 125.466 1.729 . . . . 1.0 108.457 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -121.18 131.9 54.51 Favored 'General case' 0 C--O 1.251 1.174 0 O-C-N 125.519 1.762 . . . . 1.0 109.988 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.6 133.32 55.39 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 125.202 1.563 . . . . 1.0 110.576 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.1 mttt . . . . . 0 C--O 1.252 1.236 0 O-C-N 125.338 1.649 . . . . 1.0 111.244 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.563 ' N ' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.865 -0.05 . . . . 1.0 110.865 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.81 138.95 43.14 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 125.315 1.635 . . . . 1.0 110.627 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.37 138.94 49.91 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 124.93 1.394 . . . . 1.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 13' ' ' ILE . 12.4 t -70.19 123.15 88.3 Favored Pre-proline 0 CA--C 1.577 1.992 0 O-C-N 124.477 1.11 . . . . 1.0 112.199 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.64 -11.5 26.16 Favored 'Trans proline' 1 C--N 1.43 4.826 0 C-N-CA 121.932 1.755 . . . . 1.0 114.922 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.479 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -91.81 -53.8 8.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 C-N-CA 125.299 1.44 . . . . 1.0 111.018 -177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.6 -41.15 6.05 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 124.218 0.949 . . . . 1.0 112.434 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 29.51 8.63 Favored Glycine 0 C--N 1.366 2.239 0 O-C-N 124.678 1.236 . . . . 1.0 113.748 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.22 144.68 29.39 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 116.796 -1.573 . . . . 1.0 113.096 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.88 139.29 39.45 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 122.71 2.273 . . . . 1.0 113.661 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 144.36 48.22 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.32 1.638 . . . . 1.0 110.432 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -95.76 133.17 40.19 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.928 1.392 . . . . 1.0 111.052 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 60.8 m95 -68.69 -26.45 65.3 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 124.798 1.239 . . . . 1.0 113.248 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 93' ' ' LYS . 35.9 mt-10 -72.09 -31.24 65.89 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.645 1.578 . . . . 1.0 112.623 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.92 -34.5 62.14 Favored 'General case' 0 C--N 1.385 2.123 0 C-N-CA 125.168 1.387 . . . . 1.0 112.603 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -39.89 87.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 125.758 1.623 . . . . 1.0 113.882 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.6 mm -78.58 -41.03 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 125.156 1.382 . . . . 1.0 110.676 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.3 -36.71 82.07 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 124.84 1.256 . . . . 1.0 113.311 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.72 -21.11 48.56 Favored 'General case' 0 C--N 1.375 1.714 0 C-N-CA 125.308 1.443 . . . . 1.0 112.967 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.506 ' SD ' ' HE1' ' A' ' 52' ' ' PHE . 35.0 mtp -105.56 16.78 24.9 Favored 'General case' 0 CA--C 1.575 1.923 0 O-C-N 124.67 1.231 . . . . 1.0 112.367 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.8 18.43 14.49 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.48 13.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 124.765 1.226 . . . . 1.0 111.918 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -114.81 140.5 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 124.736 1.215 . . . . 1.0 108.723 -178.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.04 -16.28 44.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 125.028 1.455 . . . . 1.0 113.411 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.424 ' H ' HG22 ' A' ' 30' ' ' ILE . 7.7 m120 -83.55 -15.66 48.38 Favored 'General case' 0 C--N 1.376 1.725 0 C-N-CA 125.065 1.346 . . . . 1.0 112.556 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.596 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.4 t80 -57.06 -35.48 69.39 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 126.354 1.862 . . . . 1.0 113.315 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.33 -29.18 69.73 Favored 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 125.384 1.474 . . . . 1.0 112.411 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.85 -33.87 19.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.43 1.492 . . . . 1.0 112.662 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.9 mt -71.46 -39.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.909 0 C-N-CA 125.837 1.655 . . . . 1.0 110.457 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.518 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.3 m -61.57 -18.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 125.669 1.588 . . . . 1.0 114.692 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -88.38 -19.05 27.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.823 1.327 . . . . 1.0 113.256 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.48 110.67 12.99 Favored 'General case' 0 C--N 1.373 1.599 0 C-N-CA 124.473 1.109 . . . . 1.0 111.973 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -61.54 -32.38 72.44 Favored 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 125.331 1.452 . . . . 1.0 113.015 176.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.95 -31.88 71.07 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 125.475 1.51 . . . . 1.0 113.207 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -82.26 -32.65 29.54 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 125.212 1.405 . . . . 1.0 112.594 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 t80 -73.08 -46.01 53.93 Favored 'General case' 0 C--N 1.386 2.186 0 C-N-CA 124.976 1.31 . . . . 1.0 113.098 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -71.59 -33.16 68.8 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.033 1.333 . . . . 1.0 112.777 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.04 72.8 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.835 1.654 . . . . 1.0 112.742 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -78.75 -35.29 44.82 Favored 'General case' 0 C--N 1.382 1.986 0 C-N-CA 124.821 1.248 . . . . 1.0 112.908 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.1 t -69.05 -40.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.117 1.367 . . . . 1.0 109.173 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.63 -25.46 59.24 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 125.676 1.59 . . . . 1.0 113.477 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -94.32 -25.31 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.803 1.315 . . . . 1.0 113.522 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -105.33 143.3 33.68 Favored 'General case' 0 C--N 1.366 1.307 0 O-C-N 124.454 1.096 . . . . 1.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.75 153.83 3.2 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 O-C-N 125.094 1.496 . . . . 1.0 111.599 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.506 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 99.1 m-85 -125.14 144.26 50.52 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 125.093 1.496 . . . . 1.0 110.332 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -95.17 139.89 30.86 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.208 1.567 . . . . 1.0 111.072 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -92.35 130.23 38.28 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 125.057 1.473 . . . . 1.0 111.807 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.68 -8.06 20.99 Favored 'Trans proline' 1 C--N 1.437 5.205 0 C-N-CA 122.698 2.265 . . . . 1.0 114.292 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.22 -55.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 124.843 1.257 . . . . 1.0 110.43 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.2 p -98.14 -52.5 3.67 Favored 'General case' 0 C--N 1.372 1.547 0 O-C-N 124.302 1.001 . . . . 1.0 111.682 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.31 25.12 7.98 Favored Glycine 0 C--N 1.367 2.267 0 O-C-N 124.722 1.264 . . . . 1.0 114.747 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -105.64 147.97 27.88 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 124.591 1.156 . . . . 1.0 111.076 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -83.65 134.38 34.78 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 124.563 1.165 . . . . 1.0 112.393 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -132.8 148.33 52.31 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 125.444 1.715 . . . . 1.0 109.826 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -94.05 149.82 20.89 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.339 1.024 . . . . 1.0 112.627 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 -9.27 86.95 Favored Glycine 0 C--N 1.375 2.714 0 O-C-N 124.727 1.267 . . . . 1.0 114.111 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -82.34 -17.29 46.22 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 125.31 1.444 . . . . 1.0 112.671 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -91.24 -5.41 54.85 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 124.363 1.065 . . . . 1.0 112.194 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 145.48 44.83 Favored Pre-proline 0 C--N 1.385 2.114 0 CA-C-O 117.232 -1.366 . . . . 1.0 111.887 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.4 160.1 44.31 Favored 'Trans proline' 1 C--N 1.437 5.234 0 C-N-CA 123.024 2.483 . . . . 1.0 114.679 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -62.44 -30.13 71.01 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.501 1.12 . . . . 1.0 113.735 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.1 -37.76 77.94 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 125.561 1.545 . . . . 1.0 112.999 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.74 -29.34 40.52 Favored 'General case' 0 C--N 1.381 1.962 0 C-N-CA 124.985 1.314 . . . . 1.0 111.746 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.06 73.48 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 125.834 1.654 . . . . 1.0 112.312 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.41 -28.12 63.79 Favored 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 125.791 1.637 . . . . 1.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HZ2' ' N ' ' A' ' 8' ' ' MET . 90.3 mttt -68.58 -27.87 66.44 Favored 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 125.978 1.711 . . . . 1.0 112.547 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.9 t -65.6 -37.37 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.019 0 C-N-CA 126.322 1.849 . . . . 1.0 109.97 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -28.37 69.9 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 125.182 1.393 . . . . 1.0 113.349 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.29 -41.21 77.09 Favored 'General case' 0 C--N 1.383 2.046 0 C-N-CA 125.473 1.509 . . . . 1.0 112.913 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -70.72 -32.1 69.19 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.763 1.225 . . . . 1.0 113.243 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -81.25 -20.31 41.25 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.237 1.415 . . . . 1.0 112.868 177.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -99.88 -16.0 18.17 Favored 'General case' 0 C--N 1.371 1.519 0 C-N-CA 124.76 1.224 . . . . 1.0 112.189 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -108.82 69.01 0.7 Allowed 'General case' 0 C--N 1.37 1.495 0 CA-C-O 122.898 1.332 . . . . 1.0 109.46 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -71.75 -28.44 63.66 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.308 -1.769 . . . . 1.0 113.083 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -103.53 134.89 46.13 Favored 'General case' 0 C--N 1.366 1.303 0 O-C-N 124.989 1.431 . . . . 1.0 109.718 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.98 -95.29 0.14 Allowed Glycine 0 C--N 1.355 1.588 0 O-C-N 125.165 1.541 . . . . 1.0 112.18 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.01 46.9 0.96 Allowed Glycine 0 C--N 1.361 1.922 0 O-C-N 125.34 1.259 . . . . 1.0 113.824 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -120.3 122.58 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -124.77 131.56 53.44 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 125.574 1.796 . . . . 1.0 110.468 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -80.85 -27.51 36.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.85 1.344 . . . . 1.0 113.51 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.44 -35.65 27.36 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.207 1.403 . . . . 1.0 112.581 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -94.88 -17.37 22.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 124.692 1.245 . . . . 1.0 113.436 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mttm 58.98 50.76 7.92 Favored 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 127.166 2.186 . . . . 1.0 113.99 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 71.7 mtm180 -115.58 130.83 57.01 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.796 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.6 123.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 125.462 1.727 . . . . 1.0 107.793 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 86.4 mttt -124.7 132.38 53.39 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 125.716 1.885 . . . . 1.0 110.387 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 132.26 56.36 Favored 'General case' 0 C--O 1.246 0.898 0 O-C-N 125.332 1.645 . . . . 1.0 108.929 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.523 3.179 0 C-N-CA 127.386 2.274 . . . . 1.0 113.465 179.887 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.529 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 1.7 tpp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.873 -0.047 . . . . 1.0 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.02 139.8 47.23 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 125.286 1.616 . . . . 1.0 110.521 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -115.12 138.78 50.51 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.896 1.372 . . . . 1.0 110.724 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.0 t -74.67 119.65 77.73 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 117.29 -1.338 . . . . 1.0 111.819 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.17 -25.16 50.73 Favored 'Trans proline' 1 C--N 1.439 5.302 0 C-N-CA 122.3 2.0 . . . . 1.0 113.789 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.26 -54.14 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 C-N-CA 126.35 1.86 . . . . 1.0 112.826 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -108.64 -44.39 4.06 Favored 'General case' 0 C--N 1.37 1.457 0 O-C-N 124.175 0.922 . . . . 1.0 112.339 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.72 6.16 Favored Glycine 0 C--N 1.367 2.28 0 O-C-N 124.717 1.261 . . . . 1.0 113.725 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.81 146.48 31.39 Favored Pre-proline 0 C--N 1.369 1.44 0 CA-C-O 117.115 -1.421 . . . . 1.0 112.467 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.18 139.35 42.01 Favored 'Trans proline' 1 C--N 1.449 5.859 0 C-N-CA 122.728 2.286 . . . . 1.0 113.854 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.59 143.52 49.26 Favored 'General case' 0 C--O 1.25 1.124 0 O-C-N 125.341 1.651 . . . . 1.0 110.177 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.78 134.7 39.73 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 124.874 1.359 . . . . 1.0 111.005 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.457 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.3 m95 -68.49 -27.01 65.75 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.955 1.302 . . . . 1.0 112.872 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 7.3 pt-20 -71.76 -32.28 67.52 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.355 1.862 . . . . 1.0 112.661 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.1 -34.29 66.1 Favored 'General case' 0 C--N 1.385 2.152 0 C-N-CA 125.443 1.497 . . . . 1.0 112.963 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -39.91 84.2 Favored 'General case' 0 C--N 1.382 2.02 0 C-N-CA 125.665 1.586 . . . . 1.0 113.372 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -78.91 -40.96 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 125.524 1.529 . . . . 1.0 110.568 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.73 -38.16 86.12 Favored 'General case' 0 C--N 1.386 2.183 0 C-N-CA 125.144 1.377 . . . . 1.0 113.369 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.39 -20.91 50.18 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 125.466 1.506 . . . . 1.0 112.929 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.492 ' O ' HD12 ' A' ' 30' ' ' ILE . 3.0 mmt -106.01 12.25 30.67 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.813 1.321 . . . . 1.0 112.09 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.72 17.95 11.02 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.587 0.755 . . . . 1.0 113.02 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.8 11.02 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 C-N-CA 125.638 1.575 . . . . 1.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 32' ' ' ASN . 1.2 mt -115.21 138.3 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.827 1.251 . . . . 1.0 108.935 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.54 -17.85 35.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.132 1.52 . . . . 1.0 112.439 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' H ' HG22 ' A' ' 30' ' ' ILE . 47.9 m-80 -91.93 14.4 15.8 Favored 'General case' 0 CA--C 1.574 1.87 0 C-N-CA 125.289 1.436 . . . . 1.0 111.786 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -76.15 -36.21 58.85 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.387 1.475 . . . . 1.0 111.799 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' HA ' HG12 ' A' ' 37' ' ' VAL . 32.9 mt-10 -57.78 -23.8 54.13 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 126.026 1.73 . . . . 1.0 114.339 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.15 -43.64 14.79 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 125.352 1.461 . . . . 1.0 111.539 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.41 -42.4 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 125.589 1.555 . . . . 1.0 110.824 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 34' ' ' GLU . 1.5 p -67.75 -14.06 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.013 0 C-N-CA 125.318 1.447 . . . . 1.0 114.243 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -92.06 -22.29 20.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.839 1.256 . . . . 1.0 112.447 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.13 106.41 10.75 Favored 'General case' 0 C--N 1.371 1.51 0 O-C-N 124.569 1.168 . . . . 1.0 111.293 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -58.1 -33.89 69.6 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 125.829 1.651 . . . . 1.0 113.908 176.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.23 -33.08 74.59 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 125.813 1.645 . . . . 1.0 112.35 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.58 -34.36 27.74 Favored 'General case' 0 C--N 1.381 1.942 0 C-N-CA 125.619 1.568 . . . . 1.0 112.502 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.0 t80 -72.7 -45.95 56.18 Favored 'General case' 0 C--N 1.394 2.519 0 C-N-CA 125.207 1.403 . . . . 1.0 112.524 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.14 -33.11 72.92 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 124.932 1.293 . . . . 1.0 112.366 178.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.58 -31.63 65.37 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.82 1.648 . . . . 1.0 112.919 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.5 tt0 -79.24 -37.09 38.86 Favored 'General case' 0 C--N 1.384 2.084 0 C-N-CA 124.96 1.304 . . . . 1.0 112.482 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.7 t -69.29 -41.56 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 C-N-CA 125.455 1.502 . . . . 1.0 109.539 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 42.3 mt-10 -70.28 -25.56 63.4 Favored 'General case' 0 N--CA 1.516 2.832 0 C-N-CA 125.658 1.583 . . . . 1.0 113.545 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.53 -25.62 16.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.097 1.359 . . . . 1.0 113.171 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.11 141.7 35.39 Favored 'General case' 0 C--N 1.369 1.454 0 O-C-N 124.384 1.053 . . . . 1.0 111.658 -179.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.96 152.23 3.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 125.255 1.597 . . . . 1.0 111.634 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.18 144.16 50.08 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.062 1.476 . . . . 1.0 110.391 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -96.35 140.54 30.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.144 1.527 . . . . 1.0 111.07 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.9 t -94.69 130.75 32.35 Favored Pre-proline 0 CA--C 1.565 1.539 0 O-C-N 125.295 1.622 . . . . 1.0 112.044 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.02 -4.24 14.88 Favored 'Trans proline' 1 C--N 1.435 5.117 0 C-N-CA 122.353 2.035 . . . . 1.0 114.504 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.95 -54.83 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 125.389 1.475 . . . . 1.0 110.133 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 p -101.89 -52.6 3.14 Favored 'General case' 0 C--N 1.371 1.537 0 O-C-N 124.434 1.084 . . . . 1.0 111.566 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 22.07 9.56 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 124.547 1.154 . . . . 1.0 114.479 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -99.95 145.55 27.71 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 124.754 1.221 . . . . 1.0 111.215 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.39 133.75 34.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.856 1.348 . . . . 1.0 111.858 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -132.69 147.4 52.33 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 125.601 1.813 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.04 151.11 19.76 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.745 1.278 . . . . 1.0 112.729 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 48' ' ' GLU . . . -80.83 1.28 84.44 Favored Glycine 0 C--N 1.372 2.564 0 O-C-N 124.912 1.382 . . . . 1.0 114.508 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -88.85 -16.42 32.03 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.911 1.285 . . . . 1.0 112.015 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 p -89.78 -12.84 38.09 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 124.883 1.273 . . . . 1.0 113.312 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -75.29 146.88 82.14 Favored Pre-proline 0 CA--C 1.584 2.25 0 CA-C-O 116.747 -1.597 . . . . 1.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.51 156.28 66.78 Favored 'Trans proline' 1 C--N 1.445 5.643 0 C-N-CA 122.999 2.466 . . . . 1.0 113.4 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -58.98 -30.75 68.19 Favored 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.982 1.313 . . . . 1.0 114.146 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -61.03 -36.26 79.06 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.622 1.569 . . . . 1.0 113.111 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -76.55 -28.97 56.48 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 125.017 1.327 . . . . 1.0 111.905 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.43 -32.41 72.43 Favored 'General case' 0 C--N 1.388 2.281 0 C-N-CA 126.002 1.721 . . . . 1.0 112.449 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.79 -26.6 62.48 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 125.943 1.697 . . . . 1.0 112.662 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 91.5 mttt -68.99 -28.66 66.81 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 126.099 1.759 . . . . 1.0 112.565 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.532 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -66.53 -35.23 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 C-N-CA 126.481 1.912 . . . . 1.0 109.975 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.62 -29.43 70.68 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 125.539 1.535 . . . . 1.0 113.014 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -67.24 -38.87 85.91 Favored 'General case' 0 C--N 1.386 2.172 0 C-N-CA 125.845 1.658 . . . . 1.0 113.05 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.9 pp -75.01 -30.89 61.25 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 124.685 1.194 . . . . 1.0 112.46 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.1 -22.35 39.21 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 125.817 1.647 . . . . 1.0 113.25 177.446 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -99.86 -9.84 22.42 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 124.752 1.221 . . . . 1.0 112.869 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 1.1 m-20 -107.01 58.78 0.63 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-O 123.106 1.432 . . . . 1.0 111.016 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.53 -30.52 70.2 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.39 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -115.11 113.57 24.18 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 124.96 1.412 . . . . 1.0 109.168 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.79 106.14 1.34 Allowed Glycine 0 C--N 1.366 2.227 0 CA-C-N 114.552 -1.204 . . . . 1.0 113.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 128.31 -59.2 0.69 Allowed Glycine 0 C--N 1.36 1.867 0 O-C-N 125.453 1.325 . . . . 1.0 113.625 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.39 126.08 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 125.103 1.12 . . . . 1.0 108.314 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -119.4 134.16 55.35 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 125.57 1.794 . . . . 1.0 110.084 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -80.0 -31.46 39.72 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.875 1.27 . . . . 1.0 113.743 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.6 -35.61 29.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.275 1.43 . . . . 1.0 113.111 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -92.09 -15.92 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.733 1.213 . . . . 1.0 113.432 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 58.55 32.89 22.64 Favored 'General case' 0 N--CA 1.533 3.71 0 C-N-CA 127.158 2.183 . . . . 1.0 113.925 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -106.24 136.42 45.98 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 114.28 -1.327 . . . . 1.0 111.355 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.28 126.72 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.405 1.691 . . . . 1.0 107.838 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 14.9 tttt -122.51 128.4 50.76 Favored 'General case' 0 C--O 1.25 1.127 0 O-C-N 125.429 1.706 . . . . 1.0 109.89 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.18 132.29 47.27 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 124.978 1.424 . . . . 1.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 C--O 1.249 1.031 0 O-C-N 125.33 1.644 . . . . 1.0 111.208 179.805 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.63 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 5.5 ptm . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 111.282 0.105 . . . . 1.0 111.282 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -111.02 139.71 46.15 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 125.316 1.635 . . . . 1.0 110.601 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -118.52 139.04 52.07 Favored 'General case' 0 C--O 1.25 1.082 0 O-C-N 124.655 1.222 . . . . 1.0 110.981 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.485 ' SG ' HD12 ' A' ' 13' ' ' ILE . 34.0 t -70.81 121.02 82.65 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 117.777 -1.106 . . . . 1.0 111.761 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.01 -4.35 15.27 Favored 'Trans proline' 1 C--N 1.434 5.044 0 C-N-CA 122.19 1.927 . . . . 1.0 114.843 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.485 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.02 -56.05 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 125.253 1.421 . . . . 1.0 109.766 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.64 -41.04 6.07 Favored 'General case' 0 C--N 1.37 1.488 0 O-C-N 124.338 1.024 . . . . 1.0 113.195 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.9 34.57 6.46 Favored Glycine 0 C--N 1.368 2.327 0 O-C-N 124.81 1.319 . . . . 1.0 114.02 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -91.39 142.59 27.16 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 116.928 -1.51 . . . . 1.0 112.796 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 131.62 24.45 Favored 'Trans proline' 1 C--N 1.449 5.819 0 C-N-CA 122.602 2.201 . . . . 1.0 114.376 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mt -122.96 144.55 49.16 Favored 'General case' 0 C--O 1.25 1.118 0 O-C-N 125.125 1.516 . . . . 1.0 110.762 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.07 133.95 41.06 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 124.802 1.313 . . . . 1.0 110.681 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 24' ' ' ILE . 52.9 m95 -68.53 -26.65 65.54 Favored 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 124.899 1.28 . . . . 1.0 113.426 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.27 -31.75 66.03 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.59 1.556 . . . . 1.0 113.097 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.15 -33.48 65.52 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 125.277 1.431 . . . . 1.0 112.915 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.03 -39.92 82.99 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.884 1.674 . . . . 1.0 112.858 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 20' ' ' TRP . 6.1 mm -74.43 -41.03 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 125.806 1.643 . . . . 1.0 110.604 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.86 -36.86 83.29 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.389 1.476 . . . . 1.0 113.24 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.29 -22.63 41.39 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 125.355 1.462 . . . . 1.0 112.841 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.49 ' O ' HD12 ' A' ' 30' ' ' ILE . 48.6 mtp -104.61 12.1 33.42 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 124.681 1.238 . . . . 1.0 112.41 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.3 16.63 8.33 Favored 'General case' 0 CA--C 1.58 2.098 0 C-N-CA 123.826 0.85 . . . . 1.0 112.914 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -3.74 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 C-N-CA 125.747 1.619 . . . . 1.0 112.965 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.5 137.48 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.982 1.313 . . . . 1.0 109.255 -177.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.36 -27.07 61.29 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 125.752 1.621 . . . . 1.0 114.374 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -77.65 -17.98 57.17 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.117 1.367 . . . . 1.0 113.209 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.583 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.5 t80 -57.92 -36.46 72.5 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 126.077 1.751 . . . . 1.0 113.188 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -60.58 -29.34 69.13 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.468 1.507 . . . . 1.0 112.463 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.41 -34.52 20.14 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.48 1.512 . . . . 1.0 112.409 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.8 mt -71.04 -41.06 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 C-N-CA 125.759 1.624 . . . . 1.0 110.664 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.9 m -59.39 -21.82 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 125.545 1.538 . . . . 1.0 114.84 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -87.94 -21.11 25.09 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 125.052 1.341 . . . . 1.0 112.796 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -121.66 106.66 11.54 Favored 'General case' 0 C--N 1.371 1.541 0 O-C-N 124.323 1.015 . . . . 1.0 112.124 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.35 -34.82 72.84 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 126.106 1.762 . . . . 1.0 113.853 176.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.0 -32.24 72.5 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 125.941 1.696 . . . . 1.0 112.727 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -82.69 -32.54 28.01 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.329 1.451 . . . . 1.0 112.228 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -75.41 -46.51 32.37 Favored 'General case' 0 C--N 1.387 2.215 0 C-N-CA 125.013 1.325 . . . . 1.0 112.946 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -69.66 -33.37 72.5 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 124.789 1.236 . . . . 1.0 112.958 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.513 1.525 . . . . 1.0 113.206 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 5.4 mt-30 -79.29 -35.21 41.61 Favored 'General case' 0 C--N 1.379 1.86 0 C-N-CA 125.077 1.351 . . . . 1.0 112.833 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.0 t -67.84 -41.22 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 125.241 1.416 . . . . 1.0 109.354 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.63 -24.3 60.0 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 125.316 1.447 . . . . 1.0 113.507 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -94.42 -25.52 16.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.859 1.264 . . . . 1.0 113.327 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.08 148.46 25.71 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 124.343 1.057 . . . . 1.0 111.049 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -97.51 155.82 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 O-C-N 124.758 1.286 . . . . 1.0 110.439 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.473 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 95.8 m-85 -126.41 143.76 51.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.086 1.491 . . . . 1.0 110.311 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -97.11 137.39 36.23 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.861 1.351 . . . . 1.0 111.423 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.08 106.52 19.81 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 124.972 1.42 . . . . 1.0 110.025 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -69.39 -7.94 22.27 Favored 'Trans proline' 1 C--N 1.44 5.355 0 C-N-CA 123.132 2.555 . . . . 1.0 114.193 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.76 -50.94 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.944 1.698 . . . . 1.0 110.403 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.7 p -104.47 -50.15 3.39 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 124.596 1.185 . . . . 1.0 112.186 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.31 -0.42 14.35 Favored Glycine 0 C--N 1.37 2.434 0 O-C-N 124.534 1.146 . . . . 1.0 114.209 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -93.74 150.85 20.05 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 125.162 1.385 . . . . 1.0 111.521 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.18 138.16 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.607 1.163 . . . . 1.0 111.141 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.13 143.17 51.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.165 1.54 . . . . 1.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.69 150.45 21.78 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.431 1.082 . . . . 1.0 112.24 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -75.22 -8.34 83.3 Favored Glycine 0 C--N 1.377 2.83 0 O-C-N 124.485 1.116 . . . . 1.0 114.867 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -86.39 -20.89 27.56 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.386 1.474 . . . . 1.0 111.87 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.9 p -94.09 1.67 56.12 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.903 1.281 . . . . 1.0 112.61 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 144.77 30.43 Favored Pre-proline 0 C--N 1.379 1.856 0 CA-C-O 117.146 -1.407 . . . . 1.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.21 158.32 55.37 Favored 'Trans proline' 1 C--N 1.445 5.641 0 C-N-CA 123.032 2.488 . . . . 1.0 114.705 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -61.96 -33.07 73.61 Favored 'General case' 0 N--CA 1.515 2.776 0 C-N-CA 124.85 1.26 . . . . 1.0 113.074 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.31 -40.4 77.81 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 125.468 1.507 . . . . 1.0 112.505 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 29.1 mt-10 -76.73 -28.84 55.94 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.044 1.338 . . . . 1.0 112.102 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -68.44 -32.99 73.41 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 125.814 1.646 . . . . 1.0 112.391 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.7 -24.99 61.91 Favored 'General case' 0 C--N 1.382 2.018 0 C-N-CA 125.637 1.575 . . . . 1.0 112.697 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.63 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 93.8 mttt -68.62 -28.18 66.68 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 125.902 1.681 . . . . 1.0 112.217 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' HD12 ' A' ' 78' ' ' LEU . 2.8 t -66.97 -38.5 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 C-N-CA 126.385 1.874 . . . . 1.0 109.738 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -27.16 69.08 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 125.355 1.462 . . . . 1.0 113.352 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -68.49 -41.05 80.65 Favored 'General case' 0 C--N 1.388 2.245 0 C-N-CA 125.789 1.636 . . . . 1.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.44 -30.52 66.13 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.83 1.252 . . . . 1.0 112.739 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.6 -24.93 49.54 Favored 'General case' 0 C--N 1.378 1.806 0 C-N-CA 125.597 1.559 . . . . 1.0 112.726 177.105 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.3 -16.69 21.2 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 124.802 1.241 . . . . 1.0 112.231 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.77 62.51 0.6 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 123.057 1.408 . . . . 1.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.57 -25.09 62.05 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 113.48 -1.691 . . . . 1.0 113.313 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -106.72 134.25 50.15 Favored 'General case' 0 C--O 1.254 1.302 0 O-C-N 125.069 1.481 . . . . 1.0 109.254 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.58 -102.54 0.22 Allowed Glycine 0 C--N 1.356 1.652 0 O-C-N 124.949 1.405 . . . . 1.0 112.095 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.9 55.52 0.73 Allowed Glycine 0 C--N 1.359 1.825 0 O-C-N 125.441 1.318 . . . . 1.0 113.272 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -118.71 120.95 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 129.92 50.6 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 125.26 1.6 . . . . 1.0 110.599 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -80.86 -33.74 34.23 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.731 1.269 . . . . 1.0 113.445 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -82.28 -35.88 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.081 1.352 . . . . 1.0 112.95 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -88.7 -16.88 31.17 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.767 1.227 . . . . 1.0 113.139 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.0 mttt 59.11 52.41 6.24 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 127.337 2.255 . . . . 1.0 112.406 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 68.3 mtp180 -122.39 124.34 43.44 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 113.934 -1.484 . . . . 1.0 110.144 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.27 124.0 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 125.347 1.654 . . . . 1.0 107.391 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -124.86 134.71 52.61 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 125.401 1.688 . . . . 1.0 110.347 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.81 127.63 55.21 Favored 'General case' 0 C--O 1.252 1.207 0 O-C-N 125.205 1.565 . . . . 1.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.283 1.615 . . . . 1.0 111.247 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.342 0.127 . . . . 1.0 111.342 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -107.72 142.5 37.62 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.215 1.572 . . . . 1.0 110.855 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -123.26 138.34 54.65 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.785 1.303 . . . . 1.0 111.259 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.535 ' SG ' HD12 ' A' ' 13' ' ' ILE . 14.3 t -72.71 122.85 88.64 Favored Pre-proline 0 CA--C 1.582 2.173 0 C-N-CA 124.731 1.212 . . . . 1.0 112.675 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.54 -1.68 11.39 Favored 'Trans proline' 1 C--N 1.435 5.085 0 C-N-CA 122.106 1.871 . . . . 1.0 115.085 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.535 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -100.0 -55.97 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 124.614 1.165 . . . . 1.0 109.406 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -103.8 -41.93 5.76 Favored 'General case' 0 C--N 1.373 1.589 0 O-C-N 124.544 1.152 . . . . 1.0 112.985 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 90.82 35.73 7.1 Favored Glycine 0 C--N 1.369 2.371 0 O-C-N 124.751 1.282 . . . . 1.0 114.253 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -95.51 148.72 35.07 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 116.871 -1.538 . . . . 1.0 111.807 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -69.22 140.78 45.61 Favored 'Trans proline' 1 C--N 1.448 5.775 0 C-N-CA 122.844 2.363 . . . . 1.0 114.955 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.37 145.43 51.08 Favored 'General case' 0 C--O 1.249 1.052 0 O-C-N 125.524 1.765 . . . . 1.0 110.324 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -99.39 135.26 41.06 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.716 1.26 . . . . 1.0 110.888 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.438 ' O ' HG12 ' A' ' 24' ' ' ILE . 59.5 m95 -69.19 -24.87 64.1 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.049 1.339 . . . . 1.0 113.326 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -70.39 -30.42 67.31 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.022 1.729 . . . . 1.0 113.03 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.42 -35.07 63.4 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 125.16 1.384 . . . . 1.0 113.127 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -40.25 85.18 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.866 1.667 . . . . 1.0 113.602 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.8 mm -74.64 -41.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 C-N-CA 125.581 1.552 . . . . 1.0 110.531 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -67.29 -35.92 80.47 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.338 1.455 . . . . 1.0 113.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.4 -22.93 40.76 Favored 'General case' 0 C--N 1.375 1.685 0 C-N-CA 125.409 1.483 . . . . 1.0 113.452 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.493 ' O ' HD12 ' A' ' 30' ' ' ILE . 55.2 mtp -102.65 1.61 34.85 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 124.563 1.164 . . . . 1.0 113.0 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.45 12.96 3.26 Favored 'General case' 0 CA--C 1.582 2.177 0 C-N-CA 124.805 1.242 . . . . 1.0 113.765 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -8.12 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 125.344 1.457 . . . . 1.0 113.283 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 27' ' ' MET . 1.1 mt -98.98 137.53 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 125.109 1.364 . . . . 1.0 108.553 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -74.6 -27.36 60.44 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 124.831 1.332 . . . . 1.0 113.879 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.79 -22.86 62.32 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 125.243 1.417 . . . . 1.0 112.926 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -56.11 -34.1 65.73 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.527 1.931 . . . . 1.0 114.384 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.48 -28.33 69.89 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 125.268 1.427 . . . . 1.0 112.303 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.22 -34.62 20.41 Favored 'General case' 0 C--N 1.376 1.758 0 C-N-CA 125.421 1.488 . . . . 1.0 112.481 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 33' ' ' PHE . 4.5 mt -71.76 -39.63 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 C-N-CA 125.679 1.592 . . . . 1.0 110.423 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.0 m -61.14 -20.07 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 125.188 1.395 . . . . 1.0 114.716 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -85.57 -19.95 30.31 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.091 1.356 . . . . 1.0 113.571 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.6 110.93 12.69 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 124.21 1.004 . . . . 1.0 111.666 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.447 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -60.35 -32.26 71.1 Favored 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 126.221 1.808 . . . . 1.0 115.451 177.296 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.43 -31.83 71.43 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.311 1.444 . . . . 1.0 113.337 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 72.3 mtp180 -82.42 -34.75 28.12 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.05 1.34 . . . . 1.0 112.869 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 t80 -70.51 -44.32 67.84 Favored 'General case' 0 C--N 1.389 2.287 0 C-N-CA 125.08 1.352 . . . . 1.0 112.605 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -70.21 -35.96 74.25 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.987 1.315 . . . . 1.0 113.144 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.15 -29.63 63.0 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.385 1.474 . . . . 1.0 113.204 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.1 tt0 -78.95 -34.4 44.41 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.368 1.467 . . . . 1.0 113.016 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 43' ' ' PHE . 89.7 t -69.89 -40.22 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.552 1.541 . . . . 1.0 109.762 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.12 -34.26 70.9 Favored 'General case' 0 N--CA 1.511 2.609 0 C-N-CA 125.575 1.55 . . . . 1.0 113.167 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.63 -27.36 29.19 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.318 1.447 . . . . 1.0 113.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -98.97 151.91 20.38 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.636 1.174 . . . . 1.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.05 148.0 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 O-C-N 124.664 1.227 . . . . 1.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.456 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 88.4 m-85 -121.71 152.04 39.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.671 1.232 . . . . 1.0 110.699 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -101.85 141.76 34.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.202 0.939 . . . . 1.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 24.1 t -96.05 119.39 64.69 Favored Pre-proline 0 CA--C 1.572 1.802 0 O-C-N 124.848 1.343 . . . . 1.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.07 -7.74 19.37 Favored 'Trans proline' 1 C--N 1.437 5.2 0 C-N-CA 122.25 1.967 . . . . 1.0 115.233 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 t -88.32 -51.94 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 C-N-CA 124.694 1.198 . . . . 1.0 110.299 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.38 -50.56 3.89 Favored 'General case' 0 C--N 1.367 1.343 0 O-C-N 124.691 1.245 . . . . 1.0 112.084 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 -14.57 12.1 Favored Glycine 0 C--N 1.371 2.523 0 O-C-N 124.473 1.108 . . . . 1.0 115.18 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -82.17 153.52 25.95 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 124.859 1.264 . . . . 1.0 112.565 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.45 138.41 31.5 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.163 1.385 . . . . 1.0 112.006 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -129.17 141.27 51.22 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 125.185 1.553 . . . . 1.0 109.814 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.3 151.53 19.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.318 1.011 . . . . 1.0 112.381 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.79 -8.02 86.33 Favored Glycine 0 C--N 1.378 2.884 0 O-C-N 124.437 1.085 . . . . 1.0 114.639 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -86.32 -19.6 29.57 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.466 1.506 . . . . 1.0 111.659 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.4 p -97.53 6.82 47.55 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.966 1.306 . . . . 1.0 112.055 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.76 159.07 55.75 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-O 117.344 -1.312 . . . . 1.0 111.393 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -69.68 154.51 67.98 Favored 'Trans proline' 1 C--N 1.441 5.432 0 C-N-CA 123.197 2.598 . . . . 1.0 114.227 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -68.26 -17.97 64.43 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 115.173 1.545 . . . . 1.0 115.173 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -83.67 -33.68 25.15 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.496 1.118 . . . . 1.0 112.221 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.5 mt-10 -69.86 -28.68 65.86 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.585 1.554 . . . . 1.0 113.49 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -64.27 -31.91 73.3 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.727 1.611 . . . . 1.0 112.852 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.19 -27.88 62.84 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 125.693 1.597 . . . . 1.0 111.987 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -68.26 -28.77 67.5 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 125.962 1.705 . . . . 1.0 112.65 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.472 ' O ' HD12 ' A' ' 78' ' ' LEU . 2.8 t -66.97 -40.06 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 C-N-CA 126.026 1.73 . . . . 1.0 109.331 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -28.0 65.57 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 125.772 1.629 . . . . 1.0 113.401 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -71.58 -42.63 67.54 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.188 1.795 . . . . 1.0 113.019 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.4 pp -67.28 -37.25 83.14 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.353 1.061 . . . . 1.0 112.513 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -71.2 -37.46 72.11 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.881 1.673 . . . . 1.0 113.079 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.68 -31.96 36.14 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.359 1.463 . . . . 1.0 114.129 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -98.64 57.81 1.18 Allowed 'General case' 0 C--O 1.26 1.646 0 CA-C-O 123.093 1.425 . . . . 1.0 110.712 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.45 145.61 24.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.005 -1.907 . . . . 1.0 111.48 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttm 77.46 112.02 0.07 Allowed 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 127.46 2.304 . . . . 1.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.22 -74.49 0.22 Allowed Glycine 0 C--N 1.36 1.874 0 O-C-N 125.037 1.46 . . . . 1.0 112.953 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.59 31.02 5.36 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 125.314 1.243 . . . . 1.0 115.348 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.39 120.12 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.05 130.17 51.75 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 125.177 1.548 . . . . 1.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.39 -32.59 32.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.887 1.275 . . . . 1.0 114.029 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.32 -35.73 40.68 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 124.964 1.305 . . . . 1.0 113.3 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -94.73 -15.34 23.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.652 1.22 . . . . 1.0 113.336 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 60.12 51.31 5.78 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 127.193 2.197 . . . . 1.0 113.903 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -113.34 128.83 56.59 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.899 -1.501 . . . . 1.0 110.435 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.46 130.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 124.99 1.431 . . . . 1.0 108.147 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -121.71 137.04 54.92 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 125.048 1.467 . . . . 1.0 111.364 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.83 130.93 53.48 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.126 1.517 . . . . 1.0 109.727 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 mttp . . . . . 0 C--O 1.253 1.238 0 O-C-N 125.213 1.57 . . . . 1.0 111.287 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 36.4 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.85 138.67 41.65 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 125.272 1.608 . . . . 1.0 110.884 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -106.81 138.64 42.61 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 124.901 1.375 . . . . 1.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.8 t -73.76 130.3 83.69 Favored Pre-proline 0 CA--C 1.582 2.207 0 CA-C-O 116.907 -1.52 . . . . 1.0 112.151 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.12 -11.75 27.37 Favored 'Trans proline' 1 C--N 1.441 5.404 0 C-N-CA 122.573 2.182 . . . . 1.0 114.406 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.507 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -93.73 -55.12 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.221 1.408 . . . . 1.0 110.482 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 29.1 p -103.35 -41.16 6.11 Favored 'General case' 0 C--N 1.372 1.569 0 O-C-N 124.302 1.001 . . . . 1.0 113.424 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 89.13 34.6 8.67 Favored Glycine 0 C--N 1.371 2.525 0 O-C-N 124.818 1.324 . . . . 1.0 113.324 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.532 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -92.74 144.63 28.91 Favored Pre-proline 0 C--N 1.369 1.447 0 CA-C-O 117.016 -1.468 . . . . 1.0 112.808 -178.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.59 135.36 38.66 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 122.46 2.107 . . . . 1.0 114.839 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mt -120.16 144.92 47.41 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 125.333 1.646 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.09 129.01 38.14 Favored 'General case' 0 C--N 1.362 1.111 0 O-C-N 124.876 1.36 . . . . 1.0 111.072 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.0 m95 -68.66 -25.58 64.89 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 125.136 1.374 . . . . 1.0 113.115 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 mt-10 -70.16 -32.27 70.15 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.936 1.695 . . . . 1.0 112.59 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -76.55 -34.1 58.51 Favored 'General case' 0 C--N 1.385 2.136 0 C-N-CA 125.225 1.41 . . . . 1.0 112.712 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -41.32 91.8 Favored 'General case' 0 C--N 1.383 2.051 0 C-N-CA 126.495 1.918 . . . . 1.0 112.764 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' TRP . 5.9 mm -78.97 -38.59 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 125.607 1.563 . . . . 1.0 110.445 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -65.49 -35.38 80.73 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 125.475 1.51 . . . . 1.0 113.491 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.46 -24.04 39.81 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.876 1.671 . . . . 1.0 112.451 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.475 ' O ' HD12 ' A' ' 30' ' ' ILE . 24.0 mtp -101.56 9.06 41.6 Favored 'General case' 0 CA--C 1.575 1.908 0 O-C-N 124.805 1.316 . . . . 1.0 112.943 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 13.4 13.77 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 124.163 0.985 . . . . 1.0 112.978 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.92 -6.36 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 125.606 1.562 . . . . 1.0 113.317 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -97.96 140.84 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 125.285 1.434 . . . . 1.0 109.048 -178.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.71 -19.1 42.22 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.852 1.345 . . . . 1.0 113.306 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.8 -19.94 50.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.183 1.393 . . . . 1.0 112.584 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.565 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.5 t80 -57.51 -35.77 70.69 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 126.327 1.851 . . . . 1.0 113.374 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.02 -28.0 69.28 Favored 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 125.337 1.455 . . . . 1.0 112.182 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -87.63 -33.88 18.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.843 1.657 . . . . 1.0 112.149 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.3 mt -71.26 -40.25 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.991 0 C-N-CA 125.739 1.616 . . . . 1.0 110.634 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.514 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.1 m -58.75 -24.47 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 C-N-CA 125.687 1.595 . . . . 1.0 114.741 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -87.73 -15.24 37.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 1.0 113.022 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -125.36 106.34 9.76 Favored 'General case' 0 C--N 1.375 1.684 0 C-N-CA 124.473 1.109 . . . . 1.0 111.767 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.457 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.6 mtm180 -59.11 -33.12 70.48 Favored 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 125.956 1.702 . . . . 1.0 113.863 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.14 -31.21 68.63 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.943 1.697 . . . . 1.0 112.839 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -82.0 -33.58 30.05 Favored 'General case' 0 C--N 1.38 1.917 0 C-N-CA 125.196 1.398 . . . . 1.0 112.552 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.4 t80 -72.19 -43.95 63.74 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 124.938 1.295 . . . . 1.0 112.815 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -70.33 -31.27 68.49 Favored 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 125.359 1.463 . . . . 1.0 113.049 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -26.68 33.58 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 125.305 1.442 . . . . 1.0 112.932 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 3.3 mm-40 -79.25 -38.18 36.18 Favored 'General case' 0 C--N 1.384 2.093 0 C-N-CA 124.798 1.239 . . . . 1.0 112.615 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 43' ' ' PHE . 68.3 t -68.16 -40.04 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 125.472 1.509 . . . . 1.0 109.68 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.48 -24.83 62.07 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 125.522 1.529 . . . . 1.0 113.142 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.29 -15.85 19.62 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.111 1.364 . . . . 1.0 113.153 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -93.19 151.29 19.92 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 124.62 1.168 . . . . 1.0 112.315 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.423 HG11 ' OE1' ' A' ' 60' ' ' GLU . 82.9 t -97.94 140.64 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 125.092 1.495 . . . . 1.0 107.791 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -128.44 146.31 50.84 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.602 1.814 . . . . 1.0 109.571 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -105.1 142.25 35.22 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 124.779 1.299 . . . . 1.0 111.259 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.69 131.38 37.95 Favored Pre-proline 0 CA--C 1.574 1.875 0 O-C-N 124.982 1.427 . . . . 1.0 111.352 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.68 -9.62 22.77 Favored 'Trans proline' 1 C--N 1.437 5.221 0 C-N-CA 122.439 2.092 . . . . 1.0 114.268 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.06 -53.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 125.274 1.43 . . . . 1.0 109.709 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 25.0 m -88.73 -53.98 4.37 Favored 'General case' 0 C--N 1.379 1.874 0 O-C-N 124.253 0.971 . . . . 1.0 112.1 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.32 6.63 61.23 Favored Glycine 0 C--N 1.37 2.45 0 O-C-N 124.885 1.366 . . . . 1.0 113.378 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.26 165.83 16.16 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 126.126 1.77 . . . . 1.0 112.332 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE1' HG11 ' A' ' 51' ' ' VAL . 43.9 mt-10 -92.2 134.28 35.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.06 1.344 . . . . 1.0 110.733 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.08 153.41 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.393 1.477 . . . . 1.0 109.983 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.49 154.04 21.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.577 1.173 . . . . 1.0 112.398 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.0 -1.19 72.39 Favored Glycine 0 C--N 1.378 2.881 0 O-C-N 124.446 1.091 . . . . 1.0 114.424 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -85.65 -17.41 36.19 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.169 1.387 . . . . 1.0 111.596 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.5 p -95.55 3.31 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.993 1.317 . . . . 1.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.44 152.71 73.35 Favored Pre-proline 0 CA--C 1.58 2.108 0 CA-C-O 116.86 -1.543 . . . . 1.0 111.703 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -64.1 149.87 89.51 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 123.252 2.634 . . . . 1.0 114.931 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -65.05 -17.83 64.79 Favored 'General case' 0 N--CA 1.51 2.533 0 C-N-CA 125.517 1.527 . . . . 1.0 114.835 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -82.53 -33.13 28.32 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.03 1.332 . . . . 1.0 111.533 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.18 -30.16 66.08 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.787 1.635 . . . . 1.0 113.042 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -66.87 -36.3 82.0 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 125.58 1.552 . . . . 1.0 112.388 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -71.8 -24.22 61.7 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 125.41 1.484 . . . . 1.0 112.356 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -74.76 -27.94 60.55 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 126.181 1.792 . . . . 1.0 112.439 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 t -67.11 -39.73 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 C-N-CA 126.195 1.798 . . . . 1.0 110.305 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 40' ' ' ARG . 1.4 t80 -60.56 -29.46 69.18 Favored 'General case' 0 N--CA 1.511 2.605 0 C-N-CA 125.608 1.563 . . . . 1.0 113.651 177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.18 -40.81 71.01 Favored 'General case' 0 C--N 1.384 2.087 0 C-N-CA 125.731 1.613 . . . . 1.0 113.212 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.7 pp -70.15 -34.96 73.68 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 124.903 1.281 . . . . 1.0 113.554 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.514 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.32 -24.18 42.98 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.105 1.362 . . . . 1.0 112.453 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.406 ' OD1' ' HD3' ' A' ' 40' ' ' ARG . 2.6 m120 -85.36 -14.61 45.87 Favored 'General case' 0 C--N 1.382 2.002 0 C-N-CA 124.862 1.265 . . . . 1.0 113.357 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.12 -36.96 84.53 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 125.667 1.587 . . . . 1.0 113.819 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 61.57 -58.72 0.11 Allowed 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 128.112 2.565 . . . . 1.0 114.174 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -128.59 136.46 50.74 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 125.115 1.366 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -174.07 -102.02 0.15 Allowed Glycine 0 C--N 1.356 1.679 0 O-C-N 125.151 1.532 . . . . 1.0 111.807 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.76 44.66 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 O-C-N 125.504 1.355 . . . . 1.0 113.395 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.3 123.6 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.812 -1.551 . . . . 1.0 106.812 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.75 128.74 45.88 Favored 'General case' 0 C--O 1.248 1.015 0 O-C-N 125.324 1.64 . . . . 1.0 110.252 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -80.81 -26.38 37.14 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.807 1.243 . . . . 1.0 114.071 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -80.94 -38.4 27.88 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 125.14 1.376 . . . . 1.0 113.178 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -97.32 -14.4 21.32 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 124.555 1.159 . . . . 1.0 113.678 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttm 60.35 55.81 3.41 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 127.342 2.257 . . . . 1.0 113.319 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 86.5 mtt180 -115.93 130.2 56.72 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.16 127.38 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 125.126 1.516 . . . . 1.0 107.996 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -119.66 136.81 54.24 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 125.374 1.671 . . . . 1.0 110.537 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.29 129.14 56.61 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 124.973 1.42 . . . . 1.0 111.583 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt . . . . . 0 N--CA 1.48 1.03 0 O-C-N 125.777 1.923 . . . . 1.0 111.06 179.562 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.4 mmt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 111.238 0.088 . . . . 1.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' HB2' ' NE1' ' A' ' 20' ' ' TRP . . . -107.5 139.91 41.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 125.268 1.605 . . . . 1.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -128.42 138.9 52.54 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.774 1.296 . . . . 1.0 111.114 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 13' ' ' ILE . 27.1 t -73.14 121.27 84.68 Favored Pre-proline 0 CA--C 1.582 2.21 0 CA-C-O 117.58 -1.2 . . . . 1.0 111.784 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 -6.37 18.97 Favored 'Trans proline' 1 C--N 1.433 4.974 0 C-N-CA 121.965 1.777 . . . . 1.0 114.834 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.536 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.3 mt -95.72 -55.41 6.13 Favored 'Isoleucine or valine' 0 C--N 1.372 1.575 0 C-N-CA 125.069 1.348 . . . . 1.0 110.05 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.2 p -103.79 -41.75 5.82 Favored 'General case' 0 C--N 1.374 1.634 0 O-C-N 124.245 0.965 . . . . 1.0 112.795 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.99 36.3 6.06 Favored Glycine 0 C--N 1.367 2.288 0 O-C-N 124.711 1.257 . . . . 1.0 114.151 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.439 ' OG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -97.89 147.52 33.17 Favored Pre-proline 0 CA--C 1.565 1.552 0 CA-C-O 116.848 -1.548 . . . . 1.0 111.83 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.71 139.13 39.64 Favored 'Trans proline' 1 C--N 1.446 5.708 0 C-N-CA 122.733 2.288 . . . . 1.0 114.33 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 mt -124.37 146.17 49.01 Favored 'General case' 0 C--O 1.25 1.131 0 O-C-N 125.436 1.71 . . . . 1.0 110.302 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.32 124.91 38.64 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 124.682 1.239 . . . . 1.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.481 ' O ' HG12 ' A' ' 24' ' ' ILE . 44.8 m95 -69.25 -24.83 64.04 Favored 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 125.091 1.356 . . . . 1.0 112.594 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 35.9 mt-10 -69.94 -31.59 69.42 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.72 1.608 . . . . 1.0 112.094 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -76.37 -34.0 58.92 Favored 'General case' 0 C--N 1.39 2.344 0 C-N-CA 124.923 1.289 . . . . 1.0 112.455 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -41.04 93.95 Favored 'General case' 0 C--N 1.381 1.967 0 C-N-CA 126.199 1.8 . . . . 1.0 112.711 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.2 mm -79.79 -39.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 C-N-CA 125.419 1.488 . . . . 1.0 110.641 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.63 -35.36 79.99 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 125.297 1.439 . . . . 1.0 113.678 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.68 -22.97 42.78 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 125.541 1.536 . . . . 1.0 112.586 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.468 ' O ' HD12 ' A' ' 30' ' ' ILE . 30.7 mtt -105.21 10.29 33.78 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 124.991 1.432 . . . . 1.0 112.128 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.39 23.26 4.62 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.007 0.923 . . . . 1.0 112.935 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.85 6.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 125.096 1.358 . . . . 1.0 112.79 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 32' ' ' ASN . 1.1 mt -109.27 139.69 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.037 1.335 . . . . 1.0 109.138 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.0 -20.47 28.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.142 1.526 . . . . 1.0 112.235 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.51 ' H ' HG22 ' A' ' 30' ' ' ILE . 10.4 m120 -91.6 19.54 6.21 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.179 1.391 . . . . 1.0 112.055 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.84 -36.3 56.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.313 1.445 . . . . 1.0 111.778 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 37' ' ' VAL . 29.1 mt-10 -55.67 -23.88 30.84 Favored 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 126.068 1.747 . . . . 1.0 114.684 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.79 -43.83 15.02 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 125.074 1.35 . . . . 1.0 111.495 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 43' ' ' PHE . 3.2 mt -72.8 -43.05 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 125.297 1.439 . . . . 1.0 110.934 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 34' ' ' GLU . 1.9 p -68.26 -19.26 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.757 0 C-N-CA 125.124 1.37 . . . . 1.0 114.132 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -91.96 -17.77 24.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.621 1.2 . . . . 1.0 112.698 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.0 105.47 9.61 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 124.351 1.06 . . . . 1.0 111.412 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -57.19 -31.63 65.65 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 125.386 1.475 . . . . 1.0 114.104 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.3 -33.49 74.42 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.778 1.631 . . . . 1.0 112.652 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -82.16 -35.84 28.01 Favored 'General case' 0 C--N 1.377 1.792 0 C-N-CA 125.339 1.456 . . . . 1.0 112.429 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.5 t80 -73.69 -45.27 53.45 Favored 'General case' 0 C--N 1.39 2.357 0 C-N-CA 125.089 1.356 . . . . 1.0 112.523 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.58 -28.18 66.72 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 124.597 1.159 . . . . 1.0 113.048 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.77 -28.61 36.36 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.154 1.382 . . . . 1.0 112.619 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.9 tt0 -79.6 -38.25 34.37 Favored 'General case' 0 C--N 1.381 1.968 0 C-N-CA 125.094 1.358 . . . . 1.0 112.337 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 43' ' ' PHE . 49.1 t -68.99 -42.07 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.215 0 C-N-CA 125.341 1.456 . . . . 1.0 109.635 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.89 -28.28 67.37 Favored 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.455 1.502 . . . . 1.0 113.544 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -91.92 -26.75 18.29 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.863 1.265 . . . . 1.0 113.488 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -97.6 147.42 24.32 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 124.566 1.146 . . . . 1.0 111.254 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.0 151.89 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 O-C-N 124.835 1.335 . . . . 1.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -122.56 144.57 49.01 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.949 1.406 . . . . 1.0 110.434 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -96.77 138.77 33.83 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 124.787 1.305 . . . . 1.0 111.268 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.6 t -96.5 111.76 57.99 Favored Pre-proline 0 CA--C 1.576 1.961 0 O-C-N 125.026 1.454 . . . . 1.0 110.654 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -70.57 -8.07 22.76 Favored 'Trans proline' 1 C--N 1.439 5.299 0 C-N-CA 122.984 2.456 . . . . 1.0 114.348 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG11 ' OG ' ' A' ' 16' ' ' SER . 1.8 t -85.31 -51.97 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 125.577 1.551 . . . . 1.0 110.597 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.1 p -103.76 -48.14 4.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.722 1.264 . . . . 1.0 112.504 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.1 -10.94 14.93 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 124.442 1.089 . . . . 1.0 114.348 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.4 147.82 25.27 Favored 'General case' 0 C--N 1.376 1.738 0 C-N-CA 124.963 1.305 . . . . 1.0 111.476 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.74 138.54 31.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.783 1.233 . . . . 1.0 112.36 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -122.35 143.11 49.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.214 1.571 . . . . 1.0 109.833 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -95.31 151.67 19.06 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 124.318 1.012 . . . . 1.0 112.659 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.21 -9.07 80.48 Favored Glycine 0 C--N 1.379 2.932 0 O-C-N 124.661 1.226 . . . . 1.0 115.125 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -87.55 -18.25 30.18 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.256 1.422 . . . . 1.0 112.047 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 p -99.63 2.68 44.73 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.841 1.256 . . . . 1.0 112.018 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 152.89 81.22 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 116.982 -1.485 . . . . 1.0 111.969 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.49 152.2 82.59 Favored 'Trans proline' 1 C--N 1.444 5.553 0 C-N-CA 123.289 2.659 . . . . 1.0 114.67 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -66.98 -19.58 65.74 Favored 'General case' 0 N--CA 1.507 2.405 0 C-N-CA 125.19 1.396 . . . . 1.0 114.566 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -79.6 -34.17 40.93 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 125.002 1.321 . . . . 1.0 112.073 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -70.12 -29.46 66.42 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.743 1.617 . . . . 1.0 113.239 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.18 71.93 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.845 1.658 . . . . 1.0 112.863 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.01 -26.2 63.02 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 1.0 112.933 176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -68.7 -28.03 66.48 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.968 1.707 . . . . 1.0 112.785 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t -65.92 -33.91 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.09 0 C-N-CA 126.519 1.928 . . . . 1.0 110.281 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.27 -29.16 69.9 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 125.784 1.634 . . . . 1.0 113.828 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -68.27 -38.5 81.81 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 125.67 1.588 . . . . 1.0 113.068 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.2 pp -72.84 -29.29 63.1 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.599 1.16 . . . . 1.0 112.825 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -26.93 43.5 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 125.405 1.482 . . . . 1.0 113.055 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -98.16 -20.18 17.45 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.423 1.089 . . . . 1.0 113.57 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.06 62.24 0.64 Allowed 'General case' 0 C--O 1.259 1.562 0 CA-C-O 123.127 1.442 . . . . 1.0 110.919 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -69.38 -34.98 75.34 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 113.349 -1.75 . . . . 1.0 113.106 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -106.36 120.3 41.52 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 124.973 1.42 . . . . 1.0 108.709 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.44 84.63 1.68 Allowed Glycine 0 C--N 1.363 2.071 0 O-C-N 124.661 1.226 . . . . 1.0 112.934 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 136.36 -57.99 0.67 Allowed Glycine 0 C--N 1.359 1.827 0 O-C-N 125.307 1.24 . . . . 1.0 113.468 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.4 mp -109.05 124.6 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 125.104 1.12 . . . . 1.0 108.126 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.06 133.11 56.01 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.495 1.747 . . . . 1.0 110.19 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -80.53 -29.35 37.19 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.588 1.18 . . . . 1.0 113.911 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.18 -35.42 28.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 124.877 1.271 . . . . 1.0 112.935 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -92.76 -17.88 23.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.613 1.196 . . . . 1.0 113.495 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 59.2 45.59 14.13 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 127.157 2.183 . . . . 1.0 113.516 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 9.1 mmm180 -115.27 138.19 51.22 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.284 -1.326 . . . . 1.0 111.435 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.84 126.92 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 125.174 1.546 . . . . 1.0 108.235 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 12.1 tttt -127.11 129.35 47.77 Favored 'General case' 0 C--O 1.251 1.143 0 O-C-N 125.28 1.612 . . . . 1.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 132.97 52.74 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.762 1.289 . . . . 1.0 110.716 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.7 mttm . . . . . 0 C--O 1.252 1.221 0 O-C-N 125.289 1.618 . . . . 1.0 111.357 179.799 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 110.851 -0.055 . . . . 1.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.73 138.61 44.78 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 125.179 1.549 . . . . 1.0 110.829 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -110.94 139.06 46.6 Favored 'General case' 0 C--O 1.248 1.013 0 O-C-N 124.9 1.375 . . . . 1.0 110.906 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 13' ' ' ILE . 47.3 t -71.8 132.34 85.14 Favored Pre-proline 0 CA--C 1.578 2.038 0 CA-C-O 117.262 -1.351 . . . . 1.0 112.44 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.71 -8.45 20.39 Favored 'Trans proline' 1 C--N 1.43 4.854 0 C-N-CA 122.178 1.919 . . . . 1.0 114.761 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.541 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.2 -55.9 5.66 Favored 'Isoleucine or valine' 0 C--N 1.372 1.569 0 C-N-CA 124.975 1.31 . . . . 1.0 109.955 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 27.2 p -101.23 -41.15 6.82 Favored 'General case' 0 C--N 1.371 1.536 0 O-C-N 124.079 0.862 . . . . 1.0 113.003 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 88.73 34.14 9.4 Favored Glycine 0 C--N 1.37 2.464 0 O-C-N 124.691 1.244 . . . . 1.0 113.112 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.461 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -93.16 145.91 30.94 Favored Pre-proline 0 C--N 1.368 1.411 0 CA-C-O 117.177 -1.392 . . . . 1.0 112.586 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.71 134.28 34.59 Favored 'Trans proline' 1 C--N 1.445 5.624 0 C-N-CA 122.422 2.081 . . . . 1.0 114.475 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt -118.63 143.16 47.0 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 125.277 1.611 . . . . 1.0 110.202 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.28 130.85 37.1 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.789 1.306 . . . . 1.0 111.212 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 24' ' ' ILE . 45.8 m95 -68.78 -24.8 64.46 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 125.078 1.351 . . . . 1.0 113.046 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.1 mt-10 -70.01 -33.77 72.45 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 125.623 1.569 . . . . 1.0 112.178 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.98 -34.69 57.53 Favored 'General case' 0 C--N 1.386 2.193 0 C-N-CA 125.268 1.427 . . . . 1.0 112.776 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.13 -41.3 94.93 Favored 'General case' 0 C--N 1.382 1.994 0 C-N-CA 126.036 1.734 . . . . 1.0 112.839 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -79.94 -37.99 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 C-N-CA 125.271 1.428 . . . . 1.0 110.48 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.57 -35.25 79.75 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.093 1.357 . . . . 1.0 113.472 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.24 -23.83 40.58 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.653 1.581 . . . . 1.0 112.55 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -103.65 13.77 32.52 Favored 'General case' 0 CA--C 1.576 1.979 0 O-C-N 124.768 1.293 . . . . 1.0 112.48 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.11 16.79 12.11 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 123.937 0.895 . . . . 1.0 112.882 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.88 -4.05 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 C-N-CA 125.457 1.503 . . . . 1.0 113.427 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -99.71 140.92 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 125.251 1.421 . . . . 1.0 109.125 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.78 -18.06 41.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.888 1.367 . . . . 1.0 113.033 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.66 -16.3 54.35 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 124.975 1.31 . . . . 1.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.87 -34.74 65.75 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 126.252 1.821 . . . . 1.0 113.006 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.06 -30.34 71.52 Favored 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 125.317 1.447 . . . . 1.0 112.281 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.71 -35.73 20.65 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 125.461 1.504 . . . . 1.0 112.251 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -72.2 -39.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.905 0 C-N-CA 126.011 1.724 . . . . 1.0 110.549 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.531 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.5 p -63.17 -18.85 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 C-N-CA 125.561 1.544 . . . . 1.0 114.237 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.98 -19.41 25.75 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.75 1.22 . . . . 1.0 113.311 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -125.3 111.11 14.82 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.364 1.066 . . . . 1.0 111.688 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.0 mpt_? -60.05 -33.45 72.06 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 125.603 1.561 . . . . 1.0 113.57 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.19 -31.06 69.41 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 125.636 1.575 . . . . 1.0 112.632 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -82.16 -33.42 29.53 Favored 'General case' 0 C--N 1.379 1.85 0 C-N-CA 125.119 1.368 . . . . 1.0 112.154 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.473 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.0 t80 -71.65 -43.98 65.12 Favored 'General case' 0 C--N 1.394 2.508 0 C-N-CA 125.137 1.375 . . . . 1.0 112.41 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.83 -28.8 65.99 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.925 1.29 . . . . 1.0 112.41 177.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 -27.07 29.64 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 125.455 1.502 . . . . 1.0 112.787 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.0 mm-40 -78.11 -39.12 42.34 Favored 'General case' 0 C--N 1.383 2.024 0 C-N-CA 124.775 1.23 . . . . 1.0 112.84 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 43' ' ' PHE . 46.0 t -68.8 -40.77 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.03 0 C-N-CA 125.234 1.414 . . . . 1.0 109.621 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.29 -26.69 63.92 Favored 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.491 1.516 . . . . 1.0 113.024 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.36 -26.0 19.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.076 1.351 . . . . 1.0 112.851 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -96.18 144.64 26.22 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 124.64 1.176 . . . . 1.0 110.943 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.9 150.85 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 O-C-N 124.948 1.405 . . . . 1.0 110.732 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.03 145.5 50.97 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.856 1.348 . . . . 1.0 110.523 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -101.4 142.69 32.43 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.663 1.227 . . . . 1.0 111.3 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -89.04 123.38 67.5 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 117.385 -1.293 . . . . 1.0 110.943 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.26 -9.93 26.27 Favored 'Trans proline' 1 C--N 1.439 5.301 0 C-N-CA 122.81 2.34 . . . . 1.0 113.548 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.15 -52.78 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 125.638 1.575 . . . . 1.0 110.177 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 46.0 m -90.13 -52.74 4.79 Favored 'General case' 0 C--N 1.38 1.893 0 O-C-N 124.22 0.95 . . . . 1.0 112.383 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.67 42.14 Favored Glycine 0 C--N 1.368 2.316 0 O-C-N 124.796 1.31 . . . . 1.0 112.899 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -86.57 152.58 22.5 Favored 'General case' 0 C--N 1.379 1.888 0 C-N-CA 125.759 1.624 . . . . 1.0 111.272 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.28 136.66 32.9 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.436 1.095 . . . . 1.0 111.577 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -130.14 144.15 51.19 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 125.475 1.734 . . . . 1.0 109.159 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -92.2 153.85 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.186 0.929 . . . . 1.0 113.047 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -77.27 -4.43 83.93 Favored Glycine 0 C--N 1.377 2.826 0 O-C-N 124.404 1.065 . . . . 1.0 114.793 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -85.81 -15.16 42.85 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.355 1.462 . . . . 1.0 112.054 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 p -95.59 5.64 50.97 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 124.524 1.13 . . . . 1.0 111.562 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 63' ' ' GLY . 5.8 mt -74.53 150.51 86.9 Favored Pre-proline 0 C--N 1.387 2.23 0 CA-C-O 116.811 -1.566 . . . . 1.0 112.48 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.98 151.69 83.31 Favored 'Trans proline' 1 C--N 1.441 5.434 0 C-N-CA 123.139 2.559 . . . . 1.0 113.739 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -65.71 -18.34 65.26 Favored 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 114.715 1.376 . . . . 1.0 114.715 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -83.45 -34.43 25.44 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.974 1.309 . . . . 1.0 111.68 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -70.36 -29.15 65.75 Favored 'General case' 0 C--N 1.387 2.198 0 C-N-CA 125.741 1.616 . . . . 1.0 113.513 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.18 75.29 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.497 1.519 . . . . 1.0 112.809 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -73.85 -28.21 61.47 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.729 1.612 . . . . 1.0 112.358 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -71.33 -26.94 63.05 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 126.054 1.742 . . . . 1.0 112.746 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.7 -38.31 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 C-N-CA 126.49 1.916 . . . . 1.0 110.366 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -60.06 -28.18 67.57 Favored 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.277 1.431 . . . . 1.0 113.864 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -40.79 79.94 Favored 'General case' 0 C--N 1.383 2.064 0 C-N-CA 125.616 1.567 . . . . 1.0 113.496 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.1 pp -71.04 -34.52 71.33 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.911 1.284 . . . . 1.0 113.013 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.08 -22.65 44.96 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.479 1.512 . . . . 1.0 112.531 177.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -86.37 -9.66 55.92 Favored 'General case' 0 C--N 1.383 2.038 0 C-N-CA 124.586 1.154 . . . . 1.0 113.061 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.55 -35.59 75.55 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.59 1.556 . . . . 1.0 113.75 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.67 -72.01 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 127.621 2.368 . . . . 1.0 113.816 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -128.48 135.31 49.27 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 125.201 1.401 . . . . 1.0 109.393 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.45 114.6 3.97 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 125.018 1.449 . . . . 1.0 111.445 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 109.3 -43.24 1.75 Allowed Glycine 0 C--N 1.356 1.648 0 O-C-N 125.404 1.296 . . . . 1.0 113.846 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -107.47 124.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.32 127.99 54.61 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 125.443 1.714 . . . . 1.0 110.002 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.55 -32.85 36.56 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.683 1.239 . . . . 1.0 113.778 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.23 -36.16 30.35 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.004 1.322 . . . . 1.0 112.901 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.34 -16.14 24.98 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.695 1.198 . . . . 1.0 113.525 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.17 44.26 16.05 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 127.112 2.165 . . . . 1.0 113.479 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 99.4 mtt180 -114.0 135.89 53.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.318 -1.31 . . . . 1.0 111.175 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.76 127.0 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 125.471 1.732 . . . . 1.0 107.727 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 2.8 tttp -122.66 133.11 54.52 Favored 'General case' 0 C--O 1.25 1.123 0 O-C-N 125.309 1.631 . . . . 1.0 110.464 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.48 129.85 53.2 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.04 1.462 . . . . 1.0 110.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 mttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.373 1.671 . . . . 1.0 111.287 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 39.6 mtt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.466 0.172 . . . . 1.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.49 139.42 40.13 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 125.253 1.596 . . . . 1.0 110.732 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.38 139.2 45.81 Favored 'General case' 0 C--O 1.249 1.027 0 O-C-N 124.79 1.307 . . . . 1.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.4 t -69.51 129.11 91.81 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 116.905 -1.521 . . . . 1.0 111.687 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.35 -13.03 30.43 Favored 'Trans proline' 1 C--N 1.438 5.238 0 C-N-CA 122.373 2.048 . . . . 1.0 114.598 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.522 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.6 mp -91.33 -54.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 125.395 1.478 . . . . 1.0 110.7 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.29 -40.4 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.261 0.976 . . . . 1.0 113.433 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.91 38.43 5.77 Favored Glycine 0 C--N 1.371 2.499 0 O-C-N 124.71 1.256 . . . . 1.0 113.05 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -92.13 142.97 26.85 Favored Pre-proline 0 CA--C 1.567 1.625 0 CA-C-O 116.609 -1.662 . . . . 1.0 113.042 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.68 137.28 38.34 Favored 'Trans proline' 1 C--N 1.451 5.94 0 C-N-CA 122.557 2.171 . . . . 1.0 113.08 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -118.76 143.45 46.89 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 125.143 1.527 . . . . 1.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.64 131.61 41.7 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.979 1.424 . . . . 1.0 110.956 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.513 ' O ' HG12 ' A' ' 24' ' ' ILE . 55.0 m95 -68.51 -26.43 65.44 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.025 1.33 . . . . 1.0 112.968 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.0 mt-10 -70.0 -33.1 71.6 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 125.692 1.597 . . . . 1.0 112.094 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.69 -33.46 58.23 Favored 'General case' 0 C--N 1.387 2.202 0 C-N-CA 125.077 1.351 . . . . 1.0 112.509 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.4 OUTLIER -65.87 -41.42 91.63 Favored 'General case' 0 C--N 1.389 2.285 0 C-N-CA 125.824 1.65 . . . . 1.0 112.743 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.8 mm -76.97 -39.46 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 C-N-CA 125.411 1.484 . . . . 1.0 110.461 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -67.61 -36.6 81.14 Favored 'General case' 0 C--N 1.385 2.151 0 C-N-CA 125.281 1.432 . . . . 1.0 113.57 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.96 -22.5 39.52 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.645 1.578 . . . . 1.0 112.842 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -104.54 12.75 32.78 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.537 1.148 . . . . 1.0 111.856 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 12.23 26.81 Favored 'General case' 0 CA--C 1.575 1.91 0 C-N-CA 123.733 0.813 . . . . 1.0 113.014 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.68 1.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 C-N-CA 125.903 1.681 . . . . 1.0 113.074 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 27' ' ' MET . 0.8 OUTLIER -108.84 140.15 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 125.187 1.395 . . . . 1.0 109.109 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -80.87 -19.67 43.95 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 124.808 1.243 . . . . 1.0 113.748 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -79.09 -21.3 46.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.979 1.312 . . . . 1.0 112.554 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.4 t80 -57.59 -34.97 69.79 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.279 1.832 . . . . 1.0 113.153 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.1 -30.7 69.43 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 125.584 1.554 . . . . 1.0 111.975 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.16 -33.95 19.22 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 125.652 1.581 . . . . 1.0 112.485 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 33' ' ' PHE . 7.0 mt -71.5 -37.18 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.841 1.656 . . . . 1.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 m -61.98 -18.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 125.06 1.344 . . . . 1.0 114.394 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -93.11 -18.88 22.08 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.341 1.456 . . . . 1.0 112.595 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -121.61 104.84 9.92 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 124.104 0.962 . . . . 1.0 111.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.4 ptp180 -58.24 -36.85 73.81 Favored 'General case' 0 N--CA 1.517 2.904 0 C-N-CA 126.071 1.748 . . . . 1.0 113.973 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.26 -32.75 74.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.042 1.737 . . . . 1.0 112.776 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -83.74 -31.67 25.88 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.417 1.487 . . . . 1.0 112.256 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.2 t80 -74.56 -46.92 35.8 Favored 'General case' 0 C--N 1.392 2.441 0 C-N-CA 124.739 1.216 . . . . 1.0 113.14 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -71.4 -33.59 69.61 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 124.928 1.291 . . . . 1.0 113.152 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.37 -28.44 61.11 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.336 1.454 . . . . 1.0 113.161 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 mt-30 -80.05 -35.82 36.56 Favored 'General case' 0 C--N 1.381 1.97 0 C-N-CA 124.985 1.314 . . . . 1.0 112.945 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.5 t -67.98 -40.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.36 0 C-N-CA 125.267 1.427 . . . . 1.0 109.547 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.02 -22.59 61.39 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.546 1.539 . . . . 1.0 113.459 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.8 -26.39 14.72 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.943 1.297 . . . . 1.0 112.603 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -99.05 144.06 28.62 Favored 'General case' 0 C--N 1.374 1.661 0 O-C-N 124.358 1.036 . . . . 1.0 111.28 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 151.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 O-C-N 125.451 1.719 . . . . 1.0 111.564 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.88 148.04 45.88 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 125.003 1.44 . . . . 1.0 109.795 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -98.64 140.97 32.06 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.666 1.229 . . . . 1.0 111.458 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.08 132.93 34.64 Favored Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 124.956 1.41 . . . . 1.0 111.635 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.15 -9.16 21.77 Favored 'Trans proline' 1 C--N 1.43 4.841 0 C-N-CA 122.535 2.156 . . . . 1.0 114.238 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.64 -51.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 125.336 1.454 . . . . 1.0 110.019 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.6 m -90.4 -52.84 4.71 Favored 'General case' 0 C--N 1.378 1.808 0 O-C-N 124.23 0.956 . . . . 1.0 112.45 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.27 Favored Glycine 0 C--N 1.37 2.417 0 O-C-N 124.67 1.231 . . . . 1.0 113.655 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.06 154.43 17.34 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 125.445 1.498 . . . . 1.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -88.07 133.86 33.88 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 124.326 1.05 . . . . 1.0 111.715 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -131.2 148.17 52.68 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 125.408 1.693 . . . . 1.0 109.382 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -91.18 149.33 21.83 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.19 -0.19 81.99 Favored Glycine 0 C--N 1.374 2.673 0 O-C-N 124.648 1.217 . . . . 1.0 114.573 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -85.22 -15.4 43.72 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.407 1.483 . . . . 1.0 111.872 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.4 p -91.07 2.28 56.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.688 1.195 . . . . 1.0 111.484 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.67 144.61 45.86 Favored Pre-proline 0 C--N 1.386 2.178 0 CA-C-O 117.242 -1.361 . . . . 1.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.1 157.06 61.57 Favored 'Trans proline' 1 C--N 1.437 5.211 0 C-N-CA 122.897 2.398 . . . . 1.0 114.066 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.48 -30.71 71.46 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 124.606 1.163 . . . . 1.0 113.502 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.22 -38.71 84.2 Favored 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.764 1.626 . . . . 1.0 113.309 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.6 -28.7 62.94 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 124.874 1.27 . . . . 1.0 112.836 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.24 72.22 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.957 1.703 . . . . 1.0 112.691 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.96 -25.07 60.89 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.713 1.605 . . . . 1.0 112.573 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -73.64 -28.51 61.83 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.743 1.617 . . . . 1.0 112.387 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.527 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.95 -36.22 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 C-N-CA 126.333 1.853 . . . . 1.0 110.17 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.17 -29.43 70.55 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.326 1.45 . . . . 1.0 113.475 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.07 -39.06 89.76 Favored 'General case' 0 C--N 1.389 2.303 0 C-N-CA 125.733 1.613 . . . . 1.0 113.09 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -74.0 -32.2 63.3 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 124.779 1.232 . . . . 1.0 112.495 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -82.86 -22.39 34.06 Favored 'General case' 0 C--N 1.371 1.54 0 C-N-CA 125.502 1.521 . . . . 1.0 112.901 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -87.01 -21.64 26.0 Favored 'General case' 0 C--N 1.381 1.941 0 C-N-CA 124.715 1.206 . . . . 1.0 112.587 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.32 -34.57 28.52 Favored 'General case' 0 C--N 1.379 1.859 0 C-N-CA 125.003 1.321 . . . . 1.0 113.023 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.95 -59.08 0.15 Allowed 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 127.931 2.493 . . . . 1.0 114.026 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -124.72 134.83 52.7 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 126.147 1.779 . . . . 1.0 109.444 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.42 -111.7 0.27 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 125.062 1.476 . . . . 1.0 111.686 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -113.73 49.09 0.87 Allowed Glycine 0 C--N 1.351 1.416 0 O-C-N 125.768 1.511 . . . . 1.0 112.238 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.19 123.2 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -118.17 128.17 54.46 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 125.417 1.698 . . . . 1.0 109.874 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -80.71 -27.37 36.99 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 124.707 1.203 . . . . 1.0 113.212 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.2 -36.15 27.57 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.434 1.494 . . . . 1.0 112.856 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -94.41 -17.48 22.47 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 124.594 1.184 . . . . 1.0 112.992 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 56.88 58.23 4.18 Favored 'General case' 0 N--CA 1.525 3.298 0 C-N-CA 126.896 2.078 . . . . 1.0 112.015 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -125.23 129.11 49.4 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.508 -1.678 . . . . 1.0 110.307 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.479 HG21 ' HB ' ' A' ' 24' ' ' ILE . 1.8 t -120.43 128.06 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 125.535 1.772 . . . . 1.0 107.9 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.23 131.4 53.91 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 125.486 1.741 . . . . 1.0 109.977 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.08 131.56 54.04 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 125.13 1.519 . . . . 1.0 110.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 C--O 1.252 1.212 0 O-C-N 125.212 1.57 . . . . 1.0 111.315 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.366 0.136 . . . . 1.0 111.366 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 140.45 41.55 Favored 'General case' 0 C--O 1.244 0.805 0 O-C-N 125.418 1.699 . . . . 1.0 110.478 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -120.87 138.27 54.16 Favored 'General case' 0 C--O 1.248 0.999 0 O-C-N 124.889 1.368 . . . . 1.0 110.825 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.5 t -73.25 131.23 83.38 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 117.28 -1.343 . . . . 1.0 111.8 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.91 -10.13 22.82 Favored 'Trans proline' 1 C--N 1.432 4.97 0 C-N-CA 121.954 1.769 . . . . 1.0 114.77 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.555 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mt -95.1 -55.62 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 125.164 1.386 . . . . 1.0 110.179 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 28.2 p -102.83 -41.72 6.08 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 124.165 0.915 . . . . 1.0 113.171 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 88.38 38.0 7.36 Favored Glycine 0 C--N 1.372 2.543 0 O-C-N 124.687 1.242 . . . . 1.0 112.572 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.564 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -88.38 143.81 33.0 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 116.962 -1.494 . . . . 1.0 113.039 -178.06 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.65 126.98 16.3 Favored 'Trans proline' 1 C--N 1.449 5.861 0 C-N-CA 122.79 2.327 . . . . 1.0 114.642 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mt -122.9 145.01 48.84 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 125.208 1.567 . . . . 1.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' O ' HD12 ' A' ' 23' ' ' LEU . 84.3 mttt -93.62 130.33 39.57 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 124.858 1.349 . . . . 1.0 110.563 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.479 ' O ' HG12 ' A' ' 24' ' ' ILE . 31.1 m95 -68.05 -27.35 66.45 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 124.736 1.215 . . . . 1.0 112.822 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 8.8 pt-20 -72.63 -33.44 66.63 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.639 1.976 . . . . 1.0 113.152 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.79 -32.6 63.85 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 125.212 1.405 . . . . 1.0 113.418 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -68.24 -37.71 81.07 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.103 1.761 . . . . 1.0 113.282 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.7 mm -77.04 -28.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 C-N-CA 125.665 1.586 . . . . 1.0 110.835 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.75 -34.3 71.71 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 125.261 1.424 . . . . 1.0 113.209 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.0 -22.79 39.17 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.346 1.458 . . . . 1.0 112.851 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.446 ' O ' HD12 ' A' ' 30' ' ' ILE . 38.7 mtp -104.62 14.7 29.39 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 124.701 1.25 . . . . 1.0 112.757 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 24.96 5.01 Favored 'General case' 0 CA--C 1.578 2.053 0 C-N-CA 123.665 0.786 . . . . 1.0 112.867 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.51 0.28 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 C-N-CA 125.092 1.357 . . . . 1.0 111.98 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.93 140.68 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 125.155 1.382 . . . . 1.0 109.205 -178.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.39 -18.43 48.96 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 124.75 1.281 . . . . 1.0 113.778 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -81.09 -18.6 46.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.902 1.281 . . . . 1.0 112.356 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.576 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.7 t80 -59.48 -35.64 74.49 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.196 1.798 . . . . 1.0 113.15 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.33 -29.87 69.15 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 125.47 1.508 . . . . 1.0 112.161 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.72 -33.36 20.04 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.596 1.559 . . . . 1.0 112.458 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.8 mt -71.63 -39.65 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.982 0 C-N-CA 125.696 1.598 . . . . 1.0 110.632 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 78' ' ' LEU . 9.2 m -60.17 -20.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 125.355 1.462 . . . . 1.0 114.66 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.89 -18.85 25.37 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.128 1.371 . . . . 1.0 113.352 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -125.55 109.31 12.51 Favored 'General case' 0 C--N 1.373 1.588 0 C-N-CA 124.195 0.998 . . . . 1.0 111.709 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.488 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.1 mpp_? -59.42 -34.1 72.06 Favored 'General case' 0 N--CA 1.517 2.918 0 C-N-CA 125.348 1.459 . . . . 1.0 113.605 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.93 -30.53 70.69 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.724 1.609 . . . . 1.0 112.742 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -82.17 -33.56 29.44 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 125.354 1.462 . . . . 1.0 112.211 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -73.06 -43.78 61.48 Favored 'General case' 0 C--N 1.392 2.455 0 C-N-CA 125.144 1.378 . . . . 1.0 112.698 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -68.64 -30.93 69.74 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 124.864 1.266 . . . . 1.0 112.45 177.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.53 40.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.899 1.374 . . . . 1.0 112.831 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.431 HE21 HD13 ' A' ' 36' ' ' ILE . 2.7 mm100 -79.37 -38.83 34.06 Favored 'General case' 0 C--N 1.385 2.121 0 C-N-CA 125.133 1.373 . . . . 1.0 112.524 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 43' ' ' PHE . 28.5 t -71.46 -40.04 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 125.238 1.415 . . . . 1.0 109.896 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.511 2.596 0 C-N-CA 125.268 1.427 . . . . 1.0 113.558 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.73 -26.61 16.21 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.853 1.261 . . . . 1.0 113.042 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.01 143.87 26.14 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 124.851 1.261 . . . . 1.0 111.521 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.4 153.09 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.677 0 O-C-N 125.062 1.476 . . . . 1.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.15 145.61 51.73 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 124.969 1.418 . . . . 1.0 111.072 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.43 141.65 35.6 Favored 'General case' 0 C--O 1.25 1.119 0 O-C-N 124.905 1.378 . . . . 1.0 111.161 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.68 128.91 48.75 Favored Pre-proline 0 CA--C 1.57 1.713 0 O-C-N 124.769 1.293 . . . . 1.0 111.231 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.19 -9.5 21.95 Favored 'Trans proline' 1 C--N 1.43 4.856 0 C-N-CA 122.418 2.079 . . . . 1.0 114.156 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.86 -51.22 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.463 1.505 . . . . 1.0 110.312 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.6 m -89.32 -52.81 4.85 Favored 'General case' 0 C--N 1.378 1.816 0 O-C-N 124.301 1.001 . . . . 1.0 112.635 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.16 -10.36 47.29 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 124.708 1.255 . . . . 1.0 113.108 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -85.69 152.48 23.05 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 125.726 1.61 . . . . 1.0 111.306 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.72 136.93 32.75 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.377 1.048 . . . . 1.0 112.056 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.97 143.75 51.2 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 125.425 1.703 . . . . 1.0 109.175 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.38 151.86 19.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.253 0.971 . . . . 1.0 112.547 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.35 -8.82 80.69 Favored Glycine 0 C--N 1.378 2.886 0 O-C-N 124.362 1.039 . . . . 1.0 114.659 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -86.77 -20.98 26.83 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.498 1.519 . . . . 1.0 111.945 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -95.34 5.49 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.959 1.303 . . . . 1.0 111.784 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.69 70.22 Favored Pre-proline 0 C--N 1.386 2.174 0 CA-C-O 116.981 -1.485 . . . . 1.0 112.034 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -62.23 147.71 94.51 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 123.102 2.535 . . . . 1.0 114.693 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -64.05 -18.41 64.32 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 125.44 1.496 . . . . 1.0 114.649 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -82.74 -30.05 29.32 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 124.98 1.312 . . . . 1.0 111.843 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -73.91 -28.41 61.52 Favored 'General case' 0 C--N 1.384 2.105 0 C-N-CA 125.659 1.584 . . . . 1.0 113.059 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.44 -32.2 73.7 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 125.819 1.648 . . . . 1.0 112.615 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -74.49 -26.34 59.95 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.606 1.563 . . . . 1.0 112.148 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -73.09 -26.94 61.44 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.931 1.692 . . . . 1.0 112.604 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.3 t -64.37 -37.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 C-N-CA 126.125 1.77 . . . . 1.0 110.048 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -60.79 -29.72 69.62 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 125.012 1.325 . . . . 1.0 114.038 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.12 -41.13 82.2 Favored 'General case' 0 C--N 1.383 2.05 0 C-N-CA 125.609 1.564 . . . . 1.0 113.175 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.63 -34.7 70.04 Favored 'General case' 0 C--N 1.379 1.881 0 C-N-CA 124.857 1.263 . . . . 1.0 112.979 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -81.21 -22.14 39.06 Favored 'General case' 0 C--N 1.373 1.614 0 O-C-N 124.915 1.384 . . . . 1.0 112.652 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.62 -15.3 42.96 Favored 'General case' 0 C--N 1.386 2.177 0 C-N-CA 124.275 1.03 . . . . 1.0 112.815 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.65 -35.91 82.15 Favored 'General case' 0 C--N 1.388 2.256 0 C-N-CA 125.356 1.462 . . . . 1.0 113.469 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.97 -66.44 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 127.864 2.466 . . . . 1.0 114.147 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -130.38 137.37 49.85 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 125.684 1.594 . . . . 1.0 109.249 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.5 -106.94 0.21 Allowed Glycine 0 C--N 1.351 1.379 0 O-C-N 125.017 1.448 . . . . 1.0 111.656 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.97 46.35 1.19 Allowed Glycine 0 C--N 1.354 1.564 0 O-C-N 125.662 1.448 . . . . 1.0 113.051 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.45 122.31 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -122.05 129.95 52.86 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.443 1.714 . . . . 1.0 110.166 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.77 -28.88 36.25 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.728 1.267 . . . . 1.0 113.326 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.36 -37.0 26.28 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.119 1.368 . . . . 1.0 112.973 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.73 -17.98 23.53 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.567 1.147 . . . . 1.0 113.091 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.4 mttt 57.4 61.85 2.36 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 127.171 2.188 . . . . 1.0 112.125 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 98.3 mtt180 -125.5 128.99 48.88 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 113.381 -1.736 . . . . 1.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 2.0 t -123.46 129.06 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 125.504 1.752 . . . . 1.0 107.424 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.22 135.31 53.34 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 125.156 1.535 . . . . 1.0 110.213 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.54 128.55 56.06 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.056 1.472 . . . . 1.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--O 1.249 1.057 0 O-C-N 125.466 1.729 . . . . 1.0 111.325 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.438 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 35.7 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 111.221 0.082 . . . . 1.0 111.221 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -112.16 140.0 47.22 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.264 1.602 . . . . 1.0 110.611 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -124.28 139.17 54.17 Favored 'General case' 0 C--O 1.247 0.961 0 O-C-N 124.947 1.405 . . . . 1.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.576 ' SG ' HD12 ' A' ' 13' ' ' ILE . 22.9 t -76.52 121.53 85.03 Favored Pre-proline 0 CA--C 1.576 1.98 0 O-C-N 124.531 1.144 . . . . 1.0 111.214 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.89 -6.07 18.01 Favored 'Trans proline' 1 C--N 1.428 4.74 0 C-N-CA 122.083 1.855 . . . . 1.0 114.512 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.576 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.2 mt -97.03 -55.59 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 124.993 1.317 . . . . 1.0 110.103 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -101.68 -39.09 7.61 Favored 'General case' 0 C--N 1.37 1.467 0 O-C-N 124.543 1.152 . . . . 1.0 112.979 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.54 30.07 12.68 Favored Glycine 0 C--N 1.368 2.325 0 O-C-N 124.901 1.376 . . . . 1.0 113.456 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -93.76 146.79 32.39 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 117.001 -1.476 . . . . 1.0 112.536 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.08 136.02 39.47 Favored 'Trans proline' 1 C--N 1.451 5.965 0 C-N-CA 122.706 2.271 . . . . 1.0 113.971 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.57 145.97 47.44 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 125.445 1.716 . . . . 1.0 110.778 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -95.14 125.73 39.99 Favored 'General case' 0 C--N 1.361 1.099 0 O-C-N 124.971 1.419 . . . . 1.0 110.96 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.51 ' O ' HG12 ' A' ' 24' ' ' ILE . 38.5 m95 -68.6 -25.0 64.65 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 124.897 1.279 . . . . 1.0 112.798 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 34.5 mt-10 -69.69 -32.8 71.62 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.64 1.576 . . . . 1.0 112.009 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.07 -34.4 57.06 Favored 'General case' 0 C--N 1.382 2.012 0 C-N-CA 124.869 1.268 . . . . 1.0 112.331 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.15 -40.67 94.7 Favored 'General case' 0 C--N 1.385 2.126 0 C-N-CA 125.934 1.694 . . . . 1.0 112.774 178.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 20' ' ' TRP . 11.0 mm -78.68 -38.68 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 C-N-CA 125.506 1.522 . . . . 1.0 110.077 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -68.54 -34.11 75.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 124.881 1.272 . . . . 1.0 113.249 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.27 -23.38 37.99 Favored 'General case' 0 C--N 1.375 1.704 0 C-N-CA 125.427 1.491 . . . . 1.0 112.53 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -103.32 15.55 28.85 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 124.652 1.22 . . . . 1.0 112.045 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 14.75 27.57 Favored 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 124.061 0.944 . . . . 1.0 112.654 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.48 4.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 C-N-CA 125.76 1.624 . . . . 1.0 112.779 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -105.12 141.36 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.654 1.182 . . . . 1.0 109.011 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -81.3 -17.6 48.73 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.783 1.302 . . . . 1.0 113.372 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -86.6 -11.19 52.16 Favored 'General case' 0 C--N 1.371 1.532 0 C-N-CA 124.899 1.28 . . . . 1.0 112.152 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -56.41 -36.86 69.42 Favored 'General case' 0 N--CA 1.511 2.616 0 C-N-CA 125.514 1.526 . . . . 1.0 112.419 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.37 -29.57 69.99 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 124.771 1.228 . . . . 1.0 112.13 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.94 -38.8 17.6 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.11 1.364 . . . . 1.0 112.006 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.411 HG12 ' OE1' ' A' ' 46' ' ' GLN . 5.2 mt -72.17 -40.78 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 C-N-CA 125.329 1.451 . . . . 1.0 110.805 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.7 p -65.85 -18.26 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.599 2.864 0 C-N-CA 125.574 1.55 . . . . 1.0 113.884 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.79 -18.64 28.92 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.716 1.207 . . . . 1.0 113.259 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.04 111.97 15.33 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 124.537 1.135 . . . . 1.0 111.17 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.494 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.5 mtm180 -59.29 -35.48 73.85 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 125.54 1.536 . . . . 1.0 113.125 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.51 -30.28 69.06 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 1.0 113.351 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 80.9 mtt180 -81.64 -34.24 30.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.055 1.342 . . . . 1.0 112.396 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.8 t80 -74.66 -41.99 59.3 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 124.829 1.252 . . . . 1.0 112.664 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.4 mt -66.21 -32.48 73.93 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.626 1.17 . . . . 1.0 112.654 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.45 -24.65 34.18 Favored 'General case' 0 C--N 1.371 1.525 0 O-C-N 124.994 1.434 . . . . 1.0 112.356 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -79.23 -36.2 40.38 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.041 1.336 . . . . 1.0 112.72 178.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 43' ' ' PHE . 32.8 t -72.13 -41.18 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 125.369 1.467 . . . . 1.0 109.463 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 125.592 1.557 . . . . 1.0 113.412 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -95.47 -25.34 16.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.605 1.19 . . . . 1.0 112.986 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -101.18 144.66 29.8 Favored 'General case' 0 C--N 1.368 1.399 0 C-N-CA 124.496 1.118 . . . . 1.0 111.126 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.24 155.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 O-C-N 125.073 1.483 . . . . 1.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.38 144.08 51.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 125.194 1.559 . . . . 1.0 110.108 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -95.2 138.59 32.7 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.823 -1.535 . . . . 1.0 111.463 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.5 t -96.54 115.11 65.49 Favored Pre-proline 0 CA--C 1.568 1.673 0 O-C-N 125.044 1.465 . . . . 1.0 110.306 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.08 -5.77 17.17 Favored 'Trans proline' 1 C--N 1.432 4.93 0 C-N-CA 122.333 2.022 . . . . 1.0 114.415 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.2 t -89.99 -51.11 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 126.12 1.768 . . . . 1.0 110.557 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.8 p -103.03 -48.68 3.98 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.625 1.203 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.53 -2.56 21.86 Favored Glycine 0 C--N 1.368 2.321 0 O-C-N 124.466 1.104 . . . . 1.0 114.123 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -94.95 146.4 24.27 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 124.961 1.304 . . . . 1.0 111.197 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.61 139.37 30.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.696 1.248 . . . . 1.0 112.23 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -123.19 145.12 48.9 Favored 'General case' 0 C--O 1.247 0.96 0 O-C-N 125.46 1.725 . . . . 1.0 109.547 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.72 151.04 20.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.348 1.03 . . . . 1.0 112.267 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.5 -9.19 81.76 Favored Glycine 0 C--N 1.377 2.861 0 O-C-N 124.293 0.996 . . . . 1.0 114.479 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -86.61 -19.59 29.13 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.186 1.394 . . . . 1.0 112.072 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -94.7 3.6 54.85 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.848 1.259 . . . . 1.0 111.752 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.22 146.44 38.13 Favored Pre-proline 0 C--N 1.382 1.996 0 CA-C-O 117.491 -1.242 . . . . 1.0 111.763 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.08 154.99 70.76 Favored 'Trans proline' 1 C--N 1.436 5.166 0 C-N-CA 122.972 2.448 . . . . 1.0 114.706 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.89 -31.62 72.86 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.437 1.095 . . . . 1.0 113.384 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.02 -37.81 75.03 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 125.333 1.453 . . . . 1.0 113.541 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.8 mt-10 -77.02 -28.32 54.91 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 124.851 1.26 . . . . 1.0 112.452 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.19 73.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.954 1.702 . . . . 1.0 112.628 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.51 -25.28 61.34 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.501 1.52 . . . . 1.0 112.398 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 91.7 mttt -73.45 -26.39 60.91 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 125.908 1.683 . . . . 1.0 112.5 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.39 -36.98 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 C-N-CA 126.37 1.868 . . . . 1.0 110.206 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.26 -29.82 69.04 Favored 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 125.398 1.479 . . . . 1.0 113.59 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -43.19 84.21 Favored 'General case' 0 C--N 1.382 1.987 0 C-N-CA 125.331 1.452 . . . . 1.0 113.196 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -69.98 -32.99 71.48 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.015 1.326 . . . . 1.0 112.849 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -81.3 -18.42 45.89 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.208 1.403 . . . . 1.0 112.835 178.071 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -102.1 -13.92 17.3 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 124.53 1.132 . . . . 1.0 111.935 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.81 69.42 0.7 Allowed 'General case' 0 C--N 1.372 1.548 0 CA-C-O 122.893 1.33 . . . . 1.0 109.339 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -75.18 -24.16 57.81 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 113.443 -1.708 . . . . 1.0 112.949 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -106.66 134.61 49.54 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 124.837 1.335 . . . . 1.0 109.342 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.63 -96.64 0.16 Allowed Glycine 0 C--N 1.356 1.657 0 O-C-N 124.981 1.426 . . . . 1.0 112.148 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.26 50.99 0.79 Allowed Glycine 0 C--N 1.362 1.993 0 O-C-N 125.439 1.317 . . . . 1.0 113.623 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -119.97 121.58 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.11 133.67 51.57 Favored 'General case' 0 C--O 1.249 1.026 0 O-C-N 125.487 1.742 . . . . 1.0 110.61 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -80.37 -32.12 37.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.71 1.256 . . . . 1.0 113.252 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.94 -36.39 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.086 1.355 . . . . 1.0 112.997 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.17 -20.09 20.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.475 1.11 . . . . 1.0 113.173 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.7 mttm 58.28 56.35 4.52 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 127.07 2.148 . . . . 1.0 113.11 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 93.3 mtt180 -115.41 128.68 56.22 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.44 -1.709 . . . . 1.0 110.431 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.48 125.26 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 125.466 1.729 . . . . 1.0 108.457 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -121.18 131.9 54.51 Favored 'General case' 0 C--O 1.251 1.174 0 O-C-N 125.519 1.762 . . . . 1.0 109.988 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.6 133.32 55.39 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 125.202 1.563 . . . . 1.0 110.576 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.1 mttt . . . . . 0 C--O 1.252 1.236 0 O-C-N 125.338 1.649 . . . . 1.0 111.244 179.899 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.563 ' N ' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.865 -0.05 . . . . 1.0 110.865 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.81 138.95 43.14 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 125.315 1.635 . . . . 1.0 110.627 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.37 138.94 49.91 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 124.93 1.394 . . . . 1.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 13' ' ' ILE . 12.4 t -70.19 123.15 88.3 Favored Pre-proline 0 CA--C 1.577 1.992 0 O-C-N 124.477 1.11 . . . . 1.0 112.199 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.64 -11.5 26.16 Favored 'Trans proline' 1 C--N 1.43 4.826 0 C-N-CA 121.932 1.755 . . . . 1.0 114.922 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.479 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -91.81 -53.8 8.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 C-N-CA 125.299 1.44 . . . . 1.0 111.018 -177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.6 -41.15 6.05 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 124.218 0.949 . . . . 1.0 112.434 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 29.51 8.63 Favored Glycine 0 C--N 1.366 2.239 0 O-C-N 124.678 1.236 . . . . 1.0 113.748 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.22 144.68 29.39 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 116.796 -1.573 . . . . 1.0 113.096 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.88 139.29 39.45 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 122.71 2.273 . . . . 1.0 113.661 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 144.36 48.22 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.32 1.638 . . . . 1.0 110.432 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -95.76 133.17 40.19 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.928 1.392 . . . . 1.0 111.052 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 60.8 m95 -68.69 -26.45 65.3 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 124.798 1.239 . . . . 1.0 113.248 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 93' ' ' LYS . 35.9 mt-10 -72.09 -31.24 65.89 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.645 1.578 . . . . 1.0 112.623 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.92 -34.5 62.14 Favored 'General case' 0 C--N 1.385 2.123 0 C-N-CA 125.168 1.387 . . . . 1.0 112.603 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -39.89 87.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 125.758 1.623 . . . . 1.0 113.882 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.6 mm -78.58 -41.03 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 125.156 1.382 . . . . 1.0 110.676 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.3 -36.71 82.07 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 124.84 1.256 . . . . 1.0 113.311 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.72 -21.11 48.56 Favored 'General case' 0 C--N 1.375 1.714 0 C-N-CA 125.308 1.443 . . . . 1.0 112.967 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.506 ' SD ' ' HE1' ' A' ' 52' ' ' PHE . 35.0 mtp -105.56 16.78 24.9 Favored 'General case' 0 CA--C 1.575 1.923 0 O-C-N 124.67 1.231 . . . . 1.0 112.367 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.8 18.43 14.49 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.48 13.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 124.765 1.226 . . . . 1.0 111.918 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -114.81 140.5 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 124.736 1.215 . . . . 1.0 108.723 -178.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.04 -16.28 44.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 125.028 1.455 . . . . 1.0 113.411 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.424 ' H ' HG22 ' A' ' 30' ' ' ILE . 7.7 m120 -83.55 -15.66 48.38 Favored 'General case' 0 C--N 1.376 1.725 0 C-N-CA 125.065 1.346 . . . . 1.0 112.556 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.596 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.4 t80 -57.06 -35.48 69.39 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 126.354 1.862 . . . . 1.0 113.315 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.33 -29.18 69.73 Favored 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 125.384 1.474 . . . . 1.0 112.411 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.85 -33.87 19.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.43 1.492 . . . . 1.0 112.662 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.9 mt -71.46 -39.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.909 0 C-N-CA 125.837 1.655 . . . . 1.0 110.457 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.518 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.3 m -61.57 -18.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 125.669 1.588 . . . . 1.0 114.692 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -88.38 -19.05 27.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.823 1.327 . . . . 1.0 113.256 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.48 110.67 12.99 Favored 'General case' 0 C--N 1.373 1.599 0 C-N-CA 124.473 1.109 . . . . 1.0 111.973 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -61.54 -32.38 72.44 Favored 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 125.331 1.452 . . . . 1.0 113.015 176.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.95 -31.88 71.07 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 125.475 1.51 . . . . 1.0 113.207 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -82.26 -32.65 29.54 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 125.212 1.405 . . . . 1.0 112.594 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 t80 -73.08 -46.01 53.93 Favored 'General case' 0 C--N 1.386 2.186 0 C-N-CA 124.976 1.31 . . . . 1.0 113.098 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -71.59 -33.16 68.8 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.033 1.333 . . . . 1.0 112.777 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.04 72.8 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.835 1.654 . . . . 1.0 112.742 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -78.75 -35.29 44.82 Favored 'General case' 0 C--N 1.382 1.986 0 C-N-CA 124.821 1.248 . . . . 1.0 112.908 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.1 t -69.05 -40.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.117 1.367 . . . . 1.0 109.173 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.63 -25.46 59.24 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 125.676 1.59 . . . . 1.0 113.477 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -94.32 -25.31 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.803 1.315 . . . . 1.0 113.522 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -105.33 143.3 33.68 Favored 'General case' 0 C--N 1.366 1.307 0 O-C-N 124.454 1.096 . . . . 1.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.75 153.83 3.2 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 O-C-N 125.094 1.496 . . . . 1.0 111.599 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.506 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 99.1 m-85 -125.14 144.26 50.52 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 125.093 1.496 . . . . 1.0 110.332 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -95.17 139.89 30.86 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.208 1.567 . . . . 1.0 111.072 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -92.35 130.23 38.28 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 125.057 1.473 . . . . 1.0 111.807 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.68 -8.06 20.99 Favored 'Trans proline' 1 C--N 1.437 5.205 0 C-N-CA 122.698 2.265 . . . . 1.0 114.292 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.22 -55.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 124.843 1.257 . . . . 1.0 110.43 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.2 p -98.14 -52.5 3.67 Favored 'General case' 0 C--N 1.372 1.547 0 O-C-N 124.302 1.001 . . . . 1.0 111.682 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.31 25.12 7.98 Favored Glycine 0 C--N 1.367 2.267 0 O-C-N 124.722 1.264 . . . . 1.0 114.747 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -105.64 147.97 27.88 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 124.591 1.156 . . . . 1.0 111.076 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -83.65 134.38 34.78 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 124.563 1.165 . . . . 1.0 112.393 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -132.8 148.33 52.31 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 125.444 1.715 . . . . 1.0 109.826 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -94.05 149.82 20.89 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.339 1.024 . . . . 1.0 112.627 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 -9.27 86.95 Favored Glycine 0 C--N 1.375 2.714 0 O-C-N 124.727 1.267 . . . . 1.0 114.111 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -82.34 -17.29 46.22 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 125.31 1.444 . . . . 1.0 112.671 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -91.24 -5.41 54.85 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 124.363 1.065 . . . . 1.0 112.194 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 145.48 44.83 Favored Pre-proline 0 C--N 1.385 2.114 0 CA-C-O 117.232 -1.366 . . . . 1.0 111.887 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.4 160.1 44.31 Favored 'Trans proline' 1 C--N 1.437 5.234 0 C-N-CA 123.024 2.483 . . . . 1.0 114.679 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -62.44 -30.13 71.01 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.501 1.12 . . . . 1.0 113.735 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.1 -37.76 77.94 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 125.561 1.545 . . . . 1.0 112.999 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.74 -29.34 40.52 Favored 'General case' 0 C--N 1.381 1.962 0 C-N-CA 124.985 1.314 . . . . 1.0 111.746 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.06 73.48 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 125.834 1.654 . . . . 1.0 112.312 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.41 -28.12 63.79 Favored 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 125.791 1.637 . . . . 1.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HZ2' ' N ' ' A' ' 8' ' ' MET . 90.3 mttt -68.58 -27.87 66.44 Favored 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 125.978 1.711 . . . . 1.0 112.547 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.9 t -65.6 -37.37 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.019 0 C-N-CA 126.322 1.849 . . . . 1.0 109.97 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -28.37 69.9 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 125.182 1.393 . . . . 1.0 113.349 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.29 -41.21 77.09 Favored 'General case' 0 C--N 1.383 2.046 0 C-N-CA 125.473 1.509 . . . . 1.0 112.913 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -70.72 -32.1 69.19 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.763 1.225 . . . . 1.0 113.243 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -81.25 -20.31 41.25 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.237 1.415 . . . . 1.0 112.868 177.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -99.88 -16.0 18.17 Favored 'General case' 0 C--N 1.371 1.519 0 C-N-CA 124.76 1.224 . . . . 1.0 112.189 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -108.82 69.01 0.7 Allowed 'General case' 0 C--N 1.37 1.495 0 CA-C-O 122.898 1.332 . . . . 1.0 109.46 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -71.75 -28.44 63.66 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.308 -1.769 . . . . 1.0 113.083 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -103.53 134.89 46.13 Favored 'General case' 0 C--N 1.366 1.303 0 O-C-N 124.989 1.431 . . . . 1.0 109.718 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.98 -95.29 0.14 Allowed Glycine 0 C--N 1.355 1.588 0 O-C-N 125.165 1.541 . . . . 1.0 112.18 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.01 46.9 0.96 Allowed Glycine 0 C--N 1.361 1.922 0 O-C-N 125.34 1.259 . . . . 1.0 113.824 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -120.3 122.58 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -124.77 131.56 53.44 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 125.574 1.796 . . . . 1.0 110.468 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -80.85 -27.51 36.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.85 1.344 . . . . 1.0 113.51 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.44 -35.65 27.36 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.207 1.403 . . . . 1.0 112.581 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -94.88 -17.37 22.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 124.692 1.245 . . . . 1.0 113.436 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mttm 58.98 50.76 7.92 Favored 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 127.166 2.186 . . . . 1.0 113.99 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 71.7 mtm180 -115.58 130.83 57.01 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.796 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.6 123.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 125.462 1.727 . . . . 1.0 107.793 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 86.4 mttt -124.7 132.38 53.39 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 125.716 1.885 . . . . 1.0 110.387 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 132.26 56.36 Favored 'General case' 0 C--O 1.246 0.898 0 O-C-N 125.332 1.645 . . . . 1.0 108.929 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.523 3.179 0 C-N-CA 127.386 2.274 . . . . 1.0 113.465 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.529 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 1.7 tpp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.873 -0.047 . . . . 1.0 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.02 139.8 47.23 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 125.286 1.616 . . . . 1.0 110.521 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -115.12 138.78 50.51 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.896 1.372 . . . . 1.0 110.724 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.0 t -74.67 119.65 77.73 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 117.29 -1.338 . . . . 1.0 111.819 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.17 -25.16 50.73 Favored 'Trans proline' 1 C--N 1.439 5.302 0 C-N-CA 122.3 2.0 . . . . 1.0 113.789 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.26 -54.14 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 C-N-CA 126.35 1.86 . . . . 1.0 112.826 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -108.64 -44.39 4.06 Favored 'General case' 0 C--N 1.37 1.457 0 O-C-N 124.175 0.922 . . . . 1.0 112.339 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.72 6.16 Favored Glycine 0 C--N 1.367 2.28 0 O-C-N 124.717 1.261 . . . . 1.0 113.725 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.81 146.48 31.39 Favored Pre-proline 0 C--N 1.369 1.44 0 CA-C-O 117.115 -1.421 . . . . 1.0 112.467 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.18 139.35 42.01 Favored 'Trans proline' 1 C--N 1.449 5.859 0 C-N-CA 122.728 2.286 . . . . 1.0 113.854 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.59 143.52 49.26 Favored 'General case' 0 C--O 1.25 1.124 0 O-C-N 125.341 1.651 . . . . 1.0 110.177 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.78 134.7 39.73 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 124.874 1.359 . . . . 1.0 111.005 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.457 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.3 m95 -68.49 -27.01 65.75 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.955 1.302 . . . . 1.0 112.872 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 7.3 pt-20 -71.76 -32.28 67.52 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.355 1.862 . . . . 1.0 112.661 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.1 -34.29 66.1 Favored 'General case' 0 C--N 1.385 2.152 0 C-N-CA 125.443 1.497 . . . . 1.0 112.963 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -39.91 84.2 Favored 'General case' 0 C--N 1.382 2.02 0 C-N-CA 125.665 1.586 . . . . 1.0 113.372 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -78.91 -40.96 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 125.524 1.529 . . . . 1.0 110.568 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.73 -38.16 86.12 Favored 'General case' 0 C--N 1.386 2.183 0 C-N-CA 125.144 1.377 . . . . 1.0 113.369 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.39 -20.91 50.18 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 125.466 1.506 . . . . 1.0 112.929 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.492 ' O ' HD12 ' A' ' 30' ' ' ILE . 3.0 mmt -106.01 12.25 30.67 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.813 1.321 . . . . 1.0 112.09 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.72 17.95 11.02 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.587 0.755 . . . . 1.0 113.02 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.8 11.02 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 C-N-CA 125.638 1.575 . . . . 1.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 32' ' ' ASN . 1.2 mt -115.21 138.3 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.827 1.251 . . . . 1.0 108.935 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.54 -17.85 35.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.132 1.52 . . . . 1.0 112.439 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' H ' HG22 ' A' ' 30' ' ' ILE . 47.9 m-80 -91.93 14.4 15.8 Favored 'General case' 0 CA--C 1.574 1.87 0 C-N-CA 125.289 1.436 . . . . 1.0 111.786 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -76.15 -36.21 58.85 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.387 1.475 . . . . 1.0 111.799 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' HA ' HG12 ' A' ' 37' ' ' VAL . 32.9 mt-10 -57.78 -23.8 54.13 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 126.026 1.73 . . . . 1.0 114.339 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.15 -43.64 14.79 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 125.352 1.461 . . . . 1.0 111.539 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.41 -42.4 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 125.589 1.555 . . . . 1.0 110.824 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 34' ' ' GLU . 1.5 p -67.75 -14.06 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.013 0 C-N-CA 125.318 1.447 . . . . 1.0 114.243 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -92.06 -22.29 20.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.839 1.256 . . . . 1.0 112.447 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.13 106.41 10.75 Favored 'General case' 0 C--N 1.371 1.51 0 O-C-N 124.569 1.168 . . . . 1.0 111.293 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -58.1 -33.89 69.6 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 125.829 1.651 . . . . 1.0 113.908 176.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.23 -33.08 74.59 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 125.813 1.645 . . . . 1.0 112.35 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.58 -34.36 27.74 Favored 'General case' 0 C--N 1.381 1.942 0 C-N-CA 125.619 1.568 . . . . 1.0 112.502 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.0 t80 -72.7 -45.95 56.18 Favored 'General case' 0 C--N 1.394 2.519 0 C-N-CA 125.207 1.403 . . . . 1.0 112.524 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.14 -33.11 72.92 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 124.932 1.293 . . . . 1.0 112.366 178.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.58 -31.63 65.37 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.82 1.648 . . . . 1.0 112.919 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.5 tt0 -79.24 -37.09 38.86 Favored 'General case' 0 C--N 1.384 2.084 0 C-N-CA 124.96 1.304 . . . . 1.0 112.482 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.7 t -69.29 -41.56 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 C-N-CA 125.455 1.502 . . . . 1.0 109.539 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 42.3 mt-10 -70.28 -25.56 63.4 Favored 'General case' 0 N--CA 1.516 2.832 0 C-N-CA 125.658 1.583 . . . . 1.0 113.545 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.53 -25.62 16.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.097 1.359 . . . . 1.0 113.171 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.11 141.7 35.39 Favored 'General case' 0 C--N 1.369 1.454 0 O-C-N 124.384 1.053 . . . . 1.0 111.658 -179.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.96 152.23 3.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 125.255 1.597 . . . . 1.0 111.634 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.18 144.16 50.08 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.062 1.476 . . . . 1.0 110.391 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -96.35 140.54 30.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.144 1.527 . . . . 1.0 111.07 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.9 t -94.69 130.75 32.35 Favored Pre-proline 0 CA--C 1.565 1.539 0 O-C-N 125.295 1.622 . . . . 1.0 112.044 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.02 -4.24 14.88 Favored 'Trans proline' 1 C--N 1.435 5.117 0 C-N-CA 122.353 2.035 . . . . 1.0 114.504 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.95 -54.83 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 125.389 1.475 . . . . 1.0 110.133 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 p -101.89 -52.6 3.14 Favored 'General case' 0 C--N 1.371 1.537 0 O-C-N 124.434 1.084 . . . . 1.0 111.566 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 22.07 9.56 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 124.547 1.154 . . . . 1.0 114.479 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -99.95 145.55 27.71 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 124.754 1.221 . . . . 1.0 111.215 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.39 133.75 34.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.856 1.348 . . . . 1.0 111.858 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -132.69 147.4 52.33 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 125.601 1.813 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.04 151.11 19.76 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.745 1.278 . . . . 1.0 112.729 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 48' ' ' GLU . . . -80.83 1.28 84.44 Favored Glycine 0 C--N 1.372 2.564 0 O-C-N 124.912 1.382 . . . . 1.0 114.508 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -88.85 -16.42 32.03 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.911 1.285 . . . . 1.0 112.015 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 p -89.78 -12.84 38.09 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 124.883 1.273 . . . . 1.0 113.312 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -75.29 146.88 82.14 Favored Pre-proline 0 CA--C 1.584 2.25 0 CA-C-O 116.747 -1.597 . . . . 1.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.51 156.28 66.78 Favored 'Trans proline' 1 C--N 1.445 5.643 0 C-N-CA 122.999 2.466 . . . . 1.0 113.4 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -58.98 -30.75 68.19 Favored 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.982 1.313 . . . . 1.0 114.146 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -61.03 -36.26 79.06 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.622 1.569 . . . . 1.0 113.111 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -76.55 -28.97 56.48 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 125.017 1.327 . . . . 1.0 111.905 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.43 -32.41 72.43 Favored 'General case' 0 C--N 1.388 2.281 0 C-N-CA 126.002 1.721 . . . . 1.0 112.449 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.79 -26.6 62.48 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 125.943 1.697 . . . . 1.0 112.662 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 91.5 mttt -68.99 -28.66 66.81 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 126.099 1.759 . . . . 1.0 112.565 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.532 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -66.53 -35.23 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 C-N-CA 126.481 1.912 . . . . 1.0 109.975 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.62 -29.43 70.68 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 125.539 1.535 . . . . 1.0 113.014 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -67.24 -38.87 85.91 Favored 'General case' 0 C--N 1.386 2.172 0 C-N-CA 125.845 1.658 . . . . 1.0 113.05 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.9 pp -75.01 -30.89 61.25 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 124.685 1.194 . . . . 1.0 112.46 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.1 -22.35 39.21 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 125.817 1.647 . . . . 1.0 113.25 177.446 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -99.86 -9.84 22.42 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 124.752 1.221 . . . . 1.0 112.869 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 1.1 m-20 -107.01 58.78 0.63 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-O 123.106 1.432 . . . . 1.0 111.016 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.53 -30.52 70.2 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.39 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -115.11 113.57 24.18 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 124.96 1.412 . . . . 1.0 109.168 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.79 106.14 1.34 Allowed Glycine 0 C--N 1.366 2.227 0 CA-C-N 114.552 -1.204 . . . . 1.0 113.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 128.31 -59.2 0.69 Allowed Glycine 0 C--N 1.36 1.867 0 O-C-N 125.453 1.325 . . . . 1.0 113.625 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.39 126.08 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 125.103 1.12 . . . . 1.0 108.314 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -119.4 134.16 55.35 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 125.57 1.794 . . . . 1.0 110.084 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -80.0 -31.46 39.72 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.875 1.27 . . . . 1.0 113.743 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.6 -35.61 29.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.275 1.43 . . . . 1.0 113.111 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -92.09 -15.92 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.733 1.213 . . . . 1.0 113.432 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 58.55 32.89 22.64 Favored 'General case' 0 N--CA 1.533 3.71 0 C-N-CA 127.158 2.183 . . . . 1.0 113.925 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -106.24 136.42 45.98 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 114.28 -1.327 . . . . 1.0 111.355 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.28 126.72 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.405 1.691 . . . . 1.0 107.838 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 14.9 tttt -122.51 128.4 50.76 Favored 'General case' 0 C--O 1.25 1.127 0 O-C-N 125.429 1.706 . . . . 1.0 109.89 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.18 132.29 47.27 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 124.978 1.424 . . . . 1.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 C--O 1.249 1.031 0 O-C-N 125.33 1.644 . . . . 1.0 111.208 179.805 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.63 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 5.5 ptm . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 111.282 0.105 . . . . 1.0 111.282 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -111.02 139.71 46.15 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 125.316 1.635 . . . . 1.0 110.601 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -118.52 139.04 52.07 Favored 'General case' 0 C--O 1.25 1.082 0 O-C-N 124.655 1.222 . . . . 1.0 110.981 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.485 ' SG ' HD12 ' A' ' 13' ' ' ILE . 34.0 t -70.81 121.02 82.65 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 117.777 -1.106 . . . . 1.0 111.761 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.01 -4.35 15.27 Favored 'Trans proline' 1 C--N 1.434 5.044 0 C-N-CA 122.19 1.927 . . . . 1.0 114.843 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.485 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.02 -56.05 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 125.253 1.421 . . . . 1.0 109.766 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.64 -41.04 6.07 Favored 'General case' 0 C--N 1.37 1.488 0 O-C-N 124.338 1.024 . . . . 1.0 113.195 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.9 34.57 6.46 Favored Glycine 0 C--N 1.368 2.327 0 O-C-N 124.81 1.319 . . . . 1.0 114.02 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -91.39 142.59 27.16 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 116.928 -1.51 . . . . 1.0 112.796 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 131.62 24.45 Favored 'Trans proline' 1 C--N 1.449 5.819 0 C-N-CA 122.602 2.201 . . . . 1.0 114.376 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mt -122.96 144.55 49.16 Favored 'General case' 0 C--O 1.25 1.118 0 O-C-N 125.125 1.516 . . . . 1.0 110.762 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.07 133.95 41.06 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 124.802 1.313 . . . . 1.0 110.681 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 24' ' ' ILE . 52.9 m95 -68.53 -26.65 65.54 Favored 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 124.899 1.28 . . . . 1.0 113.426 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.27 -31.75 66.03 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.59 1.556 . . . . 1.0 113.097 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.15 -33.48 65.52 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 125.277 1.431 . . . . 1.0 112.915 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.03 -39.92 82.99 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.884 1.674 . . . . 1.0 112.858 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 20' ' ' TRP . 6.1 mm -74.43 -41.03 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 125.806 1.643 . . . . 1.0 110.604 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.86 -36.86 83.29 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.389 1.476 . . . . 1.0 113.24 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.29 -22.63 41.39 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 125.355 1.462 . . . . 1.0 112.841 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.49 ' O ' HD12 ' A' ' 30' ' ' ILE . 48.6 mtp -104.61 12.1 33.42 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 124.681 1.238 . . . . 1.0 112.41 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.3 16.63 8.33 Favored 'General case' 0 CA--C 1.58 2.098 0 C-N-CA 123.826 0.85 . . . . 1.0 112.914 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -3.74 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 C-N-CA 125.747 1.619 . . . . 1.0 112.965 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.5 137.48 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.982 1.313 . . . . 1.0 109.255 -177.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.36 -27.07 61.29 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 125.752 1.621 . . . . 1.0 114.374 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -77.65 -17.98 57.17 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.117 1.367 . . . . 1.0 113.209 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.583 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.5 t80 -57.92 -36.46 72.5 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 126.077 1.751 . . . . 1.0 113.188 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -60.58 -29.34 69.13 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.468 1.507 . . . . 1.0 112.463 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.41 -34.52 20.14 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.48 1.512 . . . . 1.0 112.409 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.8 mt -71.04 -41.06 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 C-N-CA 125.759 1.624 . . . . 1.0 110.664 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.9 m -59.39 -21.82 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 125.545 1.538 . . . . 1.0 114.84 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -87.94 -21.11 25.09 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 125.052 1.341 . . . . 1.0 112.796 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -121.66 106.66 11.54 Favored 'General case' 0 C--N 1.371 1.541 0 O-C-N 124.323 1.015 . . . . 1.0 112.124 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.35 -34.82 72.84 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 126.106 1.762 . . . . 1.0 113.853 176.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.0 -32.24 72.5 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 125.941 1.696 . . . . 1.0 112.727 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -82.69 -32.54 28.01 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.329 1.451 . . . . 1.0 112.228 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -75.41 -46.51 32.37 Favored 'General case' 0 C--N 1.387 2.215 0 C-N-CA 125.013 1.325 . . . . 1.0 112.946 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -69.66 -33.37 72.5 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 124.789 1.236 . . . . 1.0 112.958 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.513 1.525 . . . . 1.0 113.206 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 5.4 mt-30 -79.29 -35.21 41.61 Favored 'General case' 0 C--N 1.379 1.86 0 C-N-CA 125.077 1.351 . . . . 1.0 112.833 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.0 t -67.84 -41.22 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 125.241 1.416 . . . . 1.0 109.354 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.63 -24.3 60.0 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 125.316 1.447 . . . . 1.0 113.507 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -94.42 -25.52 16.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.859 1.264 . . . . 1.0 113.327 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.08 148.46 25.71 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 124.343 1.057 . . . . 1.0 111.049 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -97.51 155.82 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 O-C-N 124.758 1.286 . . . . 1.0 110.439 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.473 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 95.8 m-85 -126.41 143.76 51.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.086 1.491 . . . . 1.0 110.311 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -97.11 137.39 36.23 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.861 1.351 . . . . 1.0 111.423 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.08 106.52 19.81 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 124.972 1.42 . . . . 1.0 110.025 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -69.39 -7.94 22.27 Favored 'Trans proline' 1 C--N 1.44 5.355 0 C-N-CA 123.132 2.555 . . . . 1.0 114.193 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.76 -50.94 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.944 1.698 . . . . 1.0 110.403 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.7 p -104.47 -50.15 3.39 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 124.596 1.185 . . . . 1.0 112.186 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.31 -0.42 14.35 Favored Glycine 0 C--N 1.37 2.434 0 O-C-N 124.534 1.146 . . . . 1.0 114.209 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -93.74 150.85 20.05 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 125.162 1.385 . . . . 1.0 111.521 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.18 138.16 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.607 1.163 . . . . 1.0 111.141 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.13 143.17 51.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.165 1.54 . . . . 1.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.69 150.45 21.78 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.431 1.082 . . . . 1.0 112.24 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -75.22 -8.34 83.3 Favored Glycine 0 C--N 1.377 2.83 0 O-C-N 124.485 1.116 . . . . 1.0 114.867 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -86.39 -20.89 27.56 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.386 1.474 . . . . 1.0 111.87 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.9 p -94.09 1.67 56.12 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.903 1.281 . . . . 1.0 112.61 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 144.77 30.43 Favored Pre-proline 0 C--N 1.379 1.856 0 CA-C-O 117.146 -1.407 . . . . 1.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.21 158.32 55.37 Favored 'Trans proline' 1 C--N 1.445 5.641 0 C-N-CA 123.032 2.488 . . . . 1.0 114.705 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -61.96 -33.07 73.61 Favored 'General case' 0 N--CA 1.515 2.776 0 C-N-CA 124.85 1.26 . . . . 1.0 113.074 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.31 -40.4 77.81 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 125.468 1.507 . . . . 1.0 112.505 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 29.1 mt-10 -76.73 -28.84 55.94 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.044 1.338 . . . . 1.0 112.102 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -68.44 -32.99 73.41 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 125.814 1.646 . . . . 1.0 112.391 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.7 -24.99 61.91 Favored 'General case' 0 C--N 1.382 2.018 0 C-N-CA 125.637 1.575 . . . . 1.0 112.697 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.63 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 93.8 mttt -68.62 -28.18 66.68 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 125.902 1.681 . . . . 1.0 112.217 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' HD12 ' A' ' 78' ' ' LEU . 2.8 t -66.97 -38.5 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 C-N-CA 126.385 1.874 . . . . 1.0 109.738 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -27.16 69.08 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 125.355 1.462 . . . . 1.0 113.352 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -68.49 -41.05 80.65 Favored 'General case' 0 C--N 1.388 2.245 0 C-N-CA 125.789 1.636 . . . . 1.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.44 -30.52 66.13 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.83 1.252 . . . . 1.0 112.739 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.6 -24.93 49.54 Favored 'General case' 0 C--N 1.378 1.806 0 C-N-CA 125.597 1.559 . . . . 1.0 112.726 177.105 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.3 -16.69 21.2 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 124.802 1.241 . . . . 1.0 112.231 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.77 62.51 0.6 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 123.057 1.408 . . . . 1.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.57 -25.09 62.05 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 113.48 -1.691 . . . . 1.0 113.313 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -106.72 134.25 50.15 Favored 'General case' 0 C--O 1.254 1.302 0 O-C-N 125.069 1.481 . . . . 1.0 109.254 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.58 -102.54 0.22 Allowed Glycine 0 C--N 1.356 1.652 0 O-C-N 124.949 1.405 . . . . 1.0 112.095 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.9 55.52 0.73 Allowed Glycine 0 C--N 1.359 1.825 0 O-C-N 125.441 1.318 . . . . 1.0 113.272 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -118.71 120.95 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 129.92 50.6 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 125.26 1.6 . . . . 1.0 110.599 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -80.86 -33.74 34.23 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.731 1.269 . . . . 1.0 113.445 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -82.28 -35.88 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.081 1.352 . . . . 1.0 112.95 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -88.7 -16.88 31.17 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.767 1.227 . . . . 1.0 113.139 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.0 mttt 59.11 52.41 6.24 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 127.337 2.255 . . . . 1.0 112.406 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 68.3 mtp180 -122.39 124.34 43.44 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 113.934 -1.484 . . . . 1.0 110.144 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.27 124.0 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 125.347 1.654 . . . . 1.0 107.391 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -124.86 134.71 52.61 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 125.401 1.688 . . . . 1.0 110.347 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.81 127.63 55.21 Favored 'General case' 0 C--O 1.252 1.207 0 O-C-N 125.205 1.565 . . . . 1.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.283 1.615 . . . . 1.0 111.247 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.342 0.127 . . . . 1.0 111.342 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -107.72 142.5 37.62 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.215 1.572 . . . . 1.0 110.855 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -123.26 138.34 54.65 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.785 1.303 . . . . 1.0 111.259 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.535 ' SG ' HD12 ' A' ' 13' ' ' ILE . 14.3 t -72.71 122.85 88.64 Favored Pre-proline 0 CA--C 1.582 2.173 0 C-N-CA 124.731 1.212 . . . . 1.0 112.675 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.54 -1.68 11.39 Favored 'Trans proline' 1 C--N 1.435 5.085 0 C-N-CA 122.106 1.871 . . . . 1.0 115.085 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.535 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -100.0 -55.97 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 124.614 1.165 . . . . 1.0 109.406 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -103.8 -41.93 5.76 Favored 'General case' 0 C--N 1.373 1.589 0 O-C-N 124.544 1.152 . . . . 1.0 112.985 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 90.82 35.73 7.1 Favored Glycine 0 C--N 1.369 2.371 0 O-C-N 124.751 1.282 . . . . 1.0 114.253 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -95.51 148.72 35.07 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 116.871 -1.538 . . . . 1.0 111.807 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -69.22 140.78 45.61 Favored 'Trans proline' 1 C--N 1.448 5.775 0 C-N-CA 122.844 2.363 . . . . 1.0 114.955 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.37 145.43 51.08 Favored 'General case' 0 C--O 1.249 1.052 0 O-C-N 125.524 1.765 . . . . 1.0 110.324 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -99.39 135.26 41.06 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.716 1.26 . . . . 1.0 110.888 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.438 ' O ' HG12 ' A' ' 24' ' ' ILE . 59.5 m95 -69.19 -24.87 64.1 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.049 1.339 . . . . 1.0 113.326 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -70.39 -30.42 67.31 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.022 1.729 . . . . 1.0 113.03 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.42 -35.07 63.4 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 125.16 1.384 . . . . 1.0 113.127 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -40.25 85.18 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.866 1.667 . . . . 1.0 113.602 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.8 mm -74.64 -41.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 C-N-CA 125.581 1.552 . . . . 1.0 110.531 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -67.29 -35.92 80.47 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.338 1.455 . . . . 1.0 113.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.4 -22.93 40.76 Favored 'General case' 0 C--N 1.375 1.685 0 C-N-CA 125.409 1.483 . . . . 1.0 113.452 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.493 ' O ' HD12 ' A' ' 30' ' ' ILE . 55.2 mtp -102.65 1.61 34.85 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 124.563 1.164 . . . . 1.0 113.0 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.45 12.96 3.26 Favored 'General case' 0 CA--C 1.582 2.177 0 C-N-CA 124.805 1.242 . . . . 1.0 113.765 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -8.12 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 125.344 1.457 . . . . 1.0 113.283 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 27' ' ' MET . 1.1 mt -98.98 137.53 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 125.109 1.364 . . . . 1.0 108.553 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -74.6 -27.36 60.44 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 124.831 1.332 . . . . 1.0 113.879 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.79 -22.86 62.32 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 125.243 1.417 . . . . 1.0 112.926 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -56.11 -34.1 65.73 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.527 1.931 . . . . 1.0 114.384 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.48 -28.33 69.89 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 125.268 1.427 . . . . 1.0 112.303 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.22 -34.62 20.41 Favored 'General case' 0 C--N 1.376 1.758 0 C-N-CA 125.421 1.488 . . . . 1.0 112.481 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 33' ' ' PHE . 4.5 mt -71.76 -39.63 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 C-N-CA 125.679 1.592 . . . . 1.0 110.423 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.0 m -61.14 -20.07 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 125.188 1.395 . . . . 1.0 114.716 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -85.57 -19.95 30.31 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.091 1.356 . . . . 1.0 113.571 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.6 110.93 12.69 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 124.21 1.004 . . . . 1.0 111.666 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.447 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -60.35 -32.26 71.1 Favored 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 126.221 1.808 . . . . 1.0 115.451 177.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.43 -31.83 71.43 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.311 1.444 . . . . 1.0 113.337 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 72.3 mtp180 -82.42 -34.75 28.12 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.05 1.34 . . . . 1.0 112.869 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 t80 -70.51 -44.32 67.84 Favored 'General case' 0 C--N 1.389 2.287 0 C-N-CA 125.08 1.352 . . . . 1.0 112.605 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -70.21 -35.96 74.25 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.987 1.315 . . . . 1.0 113.144 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.15 -29.63 63.0 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.385 1.474 . . . . 1.0 113.204 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.1 tt0 -78.95 -34.4 44.41 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.368 1.467 . . . . 1.0 113.016 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 43' ' ' PHE . 89.7 t -69.89 -40.22 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.552 1.541 . . . . 1.0 109.762 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.12 -34.26 70.9 Favored 'General case' 0 N--CA 1.511 2.609 0 C-N-CA 125.575 1.55 . . . . 1.0 113.167 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.63 -27.36 29.19 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.318 1.447 . . . . 1.0 113.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -98.97 151.91 20.38 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.636 1.174 . . . . 1.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.05 148.0 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 O-C-N 124.664 1.227 . . . . 1.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.456 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 88.4 m-85 -121.71 152.04 39.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.671 1.232 . . . . 1.0 110.699 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -101.85 141.76 34.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.202 0.939 . . . . 1.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 24.1 t -96.05 119.39 64.69 Favored Pre-proline 0 CA--C 1.572 1.802 0 O-C-N 124.848 1.343 . . . . 1.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.07 -7.74 19.37 Favored 'Trans proline' 1 C--N 1.437 5.2 0 C-N-CA 122.25 1.967 . . . . 1.0 115.233 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 t -88.32 -51.94 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 C-N-CA 124.694 1.198 . . . . 1.0 110.299 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.38 -50.56 3.89 Favored 'General case' 0 C--N 1.367 1.343 0 O-C-N 124.691 1.245 . . . . 1.0 112.084 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 -14.57 12.1 Favored Glycine 0 C--N 1.371 2.523 0 O-C-N 124.473 1.108 . . . . 1.0 115.18 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -82.17 153.52 25.95 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 124.859 1.264 . . . . 1.0 112.565 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.45 138.41 31.5 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.163 1.385 . . . . 1.0 112.006 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -129.17 141.27 51.22 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 125.185 1.553 . . . . 1.0 109.814 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.3 151.53 19.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.318 1.011 . . . . 1.0 112.381 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.79 -8.02 86.33 Favored Glycine 0 C--N 1.378 2.884 0 O-C-N 124.437 1.085 . . . . 1.0 114.639 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -86.32 -19.6 29.57 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.466 1.506 . . . . 1.0 111.659 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.4 p -97.53 6.82 47.55 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.966 1.306 . . . . 1.0 112.055 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.76 159.07 55.75 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-O 117.344 -1.312 . . . . 1.0 111.393 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -69.68 154.51 67.98 Favored 'Trans proline' 1 C--N 1.441 5.432 0 C-N-CA 123.197 2.598 . . . . 1.0 114.227 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -68.26 -17.97 64.43 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 115.173 1.545 . . . . 1.0 115.173 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -83.67 -33.68 25.15 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.496 1.118 . . . . 1.0 112.221 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.5 mt-10 -69.86 -28.68 65.86 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.585 1.554 . . . . 1.0 113.49 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -64.27 -31.91 73.3 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.727 1.611 . . . . 1.0 112.852 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.19 -27.88 62.84 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 125.693 1.597 . . . . 1.0 111.987 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -68.26 -28.77 67.5 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 125.962 1.705 . . . . 1.0 112.65 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.472 ' O ' HD12 ' A' ' 78' ' ' LEU . 2.8 t -66.97 -40.06 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 C-N-CA 126.026 1.73 . . . . 1.0 109.331 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -28.0 65.57 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 125.772 1.629 . . . . 1.0 113.401 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -71.58 -42.63 67.54 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.188 1.795 . . . . 1.0 113.019 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.4 pp -67.28 -37.25 83.14 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.353 1.061 . . . . 1.0 112.513 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -71.2 -37.46 72.11 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.881 1.673 . . . . 1.0 113.079 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.68 -31.96 36.14 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.359 1.463 . . . . 1.0 114.129 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -98.64 57.81 1.18 Allowed 'General case' 0 C--O 1.26 1.646 0 CA-C-O 123.093 1.425 . . . . 1.0 110.712 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.45 145.61 24.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.005 -1.907 . . . . 1.0 111.48 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttm 77.46 112.02 0.07 Allowed 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 127.46 2.304 . . . . 1.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.22 -74.49 0.22 Allowed Glycine 0 C--N 1.36 1.874 0 O-C-N 125.037 1.46 . . . . 1.0 112.953 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.59 31.02 5.36 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 125.314 1.243 . . . . 1.0 115.348 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.39 120.12 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.05 130.17 51.75 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 125.177 1.548 . . . . 1.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.39 -32.59 32.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.887 1.275 . . . . 1.0 114.029 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.32 -35.73 40.68 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 124.964 1.305 . . . . 1.0 113.3 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -94.73 -15.34 23.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.652 1.22 . . . . 1.0 113.336 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 60.12 51.31 5.78 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 127.193 2.197 . . . . 1.0 113.903 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -113.34 128.83 56.59 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.899 -1.501 . . . . 1.0 110.435 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.46 130.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 124.99 1.431 . . . . 1.0 108.147 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -121.71 137.04 54.92 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 125.048 1.467 . . . . 1.0 111.364 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.83 130.93 53.48 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.126 1.517 . . . . 1.0 109.727 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 mttp . . . . . 0 C--O 1.253 1.238 0 O-C-N 125.213 1.57 . . . . 1.0 111.287 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 36.4 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.85 138.67 41.65 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 125.272 1.608 . . . . 1.0 110.884 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -106.81 138.64 42.61 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 124.901 1.375 . . . . 1.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.8 t -73.76 130.3 83.69 Favored Pre-proline 0 CA--C 1.582 2.207 0 CA-C-O 116.907 -1.52 . . . . 1.0 112.151 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.12 -11.75 27.37 Favored 'Trans proline' 1 C--N 1.441 5.404 0 C-N-CA 122.573 2.182 . . . . 1.0 114.406 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.507 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -93.73 -55.12 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.221 1.408 . . . . 1.0 110.482 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 29.1 p -103.35 -41.16 6.11 Favored 'General case' 0 C--N 1.372 1.569 0 O-C-N 124.302 1.001 . . . . 1.0 113.424 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 89.13 34.6 8.67 Favored Glycine 0 C--N 1.371 2.525 0 O-C-N 124.818 1.324 . . . . 1.0 113.324 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.532 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -92.74 144.63 28.91 Favored Pre-proline 0 C--N 1.369 1.447 0 CA-C-O 117.016 -1.468 . . . . 1.0 112.808 -178.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.59 135.36 38.66 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 122.46 2.107 . . . . 1.0 114.839 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mt -120.16 144.92 47.41 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 125.333 1.646 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.09 129.01 38.14 Favored 'General case' 0 C--N 1.362 1.111 0 O-C-N 124.876 1.36 . . . . 1.0 111.072 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.0 m95 -68.66 -25.58 64.89 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 125.136 1.374 . . . . 1.0 113.115 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 mt-10 -70.16 -32.27 70.15 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.936 1.695 . . . . 1.0 112.59 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -76.55 -34.1 58.51 Favored 'General case' 0 C--N 1.385 2.136 0 C-N-CA 125.225 1.41 . . . . 1.0 112.712 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -41.32 91.8 Favored 'General case' 0 C--N 1.383 2.051 0 C-N-CA 126.495 1.918 . . . . 1.0 112.764 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' TRP . 5.9 mm -78.97 -38.59 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 125.607 1.563 . . . . 1.0 110.445 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -65.49 -35.38 80.73 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 125.475 1.51 . . . . 1.0 113.491 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.46 -24.04 39.81 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.876 1.671 . . . . 1.0 112.451 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.475 ' O ' HD12 ' A' ' 30' ' ' ILE . 24.0 mtp -101.56 9.06 41.6 Favored 'General case' 0 CA--C 1.575 1.908 0 O-C-N 124.805 1.316 . . . . 1.0 112.943 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 13.4 13.77 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 124.163 0.985 . . . . 1.0 112.978 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.92 -6.36 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 125.606 1.562 . . . . 1.0 113.317 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -97.96 140.84 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 125.285 1.434 . . . . 1.0 109.048 -178.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.71 -19.1 42.22 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.852 1.345 . . . . 1.0 113.306 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.8 -19.94 50.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.183 1.393 . . . . 1.0 112.584 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.565 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.5 t80 -57.51 -35.77 70.69 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 126.327 1.851 . . . . 1.0 113.374 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.02 -28.0 69.28 Favored 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 125.337 1.455 . . . . 1.0 112.182 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -87.63 -33.88 18.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.843 1.657 . . . . 1.0 112.149 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.3 mt -71.26 -40.25 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.991 0 C-N-CA 125.739 1.616 . . . . 1.0 110.634 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.514 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.1 m -58.75 -24.47 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 C-N-CA 125.687 1.595 . . . . 1.0 114.741 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -87.73 -15.24 37.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 1.0 113.022 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -125.36 106.34 9.76 Favored 'General case' 0 C--N 1.375 1.684 0 C-N-CA 124.473 1.109 . . . . 1.0 111.767 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.457 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.6 mtm180 -59.11 -33.12 70.48 Favored 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 125.956 1.702 . . . . 1.0 113.863 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.14 -31.21 68.63 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.943 1.697 . . . . 1.0 112.839 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -82.0 -33.58 30.05 Favored 'General case' 0 C--N 1.38 1.917 0 C-N-CA 125.196 1.398 . . . . 1.0 112.552 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.4 t80 -72.19 -43.95 63.74 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 124.938 1.295 . . . . 1.0 112.815 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -70.33 -31.27 68.49 Favored 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 125.359 1.463 . . . . 1.0 113.049 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -26.68 33.58 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 125.305 1.442 . . . . 1.0 112.932 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.449 HE21 HD13 ' A' ' 36' ' ' ILE . 1.8 mm100 -79.25 -38.18 36.18 Favored 'General case' 0 C--N 1.384 2.093 0 C-N-CA 124.798 1.239 . . . . 1.0 112.615 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 43' ' ' PHE . 68.3 t -68.16 -40.04 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 125.472 1.509 . . . . 1.0 109.68 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.48 -24.83 62.07 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 125.522 1.529 . . . . 1.0 113.142 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.29 -15.85 19.62 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.111 1.364 . . . . 1.0 113.153 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -93.19 151.29 19.92 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 124.62 1.168 . . . . 1.0 112.315 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG11 ' OE1' ' A' ' 60' ' ' GLU . 82.9 t -97.94 140.64 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 125.092 1.495 . . . . 1.0 107.791 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -128.44 146.31 50.84 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.602 1.814 . . . . 1.0 109.571 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -105.1 142.25 35.22 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 124.779 1.299 . . . . 1.0 111.259 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.69 131.38 37.95 Favored Pre-proline 0 CA--C 1.574 1.875 0 O-C-N 124.982 1.427 . . . . 1.0 111.352 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.68 -9.62 22.77 Favored 'Trans proline' 1 C--N 1.437 5.221 0 C-N-CA 122.439 2.092 . . . . 1.0 114.268 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.06 -53.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 125.274 1.43 . . . . 1.0 109.709 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 25.0 m -88.73 -53.98 4.37 Favored 'General case' 0 C--N 1.379 1.874 0 O-C-N 124.253 0.971 . . . . 1.0 112.1 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.32 6.63 61.23 Favored Glycine 0 C--N 1.37 2.45 0 O-C-N 124.885 1.366 . . . . 1.0 113.378 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.26 165.83 16.16 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 126.126 1.77 . . . . 1.0 112.332 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE1' HG11 ' A' ' 51' ' ' VAL . 43.9 mt-10 -92.2 134.28 35.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.06 1.344 . . . . 1.0 110.733 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.08 153.41 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.393 1.477 . . . . 1.0 109.983 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.49 154.04 21.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.577 1.173 . . . . 1.0 112.398 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.0 -1.19 72.39 Favored Glycine 0 C--N 1.378 2.881 0 O-C-N 124.446 1.091 . . . . 1.0 114.424 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -85.65 -17.41 36.19 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.169 1.387 . . . . 1.0 111.596 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.5 p -95.55 3.31 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.993 1.317 . . . . 1.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.44 152.71 73.35 Favored Pre-proline 0 CA--C 1.58 2.108 0 CA-C-O 116.86 -1.543 . . . . 1.0 111.703 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -64.1 149.87 89.51 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 123.252 2.634 . . . . 1.0 114.931 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -65.05 -17.83 64.79 Favored 'General case' 0 N--CA 1.51 2.533 0 C-N-CA 125.517 1.527 . . . . 1.0 114.835 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -82.53 -33.13 28.32 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.03 1.332 . . . . 1.0 111.533 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.18 -30.16 66.08 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.787 1.635 . . . . 1.0 113.042 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -66.87 -36.3 82.0 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 125.58 1.552 . . . . 1.0 112.388 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -71.8 -24.22 61.7 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 125.41 1.484 . . . . 1.0 112.356 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -74.76 -27.94 60.55 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 126.181 1.792 . . . . 1.0 112.439 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 t -67.11 -39.73 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 C-N-CA 126.195 1.798 . . . . 1.0 110.305 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 40' ' ' ARG . 1.4 t80 -60.56 -29.46 69.18 Favored 'General case' 0 N--CA 1.511 2.605 0 C-N-CA 125.608 1.563 . . . . 1.0 113.651 177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.18 -40.81 71.01 Favored 'General case' 0 C--N 1.384 2.087 0 C-N-CA 125.731 1.613 . . . . 1.0 113.212 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.7 pp -70.15 -34.96 73.68 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 124.903 1.281 . . . . 1.0 113.554 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.514 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.32 -24.18 42.98 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.105 1.362 . . . . 1.0 112.453 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.406 ' OD1' ' HD3' ' A' ' 40' ' ' ARG . 2.6 m120 -85.36 -14.61 45.87 Favored 'General case' 0 C--N 1.382 2.002 0 C-N-CA 124.862 1.265 . . . . 1.0 113.357 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.12 -36.96 84.53 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 125.667 1.587 . . . . 1.0 113.819 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 61.57 -58.72 0.11 Allowed 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 128.112 2.565 . . . . 1.0 114.174 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -128.59 136.46 50.74 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 125.115 1.366 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -174.07 -102.02 0.15 Allowed Glycine 0 C--N 1.356 1.679 0 O-C-N 125.151 1.532 . . . . 1.0 111.807 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.76 44.66 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 O-C-N 125.504 1.355 . . . . 1.0 113.395 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.3 123.6 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.812 -1.551 . . . . 1.0 106.812 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.75 128.74 45.88 Favored 'General case' 0 C--O 1.248 1.015 0 O-C-N 125.324 1.64 . . . . 1.0 110.252 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -80.81 -26.38 37.14 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.807 1.243 . . . . 1.0 114.071 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -80.94 -38.4 27.88 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 125.14 1.376 . . . . 1.0 113.178 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -97.32 -14.4 21.32 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 124.555 1.159 . . . . 1.0 113.678 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttm 60.35 55.81 3.41 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 127.342 2.257 . . . . 1.0 113.319 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 86.5 mtt180 -115.93 130.2 56.72 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.16 127.38 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 125.126 1.516 . . . . 1.0 107.996 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -119.66 136.81 54.24 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 125.374 1.671 . . . . 1.0 110.537 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.29 129.14 56.61 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 124.973 1.42 . . . . 1.0 111.583 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt . . . . . 0 N--CA 1.48 1.03 0 O-C-N 125.777 1.923 . . . . 1.0 111.06 179.562 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.4 mmt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 111.238 0.088 . . . . 1.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' HB2' ' NE1' ' A' ' 20' ' ' TRP . . . -107.5 139.91 41.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 125.268 1.605 . . . . 1.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -128.42 138.9 52.54 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.774 1.296 . . . . 1.0 111.114 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 13' ' ' ILE . 27.1 t -73.14 121.27 84.68 Favored Pre-proline 0 CA--C 1.582 2.21 0 CA-C-O 117.58 -1.2 . . . . 1.0 111.784 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 -6.37 18.97 Favored 'Trans proline' 1 C--N 1.433 4.974 0 C-N-CA 121.965 1.777 . . . . 1.0 114.834 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.536 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.3 mt -95.72 -55.41 6.13 Favored 'Isoleucine or valine' 0 C--N 1.372 1.575 0 C-N-CA 125.069 1.348 . . . . 1.0 110.05 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.2 p -103.79 -41.75 5.82 Favored 'General case' 0 C--N 1.374 1.634 0 O-C-N 124.245 0.965 . . . . 1.0 112.795 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.99 36.3 6.06 Favored Glycine 0 C--N 1.367 2.288 0 O-C-N 124.711 1.257 . . . . 1.0 114.151 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.439 ' OG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -97.89 147.52 33.17 Favored Pre-proline 0 CA--C 1.565 1.552 0 CA-C-O 116.848 -1.548 . . . . 1.0 111.83 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.71 139.13 39.64 Favored 'Trans proline' 1 C--N 1.446 5.708 0 C-N-CA 122.733 2.288 . . . . 1.0 114.33 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 mt -124.37 146.17 49.01 Favored 'General case' 0 C--O 1.25 1.131 0 O-C-N 125.436 1.71 . . . . 1.0 110.302 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.32 124.91 38.64 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 124.682 1.239 . . . . 1.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.481 ' O ' HG12 ' A' ' 24' ' ' ILE . 44.8 m95 -69.25 -24.83 64.04 Favored 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 125.091 1.356 . . . . 1.0 112.594 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 35.9 mt-10 -69.94 -31.59 69.42 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.72 1.608 . . . . 1.0 112.094 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -76.37 -34.0 58.92 Favored 'General case' 0 C--N 1.39 2.344 0 C-N-CA 124.923 1.289 . . . . 1.0 112.455 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -41.04 93.95 Favored 'General case' 0 C--N 1.381 1.967 0 C-N-CA 126.199 1.8 . . . . 1.0 112.711 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.2 mm -79.79 -39.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 C-N-CA 125.419 1.488 . . . . 1.0 110.641 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.63 -35.36 79.99 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 125.297 1.439 . . . . 1.0 113.678 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.68 -22.97 42.78 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 125.541 1.536 . . . . 1.0 112.586 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.468 ' O ' HD12 ' A' ' 30' ' ' ILE . 30.7 mtt -105.21 10.29 33.78 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 124.991 1.432 . . . . 1.0 112.128 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.39 23.26 4.62 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.007 0.923 . . . . 1.0 112.935 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.85 6.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 125.096 1.358 . . . . 1.0 112.79 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 32' ' ' ASN . 1.1 mt -109.27 139.69 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.037 1.335 . . . . 1.0 109.138 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.0 -20.47 28.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.142 1.526 . . . . 1.0 112.235 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.51 ' H ' HG22 ' A' ' 30' ' ' ILE . 10.4 m120 -91.6 19.54 6.21 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.179 1.391 . . . . 1.0 112.055 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.84 -36.3 56.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.313 1.445 . . . . 1.0 111.778 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 37' ' ' VAL . 29.1 mt-10 -55.67 -23.88 30.84 Favored 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 126.068 1.747 . . . . 1.0 114.684 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.79 -43.83 15.02 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 125.074 1.35 . . . . 1.0 111.495 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 43' ' ' PHE . 3.2 mt -72.8 -43.05 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 125.297 1.439 . . . . 1.0 110.934 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 34' ' ' GLU . 1.9 p -68.26 -19.26 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.757 0 C-N-CA 125.124 1.37 . . . . 1.0 114.132 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -91.96 -17.77 24.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.621 1.2 . . . . 1.0 112.698 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.0 105.47 9.61 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 124.351 1.06 . . . . 1.0 111.412 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -57.19 -31.63 65.65 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 125.386 1.475 . . . . 1.0 114.104 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.3 -33.49 74.42 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.778 1.631 . . . . 1.0 112.652 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -82.16 -35.84 28.01 Favored 'General case' 0 C--N 1.377 1.792 0 C-N-CA 125.339 1.456 . . . . 1.0 112.429 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.5 t80 -73.69 -45.27 53.45 Favored 'General case' 0 C--N 1.39 2.357 0 C-N-CA 125.089 1.356 . . . . 1.0 112.523 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.58 -28.18 66.72 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 124.597 1.159 . . . . 1.0 113.048 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.77 -28.61 36.36 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.154 1.382 . . . . 1.0 112.619 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 2.2 tt0 -79.6 -38.25 34.37 Favored 'General case' 0 C--N 1.381 1.968 0 C-N-CA 125.094 1.358 . . . . 1.0 112.337 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 43' ' ' PHE . 49.1 t -68.99 -42.07 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.215 0 C-N-CA 125.341 1.456 . . . . 1.0 109.635 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.89 -28.28 67.37 Favored 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.455 1.502 . . . . 1.0 113.544 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -91.92 -26.75 18.29 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.863 1.265 . . . . 1.0 113.488 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -97.6 147.42 24.32 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 124.566 1.146 . . . . 1.0 111.254 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.0 151.89 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 O-C-N 124.835 1.335 . . . . 1.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -122.56 144.57 49.01 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.949 1.406 . . . . 1.0 110.434 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -96.77 138.77 33.83 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 124.787 1.305 . . . . 1.0 111.268 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.6 t -96.5 111.76 57.99 Favored Pre-proline 0 CA--C 1.576 1.961 0 O-C-N 125.026 1.454 . . . . 1.0 110.654 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -70.57 -8.07 22.76 Favored 'Trans proline' 1 C--N 1.439 5.299 0 C-N-CA 122.984 2.456 . . . . 1.0 114.348 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG11 ' OG ' ' A' ' 16' ' ' SER . 1.8 t -85.31 -51.97 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 125.577 1.551 . . . . 1.0 110.597 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.1 p -103.76 -48.14 4.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.722 1.264 . . . . 1.0 112.504 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.1 -10.94 14.93 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 124.442 1.089 . . . . 1.0 114.348 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.4 147.82 25.27 Favored 'General case' 0 C--N 1.376 1.738 0 C-N-CA 124.963 1.305 . . . . 1.0 111.476 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.74 138.54 31.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.783 1.233 . . . . 1.0 112.36 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -122.35 143.11 49.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.214 1.571 . . . . 1.0 109.833 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -95.31 151.67 19.06 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 124.318 1.012 . . . . 1.0 112.659 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.21 -9.07 80.48 Favored Glycine 0 C--N 1.379 2.932 0 O-C-N 124.661 1.226 . . . . 1.0 115.125 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -87.55 -18.25 30.18 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.256 1.422 . . . . 1.0 112.047 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 p -99.63 2.68 44.73 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.841 1.256 . . . . 1.0 112.018 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 152.89 81.22 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 116.982 -1.485 . . . . 1.0 111.969 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.49 152.2 82.59 Favored 'Trans proline' 1 C--N 1.444 5.553 0 C-N-CA 123.289 2.659 . . . . 1.0 114.67 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -66.98 -19.58 65.74 Favored 'General case' 0 N--CA 1.507 2.405 0 C-N-CA 125.19 1.396 . . . . 1.0 114.566 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -79.6 -34.17 40.93 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 125.002 1.321 . . . . 1.0 112.073 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -70.12 -29.46 66.42 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.743 1.617 . . . . 1.0 113.239 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.18 71.93 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.845 1.658 . . . . 1.0 112.863 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.01 -26.2 63.02 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 1.0 112.933 176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -68.7 -28.03 66.48 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.968 1.707 . . . . 1.0 112.785 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t -65.92 -33.91 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.09 0 C-N-CA 126.519 1.928 . . . . 1.0 110.281 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.27 -29.16 69.9 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 125.784 1.634 . . . . 1.0 113.828 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -68.27 -38.5 81.81 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 125.67 1.588 . . . . 1.0 113.068 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.2 pp -72.84 -29.29 63.1 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.599 1.16 . . . . 1.0 112.825 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -26.93 43.5 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 125.405 1.482 . . . . 1.0 113.055 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -98.16 -20.18 17.45 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.423 1.089 . . . . 1.0 113.57 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.06 62.24 0.64 Allowed 'General case' 0 C--O 1.259 1.562 0 CA-C-O 123.127 1.442 . . . . 1.0 110.919 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -69.38 -34.98 75.34 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 113.349 -1.75 . . . . 1.0 113.106 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -106.36 120.3 41.52 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 124.973 1.42 . . . . 1.0 108.709 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.44 84.63 1.68 Allowed Glycine 0 C--N 1.363 2.071 0 O-C-N 124.661 1.226 . . . . 1.0 112.934 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 136.36 -57.99 0.67 Allowed Glycine 0 C--N 1.359 1.827 0 O-C-N 125.307 1.24 . . . . 1.0 113.468 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.4 mp -109.05 124.6 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 125.104 1.12 . . . . 1.0 108.126 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.06 133.11 56.01 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.495 1.747 . . . . 1.0 110.19 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -80.53 -29.35 37.19 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.588 1.18 . . . . 1.0 113.911 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.18 -35.42 28.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 124.877 1.271 . . . . 1.0 112.935 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -92.76 -17.88 23.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.613 1.196 . . . . 1.0 113.495 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 59.2 45.59 14.13 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 127.157 2.183 . . . . 1.0 113.516 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 9.1 mmm180 -115.27 138.19 51.22 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.284 -1.326 . . . . 1.0 111.435 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.84 126.92 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 125.174 1.546 . . . . 1.0 108.235 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 12.1 tttt -127.11 129.35 47.77 Favored 'General case' 0 C--O 1.251 1.143 0 O-C-N 125.28 1.612 . . . . 1.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 132.97 52.74 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.762 1.289 . . . . 1.0 110.716 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.7 mttm . . . . . 0 C--O 1.252 1.221 0 O-C-N 125.289 1.618 . . . . 1.0 111.357 179.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 110.851 -0.055 . . . . 1.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.73 138.61 44.78 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 125.179 1.549 . . . . 1.0 110.829 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -110.94 139.06 46.6 Favored 'General case' 0 C--O 1.248 1.013 0 O-C-N 124.9 1.375 . . . . 1.0 110.906 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 13' ' ' ILE . 47.3 t -71.8 132.34 85.14 Favored Pre-proline 0 CA--C 1.578 2.038 0 CA-C-O 117.262 -1.351 . . . . 1.0 112.44 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.71 -8.45 20.39 Favored 'Trans proline' 1 C--N 1.43 4.854 0 C-N-CA 122.178 1.919 . . . . 1.0 114.761 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.541 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.2 -55.9 5.66 Favored 'Isoleucine or valine' 0 C--N 1.372 1.569 0 C-N-CA 124.975 1.31 . . . . 1.0 109.955 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 27.2 p -101.23 -41.15 6.82 Favored 'General case' 0 C--N 1.371 1.536 0 O-C-N 124.079 0.862 . . . . 1.0 113.003 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 88.73 34.14 9.4 Favored Glycine 0 C--N 1.37 2.464 0 O-C-N 124.691 1.244 . . . . 1.0 113.112 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.461 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -93.16 145.91 30.94 Favored Pre-proline 0 C--N 1.368 1.411 0 CA-C-O 117.177 -1.392 . . . . 1.0 112.586 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.71 134.28 34.59 Favored 'Trans proline' 1 C--N 1.445 5.624 0 C-N-CA 122.422 2.081 . . . . 1.0 114.475 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt -118.63 143.16 47.0 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 125.277 1.611 . . . . 1.0 110.202 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.28 130.85 37.1 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.789 1.306 . . . . 1.0 111.212 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 24' ' ' ILE . 45.8 m95 -68.78 -24.8 64.46 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 125.078 1.351 . . . . 1.0 113.046 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.1 mt-10 -70.01 -33.77 72.45 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 125.623 1.569 . . . . 1.0 112.178 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.98 -34.69 57.53 Favored 'General case' 0 C--N 1.386 2.193 0 C-N-CA 125.268 1.427 . . . . 1.0 112.776 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.13 -41.3 94.93 Favored 'General case' 0 C--N 1.382 1.994 0 C-N-CA 126.036 1.734 . . . . 1.0 112.839 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -79.94 -37.99 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 C-N-CA 125.271 1.428 . . . . 1.0 110.48 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.57 -35.25 79.75 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.093 1.357 . . . . 1.0 113.472 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.24 -23.83 40.58 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.653 1.581 . . . . 1.0 112.55 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -103.65 13.77 32.52 Favored 'General case' 0 CA--C 1.576 1.979 0 O-C-N 124.768 1.293 . . . . 1.0 112.48 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.11 16.79 12.11 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 123.937 0.895 . . . . 1.0 112.882 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.88 -4.05 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 C-N-CA 125.457 1.503 . . . . 1.0 113.427 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -99.71 140.92 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 125.251 1.421 . . . . 1.0 109.125 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.78 -18.06 41.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.888 1.367 . . . . 1.0 113.033 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.66 -16.3 54.35 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 124.975 1.31 . . . . 1.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.87 -34.74 65.75 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 126.252 1.821 . . . . 1.0 113.006 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.06 -30.34 71.52 Favored 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 125.317 1.447 . . . . 1.0 112.281 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.71 -35.73 20.65 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 125.461 1.504 . . . . 1.0 112.251 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -72.2 -39.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.905 0 C-N-CA 126.011 1.724 . . . . 1.0 110.549 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.531 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.5 p -63.17 -18.85 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 C-N-CA 125.561 1.544 . . . . 1.0 114.237 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.98 -19.41 25.75 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.75 1.22 . . . . 1.0 113.311 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -125.3 111.11 14.82 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.364 1.066 . . . . 1.0 111.688 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.0 mpt_? -60.05 -33.45 72.06 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 125.603 1.561 . . . . 1.0 113.57 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.19 -31.06 69.41 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 125.636 1.575 . . . . 1.0 112.632 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -82.16 -33.42 29.53 Favored 'General case' 0 C--N 1.379 1.85 0 C-N-CA 125.119 1.368 . . . . 1.0 112.154 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.473 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.0 t80 -71.65 -43.98 65.12 Favored 'General case' 0 C--N 1.394 2.508 0 C-N-CA 125.137 1.375 . . . . 1.0 112.41 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.83 -28.8 65.99 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.925 1.29 . . . . 1.0 112.41 177.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 -27.07 29.64 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 125.455 1.502 . . . . 1.0 112.787 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.0 mm-40 -78.11 -39.12 42.34 Favored 'General case' 0 C--N 1.383 2.024 0 C-N-CA 124.775 1.23 . . . . 1.0 112.84 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 43' ' ' PHE . 46.0 t -68.8 -40.77 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.03 0 C-N-CA 125.234 1.414 . . . . 1.0 109.621 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.29 -26.69 63.92 Favored 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.491 1.516 . . . . 1.0 113.024 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.36 -26.0 19.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.076 1.351 . . . . 1.0 112.851 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -96.18 144.64 26.22 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 124.64 1.176 . . . . 1.0 110.943 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.9 150.85 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 O-C-N 124.948 1.405 . . . . 1.0 110.732 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.03 145.5 50.97 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.856 1.348 . . . . 1.0 110.523 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -101.4 142.69 32.43 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.663 1.227 . . . . 1.0 111.3 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -89.04 123.38 67.5 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 117.385 -1.293 . . . . 1.0 110.943 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.26 -9.93 26.27 Favored 'Trans proline' 1 C--N 1.439 5.301 0 C-N-CA 122.81 2.34 . . . . 1.0 113.548 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.15 -52.78 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 125.638 1.575 . . . . 1.0 110.177 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 46.0 m -90.13 -52.74 4.79 Favored 'General case' 0 C--N 1.38 1.893 0 O-C-N 124.22 0.95 . . . . 1.0 112.383 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.67 42.14 Favored Glycine 0 C--N 1.368 2.316 0 O-C-N 124.796 1.31 . . . . 1.0 112.899 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -86.57 152.58 22.5 Favored 'General case' 0 C--N 1.379 1.888 0 C-N-CA 125.759 1.624 . . . . 1.0 111.272 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.28 136.66 32.9 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.436 1.095 . . . . 1.0 111.577 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -130.14 144.15 51.19 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 125.475 1.734 . . . . 1.0 109.159 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -92.2 153.85 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.186 0.929 . . . . 1.0 113.047 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -77.27 -4.43 83.93 Favored Glycine 0 C--N 1.377 2.826 0 O-C-N 124.404 1.065 . . . . 1.0 114.793 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -85.81 -15.16 42.85 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.355 1.462 . . . . 1.0 112.054 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 p -95.59 5.64 50.97 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 124.524 1.13 . . . . 1.0 111.562 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 63' ' ' GLY . 5.8 mt -74.53 150.51 86.9 Favored Pre-proline 0 C--N 1.387 2.23 0 CA-C-O 116.811 -1.566 . . . . 1.0 112.48 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.98 151.69 83.31 Favored 'Trans proline' 1 C--N 1.441 5.434 0 C-N-CA 123.139 2.559 . . . . 1.0 113.739 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -65.71 -18.34 65.26 Favored 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 114.715 1.376 . . . . 1.0 114.715 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -83.45 -34.43 25.44 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.974 1.309 . . . . 1.0 111.68 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -70.36 -29.15 65.75 Favored 'General case' 0 C--N 1.387 2.198 0 C-N-CA 125.741 1.616 . . . . 1.0 113.513 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.18 75.29 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.497 1.519 . . . . 1.0 112.809 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -73.85 -28.21 61.47 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.729 1.612 . . . . 1.0 112.358 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -71.33 -26.94 63.05 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 126.054 1.742 . . . . 1.0 112.746 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.7 -38.31 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 C-N-CA 126.49 1.916 . . . . 1.0 110.366 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -60.06 -28.18 67.57 Favored 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.277 1.431 . . . . 1.0 113.864 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -40.79 79.94 Favored 'General case' 0 C--N 1.383 2.064 0 C-N-CA 125.616 1.567 . . . . 1.0 113.496 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.1 pp -71.04 -34.52 71.33 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.911 1.284 . . . . 1.0 113.013 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.08 -22.65 44.96 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.479 1.512 . . . . 1.0 112.531 177.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -86.37 -9.66 55.92 Favored 'General case' 0 C--N 1.383 2.038 0 C-N-CA 124.586 1.154 . . . . 1.0 113.061 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.55 -35.59 75.55 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.59 1.556 . . . . 1.0 113.75 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.67 -72.01 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 127.621 2.368 . . . . 1.0 113.816 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -128.48 135.31 49.27 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 125.201 1.401 . . . . 1.0 109.393 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.45 114.6 3.97 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 125.018 1.449 . . . . 1.0 111.445 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 109.3 -43.24 1.75 Allowed Glycine 0 C--N 1.356 1.648 0 O-C-N 125.404 1.296 . . . . 1.0 113.846 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -107.47 124.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.32 127.99 54.61 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 125.443 1.714 . . . . 1.0 110.002 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.55 -32.85 36.56 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.683 1.239 . . . . 1.0 113.778 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.23 -36.16 30.35 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.004 1.322 . . . . 1.0 112.901 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.34 -16.14 24.98 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.695 1.198 . . . . 1.0 113.525 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.17 44.26 16.05 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 127.112 2.165 . . . . 1.0 113.479 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 99.4 mtt180 -114.0 135.89 53.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.318 -1.31 . . . . 1.0 111.175 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.76 127.0 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 125.471 1.732 . . . . 1.0 107.727 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 2.8 tttp -122.66 133.11 54.52 Favored 'General case' 0 C--O 1.25 1.123 0 O-C-N 125.309 1.631 . . . . 1.0 110.464 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.48 129.85 53.2 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.04 1.462 . . . . 1.0 110.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 mttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.373 1.671 . . . . 1.0 111.287 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 39.6 mtt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.466 0.172 . . . . 1.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.49 139.42 40.13 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 125.253 1.596 . . . . 1.0 110.732 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.38 139.2 45.81 Favored 'General case' 0 C--O 1.249 1.027 0 O-C-N 124.79 1.307 . . . . 1.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.522 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.4 t -69.51 129.11 91.81 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 116.905 -1.521 . . . . 1.0 111.687 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.35 -13.03 30.43 Favored 'Trans proline' 1 C--N 1.438 5.238 0 C-N-CA 122.373 2.048 . . . . 1.0 114.598 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.522 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.6 mp -91.33 -54.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 125.395 1.478 . . . . 1.0 110.7 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.29 -40.4 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.261 0.976 . . . . 1.0 113.433 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.91 38.43 5.77 Favored Glycine 0 C--N 1.371 2.499 0 O-C-N 124.71 1.256 . . . . 1.0 113.05 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -92.13 142.97 26.85 Favored Pre-proline 0 CA--C 1.567 1.625 0 CA-C-O 116.609 -1.662 . . . . 1.0 113.042 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.68 137.28 38.34 Favored 'Trans proline' 1 C--N 1.451 5.94 0 C-N-CA 122.557 2.171 . . . . 1.0 113.08 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -118.76 143.45 46.89 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 125.143 1.527 . . . . 1.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.64 131.61 41.7 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.979 1.424 . . . . 1.0 110.956 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.513 ' O ' HG12 ' A' ' 24' ' ' ILE . 55.0 m95 -68.51 -26.43 65.44 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.025 1.33 . . . . 1.0 112.968 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.0 mt-10 -70.0 -33.1 71.6 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 125.692 1.597 . . . . 1.0 112.094 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.69 -33.46 58.23 Favored 'General case' 0 C--N 1.387 2.202 0 C-N-CA 125.077 1.351 . . . . 1.0 112.509 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.4 OUTLIER -65.87 -41.42 91.63 Favored 'General case' 0 C--N 1.389 2.285 0 C-N-CA 125.824 1.65 . . . . 1.0 112.743 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.8 mm -76.97 -39.46 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 C-N-CA 125.411 1.484 . . . . 1.0 110.461 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -67.61 -36.6 81.14 Favored 'General case' 0 C--N 1.385 2.151 0 C-N-CA 125.281 1.432 . . . . 1.0 113.57 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.96 -22.5 39.52 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.645 1.578 . . . . 1.0 112.842 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -104.54 12.75 32.78 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.537 1.148 . . . . 1.0 111.856 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 12.23 26.81 Favored 'General case' 0 CA--C 1.575 1.91 0 C-N-CA 123.733 0.813 . . . . 1.0 113.014 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.68 1.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 C-N-CA 125.903 1.681 . . . . 1.0 113.074 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 27' ' ' MET . 0.8 OUTLIER -108.84 140.15 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 125.187 1.395 . . . . 1.0 109.109 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -80.87 -19.67 43.95 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 124.808 1.243 . . . . 1.0 113.748 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -79.09 -21.3 46.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.979 1.312 . . . . 1.0 112.554 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.4 t80 -57.59 -34.97 69.79 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.279 1.832 . . . . 1.0 113.153 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.1 -30.7 69.43 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 125.584 1.554 . . . . 1.0 111.975 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.16 -33.95 19.22 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 125.652 1.581 . . . . 1.0 112.485 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 33' ' ' PHE . 7.0 mt -71.5 -37.18 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.841 1.656 . . . . 1.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 m -61.98 -18.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 125.06 1.344 . . . . 1.0 114.394 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -93.11 -18.88 22.08 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.341 1.456 . . . . 1.0 112.595 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -121.61 104.84 9.92 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 124.104 0.962 . . . . 1.0 111.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.4 ptp180 -58.24 -36.85 73.81 Favored 'General case' 0 N--CA 1.517 2.904 0 C-N-CA 126.071 1.748 . . . . 1.0 113.973 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.26 -32.75 74.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.042 1.737 . . . . 1.0 112.776 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -83.74 -31.67 25.88 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.417 1.487 . . . . 1.0 112.256 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.2 t80 -74.56 -46.92 35.8 Favored 'General case' 0 C--N 1.392 2.441 0 C-N-CA 124.739 1.216 . . . . 1.0 113.14 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -71.4 -33.59 69.61 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 124.928 1.291 . . . . 1.0 113.152 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.37 -28.44 61.11 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.336 1.454 . . . . 1.0 113.161 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 mt-30 -80.05 -35.82 36.56 Favored 'General case' 0 C--N 1.381 1.97 0 C-N-CA 124.985 1.314 . . . . 1.0 112.945 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.5 t -67.98 -40.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.36 0 C-N-CA 125.267 1.427 . . . . 1.0 109.547 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.02 -22.59 61.39 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.546 1.539 . . . . 1.0 113.459 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.8 -26.39 14.72 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.943 1.297 . . . . 1.0 112.603 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -99.05 144.06 28.62 Favored 'General case' 0 C--N 1.374 1.661 0 O-C-N 124.358 1.036 . . . . 1.0 111.28 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 151.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 O-C-N 125.451 1.719 . . . . 1.0 111.564 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.88 148.04 45.88 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 125.003 1.44 . . . . 1.0 109.795 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -98.64 140.97 32.06 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.666 1.229 . . . . 1.0 111.458 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.08 132.93 34.64 Favored Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 124.956 1.41 . . . . 1.0 111.635 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.15 -9.16 21.77 Favored 'Trans proline' 1 C--N 1.43 4.841 0 C-N-CA 122.535 2.156 . . . . 1.0 114.238 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.64 -51.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 125.336 1.454 . . . . 1.0 110.019 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.6 m -90.4 -52.84 4.71 Favored 'General case' 0 C--N 1.378 1.808 0 O-C-N 124.23 0.956 . . . . 1.0 112.45 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.27 Favored Glycine 0 C--N 1.37 2.417 0 O-C-N 124.67 1.231 . . . . 1.0 113.655 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.06 154.43 17.34 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 125.445 1.498 . . . . 1.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -88.07 133.86 33.88 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 124.326 1.05 . . . . 1.0 111.715 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -131.2 148.17 52.68 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 125.408 1.693 . . . . 1.0 109.382 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -91.18 149.33 21.83 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.19 -0.19 81.99 Favored Glycine 0 C--N 1.374 2.673 0 O-C-N 124.648 1.217 . . . . 1.0 114.573 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -85.22 -15.4 43.72 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.407 1.483 . . . . 1.0 111.872 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.4 p -91.07 2.28 56.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.688 1.195 . . . . 1.0 111.484 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.67 144.61 45.86 Favored Pre-proline 0 C--N 1.386 2.178 0 CA-C-O 117.242 -1.361 . . . . 1.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.1 157.06 61.57 Favored 'Trans proline' 1 C--N 1.437 5.211 0 C-N-CA 122.897 2.398 . . . . 1.0 114.066 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.48 -30.71 71.46 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 124.606 1.163 . . . . 1.0 113.502 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.22 -38.71 84.2 Favored 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.764 1.626 . . . . 1.0 113.309 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.6 -28.7 62.94 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 124.874 1.27 . . . . 1.0 112.836 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.24 72.22 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.957 1.703 . . . . 1.0 112.691 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.96 -25.07 60.89 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.713 1.605 . . . . 1.0 112.573 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -73.64 -28.51 61.83 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.743 1.617 . . . . 1.0 112.387 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.527 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.95 -36.22 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 C-N-CA 126.333 1.853 . . . . 1.0 110.17 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.17 -29.43 70.55 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.326 1.45 . . . . 1.0 113.475 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.07 -39.06 89.76 Favored 'General case' 0 C--N 1.389 2.303 0 C-N-CA 125.733 1.613 . . . . 1.0 113.09 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -74.0 -32.2 63.3 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 124.779 1.232 . . . . 1.0 112.495 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -82.86 -22.39 34.06 Favored 'General case' 0 C--N 1.371 1.54 0 C-N-CA 125.502 1.521 . . . . 1.0 112.901 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -87.01 -21.64 26.0 Favored 'General case' 0 C--N 1.381 1.941 0 C-N-CA 124.715 1.206 . . . . 1.0 112.587 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.32 -34.57 28.52 Favored 'General case' 0 C--N 1.379 1.859 0 C-N-CA 125.003 1.321 . . . . 1.0 113.023 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.95 -59.08 0.15 Allowed 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 127.931 2.493 . . . . 1.0 114.026 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -124.72 134.83 52.7 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 126.147 1.779 . . . . 1.0 109.444 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.42 -111.7 0.27 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 125.062 1.476 . . . . 1.0 111.686 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -113.73 49.09 0.87 Allowed Glycine 0 C--N 1.351 1.416 0 O-C-N 125.768 1.511 . . . . 1.0 112.238 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.19 123.2 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -118.17 128.17 54.46 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 125.417 1.698 . . . . 1.0 109.874 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -80.71 -27.37 36.99 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 124.707 1.203 . . . . 1.0 113.212 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.2 -36.15 27.57 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.434 1.494 . . . . 1.0 112.856 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -94.41 -17.48 22.47 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 124.594 1.184 . . . . 1.0 112.992 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 56.88 58.23 4.18 Favored 'General case' 0 N--CA 1.525 3.298 0 C-N-CA 126.896 2.078 . . . . 1.0 112.015 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -125.23 129.11 49.4 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.508 -1.678 . . . . 1.0 110.307 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.479 HG21 ' HB ' ' A' ' 24' ' ' ILE . 1.8 t -120.43 128.06 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 125.535 1.772 . . . . 1.0 107.9 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.23 131.4 53.91 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 125.486 1.741 . . . . 1.0 109.977 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.08 131.56 54.04 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 125.13 1.519 . . . . 1.0 110.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 C--O 1.252 1.212 0 O-C-N 125.212 1.57 . . . . 1.0 111.315 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.366 0.136 . . . . 1.0 111.366 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 140.45 41.55 Favored 'General case' 0 C--O 1.244 0.805 0 O-C-N 125.418 1.699 . . . . 1.0 110.478 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -120.87 138.27 54.16 Favored 'General case' 0 C--O 1.248 0.999 0 O-C-N 124.889 1.368 . . . . 1.0 110.825 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.5 t -73.25 131.23 83.38 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 117.28 -1.343 . . . . 1.0 111.8 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.91 -10.13 22.82 Favored 'Trans proline' 1 C--N 1.432 4.97 0 C-N-CA 121.954 1.769 . . . . 1.0 114.77 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.555 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mt -95.1 -55.62 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 125.164 1.386 . . . . 1.0 110.179 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 28.2 p -102.83 -41.72 6.08 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 124.165 0.915 . . . . 1.0 113.171 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 88.38 38.0 7.36 Favored Glycine 0 C--N 1.372 2.543 0 O-C-N 124.687 1.242 . . . . 1.0 112.572 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.564 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -88.38 143.81 33.0 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 116.962 -1.494 . . . . 1.0 113.039 -178.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.65 126.98 16.3 Favored 'Trans proline' 1 C--N 1.449 5.861 0 C-N-CA 122.79 2.327 . . . . 1.0 114.642 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mt -122.9 145.01 48.84 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 125.208 1.567 . . . . 1.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' O ' HD12 ' A' ' 23' ' ' LEU . 84.3 mttt -93.62 130.33 39.57 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 124.858 1.349 . . . . 1.0 110.563 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.479 ' O ' HG12 ' A' ' 24' ' ' ILE . 31.1 m95 -68.05 -27.35 66.45 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 124.736 1.215 . . . . 1.0 112.822 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 8.8 pt-20 -72.63 -33.44 66.63 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.639 1.976 . . . . 1.0 113.152 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.79 -32.6 63.85 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 125.212 1.405 . . . . 1.0 113.418 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -68.24 -37.71 81.07 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.103 1.761 . . . . 1.0 113.282 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.7 mm -77.04 -28.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 C-N-CA 125.665 1.586 . . . . 1.0 110.835 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.75 -34.3 71.71 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 125.261 1.424 . . . . 1.0 113.209 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.0 -22.79 39.17 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.346 1.458 . . . . 1.0 112.851 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.446 ' O ' HD12 ' A' ' 30' ' ' ILE . 38.7 mtp -104.62 14.7 29.39 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 124.701 1.25 . . . . 1.0 112.757 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 24.96 5.01 Favored 'General case' 0 CA--C 1.578 2.053 0 C-N-CA 123.665 0.786 . . . . 1.0 112.867 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.51 0.28 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 C-N-CA 125.092 1.357 . . . . 1.0 111.98 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.93 140.68 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 125.155 1.382 . . . . 1.0 109.205 -178.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.39 -18.43 48.96 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 124.75 1.281 . . . . 1.0 113.778 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -81.09 -18.6 46.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.902 1.281 . . . . 1.0 112.356 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.576 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.7 t80 -59.48 -35.64 74.49 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.196 1.798 . . . . 1.0 113.15 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.33 -29.87 69.15 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 125.47 1.508 . . . . 1.0 112.161 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.72 -33.36 20.04 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.596 1.559 . . . . 1.0 112.458 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.8 mt -71.63 -39.65 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.982 0 C-N-CA 125.696 1.598 . . . . 1.0 110.632 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 78' ' ' LEU . 9.2 m -60.17 -20.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 125.355 1.462 . . . . 1.0 114.66 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.89 -18.85 25.37 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.128 1.371 . . . . 1.0 113.352 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -125.55 109.31 12.51 Favored 'General case' 0 C--N 1.373 1.588 0 C-N-CA 124.195 0.998 . . . . 1.0 111.709 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.488 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.1 mpp_? -59.42 -34.1 72.06 Favored 'General case' 0 N--CA 1.517 2.918 0 C-N-CA 125.348 1.459 . . . . 1.0 113.605 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.93 -30.53 70.69 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.724 1.609 . . . . 1.0 112.742 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -82.17 -33.56 29.44 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 125.354 1.462 . . . . 1.0 112.211 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -73.06 -43.78 61.48 Favored 'General case' 0 C--N 1.392 2.455 0 C-N-CA 125.144 1.378 . . . . 1.0 112.698 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -68.64 -30.93 69.74 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 124.864 1.266 . . . . 1.0 112.45 177.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.53 40.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.899 1.374 . . . . 1.0 112.831 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.431 HE21 HD13 ' A' ' 36' ' ' ILE . 2.7 mm100 -79.37 -38.83 34.06 Favored 'General case' 0 C--N 1.385 2.121 0 C-N-CA 125.133 1.373 . . . . 1.0 112.524 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 43' ' ' PHE . 28.5 t -71.46 -40.04 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 125.238 1.415 . . . . 1.0 109.896 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.511 2.596 0 C-N-CA 125.268 1.427 . . . . 1.0 113.558 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.73 -26.61 16.21 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.853 1.261 . . . . 1.0 113.042 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.01 143.87 26.14 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 124.851 1.261 . . . . 1.0 111.521 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.4 153.09 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.677 0 O-C-N 125.062 1.476 . . . . 1.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.15 145.61 51.73 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 124.969 1.418 . . . . 1.0 111.072 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.43 141.65 35.6 Favored 'General case' 0 C--O 1.25 1.119 0 O-C-N 124.905 1.378 . . . . 1.0 111.161 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.68 128.91 48.75 Favored Pre-proline 0 CA--C 1.57 1.713 0 O-C-N 124.769 1.293 . . . . 1.0 111.231 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.19 -9.5 21.95 Favored 'Trans proline' 1 C--N 1.43 4.856 0 C-N-CA 122.418 2.079 . . . . 1.0 114.156 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.86 -51.22 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.463 1.505 . . . . 1.0 110.312 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.6 m -89.32 -52.81 4.85 Favored 'General case' 0 C--N 1.378 1.816 0 O-C-N 124.301 1.001 . . . . 1.0 112.635 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.16 -10.36 47.29 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 124.708 1.255 . . . . 1.0 113.108 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -85.69 152.48 23.05 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 125.726 1.61 . . . . 1.0 111.306 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.72 136.93 32.75 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.377 1.048 . . . . 1.0 112.056 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.97 143.75 51.2 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 125.425 1.703 . . . . 1.0 109.175 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.38 151.86 19.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.253 0.971 . . . . 1.0 112.547 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.35 -8.82 80.69 Favored Glycine 0 C--N 1.378 2.886 0 O-C-N 124.362 1.039 . . . . 1.0 114.659 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -86.77 -20.98 26.83 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.498 1.519 . . . . 1.0 111.945 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -95.34 5.49 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.959 1.303 . . . . 1.0 111.784 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.69 70.22 Favored Pre-proline 0 C--N 1.386 2.174 0 CA-C-O 116.981 -1.485 . . . . 1.0 112.034 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -62.23 147.71 94.51 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 123.102 2.535 . . . . 1.0 114.693 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -64.05 -18.41 64.32 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 125.44 1.496 . . . . 1.0 114.649 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -82.74 -30.05 29.32 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 124.98 1.312 . . . . 1.0 111.843 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -73.91 -28.41 61.52 Favored 'General case' 0 C--N 1.384 2.105 0 C-N-CA 125.659 1.584 . . . . 1.0 113.059 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.44 -32.2 73.7 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 125.819 1.648 . . . . 1.0 112.615 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -74.49 -26.34 59.95 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.606 1.563 . . . . 1.0 112.148 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -73.09 -26.94 61.44 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.931 1.692 . . . . 1.0 112.604 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.3 t -64.37 -37.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 C-N-CA 126.125 1.77 . . . . 1.0 110.048 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -60.79 -29.72 69.62 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 125.012 1.325 . . . . 1.0 114.038 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.12 -41.13 82.2 Favored 'General case' 0 C--N 1.383 2.05 0 C-N-CA 125.609 1.564 . . . . 1.0 113.175 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.63 -34.7 70.04 Favored 'General case' 0 C--N 1.379 1.881 0 C-N-CA 124.857 1.263 . . . . 1.0 112.979 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -81.21 -22.14 39.06 Favored 'General case' 0 C--N 1.373 1.614 0 O-C-N 124.915 1.384 . . . . 1.0 112.652 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -85.62 -15.3 42.96 Favored 'General case' 0 C--N 1.386 2.177 0 C-N-CA 124.275 1.03 . . . . 1.0 112.815 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.65 -35.91 82.15 Favored 'General case' 0 C--N 1.388 2.256 0 C-N-CA 125.356 1.462 . . . . 1.0 113.469 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.97 -66.44 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 127.864 2.466 . . . . 1.0 114.147 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -130.38 137.37 49.85 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 125.684 1.594 . . . . 1.0 109.249 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.5 -106.94 0.21 Allowed Glycine 0 C--N 1.351 1.379 0 O-C-N 125.017 1.448 . . . . 1.0 111.656 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.97 46.35 1.19 Allowed Glycine 0 C--N 1.354 1.564 0 O-C-N 125.662 1.448 . . . . 1.0 113.051 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.45 122.31 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -122.05 129.95 52.86 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.443 1.714 . . . . 1.0 110.166 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.77 -28.88 36.25 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.728 1.267 . . . . 1.0 113.326 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.36 -37.0 26.28 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.119 1.368 . . . . 1.0 112.973 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.73 -17.98 23.53 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.567 1.147 . . . . 1.0 113.091 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.4 mttt 57.4 61.85 2.36 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 127.171 2.188 . . . . 1.0 112.125 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 98.3 mtt180 -125.5 128.99 48.88 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 113.381 -1.736 . . . . 1.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 2.0 t -123.46 129.06 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 125.504 1.752 . . . . 1.0 107.424 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.22 135.31 53.34 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 125.156 1.535 . . . . 1.0 110.213 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.54 128.55 56.06 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.056 1.472 . . . . 1.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--O 1.249 1.057 0 O-C-N 125.466 1.729 . . . . 1.0 111.325 -179.912 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.438 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 35.7 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 111.221 0.082 . . . . 1.0 111.221 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -112.16 140.0 47.22 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.264 1.602 . . . . 1.0 110.611 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -124.28 139.17 54.17 Favored 'General case' 0 C--O 1.247 0.961 0 O-C-N 124.947 1.405 . . . . 1.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.576 ' SG ' HD12 ' A' ' 13' ' ' ILE . 22.9 t -76.52 121.53 85.03 Favored Pre-proline 0 CA--C 1.576 1.98 0 O-C-N 124.531 1.144 . . . . 1.0 111.214 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.89 -6.07 18.01 Favored 'Trans proline' 1 C--N 1.428 4.74 0 C-N-CA 122.083 1.855 . . . . 1.0 114.512 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.576 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.2 mt -97.03 -55.59 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 124.993 1.317 . . . . 1.0 110.103 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -101.68 -39.09 7.61 Favored 'General case' 0 C--N 1.37 1.467 0 O-C-N 124.543 1.152 . . . . 1.0 112.979 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.54 30.07 12.68 Favored Glycine 0 C--N 1.368 2.325 0 O-C-N 124.901 1.376 . . . . 1.0 113.456 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -93.76 146.79 32.39 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 117.001 -1.476 . . . . 1.0 112.536 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.08 136.02 39.47 Favored 'Trans proline' 1 C--N 1.451 5.965 0 C-N-CA 122.706 2.271 . . . . 1.0 113.971 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.57 145.97 47.44 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 125.445 1.716 . . . . 1.0 110.778 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -95.14 125.73 39.99 Favored 'General case' 0 C--N 1.361 1.099 0 O-C-N 124.971 1.419 . . . . 1.0 110.96 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.51 ' O ' HG12 ' A' ' 24' ' ' ILE . 38.5 m95 -68.6 -25.0 64.65 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 124.897 1.279 . . . . 1.0 112.798 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 34.5 mt-10 -69.69 -32.8 71.62 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.64 1.576 . . . . 1.0 112.009 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.07 -34.4 57.06 Favored 'General case' 0 C--N 1.382 2.012 0 C-N-CA 124.869 1.268 . . . . 1.0 112.331 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.15 -40.67 94.7 Favored 'General case' 0 C--N 1.385 2.126 0 C-N-CA 125.934 1.694 . . . . 1.0 112.774 178.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 20' ' ' TRP . 11.0 mm -78.68 -38.68 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 C-N-CA 125.506 1.522 . . . . 1.0 110.077 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -68.54 -34.11 75.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 124.881 1.272 . . . . 1.0 113.249 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.27 -23.38 37.99 Favored 'General case' 0 C--N 1.375 1.704 0 C-N-CA 125.427 1.491 . . . . 1.0 112.53 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -103.32 15.55 28.85 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 124.652 1.22 . . . . 1.0 112.045 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 14.75 27.57 Favored 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 124.061 0.944 . . . . 1.0 112.654 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.48 4.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 C-N-CA 125.76 1.624 . . . . 1.0 112.779 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -105.12 141.36 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.654 1.182 . . . . 1.0 109.011 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -81.3 -17.6 48.73 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.783 1.302 . . . . 1.0 113.372 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -86.6 -11.19 52.16 Favored 'General case' 0 C--N 1.371 1.532 0 C-N-CA 124.899 1.28 . . . . 1.0 112.152 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -56.41 -36.86 69.42 Favored 'General case' 0 N--CA 1.511 2.616 0 C-N-CA 125.514 1.526 . . . . 1.0 112.419 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.37 -29.57 69.99 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 124.771 1.228 . . . . 1.0 112.13 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.94 -38.8 17.6 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.11 1.364 . . . . 1.0 112.006 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.411 HG12 ' OE1' ' A' ' 46' ' ' GLN . 5.2 mt -72.17 -40.78 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 C-N-CA 125.329 1.451 . . . . 1.0 110.805 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.7 p -65.85 -18.26 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.599 2.864 0 C-N-CA 125.574 1.55 . . . . 1.0 113.884 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.79 -18.64 28.92 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.716 1.207 . . . . 1.0 113.259 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.04 111.97 15.33 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 124.537 1.135 . . . . 1.0 111.17 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.494 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.5 mtm180 -59.29 -35.48 73.85 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 125.54 1.536 . . . . 1.0 113.125 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.51 -30.28 69.06 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 1.0 113.351 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 80.9 mtt180 -81.64 -34.24 30.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.055 1.342 . . . . 1.0 112.396 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.8 t80 -74.66 -41.99 59.3 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 124.829 1.252 . . . . 1.0 112.664 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.4 mt -66.21 -32.48 73.93 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.626 1.17 . . . . 1.0 112.654 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.45 -24.65 34.18 Favored 'General case' 0 C--N 1.371 1.525 0 O-C-N 124.994 1.434 . . . . 1.0 112.356 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -79.23 -36.2 40.38 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.041 1.336 . . . . 1.0 112.72 178.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 43' ' ' PHE . 32.8 t -72.13 -41.18 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 125.369 1.467 . . . . 1.0 109.463 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 125.592 1.557 . . . . 1.0 113.412 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -95.47 -25.34 16.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.605 1.19 . . . . 1.0 112.986 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -101.18 144.66 29.8 Favored 'General case' 0 C--N 1.368 1.399 0 C-N-CA 124.496 1.118 . . . . 1.0 111.126 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.24 155.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 O-C-N 125.073 1.483 . . . . 1.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.38 144.08 51.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 125.194 1.559 . . . . 1.0 110.108 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -95.2 138.59 32.7 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.823 -1.535 . . . . 1.0 111.463 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.5 t -96.54 115.11 65.49 Favored Pre-proline 0 CA--C 1.568 1.673 0 O-C-N 125.044 1.465 . . . . 1.0 110.306 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.08 -5.77 17.17 Favored 'Trans proline' 1 C--N 1.432 4.93 0 C-N-CA 122.333 2.022 . . . . 1.0 114.415 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.2 t -89.99 -51.11 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 126.12 1.768 . . . . 1.0 110.557 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.8 p -103.03 -48.68 3.98 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.625 1.203 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.53 -2.56 21.86 Favored Glycine 0 C--N 1.368 2.321 0 O-C-N 124.466 1.104 . . . . 1.0 114.123 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -94.95 146.4 24.27 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 124.961 1.304 . . . . 1.0 111.197 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.61 139.37 30.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.696 1.248 . . . . 1.0 112.23 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -123.19 145.12 48.9 Favored 'General case' 0 C--O 1.247 0.96 0 O-C-N 125.46 1.725 . . . . 1.0 109.547 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.72 151.04 20.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.348 1.03 . . . . 1.0 112.267 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.5 -9.19 81.76 Favored Glycine 0 C--N 1.377 2.861 0 O-C-N 124.293 0.996 . . . . 1.0 114.479 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -86.61 -19.59 29.13 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.186 1.394 . . . . 1.0 112.072 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -94.7 3.6 54.85 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.848 1.259 . . . . 1.0 111.752 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.22 146.44 38.13 Favored Pre-proline 0 C--N 1.382 1.996 0 CA-C-O 117.491 -1.242 . . . . 1.0 111.763 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.08 154.99 70.76 Favored 'Trans proline' 1 C--N 1.436 5.166 0 C-N-CA 122.972 2.448 . . . . 1.0 114.706 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.89 -31.62 72.86 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.437 1.095 . . . . 1.0 113.384 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.02 -37.81 75.03 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 125.333 1.453 . . . . 1.0 113.541 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.8 mt-10 -77.02 -28.32 54.91 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 124.851 1.26 . . . . 1.0 112.452 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.19 73.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.954 1.702 . . . . 1.0 112.628 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.51 -25.28 61.34 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.501 1.52 . . . . 1.0 112.398 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 91.7 mttt -73.45 -26.39 60.91 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 125.908 1.683 . . . . 1.0 112.5 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.39 -36.98 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 C-N-CA 126.37 1.868 . . . . 1.0 110.206 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.26 -29.82 69.04 Favored 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 125.398 1.479 . . . . 1.0 113.59 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -43.19 84.21 Favored 'General case' 0 C--N 1.382 1.987 0 C-N-CA 125.331 1.452 . . . . 1.0 113.196 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -69.98 -32.99 71.48 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.015 1.326 . . . . 1.0 112.849 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -81.3 -18.42 45.89 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.208 1.403 . . . . 1.0 112.835 178.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -102.1 -13.92 17.3 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 124.53 1.132 . . . . 1.0 111.935 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.81 69.42 0.7 Allowed 'General case' 0 C--N 1.372 1.548 0 CA-C-O 122.893 1.33 . . . . 1.0 109.339 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -75.18 -24.16 57.81 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 113.443 -1.708 . . . . 1.0 112.949 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -106.66 134.61 49.54 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 124.837 1.335 . . . . 1.0 109.342 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.63 -96.64 0.16 Allowed Glycine 0 C--N 1.356 1.657 0 O-C-N 124.981 1.426 . . . . 1.0 112.148 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.26 50.99 0.79 Allowed Glycine 0 C--N 1.362 1.993 0 O-C-N 125.439 1.317 . . . . 1.0 113.623 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -119.97 121.58 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.11 133.67 51.57 Favored 'General case' 0 C--O 1.249 1.026 0 O-C-N 125.487 1.742 . . . . 1.0 110.61 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -80.37 -32.12 37.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.71 1.256 . . . . 1.0 113.252 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.94 -36.39 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.086 1.355 . . . . 1.0 112.997 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.17 -20.09 20.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.475 1.11 . . . . 1.0 113.173 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.7 mttm 58.28 56.35 4.52 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 127.07 2.148 . . . . 1.0 113.11 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 93.3 mtt180 -115.41 128.68 56.22 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.44 -1.709 . . . . 1.0 110.431 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.48 125.26 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 125.466 1.729 . . . . 1.0 108.457 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -121.18 131.9 54.51 Favored 'General case' 0 C--O 1.251 1.174 0 O-C-N 125.519 1.762 . . . . 1.0 109.988 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.6 133.32 55.39 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 125.202 1.563 . . . . 1.0 110.576 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.1 mttt . . . . . 0 C--O 1.252 1.236 0 O-C-N 125.338 1.649 . . . . 1.0 111.244 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.563 ' N ' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.865 -0.05 . . . . 1.0 110.865 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.81 138.95 43.14 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 125.315 1.635 . . . . 1.0 110.627 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.37 138.94 49.91 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 124.93 1.394 . . . . 1.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 13' ' ' ILE . 12.4 t -70.19 123.15 88.3 Favored Pre-proline 0 CA--C 1.577 1.992 0 O-C-N 124.477 1.11 . . . . 1.0 112.199 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.64 -11.5 26.16 Favored 'Trans proline' 1 C--N 1.43 4.826 0 C-N-CA 121.932 1.755 . . . . 1.0 114.922 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.479 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -91.81 -53.8 8.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 C-N-CA 125.299 1.44 . . . . 1.0 111.018 -177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.6 -41.15 6.05 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 124.218 0.949 . . . . 1.0 112.434 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 29.51 8.63 Favored Glycine 0 C--N 1.366 2.239 0 O-C-N 124.678 1.236 . . . . 1.0 113.748 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.22 144.68 29.39 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 116.796 -1.573 . . . . 1.0 113.096 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.88 139.29 39.45 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 122.71 2.273 . . . . 1.0 113.661 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 144.36 48.22 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.32 1.638 . . . . 1.0 110.432 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -95.76 133.17 40.19 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.928 1.392 . . . . 1.0 111.052 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 60.8 m95 -68.69 -26.45 65.3 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 124.798 1.239 . . . . 1.0 113.248 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 93' ' ' LYS . 35.9 mt-10 -72.09 -31.24 65.89 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.645 1.578 . . . . 1.0 112.623 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.92 -34.5 62.14 Favored 'General case' 0 C--N 1.385 2.123 0 C-N-CA 125.168 1.387 . . . . 1.0 112.603 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -39.89 87.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 125.758 1.623 . . . . 1.0 113.882 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.6 mm -78.58 -41.03 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 125.156 1.382 . . . . 1.0 110.676 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.3 -36.71 82.07 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 124.84 1.256 . . . . 1.0 113.311 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.72 -21.11 48.56 Favored 'General case' 0 C--N 1.375 1.714 0 C-N-CA 125.308 1.443 . . . . 1.0 112.967 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.506 ' SD ' ' HE1' ' A' ' 52' ' ' PHE . 35.0 mtp -105.56 16.78 24.9 Favored 'General case' 0 CA--C 1.575 1.923 0 O-C-N 124.67 1.231 . . . . 1.0 112.367 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.8 18.43 14.49 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.48 13.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 124.765 1.226 . . . . 1.0 111.918 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -114.81 140.5 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 124.736 1.215 . . . . 1.0 108.723 -178.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.04 -16.28 44.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 125.028 1.455 . . . . 1.0 113.411 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.424 ' H ' HG22 ' A' ' 30' ' ' ILE . 7.7 m120 -83.55 -15.66 48.38 Favored 'General case' 0 C--N 1.376 1.725 0 C-N-CA 125.065 1.346 . . . . 1.0 112.556 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.596 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.4 t80 -57.06 -35.48 69.39 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 126.354 1.862 . . . . 1.0 113.315 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.33 -29.18 69.73 Favored 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 125.384 1.474 . . . . 1.0 112.411 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.85 -33.87 19.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.43 1.492 . . . . 1.0 112.662 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.9 mt -71.46 -39.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.909 0 C-N-CA 125.837 1.655 . . . . 1.0 110.457 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.518 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.3 m -61.57 -18.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 125.669 1.588 . . . . 1.0 114.692 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -88.38 -19.05 27.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.823 1.327 . . . . 1.0 113.256 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.48 110.67 12.99 Favored 'General case' 0 C--N 1.373 1.599 0 C-N-CA 124.473 1.109 . . . . 1.0 111.973 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -61.54 -32.38 72.44 Favored 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 125.331 1.452 . . . . 1.0 113.015 176.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.95 -31.88 71.07 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 125.475 1.51 . . . . 1.0 113.207 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -82.26 -32.65 29.54 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 125.212 1.405 . . . . 1.0 112.594 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 t80 -73.08 -46.01 53.93 Favored 'General case' 0 C--N 1.386 2.186 0 C-N-CA 124.976 1.31 . . . . 1.0 113.098 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -71.59 -33.16 68.8 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.033 1.333 . . . . 1.0 112.777 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.04 72.8 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.835 1.654 . . . . 1.0 112.742 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -78.75 -35.29 44.82 Favored 'General case' 0 C--N 1.382 1.986 0 C-N-CA 124.821 1.248 . . . . 1.0 112.908 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.1 t -69.05 -40.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.117 1.367 . . . . 1.0 109.173 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.63 -25.46 59.24 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 125.676 1.59 . . . . 1.0 113.477 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -94.32 -25.31 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.803 1.315 . . . . 1.0 113.522 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -105.33 143.3 33.68 Favored 'General case' 0 C--N 1.366 1.307 0 O-C-N 124.454 1.096 . . . . 1.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.75 153.83 3.2 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 O-C-N 125.094 1.496 . . . . 1.0 111.599 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.506 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 99.1 m-85 -125.14 144.26 50.52 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 125.093 1.496 . . . . 1.0 110.332 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -95.17 139.89 30.86 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.208 1.567 . . . . 1.0 111.072 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -92.35 130.23 38.28 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 125.057 1.473 . . . . 1.0 111.807 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.68 -8.06 20.99 Favored 'Trans proline' 1 C--N 1.437 5.205 0 C-N-CA 122.698 2.265 . . . . 1.0 114.292 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.22 -55.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 124.843 1.257 . . . . 1.0 110.43 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.2 p -98.14 -52.5 3.67 Favored 'General case' 0 C--N 1.372 1.547 0 O-C-N 124.302 1.001 . . . . 1.0 111.682 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.31 25.12 7.98 Favored Glycine 0 C--N 1.367 2.267 0 O-C-N 124.722 1.264 . . . . 1.0 114.747 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -105.64 147.97 27.88 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 124.591 1.156 . . . . 1.0 111.076 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -83.65 134.38 34.78 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 124.563 1.165 . . . . 1.0 112.393 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -132.8 148.33 52.31 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 125.444 1.715 . . . . 1.0 109.826 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -94.05 149.82 20.89 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.339 1.024 . . . . 1.0 112.627 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 -9.27 86.95 Favored Glycine 0 C--N 1.375 2.714 0 O-C-N 124.727 1.267 . . . . 1.0 114.111 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -82.34 -17.29 46.22 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 125.31 1.444 . . . . 1.0 112.671 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -91.24 -5.41 54.85 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 124.363 1.065 . . . . 1.0 112.194 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 145.48 44.83 Favored Pre-proline 0 C--N 1.385 2.114 0 CA-C-O 117.232 -1.366 . . . . 1.0 111.887 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.4 160.1 44.31 Favored 'Trans proline' 1 C--N 1.437 5.234 0 C-N-CA 123.024 2.483 . . . . 1.0 114.679 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -62.44 -30.13 71.01 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.501 1.12 . . . . 1.0 113.735 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.1 -37.76 77.94 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 125.561 1.545 . . . . 1.0 112.999 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.74 -29.34 40.52 Favored 'General case' 0 C--N 1.381 1.962 0 C-N-CA 124.985 1.314 . . . . 1.0 111.746 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.06 73.48 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 125.834 1.654 . . . . 1.0 112.312 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.41 -28.12 63.79 Favored 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 125.791 1.637 . . . . 1.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HZ2' ' N ' ' A' ' 8' ' ' MET . 90.3 mttt -68.58 -27.87 66.44 Favored 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 125.978 1.711 . . . . 1.0 112.547 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.9 t -65.6 -37.37 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.019 0 C-N-CA 126.322 1.849 . . . . 1.0 109.97 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -28.37 69.9 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 125.182 1.393 . . . . 1.0 113.349 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.29 -41.21 77.09 Favored 'General case' 0 C--N 1.383 2.046 0 C-N-CA 125.473 1.509 . . . . 1.0 112.913 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -70.72 -32.1 69.19 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.763 1.225 . . . . 1.0 113.243 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -81.25 -20.31 41.25 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.237 1.415 . . . . 1.0 112.868 177.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -99.88 -16.0 18.17 Favored 'General case' 0 C--N 1.371 1.519 0 C-N-CA 124.76 1.224 . . . . 1.0 112.189 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -108.82 69.01 0.7 Allowed 'General case' 0 C--N 1.37 1.495 0 CA-C-O 122.898 1.332 . . . . 1.0 109.46 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -71.75 -28.44 63.66 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.308 -1.769 . . . . 1.0 113.083 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -103.53 134.89 46.13 Favored 'General case' 0 C--N 1.366 1.303 0 O-C-N 124.989 1.431 . . . . 1.0 109.718 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.98 -95.29 0.14 Allowed Glycine 0 C--N 1.355 1.588 0 O-C-N 125.165 1.541 . . . . 1.0 112.18 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.01 46.9 0.96 Allowed Glycine 0 C--N 1.361 1.922 0 O-C-N 125.34 1.259 . . . . 1.0 113.824 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -120.3 122.58 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -124.77 131.56 53.44 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 125.574 1.796 . . . . 1.0 110.468 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -80.85 -27.51 36.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.85 1.344 . . . . 1.0 113.51 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.44 -35.65 27.36 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.207 1.403 . . . . 1.0 112.581 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -94.88 -17.37 22.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 124.692 1.245 . . . . 1.0 113.436 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mttm 58.98 50.76 7.92 Favored 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 127.166 2.186 . . . . 1.0 113.99 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 71.7 mtm180 -115.58 130.83 57.01 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.796 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.6 123.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 125.462 1.727 . . . . 1.0 107.793 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 86.4 mttt -124.7 132.38 53.39 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 125.716 1.885 . . . . 1.0 110.387 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 132.26 56.36 Favored 'General case' 0 C--O 1.246 0.898 0 O-C-N 125.332 1.645 . . . . 1.0 108.929 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.523 3.179 0 C-N-CA 127.386 2.274 . . . . 1.0 113.465 179.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.529 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 1.7 tpp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.873 -0.047 . . . . 1.0 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.02 139.8 47.23 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 125.286 1.616 . . . . 1.0 110.521 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -115.12 138.78 50.51 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.896 1.372 . . . . 1.0 110.724 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.0 t -74.67 119.65 77.73 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 117.29 -1.338 . . . . 1.0 111.819 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.17 -25.16 50.73 Favored 'Trans proline' 1 C--N 1.439 5.302 0 C-N-CA 122.3 2.0 . . . . 1.0 113.789 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.26 -54.14 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 C-N-CA 126.35 1.86 . . . . 1.0 112.826 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -108.64 -44.39 4.06 Favored 'General case' 0 C--N 1.37 1.457 0 O-C-N 124.175 0.922 . . . . 1.0 112.339 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.72 6.16 Favored Glycine 0 C--N 1.367 2.28 0 O-C-N 124.717 1.261 . . . . 1.0 113.725 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.81 146.48 31.39 Favored Pre-proline 0 C--N 1.369 1.44 0 CA-C-O 117.115 -1.421 . . . . 1.0 112.467 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.18 139.35 42.01 Favored 'Trans proline' 1 C--N 1.449 5.859 0 C-N-CA 122.728 2.286 . . . . 1.0 113.854 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.59 143.52 49.26 Favored 'General case' 0 C--O 1.25 1.124 0 O-C-N 125.341 1.651 . . . . 1.0 110.177 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.78 134.7 39.73 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 124.874 1.359 . . . . 1.0 111.005 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.457 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.3 m95 -68.49 -27.01 65.75 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.955 1.302 . . . . 1.0 112.872 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 7.3 pt-20 -71.76 -32.28 67.52 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.355 1.862 . . . . 1.0 112.661 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.1 -34.29 66.1 Favored 'General case' 0 C--N 1.385 2.152 0 C-N-CA 125.443 1.497 . . . . 1.0 112.963 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -39.91 84.2 Favored 'General case' 0 C--N 1.382 2.02 0 C-N-CA 125.665 1.586 . . . . 1.0 113.372 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -78.91 -40.96 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 125.524 1.529 . . . . 1.0 110.568 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.73 -38.16 86.12 Favored 'General case' 0 C--N 1.386 2.183 0 C-N-CA 125.144 1.377 . . . . 1.0 113.369 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.39 -20.91 50.18 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 125.466 1.506 . . . . 1.0 112.929 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.492 ' O ' HD12 ' A' ' 30' ' ' ILE . 3.0 mmt -106.01 12.25 30.67 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.813 1.321 . . . . 1.0 112.09 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.72 17.95 11.02 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.587 0.755 . . . . 1.0 113.02 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.8 11.02 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 C-N-CA 125.638 1.575 . . . . 1.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 32' ' ' ASN . 1.2 mt -115.21 138.3 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.827 1.251 . . . . 1.0 108.935 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.54 -17.85 35.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.132 1.52 . . . . 1.0 112.439 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' H ' HG22 ' A' ' 30' ' ' ILE . 47.9 m-80 -91.93 14.4 15.8 Favored 'General case' 0 CA--C 1.574 1.87 0 C-N-CA 125.289 1.436 . . . . 1.0 111.786 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -76.15 -36.21 58.85 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.387 1.475 . . . . 1.0 111.799 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' HA ' HG12 ' A' ' 37' ' ' VAL . 32.9 mt-10 -57.78 -23.8 54.13 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 126.026 1.73 . . . . 1.0 114.339 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.15 -43.64 14.79 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 125.352 1.461 . . . . 1.0 111.539 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.41 -42.4 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 125.589 1.555 . . . . 1.0 110.824 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 34' ' ' GLU . 1.5 p -67.75 -14.06 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.013 0 C-N-CA 125.318 1.447 . . . . 1.0 114.243 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -92.06 -22.29 20.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.839 1.256 . . . . 1.0 112.447 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.13 106.41 10.75 Favored 'General case' 0 C--N 1.371 1.51 0 O-C-N 124.569 1.168 . . . . 1.0 111.293 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -58.1 -33.89 69.6 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 125.829 1.651 . . . . 1.0 113.908 176.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.23 -33.08 74.59 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 125.813 1.645 . . . . 1.0 112.35 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.58 -34.36 27.74 Favored 'General case' 0 C--N 1.381 1.942 0 C-N-CA 125.619 1.568 . . . . 1.0 112.502 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.0 t80 -72.7 -45.95 56.18 Favored 'General case' 0 C--N 1.394 2.519 0 C-N-CA 125.207 1.403 . . . . 1.0 112.524 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.14 -33.11 72.92 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 124.932 1.293 . . . . 1.0 112.366 178.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.58 -31.63 65.37 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.82 1.648 . . . . 1.0 112.919 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.5 tt0 -79.24 -37.09 38.86 Favored 'General case' 0 C--N 1.384 2.084 0 C-N-CA 124.96 1.304 . . . . 1.0 112.482 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.7 t -69.29 -41.56 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 C-N-CA 125.455 1.502 . . . . 1.0 109.539 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 42.3 mt-10 -70.28 -25.56 63.4 Favored 'General case' 0 N--CA 1.516 2.832 0 C-N-CA 125.658 1.583 . . . . 1.0 113.545 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.53 -25.62 16.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.097 1.359 . . . . 1.0 113.171 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.11 141.7 35.39 Favored 'General case' 0 C--N 1.369 1.454 0 O-C-N 124.384 1.053 . . . . 1.0 111.658 -179.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.96 152.23 3.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 125.255 1.597 . . . . 1.0 111.634 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.18 144.16 50.08 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.062 1.476 . . . . 1.0 110.391 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -96.35 140.54 30.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.144 1.527 . . . . 1.0 111.07 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.9 t -94.69 130.75 32.35 Favored Pre-proline 0 CA--C 1.565 1.539 0 O-C-N 125.295 1.622 . . . . 1.0 112.044 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.02 -4.24 14.88 Favored 'Trans proline' 1 C--N 1.435 5.117 0 C-N-CA 122.353 2.035 . . . . 1.0 114.504 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.95 -54.83 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 125.389 1.475 . . . . 1.0 110.133 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 p -101.89 -52.6 3.14 Favored 'General case' 0 C--N 1.371 1.537 0 O-C-N 124.434 1.084 . . . . 1.0 111.566 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 22.07 9.56 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 124.547 1.154 . . . . 1.0 114.479 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -99.95 145.55 27.71 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 124.754 1.221 . . . . 1.0 111.215 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.39 133.75 34.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.856 1.348 . . . . 1.0 111.858 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -132.69 147.4 52.33 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 125.601 1.813 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.04 151.11 19.76 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.745 1.278 . . . . 1.0 112.729 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 48' ' ' GLU . . . -80.83 1.28 84.44 Favored Glycine 0 C--N 1.372 2.564 0 O-C-N 124.912 1.382 . . . . 1.0 114.508 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -88.85 -16.42 32.03 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.911 1.285 . . . . 1.0 112.015 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 p -89.78 -12.84 38.09 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 124.883 1.273 . . . . 1.0 113.312 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -75.29 146.88 82.14 Favored Pre-proline 0 CA--C 1.584 2.25 0 CA-C-O 116.747 -1.597 . . . . 1.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.51 156.28 66.78 Favored 'Trans proline' 1 C--N 1.445 5.643 0 C-N-CA 122.999 2.466 . . . . 1.0 113.4 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -58.98 -30.75 68.19 Favored 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.982 1.313 . . . . 1.0 114.146 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -61.03 -36.26 79.06 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.622 1.569 . . . . 1.0 113.111 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -76.55 -28.97 56.48 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 125.017 1.327 . . . . 1.0 111.905 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.43 -32.41 72.43 Favored 'General case' 0 C--N 1.388 2.281 0 C-N-CA 126.002 1.721 . . . . 1.0 112.449 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.79 -26.6 62.48 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 125.943 1.697 . . . . 1.0 112.662 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 91.5 mttt -68.99 -28.66 66.81 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 126.099 1.759 . . . . 1.0 112.565 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.532 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -66.53 -35.23 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 C-N-CA 126.481 1.912 . . . . 1.0 109.975 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.62 -29.43 70.68 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 125.539 1.535 . . . . 1.0 113.014 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -67.24 -38.87 85.91 Favored 'General case' 0 C--N 1.386 2.172 0 C-N-CA 125.845 1.658 . . . . 1.0 113.05 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.9 pp -75.01 -30.89 61.25 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 124.685 1.194 . . . . 1.0 112.46 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.1 -22.35 39.21 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 125.817 1.647 . . . . 1.0 113.25 177.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -99.86 -9.84 22.42 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 124.752 1.221 . . . . 1.0 112.869 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 1.1 m-20 -107.01 58.78 0.63 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-O 123.106 1.432 . . . . 1.0 111.016 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.53 -30.52 70.2 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.39 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -115.11 113.57 24.18 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 124.96 1.412 . . . . 1.0 109.168 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.79 106.14 1.34 Allowed Glycine 0 C--N 1.366 2.227 0 CA-C-N 114.552 -1.204 . . . . 1.0 113.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 128.31 -59.2 0.69 Allowed Glycine 0 C--N 1.36 1.867 0 O-C-N 125.453 1.325 . . . . 1.0 113.625 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.39 126.08 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 125.103 1.12 . . . . 1.0 108.314 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -119.4 134.16 55.35 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 125.57 1.794 . . . . 1.0 110.084 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -80.0 -31.46 39.72 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.875 1.27 . . . . 1.0 113.743 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.6 -35.61 29.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.275 1.43 . . . . 1.0 113.111 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -92.09 -15.92 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.733 1.213 . . . . 1.0 113.432 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 58.55 32.89 22.64 Favored 'General case' 0 N--CA 1.533 3.71 0 C-N-CA 127.158 2.183 . . . . 1.0 113.925 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -106.24 136.42 45.98 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 114.28 -1.327 . . . . 1.0 111.355 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.28 126.72 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.405 1.691 . . . . 1.0 107.838 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 14.9 tttt -122.51 128.4 50.76 Favored 'General case' 0 C--O 1.25 1.127 0 O-C-N 125.429 1.706 . . . . 1.0 109.89 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.18 132.29 47.27 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 124.978 1.424 . . . . 1.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 C--O 1.249 1.031 0 O-C-N 125.33 1.644 . . . . 1.0 111.208 179.805 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.63 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 5.5 ptm . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 111.282 0.105 . . . . 1.0 111.282 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -111.02 139.71 46.15 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 125.316 1.635 . . . . 1.0 110.601 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -118.52 139.04 52.07 Favored 'General case' 0 C--O 1.25 1.082 0 O-C-N 124.655 1.222 . . . . 1.0 110.981 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.485 ' SG ' HD12 ' A' ' 13' ' ' ILE . 34.0 t -70.81 121.02 82.65 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 117.777 -1.106 . . . . 1.0 111.761 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.01 -4.35 15.27 Favored 'Trans proline' 1 C--N 1.434 5.044 0 C-N-CA 122.19 1.927 . . . . 1.0 114.843 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.485 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.02 -56.05 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 125.253 1.421 . . . . 1.0 109.766 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.64 -41.04 6.07 Favored 'General case' 0 C--N 1.37 1.488 0 O-C-N 124.338 1.024 . . . . 1.0 113.195 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.9 34.57 6.46 Favored Glycine 0 C--N 1.368 2.327 0 O-C-N 124.81 1.319 . . . . 1.0 114.02 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -91.39 142.59 27.16 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 116.928 -1.51 . . . . 1.0 112.796 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 131.62 24.45 Favored 'Trans proline' 1 C--N 1.449 5.819 0 C-N-CA 122.602 2.201 . . . . 1.0 114.376 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mt -122.96 144.55 49.16 Favored 'General case' 0 C--O 1.25 1.118 0 O-C-N 125.125 1.516 . . . . 1.0 110.762 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.07 133.95 41.06 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 124.802 1.313 . . . . 1.0 110.681 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 24' ' ' ILE . 52.9 m95 -68.53 -26.65 65.54 Favored 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 124.899 1.28 . . . . 1.0 113.426 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.27 -31.75 66.03 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.59 1.556 . . . . 1.0 113.097 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.15 -33.48 65.52 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 125.277 1.431 . . . . 1.0 112.915 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.03 -39.92 82.99 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.884 1.674 . . . . 1.0 112.858 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 20' ' ' TRP . 6.1 mm -74.43 -41.03 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 125.806 1.643 . . . . 1.0 110.604 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.86 -36.86 83.29 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.389 1.476 . . . . 1.0 113.24 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.29 -22.63 41.39 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 125.355 1.462 . . . . 1.0 112.841 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.49 ' O ' HD12 ' A' ' 30' ' ' ILE . 48.6 mtp -104.61 12.1 33.42 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 124.681 1.238 . . . . 1.0 112.41 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.3 16.63 8.33 Favored 'General case' 0 CA--C 1.58 2.098 0 C-N-CA 123.826 0.85 . . . . 1.0 112.914 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -3.74 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 C-N-CA 125.747 1.619 . . . . 1.0 112.965 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.5 137.48 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.982 1.313 . . . . 1.0 109.255 -177.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.36 -27.07 61.29 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 125.752 1.621 . . . . 1.0 114.374 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -77.65 -17.98 57.17 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.117 1.367 . . . . 1.0 113.209 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.583 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.5 t80 -57.92 -36.46 72.5 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 126.077 1.751 . . . . 1.0 113.188 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -60.58 -29.34 69.13 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.468 1.507 . . . . 1.0 112.463 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.41 -34.52 20.14 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.48 1.512 . . . . 1.0 112.409 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.8 mt -71.04 -41.06 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 C-N-CA 125.759 1.624 . . . . 1.0 110.664 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.9 m -59.39 -21.82 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 125.545 1.538 . . . . 1.0 114.84 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -87.94 -21.11 25.09 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 125.052 1.341 . . . . 1.0 112.796 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -121.66 106.66 11.54 Favored 'General case' 0 C--N 1.371 1.541 0 O-C-N 124.323 1.015 . . . . 1.0 112.124 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.35 -34.82 72.84 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 126.106 1.762 . . . . 1.0 113.853 176.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.0 -32.24 72.5 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 125.941 1.696 . . . . 1.0 112.727 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -82.69 -32.54 28.01 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.329 1.451 . . . . 1.0 112.228 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -75.41 -46.51 32.37 Favored 'General case' 0 C--N 1.387 2.215 0 C-N-CA 125.013 1.325 . . . . 1.0 112.946 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -69.66 -33.37 72.5 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 124.789 1.236 . . . . 1.0 112.958 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.513 1.525 . . . . 1.0 113.206 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 5.4 mt-30 -79.29 -35.21 41.61 Favored 'General case' 0 C--N 1.379 1.86 0 C-N-CA 125.077 1.351 . . . . 1.0 112.833 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.0 t -67.84 -41.22 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 125.241 1.416 . . . . 1.0 109.354 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.63 -24.3 60.0 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 125.316 1.447 . . . . 1.0 113.507 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -94.42 -25.52 16.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.859 1.264 . . . . 1.0 113.327 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.08 148.46 25.71 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 124.343 1.057 . . . . 1.0 111.049 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -97.51 155.82 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 O-C-N 124.758 1.286 . . . . 1.0 110.439 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.473 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 95.8 m-85 -126.41 143.76 51.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.086 1.491 . . . . 1.0 110.311 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -97.11 137.39 36.23 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.861 1.351 . . . . 1.0 111.423 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.08 106.52 19.81 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 124.972 1.42 . . . . 1.0 110.025 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -69.39 -7.94 22.27 Favored 'Trans proline' 1 C--N 1.44 5.355 0 C-N-CA 123.132 2.555 . . . . 1.0 114.193 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.76 -50.94 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.944 1.698 . . . . 1.0 110.403 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.7 p -104.47 -50.15 3.39 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 124.596 1.185 . . . . 1.0 112.186 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.31 -0.42 14.35 Favored Glycine 0 C--N 1.37 2.434 0 O-C-N 124.534 1.146 . . . . 1.0 114.209 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -93.74 150.85 20.05 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 125.162 1.385 . . . . 1.0 111.521 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.18 138.16 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.607 1.163 . . . . 1.0 111.141 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.13 143.17 51.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.165 1.54 . . . . 1.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.69 150.45 21.78 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.431 1.082 . . . . 1.0 112.24 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -75.22 -8.34 83.3 Favored Glycine 0 C--N 1.377 2.83 0 O-C-N 124.485 1.116 . . . . 1.0 114.867 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -86.39 -20.89 27.56 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.386 1.474 . . . . 1.0 111.87 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.9 p -94.09 1.67 56.12 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.903 1.281 . . . . 1.0 112.61 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 144.77 30.43 Favored Pre-proline 0 C--N 1.379 1.856 0 CA-C-O 117.146 -1.407 . . . . 1.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.21 158.32 55.37 Favored 'Trans proline' 1 C--N 1.445 5.641 0 C-N-CA 123.032 2.488 . . . . 1.0 114.705 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -61.96 -33.07 73.61 Favored 'General case' 0 N--CA 1.515 2.776 0 C-N-CA 124.85 1.26 . . . . 1.0 113.074 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.31 -40.4 77.81 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 125.468 1.507 . . . . 1.0 112.505 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 29.1 mt-10 -76.73 -28.84 55.94 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.044 1.338 . . . . 1.0 112.102 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -68.44 -32.99 73.41 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 125.814 1.646 . . . . 1.0 112.391 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.7 -24.99 61.91 Favored 'General case' 0 C--N 1.382 2.018 0 C-N-CA 125.637 1.575 . . . . 1.0 112.697 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.63 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 93.8 mttt -68.62 -28.18 66.68 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 125.902 1.681 . . . . 1.0 112.217 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' HD12 ' A' ' 78' ' ' LEU . 2.8 t -66.97 -38.5 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 C-N-CA 126.385 1.874 . . . . 1.0 109.738 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -27.16 69.08 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 125.355 1.462 . . . . 1.0 113.352 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -68.49 -41.05 80.65 Favored 'General case' 0 C--N 1.388 2.245 0 C-N-CA 125.789 1.636 . . . . 1.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.44 -30.52 66.13 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.83 1.252 . . . . 1.0 112.739 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.6 -24.93 49.54 Favored 'General case' 0 C--N 1.378 1.806 0 C-N-CA 125.597 1.559 . . . . 1.0 112.726 177.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.3 -16.69 21.2 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 124.802 1.241 . . . . 1.0 112.231 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.77 62.51 0.6 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 123.057 1.408 . . . . 1.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.57 -25.09 62.05 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 113.48 -1.691 . . . . 1.0 113.313 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -106.72 134.25 50.15 Favored 'General case' 0 C--O 1.254 1.302 0 O-C-N 125.069 1.481 . . . . 1.0 109.254 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.58 -102.54 0.22 Allowed Glycine 0 C--N 1.356 1.652 0 O-C-N 124.949 1.405 . . . . 1.0 112.095 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.9 55.52 0.73 Allowed Glycine 0 C--N 1.359 1.825 0 O-C-N 125.441 1.318 . . . . 1.0 113.272 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -118.71 120.95 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 129.92 50.6 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 125.26 1.6 . . . . 1.0 110.599 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -80.86 -33.74 34.23 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.731 1.269 . . . . 1.0 113.445 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -82.28 -35.88 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.081 1.352 . . . . 1.0 112.95 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -88.7 -16.88 31.17 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.767 1.227 . . . . 1.0 113.139 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.0 mttt 59.11 52.41 6.24 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 127.337 2.255 . . . . 1.0 112.406 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 68.3 mtp180 -122.39 124.34 43.44 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 113.934 -1.484 . . . . 1.0 110.144 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.27 124.0 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 125.347 1.654 . . . . 1.0 107.391 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -124.86 134.71 52.61 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 125.401 1.688 . . . . 1.0 110.347 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.81 127.63 55.21 Favored 'General case' 0 C--O 1.252 1.207 0 O-C-N 125.205 1.565 . . . . 1.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.283 1.615 . . . . 1.0 111.247 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.342 0.127 . . . . 1.0 111.342 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -107.72 142.5 37.62 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.215 1.572 . . . . 1.0 110.855 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -123.26 138.34 54.65 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.785 1.303 . . . . 1.0 111.259 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.535 ' SG ' HD12 ' A' ' 13' ' ' ILE . 14.3 t -72.71 122.85 88.64 Favored Pre-proline 0 CA--C 1.582 2.173 0 C-N-CA 124.731 1.212 . . . . 1.0 112.675 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.54 -1.68 11.39 Favored 'Trans proline' 1 C--N 1.435 5.085 0 C-N-CA 122.106 1.871 . . . . 1.0 115.085 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.535 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -100.0 -55.97 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 124.614 1.165 . . . . 1.0 109.406 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -103.8 -41.93 5.76 Favored 'General case' 0 C--N 1.373 1.589 0 O-C-N 124.544 1.152 . . . . 1.0 112.985 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 90.82 35.73 7.1 Favored Glycine 0 C--N 1.369 2.371 0 O-C-N 124.751 1.282 . . . . 1.0 114.253 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -95.51 148.72 35.07 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 116.871 -1.538 . . . . 1.0 111.807 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -69.22 140.78 45.61 Favored 'Trans proline' 1 C--N 1.448 5.775 0 C-N-CA 122.844 2.363 . . . . 1.0 114.955 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mt -128.37 145.43 51.08 Favored 'General case' 0 C--O 1.249 1.052 0 O-C-N 125.524 1.765 . . . . 1.0 110.324 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -99.39 135.26 41.06 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.716 1.26 . . . . 1.0 110.888 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.438 ' O ' HG12 ' A' ' 24' ' ' ILE . 59.5 m95 -69.19 -24.87 64.1 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.049 1.339 . . . . 1.0 113.326 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -70.39 -30.42 67.31 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.022 1.729 . . . . 1.0 113.03 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.42 -35.07 63.4 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 125.16 1.384 . . . . 1.0 113.127 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -40.25 85.18 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.866 1.667 . . . . 1.0 113.602 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.8 mm -74.64 -41.24 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 C-N-CA 125.581 1.552 . . . . 1.0 110.531 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -67.29 -35.92 80.47 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.338 1.455 . . . . 1.0 113.591 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.4 -22.93 40.76 Favored 'General case' 0 C--N 1.375 1.685 0 C-N-CA 125.409 1.483 . . . . 1.0 113.452 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.493 ' O ' HD12 ' A' ' 30' ' ' ILE . 55.2 mtp -102.65 1.61 34.85 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 124.563 1.164 . . . . 1.0 113.0 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.45 12.96 3.26 Favored 'General case' 0 CA--C 1.582 2.177 0 C-N-CA 124.805 1.242 . . . . 1.0 113.765 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -8.12 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 125.344 1.457 . . . . 1.0 113.283 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 27' ' ' MET . 1.1 mt -98.98 137.53 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 125.109 1.364 . . . . 1.0 108.553 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -74.6 -27.36 60.44 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 124.831 1.332 . . . . 1.0 113.879 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.79 -22.86 62.32 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 125.243 1.417 . . . . 1.0 112.926 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -56.11 -34.1 65.73 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.527 1.931 . . . . 1.0 114.384 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.48 -28.33 69.89 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 125.268 1.427 . . . . 1.0 112.303 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.22 -34.62 20.41 Favored 'General case' 0 C--N 1.376 1.758 0 C-N-CA 125.421 1.488 . . . . 1.0 112.481 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 33' ' ' PHE . 4.5 mt -71.76 -39.63 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.863 0 C-N-CA 125.679 1.592 . . . . 1.0 110.423 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.0 m -61.14 -20.07 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.328 0 C-N-CA 125.188 1.395 . . . . 1.0 114.716 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -85.57 -19.95 30.31 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.091 1.356 . . . . 1.0 113.571 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.6 110.93 12.69 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 124.21 1.004 . . . . 1.0 111.666 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.447 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -60.35 -32.26 71.1 Favored 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 126.221 1.808 . . . . 1.0 115.451 177.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -68.43 -31.83 71.43 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.311 1.444 . . . . 1.0 113.337 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 72.3 mtp180 -82.42 -34.75 28.12 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.05 1.34 . . . . 1.0 112.869 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 t80 -70.51 -44.32 67.84 Favored 'General case' 0 C--N 1.389 2.287 0 C-N-CA 125.08 1.352 . . . . 1.0 112.605 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -70.21 -35.96 74.25 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.987 1.315 . . . . 1.0 113.144 178.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.15 -29.63 63.0 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.385 1.474 . . . . 1.0 113.204 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.1 tt0 -78.95 -34.4 44.41 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.368 1.467 . . . . 1.0 113.016 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 43' ' ' PHE . 89.7 t -69.89 -40.22 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.552 1.541 . . . . 1.0 109.762 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.12 -34.26 70.9 Favored 'General case' 0 N--CA 1.511 2.609 0 C-N-CA 125.575 1.55 . . . . 1.0 113.167 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.63 -27.36 29.19 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.318 1.447 . . . . 1.0 113.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -98.97 151.91 20.38 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.636 1.174 . . . . 1.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.05 148.0 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 O-C-N 124.664 1.227 . . . . 1.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.456 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 88.4 m-85 -121.71 152.04 39.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 124.671 1.232 . . . . 1.0 110.699 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -101.85 141.76 34.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.202 0.939 . . . . 1.0 111.28 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 24.1 t -96.05 119.39 64.69 Favored Pre-proline 0 CA--C 1.572 1.802 0 O-C-N 124.848 1.343 . . . . 1.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.07 -7.74 19.37 Favored 'Trans proline' 1 C--N 1.437 5.2 0 C-N-CA 122.25 1.967 . . . . 1.0 115.233 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.3 t -88.32 -51.94 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.394 0 C-N-CA 124.694 1.198 . . . . 1.0 110.299 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.38 -50.56 3.89 Favored 'General case' 0 C--N 1.367 1.343 0 O-C-N 124.691 1.245 . . . . 1.0 112.084 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.31 -14.57 12.1 Favored Glycine 0 C--N 1.371 2.523 0 O-C-N 124.473 1.108 . . . . 1.0 115.18 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -82.17 153.52 25.95 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 124.859 1.264 . . . . 1.0 112.565 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -87.45 138.41 31.5 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.163 1.385 . . . . 1.0 112.006 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -129.17 141.27 51.22 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 125.185 1.553 . . . . 1.0 109.814 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -96.3 151.53 19.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.318 1.011 . . . . 1.0 112.381 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.79 -8.02 86.33 Favored Glycine 0 C--N 1.378 2.884 0 O-C-N 124.437 1.085 . . . . 1.0 114.639 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -86.32 -19.6 29.57 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.466 1.506 . . . . 1.0 111.659 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.4 p -97.53 6.82 47.55 Favored 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 124.966 1.306 . . . . 1.0 112.055 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.76 159.07 55.75 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-O 117.344 -1.312 . . . . 1.0 111.393 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -69.68 154.51 67.98 Favored 'Trans proline' 1 C--N 1.441 5.432 0 C-N-CA 123.197 2.598 . . . . 1.0 114.227 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -68.26 -17.97 64.43 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 115.173 1.545 . . . . 1.0 115.173 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -83.67 -33.68 25.15 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.496 1.118 . . . . 1.0 112.221 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.5 mt-10 -69.86 -28.68 65.86 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.585 1.554 . . . . 1.0 113.49 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -64.27 -31.91 73.3 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 125.727 1.611 . . . . 1.0 112.852 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.19 -27.88 62.84 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 125.693 1.597 . . . . 1.0 111.987 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -68.26 -28.77 67.5 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 125.962 1.705 . . . . 1.0 112.65 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.472 ' O ' HD12 ' A' ' 78' ' ' LEU . 2.8 t -66.97 -40.06 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 C-N-CA 126.026 1.73 . . . . 1.0 109.331 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -28.0 65.57 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 125.772 1.629 . . . . 1.0 113.401 174.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -71.58 -42.63 67.54 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.188 1.795 . . . . 1.0 113.019 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.4 pp -67.28 -37.25 83.14 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.353 1.061 . . . . 1.0 112.513 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -71.2 -37.46 72.11 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.881 1.673 . . . . 1.0 113.079 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -80.68 -31.96 36.14 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.359 1.463 . . . . 1.0 114.129 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -98.64 57.81 1.18 Allowed 'General case' 0 C--O 1.26 1.646 0 CA-C-O 123.093 1.425 . . . . 1.0 110.712 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.45 145.61 24.33 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.005 -1.907 . . . . 1.0 111.48 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttm 77.46 112.02 0.07 Allowed 'General case' 0 N--CA 1.528 3.431 0 C-N-CA 127.46 2.304 . . . . 1.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.22 -74.49 0.22 Allowed Glycine 0 C--N 1.36 1.874 0 O-C-N 125.037 1.46 . . . . 1.0 112.953 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.59 31.02 5.36 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 125.314 1.243 . . . . 1.0 115.348 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.39 120.12 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.05 130.17 51.75 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 125.177 1.548 . . . . 1.0 110.689 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -81.39 -32.59 32.74 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.887 1.275 . . . . 1.0 114.029 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.32 -35.73 40.68 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 124.964 1.305 . . . . 1.0 113.3 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -94.73 -15.34 23.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.652 1.22 . . . . 1.0 113.336 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 60.12 51.31 5.78 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 127.193 2.197 . . . . 1.0 113.903 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -113.34 128.83 56.59 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.899 -1.501 . . . . 1.0 110.435 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.46 130.7 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 124.99 1.431 . . . . 1.0 108.147 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -121.71 137.04 54.92 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 125.048 1.467 . . . . 1.0 111.364 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.83 130.93 53.48 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.126 1.517 . . . . 1.0 109.727 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.7 mttp . . . . . 0 C--O 1.253 1.238 0 O-C-N 125.213 1.57 . . . . 1.0 111.287 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 36.4 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.85 138.67 41.65 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 125.272 1.608 . . . . 1.0 110.884 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -106.81 138.64 42.61 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 124.901 1.375 . . . . 1.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.507 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.8 t -73.76 130.3 83.69 Favored Pre-proline 0 CA--C 1.582 2.207 0 CA-C-O 116.907 -1.52 . . . . 1.0 112.151 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.12 -11.75 27.37 Favored 'Trans proline' 1 C--N 1.441 5.404 0 C-N-CA 122.573 2.182 . . . . 1.0 114.406 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.507 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -93.73 -55.12 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.221 1.408 . . . . 1.0 110.482 -177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 29.1 p -103.35 -41.16 6.11 Favored 'General case' 0 C--N 1.372 1.569 0 O-C-N 124.302 1.001 . . . . 1.0 113.424 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 89.13 34.6 8.67 Favored Glycine 0 C--N 1.371 2.525 0 O-C-N 124.818 1.324 . . . . 1.0 113.324 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.532 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -92.74 144.63 28.91 Favored Pre-proline 0 C--N 1.369 1.447 0 CA-C-O 117.016 -1.468 . . . . 1.0 112.808 -178.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.59 135.36 38.66 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 122.46 2.107 . . . . 1.0 114.839 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mt -120.16 144.92 47.41 Favored 'General case' 0 C--O 1.248 1.002 0 O-C-N 125.333 1.646 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -92.09 129.01 38.14 Favored 'General case' 0 C--N 1.362 1.111 0 O-C-N 124.876 1.36 . . . . 1.0 111.072 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.0 m95 -68.66 -25.58 64.89 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 125.136 1.374 . . . . 1.0 113.115 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 mt-10 -70.16 -32.27 70.15 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.936 1.695 . . . . 1.0 112.59 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -76.55 -34.1 58.51 Favored 'General case' 0 C--N 1.385 2.136 0 C-N-CA 125.225 1.41 . . . . 1.0 112.712 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -41.32 91.8 Favored 'General case' 0 C--N 1.383 2.051 0 C-N-CA 126.495 1.918 . . . . 1.0 112.764 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' TRP . 5.9 mm -78.97 -38.59 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 125.607 1.563 . . . . 1.0 110.445 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -65.49 -35.38 80.73 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 125.475 1.51 . . . . 1.0 113.491 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -80.46 -24.04 39.81 Favored 'General case' 0 C--N 1.375 1.683 0 C-N-CA 125.876 1.671 . . . . 1.0 112.451 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.475 ' O ' HD12 ' A' ' 30' ' ' ILE . 24.0 mtp -101.56 9.06 41.6 Favored 'General case' 0 CA--C 1.575 1.908 0 O-C-N 124.805 1.316 . . . . 1.0 112.943 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 13.4 13.77 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 124.163 0.985 . . . . 1.0 112.978 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.92 -6.36 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 125.606 1.562 . . . . 1.0 113.317 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -97.96 140.84 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 125.285 1.434 . . . . 1.0 109.048 -178.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.71 -19.1 42.22 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.852 1.345 . . . . 1.0 113.306 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.8 -19.94 50.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.183 1.393 . . . . 1.0 112.584 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.565 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.5 t80 -57.51 -35.77 70.69 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 126.327 1.851 . . . . 1.0 113.374 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.02 -28.0 69.28 Favored 'General case' 0 N--CA 1.513 2.696 0 C-N-CA 125.337 1.455 . . . . 1.0 112.182 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -87.63 -33.88 18.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.843 1.657 . . . . 1.0 112.149 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.3 mt -71.26 -40.25 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.991 0 C-N-CA 125.739 1.616 . . . . 1.0 110.634 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.514 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.1 m -58.75 -24.47 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 C-N-CA 125.687 1.595 . . . . 1.0 114.741 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -87.73 -15.24 37.58 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.215 1.406 . . . . 1.0 113.022 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -125.36 106.34 9.76 Favored 'General case' 0 C--N 1.375 1.684 0 C-N-CA 124.473 1.109 . . . . 1.0 111.767 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.457 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.6 mtm180 -59.11 -33.12 70.48 Favored 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 125.956 1.702 . . . . 1.0 113.863 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.14 -31.21 68.63 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.943 1.697 . . . . 1.0 112.839 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -82.0 -33.58 30.05 Favored 'General case' 0 C--N 1.38 1.917 0 C-N-CA 125.196 1.398 . . . . 1.0 112.552 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.4 t80 -72.19 -43.95 63.74 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 124.938 1.295 . . . . 1.0 112.815 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD21 ' O ' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -70.33 -31.27 68.49 Favored 'General case' 0 N--CA 1.508 2.45 0 C-N-CA 125.359 1.463 . . . . 1.0 113.049 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.03 -26.68 33.58 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 125.305 1.442 . . . . 1.0 112.932 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.449 HE21 HD13 ' A' ' 36' ' ' ILE . 1.8 mm100 -79.25 -38.18 36.18 Favored 'General case' 0 C--N 1.384 2.093 0 C-N-CA 124.798 1.239 . . . . 1.0 112.615 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 43' ' ' PHE . 68.3 t -68.16 -40.04 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 125.472 1.509 . . . . 1.0 109.68 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.48 -24.83 62.07 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 125.522 1.529 . . . . 1.0 113.142 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.29 -15.85 19.62 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.111 1.364 . . . . 1.0 113.153 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -93.19 151.29 19.92 Favored 'General case' 0 C--N 1.376 1.73 0 C-N-CA 124.62 1.168 . . . . 1.0 112.315 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.423 HG11 ' OE1' ' A' ' 60' ' ' GLU . 82.9 t -97.94 140.64 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 125.092 1.495 . . . . 1.0 107.791 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -128.44 146.31 50.84 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 125.602 1.814 . . . . 1.0 109.571 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -105.1 142.25 35.22 Favored 'General case' 0 C--O 1.25 1.095 0 O-C-N 124.779 1.299 . . . . 1.0 111.259 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.2 t -90.69 131.38 37.95 Favored Pre-proline 0 CA--C 1.574 1.875 0 O-C-N 124.982 1.427 . . . . 1.0 111.352 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.68 -9.62 22.77 Favored 'Trans proline' 1 C--N 1.437 5.221 0 C-N-CA 122.439 2.092 . . . . 1.0 114.268 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.06 -53.49 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 125.274 1.43 . . . . 1.0 109.709 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 25.0 m -88.73 -53.98 4.37 Favored 'General case' 0 C--N 1.379 1.874 0 O-C-N 124.253 0.971 . . . . 1.0 112.1 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.32 6.63 61.23 Favored Glycine 0 C--N 1.37 2.45 0 O-C-N 124.885 1.366 . . . . 1.0 113.378 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.26 165.83 16.16 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 126.126 1.77 . . . . 1.0 112.332 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' OE1' HG11 ' A' ' 51' ' ' VAL . 43.9 mt-10 -92.2 134.28 35.02 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.06 1.344 . . . . 1.0 110.733 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -143.08 153.41 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.393 1.477 . . . . 1.0 109.983 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.49 154.04 21.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.577 1.173 . . . . 1.0 112.398 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.0 -1.19 72.39 Favored Glycine 0 C--N 1.378 2.881 0 O-C-N 124.446 1.091 . . . . 1.0 114.424 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -85.65 -17.41 36.19 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 125.169 1.387 . . . . 1.0 111.596 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.5 p -95.55 3.31 54.24 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.993 1.317 . . . . 1.0 111.383 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.44 152.71 73.35 Favored Pre-proline 0 CA--C 1.58 2.108 0 CA-C-O 116.86 -1.543 . . . . 1.0 111.703 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -64.1 149.87 89.51 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 123.252 2.634 . . . . 1.0 114.931 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -65.05 -17.83 64.79 Favored 'General case' 0 N--CA 1.51 2.533 0 C-N-CA 125.517 1.527 . . . . 1.0 114.835 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -82.53 -33.13 28.32 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.03 1.332 . . . . 1.0 111.533 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.18 -30.16 66.08 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.787 1.635 . . . . 1.0 113.042 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -66.87 -36.3 82.0 Favored 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 125.58 1.552 . . . . 1.0 112.388 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -71.8 -24.22 61.7 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 125.41 1.484 . . . . 1.0 112.356 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -74.76 -27.94 60.55 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 126.181 1.792 . . . . 1.0 112.439 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 t -67.11 -39.73 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 C-N-CA 126.195 1.798 . . . . 1.0 110.305 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 40' ' ' ARG . 1.4 t80 -60.56 -29.46 69.18 Favored 'General case' 0 N--CA 1.511 2.605 0 C-N-CA 125.608 1.563 . . . . 1.0 113.651 177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.18 -40.81 71.01 Favored 'General case' 0 C--N 1.384 2.087 0 C-N-CA 125.731 1.613 . . . . 1.0 113.212 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.7 pp -70.15 -34.96 73.68 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 124.903 1.281 . . . . 1.0 113.554 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.514 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.32 -24.18 42.98 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.105 1.362 . . . . 1.0 112.453 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.406 ' OD1' ' HD3' ' A' ' 40' ' ' ARG . 2.6 m120 -85.36 -14.61 45.87 Favored 'General case' 0 C--N 1.382 2.002 0 C-N-CA 124.862 1.265 . . . . 1.0 113.357 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.12 -36.96 84.53 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 125.667 1.587 . . . . 1.0 113.819 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 61.57 -58.72 0.11 Allowed 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 128.112 2.565 . . . . 1.0 114.174 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -128.59 136.46 50.74 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 125.115 1.366 . . . . 1.0 110.029 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -174.07 -102.02 0.15 Allowed Glycine 0 C--N 1.356 1.679 0 O-C-N 125.151 1.532 . . . . 1.0 111.807 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.76 44.66 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 O-C-N 125.504 1.355 . . . . 1.0 113.395 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.3 123.6 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.812 -1.551 . . . . 1.0 106.812 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.75 128.74 45.88 Favored 'General case' 0 C--O 1.248 1.015 0 O-C-N 125.324 1.64 . . . . 1.0 110.252 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -80.81 -26.38 37.14 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.807 1.243 . . . . 1.0 114.071 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -80.94 -38.4 27.88 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 125.14 1.376 . . . . 1.0 113.178 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -97.32 -14.4 21.32 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 124.555 1.159 . . . . 1.0 113.678 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttm 60.35 55.81 3.41 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 127.342 2.257 . . . . 1.0 113.319 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 86.5 mtt180 -115.93 130.2 56.72 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -124.16 127.38 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 125.126 1.516 . . . . 1.0 107.996 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -119.66 136.81 54.24 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 125.374 1.671 . . . . 1.0 110.537 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.29 129.14 56.61 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 124.973 1.42 . . . . 1.0 111.583 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt . . . . . 0 N--CA 1.48 1.03 0 O-C-N 125.777 1.923 . . . . 1.0 111.06 179.562 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 7.4 mmt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 111.238 0.088 . . . . 1.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' HB2' ' NE1' ' A' ' 20' ' ' TRP . . . -107.5 139.91 41.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 125.268 1.605 . . . . 1.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -128.42 138.9 52.54 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.774 1.296 . . . . 1.0 111.114 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 13' ' ' ILE . 27.1 t -73.14 121.27 84.68 Favored Pre-proline 0 CA--C 1.582 2.21 0 CA-C-O 117.58 -1.2 . . . . 1.0 111.784 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 -6.37 18.97 Favored 'Trans proline' 1 C--N 1.433 4.974 0 C-N-CA 121.965 1.777 . . . . 1.0 114.834 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.536 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.3 mt -95.72 -55.41 6.13 Favored 'Isoleucine or valine' 0 C--N 1.372 1.575 0 C-N-CA 125.069 1.348 . . . . 1.0 110.05 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.2 p -103.79 -41.75 5.82 Favored 'General case' 0 C--N 1.374 1.634 0 O-C-N 124.245 0.965 . . . . 1.0 112.795 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.99 36.3 6.06 Favored Glycine 0 C--N 1.367 2.288 0 O-C-N 124.711 1.257 . . . . 1.0 114.151 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.439 ' OG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -97.89 147.52 33.17 Favored Pre-proline 0 CA--C 1.565 1.552 0 CA-C-O 116.848 -1.548 . . . . 1.0 111.83 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -69.71 139.13 39.64 Favored 'Trans proline' 1 C--N 1.446 5.708 0 C-N-CA 122.733 2.288 . . . . 1.0 114.33 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 mt -124.37 146.17 49.01 Favored 'General case' 0 C--O 1.25 1.131 0 O-C-N 125.436 1.71 . . . . 1.0 110.302 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.32 124.91 38.64 Favored 'General case' 0 C--O 1.25 1.08 0 O-C-N 124.682 1.239 . . . . 1.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.481 ' O ' HG12 ' A' ' 24' ' ' ILE . 44.8 m95 -69.25 -24.83 64.04 Favored 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 125.091 1.356 . . . . 1.0 112.594 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 35.9 mt-10 -69.94 -31.59 69.42 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.72 1.608 . . . . 1.0 112.094 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -76.37 -34.0 58.92 Favored 'General case' 0 C--N 1.39 2.344 0 C-N-CA 124.923 1.289 . . . . 1.0 112.455 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -41.04 93.95 Favored 'General case' 0 C--N 1.381 1.967 0 C-N-CA 126.199 1.8 . . . . 1.0 112.711 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.2 mm -79.79 -39.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 C-N-CA 125.419 1.488 . . . . 1.0 110.641 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.63 -35.36 79.99 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 125.297 1.439 . . . . 1.0 113.678 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.68 -22.97 42.78 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 125.541 1.536 . . . . 1.0 112.586 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.468 ' O ' HD12 ' A' ' 30' ' ' ILE . 30.7 mtt -105.21 10.29 33.78 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 124.991 1.432 . . . . 1.0 112.128 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.39 23.26 4.62 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.007 0.923 . . . . 1.0 112.935 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.85 6.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 125.096 1.358 . . . . 1.0 112.79 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 32' ' ' ASN . 1.1 mt -109.27 139.69 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 125.037 1.335 . . . . 1.0 109.138 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.0 -20.47 28.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.142 1.526 . . . . 1.0 112.235 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.51 ' H ' HG22 ' A' ' 30' ' ' ILE . 10.4 m120 -91.6 19.54 6.21 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 125.179 1.391 . . . . 1.0 112.055 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.84 -36.3 56.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.313 1.445 . . . . 1.0 111.778 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 37' ' ' VAL . 29.1 mt-10 -55.67 -23.88 30.84 Favored 'General case' 0 N--CA 1.517 2.901 0 C-N-CA 126.068 1.747 . . . . 1.0 114.684 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.79 -43.83 15.02 Favored 'General case' 0 C--N 1.375 1.693 0 C-N-CA 125.074 1.35 . . . . 1.0 111.495 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 43' ' ' PHE . 3.2 mt -72.8 -43.05 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 125.297 1.439 . . . . 1.0 110.934 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 34' ' ' GLU . 1.9 p -68.26 -19.26 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.597 2.757 0 C-N-CA 125.124 1.37 . . . . 1.0 114.132 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -91.96 -17.77 24.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 124.621 1.2 . . . . 1.0 112.698 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.0 105.47 9.61 Favored 'General case' 0 C--N 1.37 1.477 0 C-N-CA 124.351 1.06 . . . . 1.0 111.412 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -57.19 -31.63 65.65 Favored 'General case' 0 N--CA 1.529 3.482 0 C-N-CA 125.386 1.475 . . . . 1.0 114.104 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.3 -33.49 74.42 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.778 1.631 . . . . 1.0 112.652 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -82.16 -35.84 28.01 Favored 'General case' 0 C--N 1.377 1.792 0 C-N-CA 125.339 1.456 . . . . 1.0 112.429 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.5 t80 -73.69 -45.27 53.45 Favored 'General case' 0 C--N 1.39 2.357 0 C-N-CA 125.089 1.356 . . . . 1.0 112.523 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt -68.58 -28.18 66.72 Favored 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 124.597 1.159 . . . . 1.0 113.048 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.77 -28.61 36.36 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.154 1.382 . . . . 1.0 112.619 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 2.2 tt0 -79.6 -38.25 34.37 Favored 'General case' 0 C--N 1.381 1.968 0 C-N-CA 125.094 1.358 . . . . 1.0 112.337 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 43' ' ' PHE . 49.1 t -68.99 -42.07 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.215 0 C-N-CA 125.341 1.456 . . . . 1.0 109.635 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.89 -28.28 67.37 Favored 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.455 1.502 . . . . 1.0 113.544 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -91.92 -26.75 18.29 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.863 1.265 . . . . 1.0 113.488 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -97.6 147.42 24.32 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 124.566 1.146 . . . . 1.0 111.254 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.0 151.89 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 O-C-N 124.835 1.335 . . . . 1.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -122.56 144.57 49.01 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.949 1.406 . . . . 1.0 110.434 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -96.77 138.77 33.83 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 124.787 1.305 . . . . 1.0 111.268 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.6 t -96.5 111.76 57.99 Favored Pre-proline 0 CA--C 1.576 1.961 0 O-C-N 125.026 1.454 . . . . 1.0 110.654 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -70.57 -8.07 22.76 Favored 'Trans proline' 1 C--N 1.439 5.299 0 C-N-CA 122.984 2.456 . . . . 1.0 114.348 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG11 ' OG ' ' A' ' 16' ' ' SER . 1.8 t -85.31 -51.97 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 125.577 1.551 . . . . 1.0 110.597 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.1 p -103.76 -48.14 4.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.722 1.264 . . . . 1.0 112.504 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.1 -10.94 14.93 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 124.442 1.089 . . . . 1.0 114.348 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -87.4 147.82 25.27 Favored 'General case' 0 C--N 1.376 1.738 0 C-N-CA 124.963 1.305 . . . . 1.0 111.476 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.74 138.54 31.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.783 1.233 . . . . 1.0 112.36 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -122.35 143.11 49.84 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 125.214 1.571 . . . . 1.0 109.833 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -95.31 151.67 19.06 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 124.318 1.012 . . . . 1.0 112.659 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.21 -9.07 80.48 Favored Glycine 0 C--N 1.379 2.932 0 O-C-N 124.661 1.226 . . . . 1.0 115.125 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -87.55 -18.25 30.18 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 125.256 1.422 . . . . 1.0 112.047 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.6 p -99.63 2.68 44.73 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.841 1.256 . . . . 1.0 112.018 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 152.89 81.22 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 116.982 -1.485 . . . . 1.0 111.969 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.49 152.2 82.59 Favored 'Trans proline' 1 C--N 1.444 5.553 0 C-N-CA 123.289 2.659 . . . . 1.0 114.67 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -66.98 -19.58 65.74 Favored 'General case' 0 N--CA 1.507 2.405 0 C-N-CA 125.19 1.396 . . . . 1.0 114.566 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -79.6 -34.17 40.93 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 125.002 1.321 . . . . 1.0 112.073 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -70.12 -29.46 66.42 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.743 1.617 . . . . 1.0 113.239 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.0 -31.18 71.93 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.845 1.658 . . . . 1.0 112.863 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.01 -26.2 63.02 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 125.738 1.615 . . . . 1.0 112.933 176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -68.7 -28.03 66.48 Favored 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.968 1.707 . . . . 1.0 112.785 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t -65.92 -33.91 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.09 0 C-N-CA 126.519 1.928 . . . . 1.0 110.281 177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.27 -29.16 69.9 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 125.784 1.634 . . . . 1.0 113.828 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -68.27 -38.5 81.81 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 125.67 1.588 . . . . 1.0 113.068 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.2 pp -72.84 -29.29 63.1 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.599 1.16 . . . . 1.0 112.825 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.96 -26.93 43.5 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 125.405 1.482 . . . . 1.0 113.055 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -98.16 -20.18 17.45 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.423 1.089 . . . . 1.0 113.57 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.06 62.24 0.64 Allowed 'General case' 0 C--O 1.259 1.562 0 CA-C-O 123.127 1.442 . . . . 1.0 110.919 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -69.38 -34.98 75.34 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 113.349 -1.75 . . . . 1.0 113.106 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -106.36 120.3 41.52 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 124.973 1.42 . . . . 1.0 108.709 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.44 84.63 1.68 Allowed Glycine 0 C--N 1.363 2.071 0 O-C-N 124.661 1.226 . . . . 1.0 112.934 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 136.36 -57.99 0.67 Allowed Glycine 0 C--N 1.359 1.827 0 O-C-N 125.307 1.24 . . . . 1.0 113.468 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.4 mp -109.05 124.6 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 125.104 1.12 . . . . 1.0 108.126 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.06 133.11 56.01 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.495 1.747 . . . . 1.0 110.19 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -80.53 -29.35 37.19 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 124.588 1.18 . . . . 1.0 113.911 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.18 -35.42 28.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 124.877 1.271 . . . . 1.0 112.935 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -92.76 -17.88 23.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.613 1.196 . . . . 1.0 113.495 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 mttm 59.2 45.59 14.13 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 127.157 2.183 . . . . 1.0 113.516 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 9.1 mmm180 -115.27 138.19 51.22 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.284 -1.326 . . . . 1.0 111.435 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.84 126.92 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 125.174 1.546 . . . . 1.0 108.235 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 12.1 tttt -127.11 129.35 47.77 Favored 'General case' 0 C--O 1.251 1.143 0 O-C-N 125.28 1.612 . . . . 1.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 132.97 52.74 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.762 1.289 . . . . 1.0 110.716 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.7 mttm . . . . . 0 C--O 1.252 1.221 0 O-C-N 125.289 1.618 . . . . 1.0 111.357 179.799 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 110.851 -0.055 . . . . 1.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.73 138.61 44.78 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 125.179 1.549 . . . . 1.0 110.829 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -110.94 139.06 46.6 Favored 'General case' 0 C--O 1.248 1.013 0 O-C-N 124.9 1.375 . . . . 1.0 110.906 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 13' ' ' ILE . 47.3 t -71.8 132.34 85.14 Favored Pre-proline 0 CA--C 1.578 2.038 0 CA-C-O 117.262 -1.351 . . . . 1.0 112.44 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.71 -8.45 20.39 Favored 'Trans proline' 1 C--N 1.43 4.854 0 C-N-CA 122.178 1.919 . . . . 1.0 114.761 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.541 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.2 -55.9 5.66 Favored 'Isoleucine or valine' 0 C--N 1.372 1.569 0 C-N-CA 124.975 1.31 . . . . 1.0 109.955 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 27.2 p -101.23 -41.15 6.82 Favored 'General case' 0 C--N 1.371 1.536 0 O-C-N 124.079 0.862 . . . . 1.0 113.003 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 88.73 34.14 9.4 Favored Glycine 0 C--N 1.37 2.464 0 O-C-N 124.691 1.244 . . . . 1.0 113.112 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.461 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -93.16 145.91 30.94 Favored Pre-proline 0 C--N 1.368 1.411 0 CA-C-O 117.177 -1.392 . . . . 1.0 112.586 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.71 134.28 34.59 Favored 'Trans proline' 1 C--N 1.445 5.624 0 C-N-CA 122.422 2.081 . . . . 1.0 114.475 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt -118.63 143.16 47.0 Favored 'General case' 0 C--O 1.25 1.126 0 O-C-N 125.277 1.611 . . . . 1.0 110.202 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.28 130.85 37.1 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.789 1.306 . . . . 1.0 111.212 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 24' ' ' ILE . 45.8 m95 -68.78 -24.8 64.46 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 125.078 1.351 . . . . 1.0 113.046 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.1 mt-10 -70.01 -33.77 72.45 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 125.623 1.569 . . . . 1.0 112.178 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -76.98 -34.69 57.53 Favored 'General case' 0 C--N 1.386 2.193 0 C-N-CA 125.268 1.427 . . . . 1.0 112.776 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.13 -41.3 94.93 Favored 'General case' 0 C--N 1.382 1.994 0 C-N-CA 126.036 1.734 . . . . 1.0 112.839 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -79.94 -37.99 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 C-N-CA 125.271 1.428 . . . . 1.0 110.48 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.57 -35.25 79.75 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.093 1.357 . . . . 1.0 113.472 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.24 -23.83 40.58 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 125.653 1.581 . . . . 1.0 112.55 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -103.65 13.77 32.52 Favored 'General case' 0 CA--C 1.576 1.979 0 O-C-N 124.768 1.293 . . . . 1.0 112.48 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.11 16.79 12.11 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 123.937 0.895 . . . . 1.0 112.882 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.88 -4.05 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 C-N-CA 125.457 1.503 . . . . 1.0 113.427 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -99.71 140.92 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 125.251 1.421 . . . . 1.0 109.125 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.78 -18.06 41.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.888 1.367 . . . . 1.0 113.033 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.66 -16.3 54.35 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 124.975 1.31 . . . . 1.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -55.87 -34.74 65.75 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 126.252 1.821 . . . . 1.0 113.006 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.06 -30.34 71.52 Favored 'General case' 0 N--CA 1.511 2.604 0 C-N-CA 125.317 1.447 . . . . 1.0 112.281 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -85.71 -35.73 20.65 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 125.461 1.504 . . . . 1.0 112.251 176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -72.2 -39.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.905 0 C-N-CA 126.011 1.724 . . . . 1.0 110.549 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.531 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.5 p -63.17 -18.85 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 C-N-CA 125.561 1.544 . . . . 1.0 114.237 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.98 -19.41 25.75 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 124.75 1.22 . . . . 1.0 113.311 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -125.3 111.11 14.82 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.364 1.066 . . . . 1.0 111.688 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.0 mpt_? -60.05 -33.45 72.06 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 125.603 1.561 . . . . 1.0 113.57 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.19 -31.06 69.41 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 125.636 1.575 . . . . 1.0 112.632 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -82.16 -33.42 29.53 Favored 'General case' 0 C--N 1.379 1.85 0 C-N-CA 125.119 1.368 . . . . 1.0 112.154 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.473 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.0 t80 -71.65 -43.98 65.12 Favored 'General case' 0 C--N 1.394 2.508 0 C-N-CA 125.137 1.375 . . . . 1.0 112.41 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.83 -28.8 65.99 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.925 1.29 . . . . 1.0 112.41 177.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 -27.07 29.64 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 125.455 1.502 . . . . 1.0 112.787 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.0 mm-40 -78.11 -39.12 42.34 Favored 'General case' 0 C--N 1.383 2.024 0 C-N-CA 124.775 1.23 . . . . 1.0 112.84 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 43' ' ' PHE . 46.0 t -68.8 -40.77 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.03 0 C-N-CA 125.234 1.414 . . . . 1.0 109.621 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.29 -26.69 63.92 Favored 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.491 1.516 . . . . 1.0 113.024 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.36 -26.0 19.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.076 1.351 . . . . 1.0 112.851 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -96.18 144.64 26.22 Favored 'General case' 0 C--N 1.373 1.595 0 C-N-CA 124.64 1.176 . . . . 1.0 110.943 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.9 150.85 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 O-C-N 124.948 1.405 . . . . 1.0 110.732 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -128.03 145.5 50.97 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.856 1.348 . . . . 1.0 110.523 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -101.4 142.69 32.43 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 124.663 1.227 . . . . 1.0 111.3 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -89.04 123.38 67.5 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 117.385 -1.293 . . . . 1.0 110.943 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.26 -9.93 26.27 Favored 'Trans proline' 1 C--N 1.439 5.301 0 C-N-CA 122.81 2.34 . . . . 1.0 113.548 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.15 -52.78 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 125.638 1.575 . . . . 1.0 110.177 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 46.0 m -90.13 -52.74 4.79 Favored 'General case' 0 C--N 1.38 1.893 0 O-C-N 124.22 0.95 . . . . 1.0 112.383 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -6.67 42.14 Favored Glycine 0 C--N 1.368 2.316 0 O-C-N 124.796 1.31 . . . . 1.0 112.899 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -86.57 152.58 22.5 Favored 'General case' 0 C--N 1.379 1.888 0 C-N-CA 125.759 1.624 . . . . 1.0 111.272 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.28 136.66 32.9 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.436 1.095 . . . . 1.0 111.577 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -130.14 144.15 51.19 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 125.475 1.734 . . . . 1.0 109.159 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -92.2 153.85 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 124.186 0.929 . . . . 1.0 113.047 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -77.27 -4.43 83.93 Favored Glycine 0 C--N 1.377 2.826 0 O-C-N 124.404 1.065 . . . . 1.0 114.793 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -85.81 -15.16 42.85 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.355 1.462 . . . . 1.0 112.054 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 p -95.59 5.64 50.97 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 124.524 1.13 . . . . 1.0 111.562 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 63' ' ' GLY . 5.8 mt -74.53 150.51 86.9 Favored Pre-proline 0 C--N 1.387 2.23 0 CA-C-O 116.811 -1.566 . . . . 1.0 112.48 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -65.98 151.69 83.31 Favored 'Trans proline' 1 C--N 1.441 5.434 0 C-N-CA 123.139 2.559 . . . . 1.0 113.739 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -65.71 -18.34 65.26 Favored 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 114.715 1.376 . . . . 1.0 114.715 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -83.45 -34.43 25.44 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.974 1.309 . . . . 1.0 111.68 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -70.36 -29.15 65.75 Favored 'General case' 0 C--N 1.387 2.198 0 C-N-CA 125.741 1.616 . . . . 1.0 113.513 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.18 75.29 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 125.497 1.519 . . . . 1.0 112.809 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -73.85 -28.21 61.47 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 125.729 1.612 . . . . 1.0 112.358 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -71.33 -26.94 63.05 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 126.054 1.742 . . . . 1.0 112.746 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.7 -38.31 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.039 0 C-N-CA 126.49 1.916 . . . . 1.0 110.366 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -60.06 -28.18 67.57 Favored 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.277 1.431 . . . . 1.0 113.864 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.68 -40.79 79.94 Favored 'General case' 0 C--N 1.383 2.064 0 C-N-CA 125.616 1.567 . . . . 1.0 113.496 -178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.1 pp -71.04 -34.52 71.33 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.911 1.284 . . . . 1.0 113.013 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -79.08 -22.65 44.96 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.479 1.512 . . . . 1.0 112.531 177.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -86.37 -9.66 55.92 Favored 'General case' 0 C--N 1.383 2.038 0 C-N-CA 124.586 1.154 . . . . 1.0 113.061 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.55 -35.59 75.55 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.59 1.556 . . . . 1.0 113.75 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.67 -72.01 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 127.621 2.368 . . . . 1.0 113.816 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -128.48 135.31 49.27 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 125.201 1.401 . . . . 1.0 109.393 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.45 114.6 3.97 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 125.018 1.449 . . . . 1.0 111.445 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 109.3 -43.24 1.75 Allowed Glycine 0 C--N 1.356 1.648 0 O-C-N 125.404 1.296 . . . . 1.0 113.846 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -107.47 124.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.32 127.99 54.61 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 125.443 1.714 . . . . 1.0 110.002 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.55 -32.85 36.56 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.683 1.239 . . . . 1.0 113.778 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.23 -36.16 30.35 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.004 1.322 . . . . 1.0 112.901 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.34 -16.14 24.98 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.695 1.198 . . . . 1.0 113.525 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.17 44.26 16.05 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 127.112 2.165 . . . . 1.0 113.479 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 99.4 mtt180 -114.0 135.89 53.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.318 -1.31 . . . . 1.0 111.175 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.76 127.0 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 125.471 1.732 . . . . 1.0 107.727 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 2.8 tttp -122.66 133.11 54.52 Favored 'General case' 0 C--O 1.25 1.123 0 O-C-N 125.309 1.631 . . . . 1.0 110.464 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.48 129.85 53.2 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.04 1.462 . . . . 1.0 110.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 mttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.373 1.671 . . . . 1.0 111.287 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 39.6 mtt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.466 0.172 . . . . 1.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.49 139.42 40.13 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 125.253 1.596 . . . . 1.0 110.732 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.38 139.2 45.81 Favored 'General case' 0 C--O 1.249 1.027 0 O-C-N 124.79 1.307 . . . . 1.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.4 t -69.51 129.11 91.81 Favored Pre-proline 0 CA--C 1.581 2.16 0 CA-C-O 116.905 -1.521 . . . . 1.0 111.687 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.35 -13.03 30.43 Favored 'Trans proline' 1 C--N 1.438 5.238 0 C-N-CA 122.373 2.048 . . . . 1.0 114.598 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.522 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.6 mp -91.33 -54.44 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 125.395 1.478 . . . . 1.0 110.7 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.29 -40.4 5.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.261 0.976 . . . . 1.0 113.433 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.91 38.43 5.77 Favored Glycine 0 C--N 1.371 2.499 0 O-C-N 124.71 1.256 . . . . 1.0 113.05 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 p -92.13 142.97 26.85 Favored Pre-proline 0 CA--C 1.567 1.625 0 CA-C-O 116.609 -1.662 . . . . 1.0 113.042 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.68 137.28 38.34 Favored 'Trans proline' 1 C--N 1.451 5.94 0 C-N-CA 122.557 2.171 . . . . 1.0 113.08 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -118.76 143.45 46.89 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 125.143 1.527 . . . . 1.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.64 131.61 41.7 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.979 1.424 . . . . 1.0 110.956 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.513 ' O ' HG12 ' A' ' 24' ' ' ILE . 55.0 m95 -68.51 -26.43 65.44 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.025 1.33 . . . . 1.0 112.968 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 37.0 mt-10 -70.0 -33.1 71.6 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 125.692 1.597 . . . . 1.0 112.094 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.69 -33.46 58.23 Favored 'General case' 0 C--N 1.387 2.202 0 C-N-CA 125.077 1.351 . . . . 1.0 112.509 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.4 OUTLIER -65.87 -41.42 91.63 Favored 'General case' 0 C--N 1.389 2.285 0 C-N-CA 125.824 1.65 . . . . 1.0 112.743 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.8 mm -76.97 -39.46 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 C-N-CA 125.411 1.484 . . . . 1.0 110.461 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 2.8 tt0 -67.61 -36.6 81.14 Favored 'General case' 0 C--N 1.385 2.151 0 C-N-CA 125.281 1.432 . . . . 1.0 113.57 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -80.96 -22.5 39.52 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.645 1.578 . . . . 1.0 112.842 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -104.54 12.75 32.78 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.537 1.148 . . . . 1.0 111.856 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 12.23 26.81 Favored 'General case' 0 CA--C 1.575 1.91 0 C-N-CA 123.733 0.813 . . . . 1.0 113.014 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.68 1.69 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 C-N-CA 125.903 1.681 . . . . 1.0 113.074 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 27' ' ' MET . 0.8 OUTLIER -108.84 140.15 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 125.187 1.395 . . . . 1.0 109.109 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -80.87 -19.67 43.95 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 124.808 1.243 . . . . 1.0 113.748 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -79.09 -21.3 46.9 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.979 1.312 . . . . 1.0 112.554 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.4 t80 -57.59 -34.97 69.79 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.279 1.832 . . . . 1.0 113.153 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.1 -30.7 69.43 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 125.584 1.554 . . . . 1.0 111.975 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.16 -33.95 19.22 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 125.652 1.581 . . . . 1.0 112.485 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 33' ' ' PHE . 7.0 mt -71.5 -37.18 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.841 1.656 . . . . 1.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 m -61.98 -18.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 125.06 1.344 . . . . 1.0 114.394 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -93.11 -18.88 22.08 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.341 1.456 . . . . 1.0 112.595 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -121.61 104.84 9.92 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 124.104 0.962 . . . . 1.0 111.893 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.4 ptp180 -58.24 -36.85 73.81 Favored 'General case' 0 N--CA 1.517 2.904 0 C-N-CA 126.071 1.748 . . . . 1.0 113.973 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.26 -32.75 74.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 126.042 1.737 . . . . 1.0 112.776 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -83.74 -31.67 25.88 Favored 'General case' 0 C--N 1.379 1.872 0 C-N-CA 125.417 1.487 . . . . 1.0 112.256 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.2 t80 -74.56 -46.92 35.8 Favored 'General case' 0 C--N 1.392 2.441 0 C-N-CA 124.739 1.216 . . . . 1.0 113.14 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -71.4 -33.59 69.61 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 124.928 1.291 . . . . 1.0 113.152 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.37 -28.44 61.11 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.336 1.454 . . . . 1.0 113.161 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.6 mt-30 -80.05 -35.82 36.56 Favored 'General case' 0 C--N 1.381 1.97 0 C-N-CA 124.985 1.314 . . . . 1.0 112.945 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.5 t -67.98 -40.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.36 0 C-N-CA 125.267 1.427 . . . . 1.0 109.547 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.02 -22.59 61.39 Favored 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.546 1.539 . . . . 1.0 113.459 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.8 -26.39 14.72 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.943 1.297 . . . . 1.0 112.603 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -99.05 144.06 28.62 Favored 'General case' 0 C--N 1.374 1.661 0 O-C-N 124.358 1.036 . . . . 1.0 111.28 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 151.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 O-C-N 125.451 1.719 . . . . 1.0 111.564 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.88 148.04 45.88 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 125.003 1.44 . . . . 1.0 109.795 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -98.64 140.97 32.06 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.666 1.229 . . . . 1.0 111.458 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.08 132.93 34.64 Favored Pre-proline 0 CA--C 1.568 1.645 0 O-C-N 124.956 1.41 . . . . 1.0 111.635 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.15 -9.16 21.77 Favored 'Trans proline' 1 C--N 1.43 4.841 0 C-N-CA 122.535 2.156 . . . . 1.0 114.238 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.64 -51.23 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 125.336 1.454 . . . . 1.0 110.019 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.6 m -90.4 -52.84 4.71 Favored 'General case' 0 C--N 1.378 1.808 0 O-C-N 124.23 0.956 . . . . 1.0 112.45 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.27 Favored Glycine 0 C--N 1.37 2.417 0 O-C-N 124.67 1.231 . . . . 1.0 113.655 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -97.06 154.43 17.34 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 125.445 1.498 . . . . 1.0 111.409 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -88.07 133.86 33.88 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 124.326 1.05 . . . . 1.0 111.715 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -131.2 148.17 52.68 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 125.408 1.693 . . . . 1.0 109.382 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -91.18 149.33 21.83 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.19 -0.19 81.99 Favored Glycine 0 C--N 1.374 2.673 0 O-C-N 124.648 1.217 . . . . 1.0 114.573 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -85.22 -15.4 43.72 Favored 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.407 1.483 . . . . 1.0 111.872 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.4 p -91.07 2.28 56.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 124.688 1.195 . . . . 1.0 111.484 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.67 144.61 45.86 Favored Pre-proline 0 C--N 1.386 2.178 0 CA-C-O 117.242 -1.361 . . . . 1.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.1 157.06 61.57 Favored 'Trans proline' 1 C--N 1.437 5.211 0 C-N-CA 122.897 2.398 . . . . 1.0 114.066 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.48 -30.71 71.46 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 124.606 1.163 . . . . 1.0 113.502 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.22 -38.71 84.2 Favored 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.764 1.626 . . . . 1.0 113.309 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.6 -28.7 62.94 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 124.874 1.27 . . . . 1.0 112.836 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.24 72.22 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.957 1.703 . . . . 1.0 112.691 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -72.96 -25.07 60.89 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 125.713 1.605 . . . . 1.0 112.573 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -73.64 -28.51 61.83 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.743 1.617 . . . . 1.0 112.387 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.527 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -66.95 -36.22 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 C-N-CA 126.333 1.853 . . . . 1.0 110.17 178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.17 -29.43 70.55 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.326 1.45 . . . . 1.0 113.475 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.07 -39.06 89.76 Favored 'General case' 0 C--N 1.389 2.303 0 C-N-CA 125.733 1.613 . . . . 1.0 113.09 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -74.0 -32.2 63.3 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 124.779 1.232 . . . . 1.0 112.495 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -82.86 -22.39 34.06 Favored 'General case' 0 C--N 1.371 1.54 0 C-N-CA 125.502 1.521 . . . . 1.0 112.901 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -87.01 -21.64 26.0 Favored 'General case' 0 C--N 1.381 1.941 0 C-N-CA 124.715 1.206 . . . . 1.0 112.587 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.32 -34.57 28.52 Favored 'General case' 0 C--N 1.379 1.859 0 C-N-CA 125.003 1.321 . . . . 1.0 113.023 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.95 -59.08 0.15 Allowed 'General case' 0 N--CA 1.532 3.653 0 C-N-CA 127.931 2.493 . . . . 1.0 114.026 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -124.72 134.83 52.7 Favored 'General case' 0 C--O 1.249 1.057 0 C-N-CA 126.147 1.779 . . . . 1.0 109.444 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.42 -111.7 0.27 Allowed Glycine 0 C--N 1.351 1.364 0 O-C-N 125.062 1.476 . . . . 1.0 111.686 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -113.73 49.09 0.87 Allowed Glycine 0 C--N 1.351 1.416 0 O-C-N 125.768 1.511 . . . . 1.0 112.238 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.19 123.2 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -118.17 128.17 54.46 Favored 'General case' 0 C--O 1.249 1.078 0 O-C-N 125.417 1.698 . . . . 1.0 109.874 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -80.71 -27.37 36.99 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 124.707 1.203 . . . . 1.0 113.212 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -82.2 -36.15 27.57 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.434 1.494 . . . . 1.0 112.856 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -94.41 -17.48 22.47 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 124.594 1.184 . . . . 1.0 112.992 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 56.88 58.23 4.18 Favored 'General case' 0 N--CA 1.525 3.298 0 C-N-CA 126.896 2.078 . . . . 1.0 112.015 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -125.23 129.11 49.4 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.508 -1.678 . . . . 1.0 110.307 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.479 HG21 ' HB ' ' A' ' 24' ' ' ILE . 1.8 t -120.43 128.06 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 125.535 1.772 . . . . 1.0 107.9 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.23 131.4 53.91 Favored 'General case' 0 C--O 1.251 1.163 0 O-C-N 125.486 1.741 . . . . 1.0 109.977 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.08 131.56 54.04 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 125.13 1.519 . . . . 1.0 110.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 mttt . . . . . 0 C--O 1.252 1.212 0 O-C-N 125.212 1.57 . . . . 1.0 111.315 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.366 0.136 . . . . 1.0 111.366 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 140.45 41.55 Favored 'General case' 0 C--O 1.244 0.805 0 O-C-N 125.418 1.699 . . . . 1.0 110.478 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -120.87 138.27 54.16 Favored 'General case' 0 C--O 1.248 0.999 0 O-C-N 124.889 1.368 . . . . 1.0 110.825 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 13' ' ' ILE . 48.5 t -73.25 131.23 83.38 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 117.28 -1.343 . . . . 1.0 111.8 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.91 -10.13 22.82 Favored 'Trans proline' 1 C--N 1.432 4.97 0 C-N-CA 121.954 1.769 . . . . 1.0 114.77 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.555 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mt -95.1 -55.62 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 125.164 1.386 . . . . 1.0 110.179 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 16' ' ' SER . 28.2 p -102.83 -41.72 6.08 Favored 'General case' 0 C--N 1.373 1.592 0 O-C-N 124.165 0.915 . . . . 1.0 113.171 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 11' ' ' CYS . . . 88.38 38.0 7.36 Favored Glycine 0 C--N 1.372 2.543 0 O-C-N 124.687 1.242 . . . . 1.0 112.572 -177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.564 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -88.38 143.81 33.0 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 116.962 -1.494 . . . . 1.0 113.039 -178.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.65 126.98 16.3 Favored 'Trans proline' 1 C--N 1.449 5.861 0 C-N-CA 122.79 2.327 . . . . 1.0 114.642 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mt -122.9 145.01 48.84 Favored 'General case' 0 C--O 1.251 1.162 0 O-C-N 125.208 1.567 . . . . 1.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' O ' HD12 ' A' ' 23' ' ' LEU . 84.3 mttt -93.62 130.33 39.57 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 124.858 1.349 . . . . 1.0 110.563 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.479 ' O ' HG12 ' A' ' 24' ' ' ILE . 31.1 m95 -68.05 -27.35 66.45 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 124.736 1.215 . . . . 1.0 112.822 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 8.8 pt-20 -72.63 -33.44 66.63 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.639 1.976 . . . . 1.0 113.152 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.79 -32.6 63.85 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 125.212 1.405 . . . . 1.0 113.418 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 19' ' ' LYS . 0.9 OUTLIER -68.24 -37.71 81.07 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.103 1.761 . . . . 1.0 113.282 178.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 20' ' ' TRP . 4.7 mm -77.04 -28.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 C-N-CA 125.665 1.586 . . . . 1.0 110.835 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -70.75 -34.3 71.71 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 125.261 1.424 . . . . 1.0 113.209 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.0 -22.79 39.17 Favored 'General case' 0 C--N 1.376 1.724 0 C-N-CA 125.346 1.458 . . . . 1.0 112.851 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.446 ' O ' HD12 ' A' ' 30' ' ' ILE . 38.7 mtp -104.62 14.7 29.39 Favored 'General case' 0 CA--C 1.577 2.017 0 O-C-N 124.701 1.25 . . . . 1.0 112.757 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.89 24.96 5.01 Favored 'General case' 0 CA--C 1.578 2.053 0 C-N-CA 123.665 0.786 . . . . 1.0 112.867 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.51 0.28 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 C-N-CA 125.092 1.357 . . . . 1.0 111.98 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.93 140.68 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 125.155 1.382 . . . . 1.0 109.205 -178.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -80.39 -18.43 48.96 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 124.75 1.281 . . . . 1.0 113.778 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -81.09 -18.6 46.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.902 1.281 . . . . 1.0 112.356 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.576 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.7 t80 -59.48 -35.64 74.49 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.196 1.798 . . . . 1.0 113.15 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.33 -29.87 69.15 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 125.47 1.508 . . . . 1.0 112.161 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -86.72 -33.36 20.04 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.596 1.559 . . . . 1.0 112.458 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.8 mt -71.63 -39.65 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.982 0 C-N-CA 125.696 1.598 . . . . 1.0 110.632 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.505 ' O ' HD23 ' A' ' 78' ' ' LEU . 9.2 m -60.17 -20.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 125.355 1.462 . . . . 1.0 114.66 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.89 -18.85 25.37 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.128 1.371 . . . . 1.0 113.352 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -125.55 109.31 12.51 Favored 'General case' 0 C--N 1.373 1.588 0 C-N-CA 124.195 0.998 . . . . 1.0 111.709 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.488 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.1 mpp_? -59.42 -34.1 72.06 Favored 'General case' 0 N--CA 1.517 2.918 0 C-N-CA 125.348 1.459 . . . . 1.0 113.605 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.93 -30.53 70.69 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.724 1.609 . . . . 1.0 112.742 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -82.17 -33.56 29.44 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 125.354 1.462 . . . . 1.0 112.211 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -73.06 -43.78 61.48 Favored 'General case' 0 C--N 1.392 2.455 0 C-N-CA 125.144 1.378 . . . . 1.0 112.698 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -68.64 -30.93 69.74 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 124.864 1.266 . . . . 1.0 112.45 177.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.53 40.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.899 1.374 . . . . 1.0 112.831 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.431 HE21 HD13 ' A' ' 36' ' ' ILE . 2.7 mm100 -79.37 -38.83 34.06 Favored 'General case' 0 C--N 1.385 2.121 0 C-N-CA 125.133 1.373 . . . . 1.0 112.524 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 43' ' ' PHE . 28.5 t -71.46 -40.04 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.101 0 C-N-CA 125.238 1.415 . . . . 1.0 109.896 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.52 -25.15 63.89 Favored 'General case' 0 N--CA 1.511 2.596 0 C-N-CA 125.268 1.427 . . . . 1.0 113.558 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -94.73 -26.61 16.21 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.853 1.261 . . . . 1.0 113.042 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.01 143.87 26.14 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 124.851 1.261 . . . . 1.0 111.521 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.4 153.09 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.677 0 O-C-N 125.062 1.476 . . . . 1.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.15 145.61 51.73 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 124.969 1.418 . . . . 1.0 111.072 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.43 141.65 35.6 Favored 'General case' 0 C--O 1.25 1.119 0 O-C-N 124.905 1.378 . . . . 1.0 111.161 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.68 128.91 48.75 Favored Pre-proline 0 CA--C 1.57 1.713 0 O-C-N 124.769 1.293 . . . . 1.0 111.231 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.19 -9.5 21.95 Favored 'Trans proline' 1 C--N 1.43 4.856 0 C-N-CA 122.418 2.079 . . . . 1.0 114.156 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.86 -51.22 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.463 1.505 . . . . 1.0 110.312 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.6 m -89.32 -52.81 4.85 Favored 'General case' 0 C--N 1.378 1.816 0 O-C-N 124.301 1.001 . . . . 1.0 112.635 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.16 -10.36 47.29 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 124.708 1.255 . . . . 1.0 113.108 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -85.69 152.48 23.05 Favored 'General case' 0 C--N 1.38 1.913 0 C-N-CA 125.726 1.61 . . . . 1.0 111.306 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.72 136.93 32.75 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.377 1.048 . . . . 1.0 112.056 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.97 143.75 51.2 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 125.425 1.703 . . . . 1.0 109.175 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.38 151.86 19.15 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 124.253 0.971 . . . . 1.0 112.547 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.35 -8.82 80.69 Favored Glycine 0 C--N 1.378 2.886 0 O-C-N 124.362 1.039 . . . . 1.0 114.659 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -86.77 -20.98 26.83 Favored 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 125.498 1.519 . . . . 1.0 111.945 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -95.34 5.49 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.959 1.303 . . . . 1.0 111.784 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.69 70.22 Favored Pre-proline 0 C--N 1.386 2.174 0 CA-C-O 116.981 -1.485 . . . . 1.0 112.034 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -62.23 147.71 94.51 Favored 'Trans proline' 1 C--N 1.447 5.763 0 C-N-CA 123.102 2.535 . . . . 1.0 114.693 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -64.05 -18.41 64.32 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 125.44 1.496 . . . . 1.0 114.649 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -82.74 -30.05 29.32 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 124.98 1.312 . . . . 1.0 111.843 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -73.91 -28.41 61.52 Favored 'General case' 0 C--N 1.384 2.105 0 C-N-CA 125.659 1.584 . . . . 1.0 113.059 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.44 -32.2 73.7 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 125.819 1.648 . . . . 1.0 112.615 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -74.49 -26.34 59.95 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.606 1.563 . . . . 1.0 112.148 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -73.09 -26.94 61.44 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.931 1.692 . . . . 1.0 112.604 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.3 t -64.37 -37.4 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 C-N-CA 126.125 1.77 . . . . 1.0 110.048 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -60.79 -29.72 69.62 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 125.012 1.325 . . . . 1.0 114.038 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.12 -41.13 82.2 Favored 'General case' 0 C--N 1.383 2.05 0 C-N-CA 125.609 1.564 . . . . 1.0 113.175 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.63 -34.7 70.04 Favored 'General case' 0 C--N 1.379 1.881 0 C-N-CA 124.857 1.263 . . . . 1.0 112.979 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -81.21 -22.14 39.06 Favored 'General case' 0 C--N 1.373 1.614 0 O-C-N 124.915 1.384 . . . . 1.0 112.652 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -85.62 -15.3 42.96 Favored 'General case' 0 C--N 1.386 2.177 0 C-N-CA 124.275 1.03 . . . . 1.0 112.815 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.65 -35.91 82.15 Favored 'General case' 0 C--N 1.388 2.256 0 C-N-CA 125.356 1.462 . . . . 1.0 113.469 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.97 -66.44 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 127.864 2.466 . . . . 1.0 114.147 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -130.38 137.37 49.85 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 125.684 1.594 . . . . 1.0 109.249 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -177.5 -106.94 0.21 Allowed Glycine 0 C--N 1.351 1.379 0 O-C-N 125.017 1.448 . . . . 1.0 111.656 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.97 46.35 1.19 Allowed Glycine 0 C--N 1.354 1.564 0 O-C-N 125.662 1.448 . . . . 1.0 113.051 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.45 122.31 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -122.05 129.95 52.86 Favored 'General case' 0 C--O 1.249 1.032 0 O-C-N 125.443 1.714 . . . . 1.0 110.166 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.77 -28.88 36.25 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 124.728 1.267 . . . . 1.0 113.326 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.36 -37.0 26.28 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.119 1.368 . . . . 1.0 112.973 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.73 -17.98 23.53 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.567 1.147 . . . . 1.0 113.091 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.4 mttt 57.4 61.85 2.36 Favored 'General case' 0 N--CA 1.525 3.291 0 C-N-CA 127.171 2.188 . . . . 1.0 112.125 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 98.3 mtt180 -125.5 128.99 48.88 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 113.381 -1.736 . . . . 1.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 2.0 t -123.46 129.06 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 125.504 1.752 . . . . 1.0 107.424 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.22 135.31 53.34 Favored 'General case' 0 C--O 1.25 1.125 0 O-C-N 125.156 1.535 . . . . 1.0 110.213 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.54 128.55 56.06 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 125.056 1.472 . . . . 1.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 C--O 1.249 1.057 0 O-C-N 125.466 1.729 . . . . 1.0 111.325 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.438 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 35.7 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 111.221 0.082 . . . . 1.0 111.221 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -112.16 140.0 47.22 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.264 1.602 . . . . 1.0 110.611 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -124.28 139.17 54.17 Favored 'General case' 0 C--O 1.247 0.961 0 O-C-N 124.947 1.405 . . . . 1.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.576 ' SG ' HD12 ' A' ' 13' ' ' ILE . 22.9 t -76.52 121.53 85.03 Favored Pre-proline 0 CA--C 1.576 1.98 0 O-C-N 124.531 1.144 . . . . 1.0 111.214 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.89 -6.07 18.01 Favored 'Trans proline' 1 C--N 1.428 4.74 0 C-N-CA 122.083 1.855 . . . . 1.0 114.512 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.576 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.2 mt -97.03 -55.59 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 C-N-CA 124.993 1.317 . . . . 1.0 110.103 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.0 p -101.68 -39.09 7.61 Favored 'General case' 0 C--N 1.37 1.467 0 O-C-N 124.543 1.152 . . . . 1.0 112.979 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.54 30.07 12.68 Favored Glycine 0 C--N 1.368 2.325 0 O-C-N 124.901 1.376 . . . . 1.0 113.456 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -93.76 146.79 32.39 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 117.001 -1.476 . . . . 1.0 112.536 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.08 136.02 39.47 Favored 'Trans proline' 1 C--N 1.451 5.965 0 C-N-CA 122.706 2.271 . . . . 1.0 113.971 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.57 145.97 47.44 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 125.445 1.716 . . . . 1.0 110.778 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -95.14 125.73 39.99 Favored 'General case' 0 C--N 1.361 1.099 0 O-C-N 124.971 1.419 . . . . 1.0 110.96 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.51 ' O ' HG12 ' A' ' 24' ' ' ILE . 38.5 m95 -68.6 -25.0 64.65 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 124.897 1.279 . . . . 1.0 112.798 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 34.5 mt-10 -69.69 -32.8 71.62 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.64 1.576 . . . . 1.0 112.009 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.07 -34.4 57.06 Favored 'General case' 0 C--N 1.382 2.012 0 C-N-CA 124.869 1.268 . . . . 1.0 112.331 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.3 OUTLIER -65.15 -40.67 94.7 Favored 'General case' 0 C--N 1.385 2.126 0 C-N-CA 125.934 1.694 . . . . 1.0 112.774 178.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 20' ' ' TRP . 11.0 mm -78.68 -38.68 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 C-N-CA 125.506 1.522 . . . . 1.0 110.077 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -68.54 -34.11 75.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 124.881 1.272 . . . . 1.0 113.249 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.27 -23.38 37.99 Favored 'General case' 0 C--N 1.375 1.704 0 C-N-CA 125.427 1.491 . . . . 1.0 112.53 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -103.32 15.55 28.85 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 124.652 1.22 . . . . 1.0 112.045 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 14.75 27.57 Favored 'General case' 0 CA--C 1.576 1.96 0 C-N-CA 124.061 0.944 . . . . 1.0 112.654 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.48 4.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 C-N-CA 125.76 1.624 . . . . 1.0 112.779 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -105.12 141.36 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 124.654 1.182 . . . . 1.0 109.011 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -81.3 -17.6 48.73 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.783 1.302 . . . . 1.0 113.372 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -86.6 -11.19 52.16 Favored 'General case' 0 C--N 1.371 1.532 0 C-N-CA 124.899 1.28 . . . . 1.0 112.152 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -56.41 -36.86 69.42 Favored 'General case' 0 N--CA 1.511 2.616 0 C-N-CA 125.514 1.526 . . . . 1.0 112.419 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.37 -29.57 69.99 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 124.771 1.228 . . . . 1.0 112.13 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -85.94 -38.8 17.6 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.11 1.364 . . . . 1.0 112.006 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.411 HG12 ' OE1' ' A' ' 46' ' ' GLN . 5.2 mt -72.17 -40.78 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 C-N-CA 125.329 1.451 . . . . 1.0 110.805 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.7 p -65.85 -18.26 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.599 2.864 0 C-N-CA 125.574 1.55 . . . . 1.0 113.884 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -87.79 -18.64 28.92 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.716 1.207 . . . . 1.0 113.259 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.04 111.97 15.33 Favored 'General case' 0 C--N 1.369 1.455 0 C-N-CA 124.537 1.135 . . . . 1.0 111.17 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.494 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.5 mtm180 -59.29 -35.48 73.85 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 125.54 1.536 . . . . 1.0 113.125 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.51 -30.28 69.06 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 1.0 113.351 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 80.9 mtt180 -81.64 -34.24 30.94 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.055 1.342 . . . . 1.0 112.396 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.8 t80 -74.66 -41.99 59.3 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 124.829 1.252 . . . . 1.0 112.664 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.4 mt -66.21 -32.48 73.93 Favored 'General case' 0 N--CA 1.509 2.496 0 C-N-CA 124.626 1.17 . . . . 1.0 112.654 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.45 -24.65 34.18 Favored 'General case' 0 C--N 1.371 1.525 0 O-C-N 124.994 1.434 . . . . 1.0 112.356 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -79.23 -36.2 40.38 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.041 1.336 . . . . 1.0 112.72 178.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 43' ' ' PHE . 32.8 t -72.13 -41.18 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 125.369 1.467 . . . . 1.0 109.463 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 125.592 1.557 . . . . 1.0 113.412 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -95.47 -25.34 16.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.605 1.19 . . . . 1.0 112.986 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -101.18 144.66 29.8 Favored 'General case' 0 C--N 1.368 1.399 0 C-N-CA 124.496 1.118 . . . . 1.0 111.126 -179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.24 155.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 O-C-N 125.073 1.483 . . . . 1.0 110.918 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.38 144.08 51.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 125.194 1.559 . . . . 1.0 110.108 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -95.2 138.59 32.7 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.823 -1.535 . . . . 1.0 111.463 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 15.5 t -96.54 115.11 65.49 Favored Pre-proline 0 CA--C 1.568 1.673 0 O-C-N 125.044 1.465 . . . . 1.0 110.306 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.08 -5.77 17.17 Favored 'Trans proline' 1 C--N 1.432 4.93 0 C-N-CA 122.333 2.022 . . . . 1.0 114.415 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.2 t -89.99 -51.11 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 126.12 1.768 . . . . 1.0 110.557 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.8 p -103.03 -48.68 3.98 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.625 1.203 . . . . 1.0 112.011 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.53 -2.56 21.86 Favored Glycine 0 C--N 1.368 2.321 0 O-C-N 124.466 1.104 . . . . 1.0 114.123 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -94.95 146.4 24.27 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 124.961 1.304 . . . . 1.0 111.197 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.61 139.37 30.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.696 1.248 . . . . 1.0 112.23 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -123.19 145.12 48.9 Favored 'General case' 0 C--O 1.247 0.96 0 O-C-N 125.46 1.725 . . . . 1.0 109.547 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -96.72 151.04 20.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 124.348 1.03 . . . . 1.0 112.267 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -74.5 -9.19 81.76 Favored Glycine 0 C--N 1.377 2.861 0 O-C-N 124.293 0.996 . . . . 1.0 114.479 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -86.61 -19.59 29.13 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 125.186 1.394 . . . . 1.0 112.072 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -94.7 3.6 54.85 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.848 1.259 . . . . 1.0 111.752 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.22 146.44 38.13 Favored Pre-proline 0 C--N 1.382 1.996 0 CA-C-O 117.491 -1.242 . . . . 1.0 111.763 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.08 154.99 70.76 Favored 'Trans proline' 1 C--N 1.436 5.166 0 C-N-CA 122.972 2.448 . . . . 1.0 114.706 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -63.89 -31.62 72.86 Favored 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.437 1.095 . . . . 1.0 113.384 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.02 -37.81 75.03 Favored 'General case' 0 N--CA 1.515 2.804 0 C-N-CA 125.333 1.453 . . . . 1.0 113.541 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 25.8 mt-10 -77.02 -28.32 54.91 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 124.851 1.26 . . . . 1.0 112.452 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.19 73.25 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 125.954 1.702 . . . . 1.0 112.628 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.51 -25.28 61.34 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.501 1.52 . . . . 1.0 112.398 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 91.7 mttt -73.45 -26.39 60.91 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 125.908 1.683 . . . . 1.0 112.5 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t -64.39 -36.98 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 C-N-CA 126.37 1.868 . . . . 1.0 110.206 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.26 -29.82 69.04 Favored 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 125.398 1.479 . . . . 1.0 113.59 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -43.19 84.21 Favored 'General case' 0 C--N 1.382 1.987 0 C-N-CA 125.331 1.452 . . . . 1.0 113.196 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -69.98 -32.99 71.48 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.015 1.326 . . . . 1.0 112.849 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -81.3 -18.42 45.89 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 125.208 1.403 . . . . 1.0 112.835 178.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -102.1 -13.92 17.3 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 124.53 1.132 . . . . 1.0 111.935 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.81 69.42 0.7 Allowed 'General case' 0 C--N 1.372 1.548 0 CA-C-O 122.893 1.33 . . . . 1.0 109.339 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -75.18 -24.16 57.81 Favored 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 113.443 -1.708 . . . . 1.0 112.949 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -106.66 134.61 49.54 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 124.837 1.335 . . . . 1.0 109.342 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.63 -96.64 0.16 Allowed Glycine 0 C--N 1.356 1.657 0 O-C-N 124.981 1.426 . . . . 1.0 112.148 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.26 50.99 0.79 Allowed Glycine 0 C--N 1.362 1.993 0 O-C-N 125.439 1.317 . . . . 1.0 113.623 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -119.97 121.58 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.11 133.67 51.57 Favored 'General case' 0 C--O 1.249 1.026 0 O-C-N 125.487 1.742 . . . . 1.0 110.61 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -80.37 -32.12 37.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.71 1.256 . . . . 1.0 113.252 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.94 -36.39 28.06 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.086 1.355 . . . . 1.0 112.997 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.17 -20.09 20.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.475 1.11 . . . . 1.0 113.173 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.7 mttm 58.28 56.35 4.52 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 127.07 2.148 . . . . 1.0 113.11 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 93.3 mtt180 -115.41 128.68 56.22 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.44 -1.709 . . . . 1.0 110.431 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.48 125.26 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 125.466 1.729 . . . . 1.0 108.457 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -121.18 131.9 54.51 Favored 'General case' 0 C--O 1.251 1.174 0 O-C-N 125.519 1.762 . . . . 1.0 109.988 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.6 133.32 55.39 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 125.202 1.563 . . . . 1.0 110.576 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.1 mttt . . . . . 0 C--O 1.252 1.236 0 O-C-N 125.338 1.649 . . . . 1.0 111.244 179.899 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.563 ' N ' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.865 -0.05 . . . . 1.0 110.865 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.81 138.95 43.14 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 125.315 1.635 . . . . 1.0 110.627 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.37 138.94 49.91 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 124.93 1.394 . . . . 1.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 13' ' ' ILE . 12.4 t -70.19 123.15 88.3 Favored Pre-proline 0 CA--C 1.577 1.992 0 O-C-N 124.477 1.11 . . . . 1.0 112.199 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.64 -11.5 26.16 Favored 'Trans proline' 1 C--N 1.43 4.826 0 C-N-CA 121.932 1.755 . . . . 1.0 114.922 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.479 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.5 mp -91.81 -53.8 8.26 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 C-N-CA 125.299 1.44 . . . . 1.0 111.018 -177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.6 -41.15 6.05 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 124.218 0.949 . . . . 1.0 112.434 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 29.51 8.63 Favored Glycine 0 C--N 1.366 2.239 0 O-C-N 124.678 1.236 . . . . 1.0 113.748 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.22 144.68 29.39 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 116.796 -1.573 . . . . 1.0 113.096 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.88 139.29 39.45 Favored 'Trans proline' 1 C--N 1.447 5.728 0 C-N-CA 122.71 2.273 . . . . 1.0 113.661 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 144.36 48.22 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.32 1.638 . . . . 1.0 110.432 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -95.76 133.17 40.19 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.928 1.392 . . . . 1.0 111.052 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.493 ' O ' HG12 ' A' ' 24' ' ' ILE . 60.8 m95 -68.69 -26.45 65.3 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 124.798 1.239 . . . . 1.0 113.248 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 93' ' ' LYS . 35.9 mt-10 -72.09 -31.24 65.89 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.645 1.578 . . . . 1.0 112.623 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.92 -34.5 62.14 Favored 'General case' 0 C--N 1.385 2.123 0 C-N-CA 125.168 1.387 . . . . 1.0 112.603 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -39.89 87.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 125.758 1.623 . . . . 1.0 113.882 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 20' ' ' TRP . 7.6 mm -78.58 -41.03 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 C-N-CA 125.156 1.382 . . . . 1.0 110.676 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.3 -36.71 82.07 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 124.84 1.256 . . . . 1.0 113.311 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -78.72 -21.11 48.56 Favored 'General case' 0 C--N 1.375 1.714 0 C-N-CA 125.308 1.443 . . . . 1.0 112.967 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.506 ' SD ' ' HE1' ' A' ' 52' ' ' PHE . 35.0 mtp -105.56 16.78 24.9 Favored 'General case' 0 CA--C 1.575 1.923 0 O-C-N 124.67 1.231 . . . . 1.0 112.367 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.8 18.43 14.49 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.48 13.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 C-N-CA 124.765 1.226 . . . . 1.0 111.918 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 27' ' ' MET . 1.0 OUTLIER -114.81 140.5 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 124.736 1.215 . . . . 1.0 108.723 -178.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.04 -16.28 44.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 125.028 1.455 . . . . 1.0 113.411 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.424 ' H ' HG22 ' A' ' 30' ' ' ILE . 7.7 m120 -83.55 -15.66 48.38 Favored 'General case' 0 C--N 1.376 1.725 0 C-N-CA 125.065 1.346 . . . . 1.0 112.556 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.596 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.4 t80 -57.06 -35.48 69.39 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 126.354 1.862 . . . . 1.0 113.315 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.33 -29.18 69.73 Favored 'General case' 0 N--CA 1.513 2.681 0 C-N-CA 125.384 1.474 . . . . 1.0 112.411 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.85 -33.87 19.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 125.43 1.492 . . . . 1.0 112.662 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.9 mt -71.46 -39.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.909 0 C-N-CA 125.837 1.655 . . . . 1.0 110.457 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.518 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.3 m -61.57 -18.47 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 125.669 1.588 . . . . 1.0 114.692 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -88.38 -19.05 27.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.823 1.327 . . . . 1.0 113.256 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.48 110.67 12.99 Favored 'General case' 0 C--N 1.373 1.599 0 C-N-CA 124.473 1.109 . . . . 1.0 111.973 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -61.54 -32.38 72.44 Favored 'General case' 0 N--CA 1.517 2.878 0 C-N-CA 125.331 1.452 . . . . 1.0 113.015 176.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.95 -31.88 71.07 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 125.475 1.51 . . . . 1.0 113.207 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -82.26 -32.65 29.54 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 125.212 1.405 . . . . 1.0 112.594 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 47' ' ' VAL . 3.4 t80 -73.08 -46.01 53.93 Favored 'General case' 0 C--N 1.386 2.186 0 C-N-CA 124.976 1.31 . . . . 1.0 113.098 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -71.59 -33.16 68.8 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 125.033 1.333 . . . . 1.0 112.777 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.04 72.8 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.835 1.654 . . . . 1.0 112.742 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -78.75 -35.29 44.82 Favored 'General case' 0 C--N 1.382 1.986 0 C-N-CA 124.821 1.248 . . . . 1.0 112.908 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.1 t -69.05 -40.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.102 0 C-N-CA 125.117 1.367 . . . . 1.0 109.173 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.63 -25.46 59.24 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 125.676 1.59 . . . . 1.0 113.477 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -94.32 -25.31 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.803 1.315 . . . . 1.0 113.522 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -105.33 143.3 33.68 Favored 'General case' 0 C--N 1.366 1.307 0 O-C-N 124.454 1.096 . . . . 1.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.75 153.83 3.2 Favored 'Isoleucine or valine' 0 C--O 1.251 1.14 0 O-C-N 125.094 1.496 . . . . 1.0 111.599 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.506 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 99.1 m-85 -125.14 144.26 50.52 Favored 'General case' 0 C--O 1.249 1.07 0 O-C-N 125.093 1.496 . . . . 1.0 110.332 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -95.17 139.89 30.86 Favored 'General case' 0 C--O 1.25 1.103 0 O-C-N 125.208 1.567 . . . . 1.0 111.072 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -92.35 130.23 38.28 Favored Pre-proline 0 CA--C 1.572 1.8 0 O-C-N 125.057 1.473 . . . . 1.0 111.807 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.68 -8.06 20.99 Favored 'Trans proline' 1 C--N 1.437 5.205 0 C-N-CA 122.698 2.265 . . . . 1.0 114.292 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -98.22 -55.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 124.843 1.257 . . . . 1.0 110.43 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 26.2 p -98.14 -52.5 3.67 Favored 'General case' 0 C--N 1.372 1.547 0 O-C-N 124.302 1.001 . . . . 1.0 111.682 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.31 25.12 7.98 Favored Glycine 0 C--N 1.367 2.267 0 O-C-N 124.722 1.264 . . . . 1.0 114.747 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -105.64 147.97 27.88 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 124.591 1.156 . . . . 1.0 111.076 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -83.65 134.38 34.78 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 124.563 1.165 . . . . 1.0 112.393 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -132.8 148.33 52.31 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 125.444 1.715 . . . . 1.0 109.826 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -94.05 149.82 20.89 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.339 1.024 . . . . 1.0 112.627 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.49 -9.27 86.95 Favored Glycine 0 C--N 1.375 2.714 0 O-C-N 124.727 1.267 . . . . 1.0 114.111 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -82.34 -17.29 46.22 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 125.31 1.444 . . . . 1.0 112.671 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -91.24 -5.41 54.85 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 124.363 1.065 . . . . 1.0 112.194 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 145.48 44.83 Favored Pre-proline 0 C--N 1.385 2.114 0 CA-C-O 117.232 -1.366 . . . . 1.0 111.887 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.4 160.1 44.31 Favored 'Trans proline' 1 C--N 1.437 5.234 0 C-N-CA 123.024 2.483 . . . . 1.0 114.679 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -62.44 -30.13 71.01 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.501 1.12 . . . . 1.0 113.735 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.1 -37.76 77.94 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 125.561 1.545 . . . . 1.0 112.999 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.74 -29.34 40.52 Favored 'General case' 0 C--N 1.381 1.962 0 C-N-CA 124.985 1.314 . . . . 1.0 111.746 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.06 73.48 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 125.834 1.654 . . . . 1.0 112.312 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.41 -28.12 63.79 Favored 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 125.791 1.637 . . . . 1.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HZ2' ' N ' ' A' ' 8' ' ' MET . 90.3 mttt -68.58 -27.87 66.44 Favored 'General case' 0 N--CA 1.507 2.414 0 C-N-CA 125.978 1.711 . . . . 1.0 112.547 175.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.9 t -65.6 -37.37 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.019 0 C-N-CA 126.322 1.849 . . . . 1.0 109.97 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.7 -28.37 69.9 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 125.182 1.393 . . . . 1.0 113.349 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.29 -41.21 77.09 Favored 'General case' 0 C--N 1.383 2.046 0 C-N-CA 125.473 1.509 . . . . 1.0 112.913 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.7 pp -70.72 -32.1 69.19 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.763 1.225 . . . . 1.0 113.243 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -81.25 -20.31 41.25 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.237 1.415 . . . . 1.0 112.868 177.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -99.88 -16.0 18.17 Favored 'General case' 0 C--N 1.371 1.519 0 C-N-CA 124.76 1.224 . . . . 1.0 112.189 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -108.82 69.01 0.7 Allowed 'General case' 0 C--N 1.37 1.495 0 CA-C-O 122.898 1.332 . . . . 1.0 109.46 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -71.75 -28.44 63.66 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-N 113.308 -1.769 . . . . 1.0 113.083 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -103.53 134.89 46.13 Favored 'General case' 0 C--N 1.366 1.303 0 O-C-N 124.989 1.431 . . . . 1.0 109.718 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.98 -95.29 0.14 Allowed Glycine 0 C--N 1.355 1.588 0 O-C-N 125.165 1.541 . . . . 1.0 112.18 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.01 46.9 0.96 Allowed Glycine 0 C--N 1.361 1.922 0 O-C-N 125.34 1.259 . . . . 1.0 113.824 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER -120.3 122.58 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -124.77 131.56 53.44 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 125.574 1.796 . . . . 1.0 110.468 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -80.85 -27.51 36.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.85 1.344 . . . . 1.0 113.51 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.44 -35.65 27.36 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.207 1.403 . . . . 1.0 112.581 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -94.88 -17.37 22.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 124.692 1.245 . . . . 1.0 113.436 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.3 mttm 58.98 50.76 7.92 Favored 'General case' 0 N--CA 1.524 3.259 0 C-N-CA 127.166 2.186 . . . . 1.0 113.99 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 71.7 mtm180 -115.58 130.83 57.01 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.796 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.3 t -122.6 123.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 125.462 1.727 . . . . 1.0 107.793 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 86.4 mttt -124.7 132.38 53.39 Favored 'General case' 0 C--O 1.251 1.178 0 O-C-N 125.716 1.885 . . . . 1.0 110.387 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.51 132.26 56.36 Favored 'General case' 0 C--O 1.246 0.898 0 O-C-N 125.332 1.645 . . . . 1.0 108.929 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.523 3.179 0 C-N-CA 127.386 2.274 . . . . 1.0 113.465 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.529 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 1.7 tpp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.873 -0.047 . . . . 1.0 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.02 139.8 47.23 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 125.286 1.616 . . . . 1.0 110.521 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -115.12 138.78 50.51 Favored 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.896 1.372 . . . . 1.0 110.724 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.0 t -74.67 119.65 77.73 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 117.29 -1.338 . . . . 1.0 111.819 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.17 -25.16 50.73 Favored 'Trans proline' 1 C--N 1.439 5.302 0 C-N-CA 122.3 2.0 . . . . 1.0 113.789 176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.26 -54.14 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 C-N-CA 126.35 1.86 . . . . 1.0 112.826 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -108.64 -44.39 4.06 Favored 'General case' 0 C--N 1.37 1.457 0 O-C-N 124.175 0.922 . . . . 1.0 112.339 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.72 6.16 Favored Glycine 0 C--N 1.367 2.28 0 O-C-N 124.717 1.261 . . . . 1.0 113.725 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.81 146.48 31.39 Favored Pre-proline 0 C--N 1.369 1.44 0 CA-C-O 117.115 -1.421 . . . . 1.0 112.467 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.18 139.35 42.01 Favored 'Trans proline' 1 C--N 1.449 5.859 0 C-N-CA 122.728 2.286 . . . . 1.0 113.854 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.59 143.52 49.26 Favored 'General case' 0 C--O 1.25 1.124 0 O-C-N 125.341 1.651 . . . . 1.0 110.177 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -96.78 134.7 39.73 Favored 'General case' 0 C--O 1.247 0.974 0 O-C-N 124.874 1.359 . . . . 1.0 111.005 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.457 ' O ' HG12 ' A' ' 24' ' ' ILE . 50.3 m95 -68.49 -27.01 65.75 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.955 1.302 . . . . 1.0 112.872 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 7.3 pt-20 -71.76 -32.28 67.52 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.355 1.862 . . . . 1.0 112.661 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -73.1 -34.29 66.1 Favored 'General case' 0 C--N 1.385 2.152 0 C-N-CA 125.443 1.497 . . . . 1.0 112.963 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -39.91 84.2 Favored 'General case' 0 C--N 1.382 2.02 0 C-N-CA 125.665 1.586 . . . . 1.0 113.372 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 20' ' ' TRP . 8.4 mm -78.91 -40.96 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 125.524 1.529 . . . . 1.0 110.568 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 3.0 tt0 -66.73 -38.16 86.12 Favored 'General case' 0 C--N 1.386 2.183 0 C-N-CA 125.144 1.377 . . . . 1.0 113.369 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.39 -20.91 50.18 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 125.466 1.506 . . . . 1.0 112.929 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.492 ' O ' HD12 ' A' ' 30' ' ' ILE . 3.0 mmt -106.01 12.25 30.67 Favored 'General case' 0 CA--C 1.577 1.997 0 O-C-N 124.813 1.321 . . . . 1.0 112.09 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.72 17.95 11.02 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.587 0.755 . . . . 1.0 113.02 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.8 11.02 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 C-N-CA 125.638 1.575 . . . . 1.0 112.566 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 32' ' ' ASN . 1.2 mt -115.21 138.3 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 124.827 1.251 . . . . 1.0 108.935 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.54 -17.85 35.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.132 1.52 . . . . 1.0 112.439 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' H ' HG22 ' A' ' 30' ' ' ILE . 47.9 m-80 -91.93 14.4 15.8 Favored 'General case' 0 CA--C 1.574 1.87 0 C-N-CA 125.289 1.436 . . . . 1.0 111.786 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -76.15 -36.21 58.85 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.387 1.475 . . . . 1.0 111.799 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' HA ' HG12 ' A' ' 37' ' ' VAL . 32.9 mt-10 -57.78 -23.8 54.13 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 126.026 1.73 . . . . 1.0 114.339 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.15 -43.64 14.79 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 125.352 1.461 . . . . 1.0 111.539 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -72.41 -42.4 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 125.589 1.555 . . . . 1.0 110.824 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 34' ' ' GLU . 1.5 p -67.75 -14.06 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.013 0 C-N-CA 125.318 1.447 . . . . 1.0 114.243 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -92.06 -22.29 20.01 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.839 1.256 . . . . 1.0 112.447 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.13 106.41 10.75 Favored 'General case' 0 C--N 1.371 1.51 0 O-C-N 124.569 1.168 . . . . 1.0 111.293 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -58.1 -33.89 69.6 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 125.829 1.651 . . . . 1.0 113.908 176.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.23 -33.08 74.59 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 125.813 1.645 . . . . 1.0 112.35 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.58 -34.36 27.74 Favored 'General case' 0 C--N 1.381 1.942 0 C-N-CA 125.619 1.568 . . . . 1.0 112.502 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.0 t80 -72.7 -45.95 56.18 Favored 'General case' 0 C--N 1.394 2.519 0 C-N-CA 125.207 1.403 . . . . 1.0 112.524 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -69.14 -33.11 72.92 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 124.932 1.293 . . . . 1.0 112.366 178.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.58 -31.63 65.37 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.82 1.648 . . . . 1.0 112.919 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 1.5 tt0 -79.24 -37.09 38.86 Favored 'General case' 0 C--N 1.384 2.084 0 C-N-CA 124.96 1.304 . . . . 1.0 112.482 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 43' ' ' PHE . 59.7 t -69.29 -41.56 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 C-N-CA 125.455 1.502 . . . . 1.0 109.539 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 42.3 mt-10 -70.28 -25.56 63.4 Favored 'General case' 0 N--CA 1.516 2.832 0 C-N-CA 125.658 1.583 . . . . 1.0 113.545 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.53 -25.62 16.12 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.097 1.359 . . . . 1.0 113.171 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.11 141.7 35.39 Favored 'General case' 0 C--N 1.369 1.454 0 O-C-N 124.384 1.053 . . . . 1.0 111.658 -179.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.96 152.23 3.38 Favored 'Isoleucine or valine' 0 C--O 1.25 1.092 0 O-C-N 125.255 1.597 . . . . 1.0 111.634 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.18 144.16 50.08 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.062 1.476 . . . . 1.0 110.391 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -96.35 140.54 30.86 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.144 1.527 . . . . 1.0 111.07 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.9 t -94.69 130.75 32.35 Favored Pre-proline 0 CA--C 1.565 1.539 0 O-C-N 125.295 1.622 . . . . 1.0 112.044 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.02 -4.24 14.88 Favored 'Trans proline' 1 C--N 1.435 5.117 0 C-N-CA 122.353 2.035 . . . . 1.0 114.504 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.95 -54.83 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 125.389 1.475 . . . . 1.0 110.133 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 22.1 p -101.89 -52.6 3.14 Favored 'General case' 0 C--N 1.371 1.537 0 O-C-N 124.434 1.084 . . . . 1.0 111.566 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 22.07 9.56 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 124.547 1.154 . . . . 1.0 114.479 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -99.95 145.55 27.71 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 124.754 1.221 . . . . 1.0 111.215 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.39 133.75 34.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 124.856 1.348 . . . . 1.0 111.858 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -132.69 147.4 52.33 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 125.601 1.813 . . . . 1.0 110.223 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.04 151.11 19.76 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.745 1.278 . . . . 1.0 112.729 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 48' ' ' GLU . . . -80.83 1.28 84.44 Favored Glycine 0 C--N 1.372 2.564 0 O-C-N 124.912 1.382 . . . . 1.0 114.508 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -88.85 -16.42 32.03 Favored 'General case' 0 CA--C 1.57 1.72 0 C-N-CA 124.911 1.285 . . . . 1.0 112.015 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 p -89.78 -12.84 38.09 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 124.883 1.273 . . . . 1.0 113.312 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -75.29 146.88 82.14 Favored Pre-proline 0 CA--C 1.584 2.25 0 CA-C-O 116.747 -1.597 . . . . 1.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.51 156.28 66.78 Favored 'Trans proline' 1 C--N 1.445 5.643 0 C-N-CA 122.999 2.466 . . . . 1.0 113.4 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -58.98 -30.75 68.19 Favored 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.982 1.313 . . . . 1.0 114.146 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -61.03 -36.26 79.06 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.622 1.569 . . . . 1.0 113.111 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -76.55 -28.97 56.48 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 125.017 1.327 . . . . 1.0 111.905 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.43 -32.41 72.43 Favored 'General case' 0 C--N 1.388 2.281 0 C-N-CA 126.002 1.721 . . . . 1.0 112.449 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.79 -26.6 62.48 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 125.943 1.697 . . . . 1.0 112.662 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 91.5 mttt -68.99 -28.66 66.81 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 126.099 1.759 . . . . 1.0 112.565 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.532 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -66.53 -35.23 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.166 0 C-N-CA 126.481 1.912 . . . . 1.0 109.975 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.62 -29.43 70.68 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 125.539 1.535 . . . . 1.0 113.014 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -67.24 -38.87 85.91 Favored 'General case' 0 C--N 1.386 2.172 0 C-N-CA 125.845 1.658 . . . . 1.0 113.05 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.9 pp -75.01 -30.89 61.25 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 124.685 1.194 . . . . 1.0 112.46 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -81.1 -22.35 39.21 Favored 'General case' 0 C--N 1.374 1.666 0 C-N-CA 125.817 1.647 . . . . 1.0 113.25 177.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -99.86 -9.84 22.42 Favored 'General case' 0 C--N 1.372 1.571 0 C-N-CA 124.752 1.221 . . . . 1.0 112.869 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 1.1 m-20 -107.01 58.78 0.63 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-O 123.106 1.432 . . . . 1.0 111.016 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.53 -30.52 70.2 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.39 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -115.11 113.57 24.18 Favored 'General case' 0 C--O 1.257 1.447 0 O-C-N 124.96 1.412 . . . . 1.0 109.168 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.79 106.14 1.34 Allowed Glycine 0 C--N 1.366 2.227 0 CA-C-N 114.552 -1.204 . . . . 1.0 113.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 93' ' ' LYS . . . 128.31 -59.2 0.69 Allowed Glycine 0 C--N 1.36 1.867 0 O-C-N 125.453 1.325 . . . . 1.0 113.625 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.39 126.08 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 125.103 1.12 . . . . 1.0 108.314 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -119.4 134.16 55.35 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 125.57 1.794 . . . . 1.0 110.084 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -80.0 -31.46 39.72 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.875 1.27 . . . . 1.0 113.743 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.6 -35.61 29.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.275 1.43 . . . . 1.0 113.111 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -92.09 -15.92 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.733 1.213 . . . . 1.0 113.432 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 58.55 32.89 22.64 Favored 'General case' 0 N--CA 1.533 3.71 0 C-N-CA 127.158 2.183 . . . . 1.0 113.925 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -106.24 136.42 45.98 Favored 'General case' 0 C--N 1.364 1.226 0 CA-C-N 114.28 -1.327 . . . . 1.0 111.355 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.28 126.72 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.405 1.691 . . . . 1.0 107.838 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 14.9 tttt -122.51 128.4 50.76 Favored 'General case' 0 C--O 1.25 1.127 0 O-C-N 125.429 1.706 . . . . 1.0 109.89 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.18 132.29 47.27 Favored 'General case' 0 C--O 1.249 1.064 0 O-C-N 124.978 1.424 . . . . 1.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.5 mttp . . . . . 0 C--O 1.249 1.031 0 O-C-N 125.33 1.644 . . . . 1.0 111.208 179.805 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.63 ' N ' ' HZ3' ' A' ' 73' ' ' LYS . 5.5 ptm . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 111.282 0.105 . . . . 1.0 111.282 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . . . -111.02 139.71 46.15 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 125.316 1.635 . . . . 1.0 110.601 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -118.52 139.04 52.07 Favored 'General case' 0 C--O 1.25 1.082 0 O-C-N 124.655 1.222 . . . . 1.0 110.981 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.485 ' SG ' HD12 ' A' ' 13' ' ' ILE . 34.0 t -70.81 121.02 82.65 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 117.777 -1.106 . . . . 1.0 111.761 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.01 -4.35 15.27 Favored 'Trans proline' 1 C--N 1.434 5.044 0 C-N-CA 122.19 1.927 . . . . 1.0 114.843 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.485 HD12 ' SG ' ' A' ' 11' ' ' CYS . 1.4 mp -98.02 -56.05 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 125.253 1.421 . . . . 1.0 109.766 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.64 -41.04 6.07 Favored 'General case' 0 C--N 1.37 1.488 0 O-C-N 124.338 1.024 . . . . 1.0 113.195 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.9 34.57 6.46 Favored Glycine 0 C--N 1.368 2.327 0 O-C-N 124.81 1.319 . . . . 1.0 114.02 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -91.39 142.59 27.16 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 116.928 -1.51 . . . . 1.0 112.796 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.9 131.62 24.45 Favored 'Trans proline' 1 C--N 1.449 5.819 0 C-N-CA 122.602 2.201 . . . . 1.0 114.376 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 mt -122.96 144.55 49.16 Favored 'General case' 0 C--O 1.25 1.118 0 O-C-N 125.125 1.516 . . . . 1.0 110.762 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.07 133.95 41.06 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 124.802 1.313 . . . . 1.0 110.681 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.511 ' O ' HG12 ' A' ' 24' ' ' ILE . 52.9 m95 -68.53 -26.65 65.54 Favored 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 124.899 1.28 . . . . 1.0 113.426 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.27 -31.75 66.03 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.59 1.556 . . . . 1.0 113.097 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.15 -33.48 65.52 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 125.277 1.431 . . . . 1.0 112.915 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.03 -39.92 82.99 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.884 1.674 . . . . 1.0 112.858 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 20' ' ' TRP . 6.1 mm -74.43 -41.03 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 125.806 1.643 . . . . 1.0 110.604 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -66.86 -36.86 83.29 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.389 1.476 . . . . 1.0 113.24 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.29 -22.63 41.39 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 125.355 1.462 . . . . 1.0 112.841 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.49 ' O ' HD12 ' A' ' 30' ' ' ILE . 48.6 mtp -104.61 12.1 33.42 Favored 'General case' 0 CA--C 1.575 1.934 0 O-C-N 124.681 1.238 . . . . 1.0 112.41 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.3 16.63 8.33 Favored 'General case' 0 CA--C 1.58 2.098 0 C-N-CA 123.826 0.85 . . . . 1.0 112.914 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.8 -3.74 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 C-N-CA 125.747 1.619 . . . . 1.0 112.965 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 27' ' ' MET . 0.9 OUTLIER -104.5 137.48 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.982 1.313 . . . . 1.0 109.255 -177.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.36 -27.07 61.29 Favored 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 125.752 1.621 . . . . 1.0 114.374 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -77.65 -17.98 57.17 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.117 1.367 . . . . 1.0 113.209 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.583 ' HA ' HD12 ' A' ' 36' ' ' ILE . 1.5 t80 -57.92 -36.46 72.5 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 126.077 1.751 . . . . 1.0 113.188 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -60.58 -29.34 69.13 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 125.468 1.507 . . . . 1.0 112.463 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.41 -34.52 20.14 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.48 1.512 . . . . 1.0 112.409 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 33' ' ' PHE . 6.8 mt -71.04 -41.06 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 C-N-CA 125.759 1.624 . . . . 1.0 110.664 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' O ' HD23 ' A' ' 78' ' ' LEU . 8.9 m -59.39 -21.82 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 125.545 1.538 . . . . 1.0 114.84 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -87.94 -21.11 25.09 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 125.052 1.341 . . . . 1.0 112.796 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -121.66 106.66 11.54 Favored 'General case' 0 C--N 1.371 1.541 0 O-C-N 124.323 1.015 . . . . 1.0 112.124 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.35 -34.82 72.84 Favored 'General case' 0 N--CA 1.523 3.192 0 C-N-CA 126.106 1.762 . . . . 1.0 113.853 176.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.0 -32.24 72.5 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 125.941 1.696 . . . . 1.0 112.727 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -82.69 -32.54 28.01 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.329 1.451 . . . . 1.0 112.228 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 47' ' ' VAL . 2.3 t80 -75.41 -46.51 32.37 Favored 'General case' 0 C--N 1.387 2.215 0 C-N-CA 125.013 1.325 . . . . 1.0 112.946 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 40' ' ' ARG . 1.1 mt -69.66 -33.37 72.5 Favored 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 124.789 1.236 . . . . 1.0 112.958 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.513 1.525 . . . . 1.0 113.206 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 5.4 mt-30 -79.29 -35.21 41.61 Favored 'General case' 0 C--N 1.379 1.86 0 C-N-CA 125.077 1.351 . . . . 1.0 112.833 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 43' ' ' PHE . 58.0 t -67.84 -41.22 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 C-N-CA 125.241 1.416 . . . . 1.0 109.354 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.63 -24.3 60.0 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 125.316 1.447 . . . . 1.0 113.507 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -94.42 -25.52 16.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.859 1.264 . . . . 1.0 113.327 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -103.08 148.46 25.71 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 124.343 1.057 . . . . 1.0 111.049 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 p -97.51 155.82 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 O-C-N 124.758 1.286 . . . . 1.0 110.439 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.473 ' HE1' ' SD ' ' A' ' 27' ' ' MET . 95.8 m-85 -126.41 143.76 51.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 125.086 1.491 . . . . 1.0 110.311 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -97.11 137.39 36.23 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.861 1.351 . . . . 1.0 111.423 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 17.7 t -93.08 106.52 19.81 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 124.972 1.42 . . . . 1.0 110.025 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -69.39 -7.94 22.27 Favored 'Trans proline' 1 C--N 1.44 5.355 0 C-N-CA 123.132 2.555 . . . . 1.0 114.193 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.76 -50.94 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.944 1.698 . . . . 1.0 110.403 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 31.7 p -104.47 -50.15 3.39 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 124.596 1.185 . . . . 1.0 112.186 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.31 -0.42 14.35 Favored Glycine 0 C--N 1.37 2.434 0 O-C-N 124.534 1.146 . . . . 1.0 114.209 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -93.74 150.85 20.05 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 125.162 1.385 . . . . 1.0 111.521 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.18 138.16 34.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.607 1.163 . . . . 1.0 111.141 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -126.13 143.17 51.23 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.165 1.54 . . . . 1.0 109.94 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.69 150.45 21.78 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.431 1.082 . . . . 1.0 112.24 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 47' ' ' VAL . . . -75.22 -8.34 83.3 Favored Glycine 0 C--N 1.377 2.83 0 O-C-N 124.485 1.116 . . . . 1.0 114.867 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -86.39 -20.89 27.56 Favored 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 125.386 1.474 . . . . 1.0 111.87 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.9 p -94.09 1.67 56.12 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.903 1.281 . . . . 1.0 112.61 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 144.77 30.43 Favored Pre-proline 0 C--N 1.379 1.856 0 CA-C-O 117.146 -1.407 . . . . 1.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.21 158.32 55.37 Favored 'Trans proline' 1 C--N 1.445 5.641 0 C-N-CA 123.032 2.488 . . . . 1.0 114.705 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -61.96 -33.07 73.61 Favored 'General case' 0 N--CA 1.515 2.776 0 C-N-CA 124.85 1.26 . . . . 1.0 113.074 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.31 -40.4 77.81 Favored 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 125.468 1.507 . . . . 1.0 112.505 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' OE1' ' HA ' ' A' ' 9' ' ' ALA . 29.1 mt-10 -76.73 -28.84 55.94 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.044 1.338 . . . . 1.0 112.102 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' HD21 ' A' ' 44' ' ' LEU . . . -68.44 -32.99 73.41 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 125.814 1.646 . . . . 1.0 112.391 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -71.7 -24.99 61.91 Favored 'General case' 0 C--N 1.382 2.018 0 C-N-CA 125.637 1.575 . . . . 1.0 112.697 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.63 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 93.8 mttt -68.62 -28.18 66.68 Favored 'General case' 0 N--CA 1.508 2.46 0 C-N-CA 125.902 1.681 . . . . 1.0 112.217 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' O ' HD12 ' A' ' 78' ' ' LEU . 2.8 t -66.97 -38.5 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 C-N-CA 126.385 1.874 . . . . 1.0 109.738 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.52 -27.16 69.08 Favored 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 125.355 1.462 . . . . 1.0 113.352 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -68.49 -41.05 80.65 Favored 'General case' 0 C--N 1.388 2.245 0 C-N-CA 125.789 1.636 . . . . 1.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 1.8 pp -71.44 -30.52 66.13 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.83 1.252 . . . . 1.0 112.739 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.6 -24.93 49.54 Favored 'General case' 0 C--N 1.378 1.806 0 C-N-CA 125.597 1.559 . . . . 1.0 112.726 177.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -96.3 -16.69 21.2 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 124.802 1.241 . . . . 1.0 112.231 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -108.77 62.51 0.6 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 123.057 1.408 . . . . 1.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -71.57 -25.09 62.05 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 113.48 -1.691 . . . . 1.0 113.313 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -106.72 134.25 50.15 Favored 'General case' 0 C--O 1.254 1.302 0 O-C-N 125.069 1.481 . . . . 1.0 109.254 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.58 -102.54 0.22 Allowed Glycine 0 C--N 1.356 1.652 0 O-C-N 124.949 1.405 . . . . 1.0 112.095 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.9 55.52 0.73 Allowed Glycine 0 C--N 1.359 1.825 0 O-C-N 125.441 1.318 . . . . 1.0 113.272 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -118.71 120.95 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.62 129.92 50.6 Favored 'General case' 0 C--O 1.248 1.011 0 O-C-N 125.26 1.6 . . . . 1.0 110.599 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -80.86 -33.74 34.23 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 124.731 1.269 . . . . 1.0 113.445 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -82.28 -35.88 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.081 1.352 . . . . 1.0 112.95 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -88.7 -16.88 31.17 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.767 1.227 . . . . 1.0 113.139 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.0 mttt 59.11 52.41 6.24 Favored 'General case' 0 N--CA 1.53 3.558 0 C-N-CA 127.337 2.255 . . . . 1.0 112.406 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 68.3 mtp180 -122.39 124.34 43.44 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-N 113.934 -1.484 . . . . 1.0 110.144 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.27 124.0 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 125.347 1.654 . . . . 1.0 107.391 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -124.86 134.71 52.61 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 125.401 1.688 . . . . 1.0 110.347 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.81 127.63 55.21 Favored 'General case' 0 C--O 1.252 1.207 0 O-C-N 125.205 1.565 . . . . 1.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 C--O 1.249 1.075 0 O-C-N 125.283 1.615 . . . . 1.0 111.247 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_